id	sid	tid	token	lemma	pos
bptjm-30	1	1	berkeley	berkeley	PROPN
bptjm-30	1	2	pharma	pharma	PROPN
bptjm-30	1	3	tech	tech	NOUN
bptjm-30	1	4	journal	journal	NOUN
bptjm-30	1	5	of	of	ADP
bptjm-30	1	6	medicine	medicine	NOUN
bptjm-30	1	7	correspondence	correspondence	NOUN
bptjm-30	1	8	:	:	PUNCT
bptjm-30	1	9	suhina.sharma@berkeley.edu	suhina.sharma@berkeley.edu	NOUN
bptjm-30	1	10	keywords	keyword	NOUN
bptjm-30	1	11	:	:	PUNCT
bptjm-30	1	12	major	major	ADJ
bptjm-30	1	13	depressive	depressive	ADJ
bptjm-30	1	14	disorder	disorder	NOUN
bptjm-30	1	15	(	(	PUNCT
bptjm-30	1	16	mdd	mdd	PROPN
bptjm-30	1	17	)	)	PUNCT
bptjm-30	1	18	antidepressants	antidepressant	VERB
bptjm-30	1	19	ketamine	ketamine	PROPN
bptjm-30	1	20	psilocybin	psilocybin	NOUN
bptjm-30	1	21	psychedelics	psychedelic	NOUN
bptjm-30	1	22	glutamate	glutamate	VERB
bptjm-30	1	23	serotonin	serotonin	NOUN
bptjm-30	1	24	submitted	submit	VERB
bptjm-30	1	25	:	:	PUNCT
bptjm-30	1	26	august	august	PROPN
bptjm-30	1	27	12	12	NUM
bptjm-30	1	28	,	,	PUNCT
bptjm-30	1	29	2022	2022	NUM
bptjm-30	1	30	accepted	accept	VERB
bptjm-30	1	31	:	:	PUNCT
bptjm-30	1	32	october	october	PROPN
bptjm-30	1	33	31	31	NUM
bptjm-30	1	34	,	,	PUNCT
bptjm-30	1	35	2022	2022	NUM
bptjm-30	1	36	published	publish	VERB
bptjm-30	1	37	:	:	PUNCT
bptjm-30	1	38	december	december	PROPN
bptjm-30	1	39	28	28	NUM
bptjm-30	1	40	,	,	PUNCT
bptjm-30	1	41	2022	2022	NUM
bptjm-30	1	42	full	full	ADJ
bptjm-30	1	43	open	open	ADJ
bptjm-30	1	44	access	access	NOUN
bptjm-30	1	45	creative	creative	ADJ
bptjm-30	1	46	commons	common	NOUN
bptjm-30	1	47	attribution	attribution	NOUN
bptjm-30	1	48	license	license	VERB
bptjm-30	1	49	4.0	4.0	NUM
bptjm-30	1	50	abstract	abstract	ADJ
bptjm-30	1	51	depression	depression	NOUN
bptjm-30	1	52	is	be	AUX
bptjm-30	1	53	a	a	DET
bptjm-30	1	54	complex	complex	ADJ
bptjm-30	1	55	neurological	neurological	ADJ
bptjm-30	1	56	disorder	disorder	NOUN
bptjm-30	1	57	that	that	PRON
bptjm-30	1	58	has	have	VERB
bptjm-30	1	59	many	many	ADJ
bptjm-30	1	60	potential	potential	ADJ
bptjm-30	1	61	causes	cause	NOUN
bptjm-30	1	62	and	and	CCONJ
bptjm-30	1	63	treatment	treatment	NOUN
bptjm-30	1	64	approaches	approach	NOUN
bptjm-30	1	65	.	.	PUNCT
bptjm-30	2	1	though	though	SCONJ
bptjm-30	2	2	there	there	PRON
bptjm-30	2	3	are	be	VERB
bptjm-30	2	4	many	many	ADJ
bptjm-30	2	5	conventional	conventional	ADJ
bptjm-30	2	6	antidepressants	antidepressant	NOUN
bptjm-30	2	7	available	available	ADJ
bptjm-30	2	8	in	in	ADP
bptjm-30	2	9	the	the	DET
bptjm-30	2	10	market	market	NOUN
bptjm-30	2	11	,	,	PUNCT
bptjm-30	2	12	it	it	PRON
bptjm-30	2	13	is	be	AUX
bptjm-30	2	14	becoming	become	VERB
bptjm-30	2	15	increasingly	increasingly	ADV
bptjm-30	2	16	difficult	difficult	ADJ
bptjm-30	2	17	to	to	PART
bptjm-30	2	18	rely	rely	VERB
bptjm-30	2	19	on	on	ADP
bptjm-30	2	20	them	they	PRON
bptjm-30	2	21	as	as	SCONJ
bptjm-30	2	22	many	many	ADJ
bptjm-30	2	23	patients	patient	NOUN
bptjm-30	2	24	may	may	AUX
bptjm-30	2	25	experience	experience	VERB
bptjm-30	2	26	a	a	DET
bptjm-30	2	27	lack	lack	NOUN
bptjm-30	2	28	of	of	ADP
bptjm-30	2	29	effectiveness	effectiveness	NOUN
bptjm-30	2	30	or	or	CCONJ
bptjm-30	2	31	tolerance	tolerance	NOUN
bptjm-30	2	32	to	to	ADP
bptjm-30	2	33	these	these	DET
bptjm-30	2	34	antidepressants	antidepressant	NOUN
bptjm-30	2	35	.	.	PUNCT
bptjm-30	3	1	while	while	SCONJ
bptjm-30	3	2	current	current	ADJ
bptjm-30	3	3	antidepressants	antidepressant	NOUN
bptjm-30	3	4	increase	increase	VERB
bptjm-30	3	5	serotonin	serotonin	VERB
bptjm-30	3	6	and	and	CCONJ
bptjm-30	3	7	norepinephrine	norepinephrine	ADJ
bptjm-30	3	8	concentrations	concentration	NOUN
bptjm-30	3	9	through	through	ADP
bptjm-30	3	10	reuptake	reuptake	NOUN
bptjm-30	3	11	inhibition	inhibition	NOUN
bptjm-30	3	12	,	,	PUNCT
bptjm-30	3	13	novel	novel	ADJ
bptjm-30	3	14	forms	form	NOUN
bptjm-30	3	15	of	of	ADP
bptjm-30	3	16	antidepressants	antidepressant	NOUN
bptjm-30	3	17	rely	rely	VERB
bptjm-30	3	18	on	on	ADP
bptjm-30	3	19	the	the	DET
bptjm-30	3	20	direct	direct	ADJ
bptjm-30	3	21	manipulation	manipulation	NOUN
bptjm-30	3	22	of	of	ADP
bptjm-30	3	23	receptors	receptor	NOUN
bptjm-30	3	24	,	,	PUNCT
bptjm-30	3	25	thereby	thereby	ADV
bptjm-30	3	26	also	also	ADV
bptjm-30	3	27	improving	improve	VERB
bptjm-30	3	28	neuroplasticity	neuroplasticity	NOUN
bptjm-30	3	29	,	,	PUNCT
bptjm-30	3	30	which	which	PRON
bptjm-30	3	31	has	have	AUX
bptjm-30	3	32	emerged	emerge	VERB
bptjm-30	3	33	as	as	ADP
bptjm-30	3	34	a	a	DET
bptjm-30	3	35	promising	promising	ADJ
bptjm-30	3	36	approach	approach	NOUN
bptjm-30	3	37	to	to	ADP
bptjm-30	3	38	treating	treat	VERB
bptjm-30	3	39	depressive	depressive	ADJ
bptjm-30	3	40	symptoms	symptom	NOUN
bptjm-30	3	41	.	.	PUNCT
bptjm-30	4	1	in	in	ADP
bptjm-30	4	2	this	this	DET
bptjm-30	4	3	literature	literature	NOUN
bptjm-30	4	4	review	review	NOUN
bptjm-30	4	5	,	,	PUNCT
bptjm-30	4	6	various	various	ADJ
bptjm-30	4	7	forms	form	NOUN
bptjm-30	4	8	of	of	ADP
bptjm-30	4	9	novel	novel	ADJ
bptjm-30	4	10	antidepressants	antidepressant	NOUN
bptjm-30	4	11	are	be	AUX
bptjm-30	4	12	analyzed	analyze	VERB
bptjm-30	4	13	.	.	PUNCT
bptjm-30	5	1	the	the	DET
bptjm-30	5	2	mechanisms	mechanism	NOUN
bptjm-30	5	3	studied	study	VERB
bptjm-30	5	4	are	be	AUX
bptjm-30	5	5	psilocybin	psilocybin	NOUN
bptjm-30	5	6	’s	’s	PART
bptjm-30	5	7	long	long	ADJ
bptjm-30	5	8	-	-	PUNCT
bptjm-30	5	9	term	term	NOUN
bptjm-30	5	10	success	success	NOUN
bptjm-30	5	11	,	,	PUNCT
bptjm-30	5	12	ketamine	ketamine	PROPN
bptjm-30	5	13	’s	’s	PART
bptjm-30	5	14	rapid	rapid	ADJ
bptjm-30	5	15	action	action	NOUN
bptjm-30	5	16	,	,	PUNCT
bptjm-30	5	17	hormonal	hormonal	ADJ
bptjm-30	5	18	treatments	treatment	NOUN
bptjm-30	5	19	’	'	PUNCT
bptjm-30	5	20	direct	direct	ADJ
bptjm-30	5	21	targeted	target	VERB
bptjm-30	5	22	approach	approach	NOUN
bptjm-30	5	23	,	,	PUNCT
bptjm-30	5	24	and	and	CCONJ
bptjm-30	5	25	natural	natural	ADJ
bptjm-30	5	26	products	product	NOUN
bptjm-30	5	27	’	'	PUNCT
bptjm-30	5	28	reduction	reduction	NOUN
bptjm-30	5	29	of	of	ADP
bptjm-30	5	30	neurotoxic	neurotoxic	ADJ
bptjm-30	5	31	side	side	NOUN
bptjm-30	5	32	effects	effect	NOUN
bptjm-30	5	33	.	.	PUNCT
bptjm-30	6	1	understanding	understand	VERB
bptjm-30	6	2	how	how	SCONJ
bptjm-30	6	3	these	these	DET
bptjm-30	6	4	powerful	powerful	ADJ
bptjm-30	6	5	mechanisms	mechanism	NOUN
bptjm-30	6	6	work	work	NOUN
bptjm-30	6	7	may	may	AUX
bptjm-30	6	8	allow	allow	VERB
bptjm-30	6	9	for	for	ADP
bptjm-30	6	10	the	the	DET
bptjm-30	6	11	research	research	NOUN
bptjm-30	6	12	and	and	CCONJ
bptjm-30	6	13	creation	creation	NOUN
bptjm-30	6	14	of	of	ADP
bptjm-30	6	15	more	more	ADV
bptjm-30	6	16	effective	effective	ADJ
bptjm-30	6	17	antidepressants	antidepressant	NOUN
bptjm-30	6	18	in	in	ADP
bptjm-30	6	19	the	the	DET
bptjm-30	6	20	future	future	NOUN
bptjm-30	6	21	.	.	PUNCT
bptjm-30	7	1	novel	novel	ADJ
bptjm-30	7	2	therapeutic	therapeutic	ADJ
bptjm-30	7	3	strategies	strategy	NOUN
bptjm-30	7	4	for	for	ADP
bptjm-30	7	5	depression	depression	NOUN
bptjm-30	7	6	by	by	ADP
bptjm-30	7	7	:	:	PUNCT
bptjm-30	7	8	suhina	suhina	PROPN
bptjm-30	7	9	sharma	sharma	PROPN
bptjm-30	7	10	,	,	PUNCT
bptjm-30	7	11	matt	matt	PROPN
bptjm-30	7	12	gostkowski	gostkowski	PROPN
bptjm-30	7	13	,	,	PUNCT
bptjm-30	7	14	jay	jay	PROPN
bptjm-30	7	15	patel	patel	PROPN
bptjm-30	7	16	and	and	CCONJ
bptjm-30	7	17	christina	christina	PROPN
bptjm-30	7	18	yang	yang	PROPN
bptjm-30	7	19	berkeley	berkeley	PROPN
bptjm-30	7	20	pharma	pharma	PROPN
bptjm-30	7	21	tech	tech	PROPN
bptjm-30	7	22	journal	journal	NOUN
bptjm-30	7	23	of	of	ADP
bptjm-30	7	24	medicine	medicine	NOUN
bptjm-30	7	25	|	|	ADV
bptjm-30	7	26	21	21	NUM
bptjm-30	7	27	1	1	NUM
bptjm-30	7	28	.	.	PUNCT
bptjm-30	8	1	introduction	introduction	NOUN
bptjm-30	8	2	within	within	ADP
bptjm-30	8	3	the	the	DET
bptjm-30	8	4	last	last	ADJ
bptjm-30	8	5	few	few	ADJ
bptjm-30	8	6	years	year	NOUN
bptjm-30	8	7	,	,	PUNCT
bptjm-30	8	8	major	major	ADJ
bptjm-30	8	9	depressive	depressive	ADJ
bptjm-30	8	10	disorder	disorder	NOUN
bptjm-30	8	11	(	(	PUNCT
bptjm-30	8	12	mdd	mdd	PROPN
bptjm-30	8	13	)	)	PUNCT
bptjm-30	8	14	has	have	AUX
bptjm-30	8	15	become	become	VERB
bptjm-30	8	16	one	one	NUM
bptjm-30	8	17	of	of	ADP
bptjm-30	8	18	the	the	DET
bptjm-30	8	19	world	world	NOUN
bptjm-30	8	20	’s	’s	PART
bptjm-30	8	21	leading	lead	VERB
bptjm-30	8	22	health	health	NOUN
bptjm-30	8	23	problems	problem	NOUN
bptjm-30	8	24	.	.	PUNCT
bptjm-30	9	1	within	within	ADP
bptjm-30	9	2	the	the	DET
bptjm-30	9	3	last	last	ADJ
bptjm-30	9	4	year	year	NOUN
bptjm-30	9	5	,	,	PUNCT
bptjm-30	9	6	there	there	PRON
bptjm-30	9	7	were	be	VERB
bptjm-30	9	8	over	over	ADP
bptjm-30	9	9	45,000	45,000	NUM
bptjm-30	9	10	deaths	death	NOUN
bptjm-30	9	11	,	,	PUNCT
bptjm-30	9	12	about	about	ADV
bptjm-30	9	13	one	one	NUM
bptjm-30	9	14	death	death	NOUN
bptjm-30	9	15	every	every	DET
bptjm-30	9	16	11	11	NUM
bptjm-30	9	17	minutes	minute	NOUN
bptjm-30	9	18	,	,	PUNCT
bptjm-30	9	19	by	by	ADP
bptjm-30	9	20	suicide	suicide	NOUN
bptjm-30	9	21	,	,	PUNCT
bptjm-30	9	22	making	make	VERB
bptjm-30	9	23	it	it	PRON
bptjm-30	9	24	one	one	NUM
bptjm-30	9	25	of	of	ADP
bptjm-30	9	26	the	the	DET
bptjm-30	9	27	leading	lead	VERB
bptjm-30	9	28	causes	cause	NOUN
bptjm-30	9	29	of	of	ADP
bptjm-30	9	30	death	death	NOUN
bptjm-30	9	31	in	in	ADP
bptjm-30	9	32	the	the	DET
bptjm-30	9	33	united	united	PROPN
bptjm-30	9	34	states1	states1	PROPN
bptjm-30	9	35	.	.	PUNCT
bptjm-30	10	1	since	since	SCONJ
bptjm-30	10	2	mdd	mdd	PROPN
bptjm-30	10	3	causes	cause	VERB
bptjm-30	10	4	significant	significant	ADJ
bptjm-30	10	5	impairment	impairment	NOUN
bptjm-30	10	6	in	in	ADP
bptjm-30	10	7	daily	daily	ADJ
bptjm-30	10	8	life	life	NOUN
bptjm-30	10	9	,	,	PUNCT
bptjm-30	10	10	effective	effective	ADJ
bptjm-30	10	11	antidepressant	antidepressant	ADJ
bptjm-30	10	12	treatments	treatment	NOUN
bptjm-30	10	13	are	be	AUX
bptjm-30	10	14	necessary	necessary	ADJ
bptjm-30	10	15	.	.	PUNCT
bptjm-30	11	1	many	many	ADJ
bptjm-30	11	2	current	current	ADJ
bptjm-30	11	3	antidepressants	antidepressant	NOUN
bptjm-30	11	4	focus	focus	VERB
bptjm-30	11	5	on	on	ADP
bptjm-30	11	6	increasing	increase	VERB
bptjm-30	11	7	serotonin	serotonin	NOUN
bptjm-30	11	8	,	,	PUNCT
bptjm-30	11	9	norepinephrine	norepinephrine	NOUN
bptjm-30	11	10	,	,	PUNCT
bptjm-30	11	11	or	or	CCONJ
bptjm-30	11	12	dopamine	dopamine	VERB
bptjm-30	11	13	in	in	ADP
bptjm-30	11	14	patients	patient	NOUN
bptjm-30	11	15	with	with	ADP
bptjm-30	11	16	moderate	moderate	ADJ
bptjm-30	11	17	to	to	ADP
bptjm-30	11	18	severe	severe	ADJ
bptjm-30	11	19	depressive	depressive	ADJ
bptjm-30	11	20	symptoms	symptom	NOUN
bptjm-30	11	21	through	through	ADP
bptjm-30	11	22	reuptake	reuptake	NOUN
bptjm-30	11	23	inhibition2	inhibition2	NOUN
bptjm-30	11	24	.	.	PUNCT
bptjm-30	12	1	however	however	ADV
bptjm-30	12	2	,	,	PUNCT
bptjm-30	12	3	these	these	DET
bptjm-30	12	4	conventional	conventional	ADJ
bptjm-30	12	5	forms	form	NOUN
bptjm-30	12	6	of	of	ADP
bptjm-30	12	7	antidepressant	antidepressant	ADJ
bptjm-30	12	8	therapies	therapy	NOUN
bptjm-30	12	9	are	be	AUX
bptjm-30	12	10	often	often	ADV
bptjm-30	12	11	ineffective	ineffective	ADJ
bptjm-30	12	12	in	in	ADP
bptjm-30	12	13	patients	patient	NOUN
bptjm-30	12	14	because	because	SCONJ
bptjm-30	12	15	there	there	PRON
bptjm-30	12	16	are	be	VERB
bptjm-30	12	17	many	many	ADJ
bptjm-30	12	18	types	type	NOUN
bptjm-30	12	19	of	of	ADP
bptjm-30	12	20	depression	depression	NOUN
bptjm-30	12	21	,	,	PUNCT
bptjm-30	12	22	including	include	VERB
bptjm-30	12	23	stress	stress	NOUN
bptjm-30	12	24	-	-	PUNCT
bptjm-30	12	25	induced	induced	ADJ
bptjm-30	12	26	,	,	PUNCT
bptjm-30	12	27	anxious	anxious	ADJ
bptjm-30	12	28	depression	depression	NOUN
bptjm-30	12	29	,	,	PUNCT
bptjm-30	12	30	and	and	CCONJ
bptjm-30	12	31	treatment	treatment	NOUN
bptjm-30	12	32	-	-	PUNCT
bptjm-30	12	33	resistant	resistant	ADJ
bptjm-30	12	34	depression3	depression3	NOUN
bptjm-30	12	35	.	.	PUNCT
bptjm-30	13	1	this	this	DET
bptjm-30	13	2	complexity	complexity	NOUN
bptjm-30	13	3	makes	make	VERB
bptjm-30	13	4	it	it	PRON
bptjm-30	13	5	difficult	difficult	ADJ
bptjm-30	13	6	to	to	PART
bptjm-30	13	7	find	find	VERB
bptjm-30	13	8	therapies	therapy	NOUN
bptjm-30	13	9	that	that	PRON
bptjm-30	13	10	work	work	VERB
bptjm-30	13	11	for	for	ADP
bptjm-30	13	12	each	each	DET
bptjm-30	13	13	patient	patient	NOUN
bptjm-30	13	14	.	.	PUNCT
bptjm-30	14	1	furthermore	furthermore	ADV
bptjm-30	14	2	,	,	PUNCT
bptjm-30	14	3	there	there	PRON
bptjm-30	14	4	is	be	VERB
bptjm-30	14	5	a	a	DET
bptjm-30	14	6	lot	lot	NOUN
bptjm-30	14	7	of	of	ADP
bptjm-30	14	8	uncertainty	uncertainty	NOUN
bptjm-30	14	9	regarding	regard	VERB
bptjm-30	14	10	the	the	DET
bptjm-30	14	11	long	long	ADJ
bptjm-30	14	12	-	-	PUNCT
bptjm-30	14	13	term	term	NOUN
bptjm-30	14	14	effects	effect	NOUN
bptjm-30	14	15	of	of	ADP
bptjm-30	14	16	conventional	conventional	ADJ
bptjm-30	14	17	antidepressants	antidepressant	NOUN
bptjm-30	14	18	and	and	CCONJ
bptjm-30	14	19	the	the	DET
bptjm-30	14	20	potentially	potentially	ADV
bptjm-30	14	21	toxic	toxic	ADJ
bptjm-30	14	22	side	side	NOUN
bptjm-30	14	23	effects	effect	NOUN
bptjm-30	14	24	.	.	PUNCT
bptjm-30	15	1	there	there	PRON
bptjm-30	15	2	have	have	AUX
bptjm-30	15	3	been	be	AUX
bptjm-30	15	4	recent	recent	ADJ
bptjm-30	15	5	attempts	attempt	NOUN
bptjm-30	15	6	at	at	ADP
bptjm-30	15	7	implementing	implement	VERB
bptjm-30	15	8	novel	novel	ADJ
bptjm-30	15	9	therapeutic	therapeutic	ADJ
bptjm-30	15	10	strategies	strategy	NOUN
bptjm-30	15	11	for	for	ADP
bptjm-30	15	12	depression	depression	NOUN
bptjm-30	15	13	that	that	PRON
bptjm-30	15	14	are	be	AUX
bptjm-30	15	15	more	more	ADV
bptjm-30	15	16	effective	effective	ADJ
bptjm-30	15	17	than	than	ADP
bptjm-30	15	18	conventional	conventional	ADJ
bptjm-30	15	19	treatments	treatment	NOUN
bptjm-30	15	20	.	.	PUNCT
bptjm-30	16	1	in	in	ADP
bptjm-30	16	2	this	this	DET
bptjm-30	16	3	literature	literature	NOUN
bptjm-30	16	4	review	review	NOUN
bptjm-30	16	5	,	,	PUNCT
bptjm-30	16	6	we	we	PRON
bptjm-30	16	7	will	will	AUX
bptjm-30	16	8	analyze	analyze	VERB
bptjm-30	16	9	ketamine	ketamine	PROPN
bptjm-30	16	10	as	as	ADP
bptjm-30	16	11	a	a	DET
bptjm-30	16	12	shortterm	shortterm	NOUN
bptjm-30	16	13	therapeutic	therapeutic	ADJ
bptjm-30	16	14	option4	option4	PROPN
bptjm-30	16	15	,	,	PUNCT
bptjm-30	16	16	psilocybin	psilocybin	NOUN
bptjm-30	16	17	as	as	ADP
bptjm-30	16	18	a	a	DET
bptjm-30	16	19	long	long	ADJ
bptjm-30	16	20	-	-	PUNCT
bptjm-30	16	21	term	term	NOUN
bptjm-30	16	22	therapeutic	therapeutic	ADJ
bptjm-30	16	23	option5	option5	NOUN
bptjm-30	16	24	,	,	PUNCT
bptjm-30	16	25	other	other	ADJ
bptjm-30	16	26	psychedelic	psychedelic	ADJ
bptjm-30	16	27	-	-	PUNCT
bptjm-30	16	28	related	relate	VERB
bptjm-30	16	29	drugs6	drugs6	NOUN
bptjm-30	16	30	,	,	PUNCT
bptjm-30	16	31	natural	natural	ADJ
bptjm-30	16	32	depression	depression	NOUN
bptjm-30	16	33	remedies7	remedies7	NOUN
bptjm-30	16	34	,	,	PUNCT
bptjm-30	16	35	as	as	ADV
bptjm-30	16	36	well	well	ADV
bptjm-30	16	37	as	as	ADP
bptjm-30	16	38	hormonal	hormonal	ADJ
bptjm-30	16	39	treatments	treatment	NOUN
bptjm-30	16	40	for	for	ADP
bptjm-30	16	41	depression8	depression8	NOUN
bptjm-30	16	42	.	.	PUNCT
bptjm-30	17	1	all	all	DET
bptjm-30	17	2	these	these	DET
bptjm-30	17	3	novel	novel	ADJ
bptjm-30	17	4	strategies	strategy	NOUN
bptjm-30	17	5	target	target	NOUN
bptjm-30	17	6	depression	depression	NOUN
bptjm-30	17	7	differently	differently	ADV
bptjm-30	17	8	through	through	ADP
bptjm-30	17	9	inhibition	inhibition	NOUN
bptjm-30	17	10	and	and	CCONJ
bptjm-30	17	11	modulation	modulation	NOUN
bptjm-30	17	12	of	of	ADP
bptjm-30	17	13	specific	specific	ADJ
bptjm-30	17	14	receptors	receptor	NOUN
bptjm-30	17	15	,	,	PUNCT
bptjm-30	17	16	neurotransmitters	neurotransmitter	NOUN
bptjm-30	17	17	,	,	PUNCT
bptjm-30	17	18	and	and	CCONJ
bptjm-30	17	19	other	other	ADJ
bptjm-30	17	20	biomarkers	biomarker	NOUN
bptjm-30	17	21	to	to	PART
bptjm-30	17	22	significantly	significantly	ADV
bptjm-30	17	23	reduce	reduce	VERB
bptjm-30	17	24	suicide	suicide	NOUN
bptjm-30	17	25	ideation	ideation	NOUN
bptjm-30	17	26	and	and	CCONJ
bptjm-30	17	27	depressive	depressive	ADJ
bptjm-30	17	28	symptoms	symptom	NOUN
bptjm-30	17	29	.	.	PUNCT
bptjm-30	18	1	these	these	DET
bptjm-30	18	2	novel	novel	ADJ
bptjm-30	18	3	antidepressants	antidepressant	NOUN
bptjm-30	18	4	are	be	AUX
bptjm-30	18	5	researched	research	VERB
bptjm-30	18	6	because	because	SCONJ
bptjm-30	18	7	of	of	ADP
bptjm-30	18	8	their	their	PRON
bptjm-30	18	9	promising	promising	ADJ
bptjm-30	18	10	clinical	clinical	ADJ
bptjm-30	18	11	tests	test	NOUN
bptjm-30	18	12	and	and	CCONJ
bptjm-30	18	13	diverse	diverse	ADJ
bptjm-30	18	14	mechanisms	mechanism	NOUN
bptjm-30	18	15	.	.	PUNCT
bptjm-30	19	1	because	because	SCONJ
bptjm-30	19	2	these	these	DET
bptjm-30	19	3	antidepressants	antidepressant	NOUN
bptjm-30	19	4	have	have	VERB
bptjm-30	19	5	different	different	ADJ
bptjm-30	19	6	mechanisms	mechanism	NOUN
bptjm-30	19	7	of	of	ADP
bptjm-30	19	8	treating	treat	VERB
bptjm-30	19	9	depression	depression	NOUN
bptjm-30	19	10	,	,	PUNCT
bptjm-30	19	11	it	it	PRON
bptjm-30	19	12	is	be	AUX
bptjm-30	19	13	important	important	ADJ
bptjm-30	19	14	to	to	PART
bptjm-30	19	15	analyze	analyze	VERB
bptjm-30	19	16	which	which	DET
bptjm-30	19	17	mechanisms	mechanism	NOUN
bptjm-30	19	18	are	be	AUX
bptjm-30	19	19	the	the	DET
bptjm-30	19	20	most	most	ADV
bptjm-30	19	21	powerful	powerful	ADJ
bptjm-30	19	22	in	in	ADP
bptjm-30	19	23	contributing	contribute	VERB
bptjm-30	19	24	to	to	ADP
bptjm-30	19	25	the	the	DET
bptjm-30	19	26	most	most	ADV
bptjm-30	19	27	successful	successful	ADJ
bptjm-30	19	28	antidepressant	antidepressant	NOUN
bptjm-30	19	29	,	,	PUNCT
bptjm-30	19	30	as	as	SCONJ
bptjm-30	19	31	it	it	PRON
bptjm-30	19	32	can	can	AUX
bptjm-30	19	33	be	be	AUX
bptjm-30	19	34	the	the	DET
bptjm-30	19	35	baseline	baseline	NOUN
bptjm-30	19	36	for	for	ADP
bptjm-30	19	37	the	the	DET
bptjm-30	19	38	research	research	NOUN
bptjm-30	19	39	and	and	CCONJ
bptjm-30	19	40	creation	creation	NOUN
bptjm-30	19	41	of	of	ADP
bptjm-30	19	42	more	more	ADV
bptjm-30	19	43	effective	effective	ADJ
bptjm-30	19	44	antidepressants	antidepressant	NOUN
bptjm-30	19	45	in	in	ADP
bptjm-30	19	46	the	the	DET
bptjm-30	19	47	future	future	NOUN
bptjm-30	19	48	.	.	PUNCT
bptjm-30	20	1	the	the	DET
bptjm-30	20	2	success	success	NOUN
bptjm-30	20	3	of	of	ADP
bptjm-30	20	4	these	these	DET
bptjm-30	20	5	novel	novel	ADJ
bptjm-30	20	6	antidepressants	antidepressant	NOUN
bptjm-30	20	7	is	be	AUX
bptjm-30	20	8	measured	measure	VERB
bptjm-30	20	9	based	base	VERB
bptjm-30	20	10	on	on	ADP
bptjm-30	20	11	their	their	PRON
bptjm-30	20	12	ability	ability	NOUN
bptjm-30	20	13	to	to	PART
bptjm-30	20	14	prolong	prolong	VERB
bptjm-30	20	15	the	the	DET
bptjm-30	20	16	therapeutic	therapeutic	ADJ
bptjm-30	20	17	effect	effect	NOUN
bptjm-30	20	18	,	,	PUNCT
bptjm-30	20	19	increase	increase	VERB
bptjm-30	20	20	neuroplasticity	neuroplasticity	NOUN
bptjm-30	20	21	,	,	PUNCT
bptjm-30	20	22	and	and	CCONJ
bptjm-30	20	23	reduce	reduce	VERB
bptjm-30	20	24	neural	neural	ADJ
bptjm-30	20	25	toxicity	toxicity	NOUN
bptjm-30	20	26	.	.	PUNCT
bptjm-30	21	1	berkeley	berkeley	PROPN
bptjm-30	21	2	pharma	pharma	PROPN
bptjm-30	21	3	tech	tech	PROPN
bptjm-30	21	4	journal	journal	NOUN
bptjm-30	21	5	of	of	ADP
bptjm-30	21	6	medicine	medicine	NOUN
bptjm-30	21	7	|	|	ADV
bptjm-30	21	8	22	22	NUM
bptjm-30	21	9	2	2	NUM
bptjm-30	21	10	.	.	PUNCT
bptjm-30	21	11	pathophysiology	pathophysiology	NOUN
bptjm-30	21	12	of	of	ADP
bptjm-30	21	13	depression	depression	NOUN
bptjm-30	21	14	currently	currently	ADV
bptjm-30	21	15	,	,	PUNCT
bptjm-30	21	16	many	many	ADJ
bptjm-30	21	17	neurobiological	neurobiological	ADJ
bptjm-30	21	18	theories	theory	NOUN
bptjm-30	21	19	exist	exist	VERB
bptjm-30	21	20	for	for	ADP
bptjm-30	21	21	the	the	DET
bptjm-30	21	22	pathophysiology	pathophysiology	NOUN
bptjm-30	21	23	of	of	ADP
bptjm-30	21	24	mdd	mdd	PROPN
bptjm-30	21	25	.	.	PUNCT
bptjm-30	22	1	however	however	ADV
bptjm-30	22	2	,	,	PUNCT
bptjm-30	22	3	it	it	PRON
bptjm-30	22	4	has	have	AUX
bptjm-30	22	5	been	be	AUX
bptjm-30	22	6	difficult	difficult	ADJ
bptjm-30	22	7	to	to	PART
bptjm-30	22	8	choose	choose	VERB
bptjm-30	22	9	one	one	NUM
bptjm-30	22	10	unified	unified	ADJ
bptjm-30	22	11	theory	theory	NOUN
bptjm-30	22	12	due	due	ADP
bptjm-30	22	13	to	to	ADP
bptjm-30	22	14	the	the	DET
bptjm-30	22	15	clinical	clinical	ADJ
bptjm-30	22	16	and	and	CCONJ
bptjm-30	22	17	etiological	etiological	ADJ
bptjm-30	22	18	heterogeneity	heterogeneity	NOUN
bptjm-30	22	19	of	of	ADP
bptjm-30	22	20	the	the	DET
bptjm-30	22	21	disorder9	disorder9	NOUN
bptjm-30	22	22	.	.	PUNCT
bptjm-30	23	1	for	for	ADP
bptjm-30	23	2	example	example	NOUN
bptjm-30	23	3	,	,	PUNCT
bptjm-30	23	4	depressive	depressive	ADJ
bptjm-30	23	5	pathophysiology	pathophysiology	NOUN
bptjm-30	23	6	can	can	AUX
bptjm-30	23	7	change	change	VERB
bptjm-30	23	8	significantly	significantly	ADV
bptjm-30	23	9	over	over	ADP
bptjm-30	23	10	the	the	DET
bptjm-30	23	11	course	course	NOUN
bptjm-30	23	12	of	of	ADP
bptjm-30	23	13	the	the	DET
bptjm-30	23	14	illness	illness	NOUN
bptjm-30	23	15	,	,	PUNCT
bptjm-30	23	16	and	and	CCONJ
bptjm-30	23	17	all	all	DET
bptjm-30	23	18	theories	theory	NOUN
bptjm-30	23	19	of	of	ADP
bptjm-30	23	20	depression	depression	NOUN
bptjm-30	23	21	are	be	AUX
bptjm-30	23	22	only	only	ADV
bptjm-30	23	23	relevant	relevant	ADJ
bptjm-30	23	24	to	to	ADP
bptjm-30	23	25	some	some	DET
bptjm-30	23	26	depressed	depressed	ADJ
bptjm-30	23	27	patients	patient	NOUN
bptjm-30	23	28	in	in	ADP
bptjm-30	23	29	the	the	DET
bptjm-30	23	30	population	population	NOUN
bptjm-30	23	31	.	.	PUNCT
bptjm-30	24	1	as	as	SCONJ
bptjm-30	24	2	each	each	DET
bptjm-30	24	3	patient	patient	NOUN
bptjm-30	24	4	is	be	AUX
bptjm-30	24	5	likely	likely	ADV
bptjm-30	24	6	unique	unique	ADJ
bptjm-30	24	7	,	,	PUNCT
bptjm-30	24	8	it	it	PRON
bptjm-30	24	9	is	be	AUX
bptjm-30	24	10	critical	critical	ADJ
bptjm-30	24	11	to	to	PART
bptjm-30	24	12	tailor	tailor	NOUN
bptjm-30	24	13	treatment	treatment	NOUN
bptjm-30	24	14	approaches	approach	NOUN
bptjm-30	24	15	specifically	specifically	ADV
bptjm-30	24	16	.	.	PUNCT
bptjm-30	25	1	this	this	DET
bptjm-30	25	2	review	review	NOUN
bptjm-30	25	3	will	will	AUX
bptjm-30	25	4	discuss	discuss	VERB
bptjm-30	25	5	a	a	DET
bptjm-30	25	6	few	few	ADJ
bptjm-30	25	7	of	of	ADP
bptjm-30	25	8	the	the	DET
bptjm-30	25	9	current	current	ADJ
bptjm-30	25	10	theories	theory	NOUN
bptjm-30	25	11	with	with	ADP
bptjm-30	25	12	the	the	DET
bptjm-30	25	13	strongest	strong	ADJ
bptjm-30	25	14	empirical	empirical	ADJ
bptjm-30	25	15	foundation	foundation	NOUN
bptjm-30	25	16	,	,	PUNCT
bptjm-30	25	17	as	as	SCONJ
bptjm-30	25	18	each	each	PRON
bptjm-30	25	19	can	can	AUX
bptjm-30	25	20	be	be	AUX
bptjm-30	25	21	useful	useful	ADJ
bptjm-30	25	22	in	in	ADP
bptjm-30	25	23	developing	develop	VERB
bptjm-30	25	24	novel	novel	ADJ
bptjm-30	25	25	therapies	therapy	NOUN
bptjm-30	25	26	.	.	PUNCT
bptjm-30	26	1	the	the	DET
bptjm-30	26	2	monoamine	monoamine	ADJ
bptjm-30	26	3	deficiency	deficiency	NOUN
bptjm-30	26	4	theory	theory	NOUN
bptjm-30	26	5	posits	posit	NOUN
bptjm-30	26	6	that	that	SCONJ
bptjm-30	26	7	the	the	DET
bptjm-30	26	8	underlying	underlying	ADJ
bptjm-30	26	9	pathophysiological	pathophysiological	ADJ
bptjm-30	26	10	basis	basis	NOUN
bptjm-30	26	11	of	of	ADP
bptjm-30	26	12	depression	depression	NOUN
bptjm-30	26	13	is	be	AUX
bptjm-30	26	14	a	a	DET
bptjm-30	26	15	depletion	depletion	NOUN
bptjm-30	26	16	of	of	ADP
bptjm-30	26	17	the	the	DET
bptjm-30	26	18	neurotransmitters	neurotransmitter	NOUN
bptjm-30	26	19	—	—	PUNCT
bptjm-30	26	20	serotonin	serotonin	NOUN
bptjm-30	26	21	,	,	PUNCT
bptjm-30	26	22	norepinephrine	norepinephrine	NOUN
bptjm-30	26	23	,	,	PUNCT
bptjm-30	26	24	or	or	CCONJ
bptjm-30	26	25	dopamine	dopamine	NOUN
bptjm-30	26	26	—	—	PUNCT
bptjm-30	26	27	in	in	ADP
bptjm-30	26	28	the	the	DET
bptjm-30	26	29	central	central	ADJ
bptjm-30	26	30	nervous	nervous	ADJ
bptjm-30	26	31	system9	system9	PROPN
bptjm-30	26	32	.	.	PUNCT
bptjm-30	27	1	depletion	depletion	NOUN
bptjm-30	27	2	of	of	ADP
bptjm-30	27	3	these	these	DET
bptjm-30	27	4	neurotransmitters	neurotransmitter	NOUN
bptjm-30	27	5	happens	happen	VERB
bptjm-30	27	6	when	when	SCONJ
bptjm-30	27	7	presynaptic	presynaptic	ADJ
bptjm-30	27	8	cells	cell	NOUN
bptjm-30	27	9	take	take	VERB
bptjm-30	27	10	the	the	DET
bptjm-30	27	11	neurotransmitters	neurotransmitter	NOUN
bptjm-30	27	12	back	back	ADV
bptjm-30	27	13	up	up	ADV
bptjm-30	27	14	before	before	SCONJ
bptjm-30	27	15	it	it	PRON
bptjm-30	27	16	reaches	reach	VERB
bptjm-30	27	17	the	the	DET
bptjm-30	27	18	receptor	receptor	NOUN
bptjm-30	27	19	or	or	CCONJ
bptjm-30	27	20	when	when	SCONJ
bptjm-30	27	21	too	too	ADV
bptjm-30	27	22	little	little	ADJ
bptjm-30	27	23	of	of	ADP
bptjm-30	27	24	a	a	DET
bptjm-30	27	25	specific	specific	ADJ
bptjm-30	27	26	neurotransmitter	neurotransmitter	NOUN
bptjm-30	27	27	is	be	AUX
bptjm-30	27	28	produced	produce	VERB
bptjm-30	27	29	.	.	PUNCT
bptjm-30	28	1	these	these	DET
bptjm-30	28	2	neurotransmitters	neurotransmitter	NOUN
bptjm-30	28	3	are	be	AUX
bptjm-30	28	4	part	part	NOUN
bptjm-30	28	5	of	of	ADP
bptjm-30	28	6	the	the	DET
bptjm-30	28	7	monoaminergic	monoaminergic	ADJ
bptjm-30	28	8	systems	system	NOUN
bptjm-30	28	9	,	,	PUNCT
bptjm-30	28	10	which	which	PRON
bptjm-30	28	11	are	be	AUX
bptjm-30	28	12	involved	involve	VERB
bptjm-30	28	13	in	in	ADP
bptjm-30	28	14	important	important	ADJ
bptjm-30	28	15	brain	brain	NOUN
bptjm-30	28	16	functions	function	NOUN
bptjm-30	28	17	such	such	ADJ
bptjm-30	28	18	as	as	ADP
bptjm-30	28	19	mood	mood	NOUN
bptjm-30	28	20	regulation	regulation	NOUN
bptjm-30	28	21	,	,	PUNCT
bptjm-30	28	22	reward	reward	NOUN
bptjm-30	28	23	processing	processing	NOUN
bptjm-30	28	24	,	,	PUNCT
bptjm-30	28	25	circadian	circadian	ADJ
bptjm-30	28	26	rhythm	rhythm	NOUN
bptjm-30	28	27	,	,	PUNCT
bptjm-30	28	28	and	and	CCONJ
bptjm-30	28	29	attention	attention	NOUN
bptjm-30	28	30	.	.	PUNCT
bptjm-30	29	1	in	in	ADP
bptjm-30	29	2	clinical	clinical	ADJ
bptjm-30	29	3	trials	trial	NOUN
bptjm-30	29	4	,	,	PUNCT
bptjm-30	29	5	almost	almost	ADV
bptjm-30	29	6	every	every	PRON
bptjm-30	29	7	compound	compound	NOUN
bptjm-30	29	8	that	that	PRON
bptjm-30	29	9	inhibits	inhibit	VERB
bptjm-30	29	10	monoamine	monoamine	ADJ
bptjm-30	29	11	reuptake	reuptake	NOUN
bptjm-30	29	12	has	have	AUX
bptjm-30	29	13	been	be	AUX
bptjm-30	29	14	an	an	DET
bptjm-30	29	15	effective	effective	ADJ
bptjm-30	29	16	antidepressant	antidepressant	NOUN
bptjm-30	29	17	.	.	PUNCT
bptjm-30	30	1	this	this	DET
bptjm-30	30	2	observation	observation	NOUN
bptjm-30	30	3	is	be	AUX
bptjm-30	30	4	what	what	PRON
bptjm-30	30	5	led	lead	VERB
bptjm-30	30	6	to	to	ADP
bptjm-30	30	7	the	the	DET
bptjm-30	30	8	development	development	NOUN
bptjm-30	30	9	of	of	ADP
bptjm-30	30	10	the	the	DET
bptjm-30	30	11	monoamine	monoamine	ADJ
bptjm-30	30	12	deficiency	deficiency	NOUN
bptjm-30	30	13	theory	theory	NOUN
bptjm-30	30	14	.	.	PUNCT
bptjm-30	31	1	although	although	SCONJ
bptjm-30	31	2	antidepressants	antidepressant	NOUN
bptjm-30	31	3	that	that	PRON
bptjm-30	31	4	target	target	VERB
bptjm-30	31	5	the	the	DET
bptjm-30	31	6	monoamine	monoamine	NOUN
bptjm-30	31	7	systems	system	NOUN
bptjm-30	31	8	can	can	AUX
bptjm-30	31	9	be	be	AUX
bptjm-30	31	10	initially	initially	ADV
bptjm-30	31	11	effective	effective	ADJ
bptjm-30	31	12	,	,	PUNCT
bptjm-30	31	13	full	full	ADJ
bptjm-30	31	14	,	,	PUNCT
bptjm-30	31	15	and	and	CCONJ
bptjm-30	31	16	partial	partial	ADJ
bptjm-30	31	17	resistance	resistance	NOUN
bptjm-30	31	18	to	to	ADP
bptjm-30	31	19	these	these	DET
bptjm-30	31	20	drugs	drug	NOUN
bptjm-30	31	21	and	and	CCONJ
bptjm-30	31	22	delayed	delay	VERB
bptjm-30	31	23	onset	onset	NOUN
bptjm-30	31	24	of	of	ADP
bptjm-30	31	25	action	action	NOUN
bptjm-30	31	26	occurs	occur	VERB
bptjm-30	31	27	.	.	PUNCT
bptjm-30	32	1	these	these	DET
bptjm-30	32	2	limitations	limitation	NOUN
bptjm-30	32	3	suggest	suggest	VERB
bptjm-30	32	4	that	that	SCONJ
bptjm-30	32	5	dysfunctions	dysfunction	NOUN
bptjm-30	32	6	of	of	ADP
bptjm-30	32	7	monoaminergic	monoaminergic	ADJ
bptjm-30	32	8	neurotransmitter	neurotransmitter	NOUN
bptjm-30	32	9	systems	system	NOUN
bptjm-30	32	10	in	in	ADP
bptjm-30	32	11	mdd	mdd	PROPN
bptjm-30	32	12	represent	represent	VERB
bptjm-30	32	13	effects	effect	NOUN
bptjm-30	32	14	of	of	ADP
bptjm-30	32	15	other	other	ADJ
bptjm-30	32	16	abnormalities9	abnormalities9	PROPN
bptjm-30	32	17	.	.	PUNCT
bptjm-30	33	1	the	the	DET
bptjm-30	33	2	monoamine	monoamine	ADJ
bptjm-30	33	3	deficiency	deficiency	NOUN
bptjm-30	33	4	theory	theory	NOUN
bptjm-30	33	5	remains	remain	VERB
bptjm-30	33	6	the	the	DET
bptjm-30	33	7	clinically	clinically	ADV
bptjm-30	33	8	most	most	ADV
bptjm-30	33	9	relevant	relevant	ADJ
bptjm-30	33	10	theory	theory	NOUN
bptjm-30	33	11	,	,	PUNCT
bptjm-30	33	12	and	and	CCONJ
bptjm-30	33	13	new	new	ADJ
bptjm-30	33	14	findings	finding	NOUN
bptjm-30	33	15	on	on	ADP
bptjm-30	33	16	dopamine	dopamine	NOUN
bptjm-30	33	17	have	have	AUX
bptjm-30	33	18	shown	show	VERB
bptjm-30	33	19	further	further	ADJ
bptjm-30	33	20	potential	potential	NOUN
bptjm-30	33	21	in	in	ADP
bptjm-30	33	22	producing	produce	VERB
bptjm-30	33	23	novel	novel	ADJ
bptjm-30	33	24	therapeutic	therapeutic	ADJ
bptjm-30	33	25	strategies	strategy	NOUN
bptjm-30	33	26	for	for	ADP
bptjm-30	33	27	depression	depression	NOUN
bptjm-30	33	28	.	.	PUNCT
bptjm-30	34	1	the	the	DET
bptjm-30	34	2	gabaergic	gabaergic	ADJ
bptjm-30	34	3	hypothesis	hypothesis	NOUN
bptjm-30	34	4	of	of	ADP
bptjm-30	34	5	mdd	mdd	PROPN
bptjm-30	34	6	suggests	suggest	VERB
bptjm-30	34	7	that	that	SCONJ
bptjm-30	34	8	alterations	alteration	NOUN
bptjm-30	34	9	in	in	ADP
bptjm-30	34	10	gabaergic	gabaergic	ADJ
bptjm-30	34	11	transmission	transmission	NOUN
bptjm-30	34	12	represent	represent	VERB
bptjm-30	34	13	fundamentally	fundamentally	ADV
bptjm-30	34	14	important	important	ADJ
bptjm-30	34	15	aspects	aspect	NOUN
bptjm-30	34	16	of	of	ADP
bptjm-30	34	17	the	the	DET
bptjm-30	34	18	etiological	etiological	ADJ
bptjm-30	34	19	sequelae	sequelae	NOUN
bptjm-30	34	20	of	of	ADP
bptjm-30	34	21	mdd	mdd	PROPN
bptjm-30	34	22	that	that	PRON
bptjm-30	34	23	are	be	AUX
bptjm-30	34	24	reversed	reverse	VERB
bptjm-30	34	25	by	by	ADP
bptjm-30	34	26	monoaminergic	monoaminergic	ADJ
bptjm-30	34	27	antidepressant	antidepressant	ADJ
bptjm-30	34	28	drug	drug	NOUN
bptjm-30	34	29	action10	action10	NOUN
bptjm-30	34	30	.	.	PUNCT
bptjm-30	35	1	gaba	gaba	PROPN
bptjm-30	35	2	is	be	AUX
bptjm-30	35	3	a	a	DET
bptjm-30	35	4	neurotransmitter	neurotransmitter	NOUN
bptjm-30	35	5	predominantly	predominantly	ADV
bptjm-30	35	6	responsible	responsible	ADJ
bptjm-30	35	7	for	for	ADP
bptjm-30	35	8	mediating	mediate	VERB
bptjm-30	35	9	neural	neural	ADJ
bptjm-30	35	10	inhibition	inhibition	NOUN
bptjm-30	35	11	in	in	ADP
bptjm-30	35	12	the	the	DET
bptjm-30	35	13	brain	brain	NOUN
bptjm-30	35	14	.	.	PUNCT
bptjm-30	36	1	magnetic	magnetic	ADJ
bptjm-30	36	2	resonance	resonance	NOUN
bptjm-30	36	3	imaging	image	VERB
bptjm-30	36	4	berkeley	berkeley	PROPN
bptjm-30	36	5	pharma	pharma	PROPN
bptjm-30	36	6	tech	tech	NOUN
bptjm-30	36	7	journal	journal	NOUN
bptjm-30	36	8	of	of	ADP
bptjm-30	36	9	medicine	medicine	NOUN
bptjm-30	36	10	|	|	ADV
bptjm-30	36	11	23	23	NUM
bptjm-30	36	12	studies	study	NOUN
bptjm-30	36	13	have	have	AUX
bptjm-30	36	14	shown	show	VERB
bptjm-30	36	15	that	that	SCONJ
bptjm-30	36	16	in	in	ADP
bptjm-30	36	17	acute	acute	ADJ
bptjm-30	36	18	depression	depression	NOUN
bptjm-30	36	19	,	,	PUNCT
bptjm-30	36	20	there	there	PRON
bptjm-30	36	21	are	be	VERB
bptjm-30	36	22	consistent	consistent	ADJ
bptjm-30	36	23	reductions	reduction	NOUN
bptjm-30	36	24	in	in	ADP
bptjm-30	36	25	total	total	ADJ
bptjm-30	36	26	gaba	gaba	NOUN
bptjm-30	36	27	concentrations	concentration	NOUN
bptjm-30	36	28	in	in	ADP
bptjm-30	36	29	the	the	DET
bptjm-30	36	30	prefrontal	prefrontal	ADJ
bptjm-30	36	31	and	and	CCONJ
bptjm-30	36	32	occipital	occipital	ADJ
bptjm-30	36	33	cortex	cortex	NOUN
bptjm-30	36	34	.	.	PUNCT
bptjm-30	37	1	this	this	DET
bptjm-30	37	2	observation	observation	NOUN
bptjm-30	37	3	may	may	AUX
bptjm-30	37	4	be	be	AUX
bptjm-30	37	5	due	due	ADJ
bptjm-30	37	6	to	to	ADP
bptjm-30	37	7	acute	acute	VERB
bptjm-30	37	8	stress	stress	NOUN
bptjm-30	37	9	effects	effect	NOUN
bptjm-30	37	10	or	or	CCONJ
bptjm-30	37	11	reduction	reduction	NOUN
bptjm-30	37	12	in	in	ADP
bptjm-30	37	13	the	the	DET
bptjm-30	37	14	density	density	NOUN
bptjm-30	37	15	and	and	CCONJ
bptjm-30	37	16	size	size	NOUN
bptjm-30	37	17	of	of	ADP
bptjm-30	37	18	gabaergic	gabaergic	ADJ
bptjm-30	37	19	interneurons	interneuron	NOUN
bptjm-30	37	20	.	.	PUNCT
bptjm-30	38	1	however	however	ADV
bptjm-30	38	2	,	,	PUNCT
bptjm-30	38	3	there	there	PRON
bptjm-30	38	4	is	be	VERB
bptjm-30	38	5	also	also	ADV
bptjm-30	38	6	contradictory	contradictory	ADJ
bptjm-30	38	7	evidence	evidence	NOUN
bptjm-30	38	8	of	of	ADP
bptjm-30	38	9	the	the	DET
bptjm-30	38	10	gaba	gaba	PROPN
bptjm-30	38	11	hypothesis9	hypothesis9	PROPN
bptjm-30	38	12	.	.	PUNCT
bptjm-30	39	1	circadian	circadian	ADJ
bptjm-30	39	2	abnormalities	abnormality	NOUN
bptjm-30	39	3	have	have	AUX
bptjm-30	39	4	been	be	AUX
bptjm-30	39	5	hypothesized	hypothesize	VERB
bptjm-30	39	6	to	to	PART
bptjm-30	39	7	be	be	AUX
bptjm-30	39	8	etiologically	etiologically	ADV
bptjm-30	39	9	associated	associate	VERB
bptjm-30	39	10	with	with	ADP
bptjm-30	39	11	mdd	mdd	PROPN
bptjm-30	39	12	.	.	PUNCT
bptjm-30	40	1	the	the	DET
bptjm-30	40	2	circadian	circadian	ADJ
bptjm-30	40	3	rhythm	rhythm	NOUN
bptjm-30	40	4	is	be	AUX
bptjm-30	40	5	part	part	NOUN
bptjm-30	40	6	of	of	ADP
bptjm-30	40	7	the	the	DET
bptjm-30	40	8	body	body	NOUN
bptjm-30	40	9	clock	clock	NOUN
bptjm-30	40	10	that	that	PRON
bptjm-30	40	11	helps	help	VERB
bptjm-30	40	12	regulate	regulate	VERB
bptjm-30	40	13	body	body	NOUN
bptjm-30	40	14	fatigue	fatigue	NOUN
bptjm-30	40	15	through	through	ADP
bptjm-30	40	16	day	day	NOUN
bptjm-30	40	17	and	and	CCONJ
bptjm-30	40	18	night11	night11	NOUN
bptjm-30	40	19	.	.	PUNCT
bptjm-30	41	1	disruptions	disruption	NOUN
bptjm-30	41	2	to	to	PART
bptjm-30	41	3	sleep	sleep	VERB
bptjm-30	41	4	and	and	CCONJ
bptjm-30	41	5	daytime	daytime	ADJ
bptjm-30	41	6	fatigue	fatigue	NOUN
bptjm-30	41	7	is	be	AUX
bptjm-30	41	8	a	a	DET
bptjm-30	41	9	criterion	criterion	NOUN
bptjm-30	41	10	for	for	ADP
bptjm-30	41	11	depression	depression	NOUN
bptjm-30	41	12	,	,	PUNCT
bptjm-30	41	13	which	which	PRON
bptjm-30	41	14	suggests	suggest	VERB
bptjm-30	41	15	a	a	DET
bptjm-30	41	16	subgroup	subgroup	NOUN
bptjm-30	41	17	of	of	ADP
bptjm-30	41	18	depression	depression	NOUN
bptjm-30	41	19	patients	patient	NOUN
bptjm-30	41	20	may	may	AUX
bptjm-30	41	21	have	have	VERB
bptjm-30	41	22	impaired	impair	VERB
bptjm-30	41	23	circadian	circadian	ADJ
bptjm-30	41	24	rhythms	rhythm	NOUN
bptjm-30	41	25	.	.	PUNCT
bptjm-30	42	1	in	in	ADP
bptjm-30	42	2	clinical	clinical	ADJ
bptjm-30	42	3	studies	study	NOUN
bptjm-30	42	4	,	,	PUNCT
bptjm-30	42	5	adjustments	adjustment	NOUN
bptjm-30	42	6	to	to	ADP
bptjm-30	42	7	the	the	DET
bptjm-30	42	8	circadian	circadian	ADJ
bptjm-30	42	9	cycle	cycle	NOUN
bptjm-30	42	10	have	have	AUX
bptjm-30	42	11	been	be	AUX
bptjm-30	42	12	shown	show	VERB
bptjm-30	42	13	to	to	PART
bptjm-30	42	14	have	have	VERB
bptjm-30	42	15	specific	specific	ADJ
bptjm-30	42	16	effects	effect	NOUN
bptjm-30	42	17	on	on	ADP
bptjm-30	42	18	subsequent	subsequent	ADJ
bptjm-30	42	19	mood	mood	NOUN
bptjm-30	42	20	and	and	CCONJ
bptjm-30	42	21	can	can	AUX
bptjm-30	42	22	even	even	ADV
bptjm-30	42	23	have	have	VERB
bptjm-30	42	24	antidepressant	antidepressant	ADJ
bptjm-30	42	25	effects	effect	NOUN
bptjm-30	42	26	.	.	PUNCT
bptjm-30	43	1	based	base	VERB
bptjm-30	43	2	on	on	ADP
bptjm-30	43	3	these	these	DET
bptjm-30	43	4	findings	finding	NOUN
bptjm-30	43	5	,	,	PUNCT
bptjm-30	43	6	this	this	DET
bptjm-30	43	7	hypothesis	hypothesis	NOUN
bptjm-30	43	8	suggests	suggest	VERB
bptjm-30	43	9	that	that	SCONJ
bptjm-30	43	10	shortened	shorten	VERB
bptjm-30	43	11	rem	rem	NOUN
bptjm-30	43	12	latency	latency	NOUN
bptjm-30	43	13	,	,	PUNCT
bptjm-30	43	14	the	the	DET
bptjm-30	43	15	association	association	NOUN
bptjm-30	43	16	between	between	ADP
bptjm-30	43	17	phase	phase	NOUN
bptjm-30	43	18	advance	advance	NOUN
bptjm-30	43	19	of	of	ADP
bptjm-30	43	20	the	the	DET
bptjm-30	43	21	sleep	sleep	NOUN
bptjm-30	43	22	-	-	PUNCT
bptjm-30	43	23	wake	wake	VERB
bptjm-30	43	24	cycle	cycle	NOUN
bptjm-30	43	25	and	and	CCONJ
bptjm-30	43	26	phase	phase	NOUN
bptjm-30	43	27	advances	advance	NOUN
bptjm-30	43	28	in	in	ADP
bptjm-30	43	29	nocturnal	nocturnal	ADJ
bptjm-30	43	30	cortisol	cortisol	ADJ
bptjm-30	43	31	secretion	secretion	NOUN
bptjm-30	43	32	,	,	PUNCT
bptjm-30	43	33	and	and	CCONJ
bptjm-30	43	34	the	the	DET
bptjm-30	43	35	effect	effect	NOUN
bptjm-30	43	36	of	of	ADP
bptjm-30	43	37	antidepressants	antidepressant	NOUN
bptjm-30	43	38	on	on	ADP
bptjm-30	43	39	circadian	circadian	ADJ
bptjm-30	43	40	rhythms	rhythm	NOUN
bptjm-30	43	41	are	be	AUX
bptjm-30	43	42	etiologically	etiologically	ADV
bptjm-30	43	43	associated	associate	VERB
bptjm-30	43	44	with	with	ADP
bptjm-30	43	45	mdd9	mdd9	PROPN
bptjm-30	43	46	.	.	PUNCT
bptjm-30	44	1	however	however	ADV
bptjm-30	44	2	,	,	PUNCT
bptjm-30	44	3	more	more	ADJ
bptjm-30	44	4	research	research	NOUN
bptjm-30	44	5	is	be	AUX
bptjm-30	44	6	required	require	VERB
bptjm-30	44	7	into	into	ADP
bptjm-30	44	8	the	the	DET
bptjm-30	44	9	molecular	molecular	ADJ
bptjm-30	44	10	explanation	explanation	NOUN
bptjm-30	44	11	.	.	PUNCT
bptjm-30	45	1	3	3	X
bptjm-30	45	2	.	.	X
bptjm-30	45	3	important	important	ADJ
bptjm-30	45	4	receptors	receptor	NOUN
bptjm-30	45	5	involved	involve	VERB
bptjm-30	45	6	in	in	ADP
bptjm-30	45	7	depressive	depressive	ADJ
bptjm-30	45	8	symptoms	symptom	NOUN
bptjm-30	45	9	the	the	DET
bptjm-30	45	10	serotonin	serotonin	NOUN
bptjm-30	45	11	hypothesis	hypothesis	NOUN
bptjm-30	45	12	has	have	AUX
bptjm-30	45	13	dominated	dominate	VERB
bptjm-30	45	14	the	the	DET
bptjm-30	45	15	field	field	NOUN
bptjm-30	45	16	of	of	ADP
bptjm-30	45	17	depression	depression	NOUN
bptjm-30	45	18	research	research	NOUN
bptjm-30	45	19	for	for	ADP
bptjm-30	45	20	decades	decade	NOUN
bptjm-30	45	21	.	.	PUNCT
bptjm-30	46	1	there	there	PRON
bptjm-30	46	2	are	be	VERB
bptjm-30	46	3	multiple	multiple	ADJ
bptjm-30	46	4	receptors	receptor	NOUN
bptjm-30	46	5	that	that	PRON
bptjm-30	46	6	have	have	AUX
bptjm-30	46	7	been	be	AUX
bptjm-30	46	8	implicated	implicate	VERB
bptjm-30	46	9	,	,	PUNCT
bptjm-30	46	10	but	but	CCONJ
bptjm-30	46	11	serotonin-1a	serotonin-1a	PUNCT
bptjm-30	46	12	(	(	PUNCT
bptjm-30	46	13	5	5	NUM
bptjm-30	46	14	-	-	NUM
bptjm-30	46	15	ht1a	ht1a	NUM
bptjm-30	46	16	)	)	PUNCT
bptjm-30	46	17	and	and	CCONJ
bptjm-30	46	18	serotonin-1b	serotonin-1b	NUM
bptjm-30	46	19	(	(	PUNCT
bptjm-30	46	20	5	5	NUM
bptjm-30	46	21	-	-	SYM
bptjm-30	46	22	ht1b	ht1b	NUM
bptjm-30	46	23	)	)	PUNCT
bptjm-30	46	24	are	be	AUX
bptjm-30	46	25	among	among	ADP
bptjm-30	46	26	the	the	DET
bptjm-30	46	27	most	most	ADV
bptjm-30	46	28	important	important	ADJ
bptjm-30	46	29	receptors	receptor	NOUN
bptjm-30	46	30	as	as	SCONJ
bptjm-30	46	31	deemed	deem	VERB
bptjm-30	46	32	by	by	ADP
bptjm-30	46	33	recent	recent	ADJ
bptjm-30	46	34	and	and	CCONJ
bptjm-30	46	35	ongoing	ongoing	ADJ
bptjm-30	46	36	research	research	NOUN
bptjm-30	46	37	projects12	projects12	NOUN
bptjm-30	46	38	.	.	PUNCT
bptjm-30	47	1	the	the	DET
bptjm-30	47	2	5	5	NUM
bptjm-30	47	3	-	-	PUNCT
bptjm-30	47	4	ht	ht	PROPN
bptjm-30	47	5	serotonin	serotonin	NOUN
bptjm-30	47	6	receptor	receptor	NOUN
bptjm-30	47	7	group	group	NOUN
bptjm-30	47	8	has	have	AUX
bptjm-30	47	9	been	be	AUX
bptjm-30	47	10	broadly	broadly	ADV
bptjm-30	47	11	linked	link	VERB
bptjm-30	47	12	to	to	ADP
bptjm-30	47	13	both	both	CCONJ
bptjm-30	47	14	anxiety	anxiety	NOUN
bptjm-30	47	15	and	and	CCONJ
bptjm-30	47	16	depression	depression	NOUN
bptjm-30	47	17	disorders13	disorders13	NOUN
bptjm-30	47	18	.	.	PUNCT
bptjm-30	48	1	the	the	DET
bptjm-30	48	2	5	5	NUM
bptjm-30	48	3	-	-	PUNCT
bptjm-30	48	4	ht	ht	NOUN
bptjm-30	48	5	receptor	receptor	NOUN
bptjm-30	48	6	is	be	AUX
bptjm-30	48	7	found	find	VERB
bptjm-30	48	8	throughout	throughout	ADP
bptjm-30	48	9	the	the	DET
bptjm-30	48	10	central	central	ADJ
bptjm-30	48	11	and	and	CCONJ
bptjm-30	48	12	peripheral	peripheral	ADJ
bptjm-30	48	13	nervous	nervous	ADJ
bptjm-30	48	14	systems	system	NOUN
bptjm-30	48	15	in	in	ADP
bptjm-30	48	16	the	the	DET
bptjm-30	48	17	form	form	NOUN
bptjm-30	48	18	of	of	ADP
bptjm-30	48	19	either	either	CCONJ
bptjm-30	48	20	a	a	DET
bptjm-30	48	21	g	g	NOUN
bptjm-30	48	22	proteincoupled	proteincouple	VERB
bptjm-30	48	23	receptor	receptor	NOUN
bptjm-30	48	24	or	or	CCONJ
bptjm-30	48	25	a	a	DET
bptjm-30	48	26	ligand	ligand	NOUN
bptjm-30	48	27	-	-	PUNCT
bptjm-30	48	28	gated	gate	VERB
bptjm-30	48	29	ion	ion	NOUN
bptjm-30	48	30	channel	channel	NOUN
bptjm-30	48	31	.	.	PUNCT
bptjm-30	49	1	it	it	PRON
bptjm-30	49	2	is	be	AUX
bptjm-30	49	3	acted	act	VERB
bptjm-30	49	4	upon	upon	SCONJ
bptjm-30	49	5	by	by	ADP
bptjm-30	49	6	the	the	DET
bptjm-30	49	7	chemical	chemical	NOUN
bptjm-30	49	8	serotonin	serotonin	NOUN
bptjm-30	49	9	and	and	CCONJ
bptjm-30	49	10	then	then	ADV
bptjm-30	49	11	proceeds	proceed	VERB
bptjm-30	49	12	to	to	PART
bptjm-30	49	13	promote	promote	VERB
bptjm-30	49	14	either	either	CCONJ
bptjm-30	49	15	excitatory	excitatory	NOUN
bptjm-30	49	16	or	or	CCONJ
bptjm-30	49	17	inhibitory	inhibitory	ADJ
bptjm-30	49	18	neurotransmission	neurotransmission	NOUN
bptjm-30	49	19	.	.	PUNCT
bptjm-30	50	1	after	after	ADP
bptjm-30	50	2	binding	bind	VERB
bptjm-30	50	3	to	to	PART
bptjm-30	50	4	serotonin	serotonin	VERB
bptjm-30	50	5	presynaptically	presynaptically	ADV
bptjm-30	50	6	,	,	PUNCT
bptjm-30	50	7	the	the	DET
bptjm-30	50	8	receptor	receptor	NOUN
bptjm-30	50	9	modulates	modulate	VERB
bptjm-30	50	10	the	the	DET
bptjm-30	50	11	release	release	NOUN
bptjm-30	50	12	of	of	ADP
bptjm-30	50	13	neurotransmitters	neurotransmitter	NOUN
bptjm-30	50	14	such	such	ADJ
bptjm-30	50	15	as	as	ADP
bptjm-30	50	16	glutamate	glutamate	NOUN
bptjm-30	50	17	,	,	PUNCT
bptjm-30	50	18	gaba	gaba	NOUN
bptjm-30	50	19	,	,	PUNCT
bptjm-30	50	20	and	and	CCONJ
bptjm-30	50	21	dopamine	dopamine	NOUN
bptjm-30	50	22	and	and	CCONJ
bptjm-30	50	23	hormones	hormone	NOUN
bptjm-30	50	24	such	such	ADJ
bptjm-30	50	25	as	as	ADP
bptjm-30	50	26	oxytocin	oxytocin	PROPN
bptjm-30	50	27	,	,	PUNCT
bptjm-30	50	28	prolactin	prolactin	NOUN
bptjm-30	50	29	,	,	PUNCT
bptjm-30	50	30	and	and	CCONJ
bptjm-30	50	31	cortisol	cortisol	NOUN
bptjm-30	50	32	,	,	PUNCT
bptjm-30	50	33	leading	lead	VERB
bptjm-30	50	34	to	to	ADP
bptjm-30	50	35	physiological	physiological	ADJ
bptjm-30	50	36	changes	change	NOUN
bptjm-30	50	37	affecting	affect	VERB
bptjm-30	50	38	emotion	emotion	NOUN
bptjm-30	50	39	and	and	CCONJ
bptjm-30	50	40	cognition14	cognition14	NOUN
bptjm-30	50	41	.	.	PUNCT
bptjm-30	51	1	furthermore	furthermore	ADV
bptjm-30	51	2	,	,	PUNCT
bptjm-30	51	3	a	a	DET
bptjm-30	51	4	growing	grow	VERB
bptjm-30	51	5	and	and	CCONJ
bptjm-30	51	6	diverse	diverse	ADJ
bptjm-30	51	7	body	body	NOUN
bptjm-30	51	8	of	of	ADP
bptjm-30	51	9	evidence	evidence	NOUN
bptjm-30	51	10	support	support	VERB
bptjm-30	51	11	the	the	DET
bptjm-30	51	12	berkeley	berkeley	PROPN
bptjm-30	51	13	pharma	pharma	PROPN
bptjm-30	51	14	tech	tech	NOUN
bptjm-30	51	15	journal	journal	NOUN
bptjm-30	51	16	of	of	ADP
bptjm-30	51	17	medicine	medicine	NOUN
bptjm-30	51	18	|	|	ADV
bptjm-30	51	19	24	24	NUM
bptjm-30	51	20	involvement	involvement	NOUN
bptjm-30	51	21	of	of	ADP
bptjm-30	51	22	5	5	NUM
bptjm-30	51	23	-	-	SYM
bptjm-30	51	24	ht1a	ht1a	PRON
bptjm-30	51	25	,	,	PUNCT
bptjm-30	51	26	the	the	DET
bptjm-30	51	27	main	main	ADJ
bptjm-30	51	28	inhibitory	inhibitory	ADJ
bptjm-30	51	29	serotonergic	serotonergic	ADJ
bptjm-30	51	30	receptor	receptor	NOUN
bptjm-30	51	31	,	,	PUNCT
bptjm-30	51	32	in	in	ADP
bptjm-30	51	33	both	both	CCONJ
bptjm-30	51	34	mental	mental	ADJ
bptjm-30	51	35	disorders	disorder	NOUN
bptjm-30	51	36	.	.	PUNCT
bptjm-30	52	1	this	this	DET
bptjm-30	52	2	important	important	ADJ
bptjm-30	52	3	role	role	NOUN
bptjm-30	52	4	of	of	ADP
bptjm-30	52	5	the	the	DET
bptjm-30	52	6	serotonin	serotonin	NOUN
bptjm-30	52	7	receptor	receptor	NOUN
bptjm-30	52	8	was	be	AUX
bptjm-30	52	9	initially	initially	ADV
bptjm-30	52	10	discovered	discover	VERB
bptjm-30	52	11	through	through	ADP
bptjm-30	52	12	studies	study	NOUN
bptjm-30	52	13	of	of	ADP
bptjm-30	52	14	tryptophan	tryptophan	NOUN
bptjm-30	52	15	depletion	depletion	NOUN
bptjm-30	52	16	,	,	PUNCT
bptjm-30	52	17	as	as	SCONJ
bptjm-30	52	18	tryptophan	tryptophan	NOUN
bptjm-30	52	19	is	be	AUX
bptjm-30	52	20	the	the	DET
bptjm-30	52	21	molecular	molecular	ADJ
bptjm-30	52	22	precursor	precursor	NOUN
bptjm-30	52	23	to	to	ADP
bptjm-30	52	24	the	the	DET
bptjm-30	52	25	5	5	NUM
bptjm-30	52	26	-	-	PUNCT
bptjm-30	52	27	ht	ht	NOUN
bptjm-30	52	28	receptors15	receptors15	NOUN
bptjm-30	52	29	.	.	PUNCT
bptjm-30	53	1	recent	recent	ADJ
bptjm-30	53	2	studies	study	NOUN
bptjm-30	53	3	have	have	AUX
bptjm-30	53	4	focused	focus	VERB
bptjm-30	53	5	on	on	ADP
bptjm-30	53	6	the	the	DET
bptjm-30	53	7	direct	direct	ADJ
bptjm-30	53	8	role	role	NOUN
bptjm-30	53	9	of	of	ADP
bptjm-30	53	10	5	5	NUM
bptjm-30	53	11	-	-	PUNCT
bptjm-30	53	12	ht	ht	NOUN
bptjm-30	53	13	receptors	receptor	NOUN
bptjm-30	53	14	.	.	PUNCT
bptjm-30	54	1	studies	study	NOUN
bptjm-30	54	2	have	have	AUX
bptjm-30	54	3	implicated	implicate	VERB
bptjm-30	54	4	dysregulation	dysregulation	NOUN
bptjm-30	54	5	of	of	ADP
bptjm-30	54	6	5	5	NUM
bptjm-30	54	7	-	-	PUNCT
bptjm-30	54	8	ht	ht	PROPN
bptjm-30	54	9	neurotransmission	neurotransmission	NOUN
bptjm-30	54	10	as	as	ADP
bptjm-30	54	11	a	a	DET
bptjm-30	54	12	primary	primary	ADJ
bptjm-30	54	13	defect	defect	NOUN
bptjm-30	54	14	in	in	ADP
bptjm-30	54	15	mood	mood	NOUN
bptjm-30	54	16	and	and	CCONJ
bptjm-30	54	17	anxiety	anxiety	NOUN
bptjm-30	54	18	disorders13,15	disorders13,15	PROPN
bptjm-30	54	19	.	.	PUNCT
bptjm-30	55	1	complementary	complementary	PROPN
bptjm-30	55	2	research	research	NOUN
bptjm-30	55	3	findings	finding	NOUN
bptjm-30	55	4	suggested	suggest	VERB
bptjm-30	55	5	that	that	SCONJ
bptjm-30	55	6	5	5	NUM
bptjm-30	55	7	-	-	NUM
bptjm-30	55	8	ht	ht	PROPN
bptjm-30	55	9	may	may	AUX
bptjm-30	55	10	play	play	VERB
bptjm-30	55	11	a	a	DET
bptjm-30	55	12	role	role	NOUN
bptjm-30	55	13	in	in	ADP
bptjm-30	55	14	recovery	recovery	NOUN
bptjm-30	55	15	from	from	ADP
bptjm-30	55	16	mood	mood	NOUN
bptjm-30	55	17	disorders	disorder	NOUN
bptjm-30	55	18	via	via	ADP
bptjm-30	55	19	selective	selective	ADJ
bptjm-30	55	20	serotonin	serotonin	NOUN
bptjm-30	55	21	reuptake	reuptake	NOUN
bptjm-30	55	22	inhibitors	inhibitor	NOUN
bptjm-30	55	23	(	(	PUNCT
bptjm-30	55	24	ssris	ssris	NOUN
bptjm-30	55	25	)	)	PUNCT
bptjm-30	55	26	and	and	CCONJ
bptjm-30	55	27	other	other	ADJ
bptjm-30	55	28	serotonergic	serotonergic	ADJ
bptjm-30	55	29	agents16	agents16	NOUN
bptjm-30	55	30	.	.	PUNCT
bptjm-30	56	1	the	the	DET
bptjm-30	56	2	role	role	NOUN
bptjm-30	56	3	of	of	ADP
bptjm-30	56	4	5	5	NUM
bptjm-30	56	5	-	-	PUNCT
bptjm-30	56	6	ht	ht	NOUN
bptjm-30	56	7	receptors	receptor	NOUN
bptjm-30	56	8	in	in	ADP
bptjm-30	56	9	depression	depression	NOUN
bptjm-30	56	10	has	have	AUX
bptjm-30	56	11	additionally	additionally	ADV
bptjm-30	56	12	been	be	AUX
bptjm-30	56	13	shown	show	VERB
bptjm-30	56	14	through	through	ADP
bptjm-30	56	15	human	human	ADJ
bptjm-30	56	16	studies	study	NOUN
bptjm-30	56	17	,	,	PUNCT
bptjm-30	56	18	5	5	NUM
bptjm-30	56	19	-	-	PUNCT
bptjm-30	56	20	ht1a	ht1a	NUM
bptjm-30	56	21	polymorphism	polymorphism	NOUN
bptjm-30	56	22	research	research	NOUN
bptjm-30	56	23	,	,	PUNCT
bptjm-30	56	24	preclinical	preclinical	ADJ
bptjm-30	56	25	pharmacological	pharmacological	ADJ
bptjm-30	56	26	studies	study	NOUN
bptjm-30	56	27	,	,	PUNCT
bptjm-30	56	28	and	and	CCONJ
bptjm-30	56	29	preclinical	preclinical	ADJ
bptjm-30	56	30	genetic	genetic	ADJ
bptjm-30	56	31	approaches	approach	NOUN
bptjm-30	56	32	.	.	PUNCT
bptjm-30	57	1	beyond	beyond	ADP
bptjm-30	57	2	the	the	DET
bptjm-30	57	3	5	5	NUM
bptjm-30	57	4	-	-	PUNCT
bptjm-30	57	5	ht	ht	NOUN
bptjm-30	57	6	receptor	receptor	NOUN
bptjm-30	57	7	,	,	PUNCT
bptjm-30	57	8	other	other	ADJ
bptjm-30	57	9	receptors	receptor	NOUN
bptjm-30	57	10	affecting	affect	VERB
bptjm-30	57	11	brain	brain	NOUN
bptjm-30	57	12	chemistry	chemistry	NOUN
bptjm-30	57	13	have	have	AUX
bptjm-30	57	14	been	be	AUX
bptjm-30	57	15	indicated	indicate	VERB
bptjm-30	57	16	to	to	PART
bptjm-30	57	17	improve	improve	VERB
bptjm-30	57	18	outcomes	outcome	NOUN
bptjm-30	57	19	for	for	ADP
bptjm-30	57	20	patients	patient	NOUN
bptjm-30	57	21	with	with	ADP
bptjm-30	57	22	mdd	mdd	PROPN
bptjm-30	57	23	.	.	PUNCT
bptjm-30	57	24	nmda	nmda	ADJ
bptjm-30	57	25	antagonists	antagonist	NOUN
bptjm-30	57	26	,	,	PUNCT
bptjm-30	57	27	such	such	ADJ
bptjm-30	57	28	as	as	ADP
bptjm-30	57	29	ketamine	ketamine	PROPN
bptjm-30	57	30	,	,	PUNCT
bptjm-30	57	31	have	have	AUX
bptjm-30	57	32	been	be	AUX
bptjm-30	57	33	associated	associate	VERB
bptjm-30	57	34	with	with	ADP
bptjm-30	57	35	antidepressant	antidepressant	ADJ
bptjm-30	57	36	effects	effect	NOUN
bptjm-30	57	37	in	in	ADP
bptjm-30	57	38	patients	patient	NOUN
bptjm-30	57	39	suffering	suffer	VERB
bptjm-30	57	40	from	from	ADP
bptjm-30	57	41	mdd17	mdd17	PROPN
bptjm-30	57	42	.	.	PUNCT
bptjm-30	58	1	the	the	DET
bptjm-30	58	2	nmda	nmda	ADJ
bptjm-30	58	3	receptor	receptor	NOUN
bptjm-30	58	4	is	be	AUX
bptjm-30	58	5	typically	typically	ADV
bptjm-30	58	6	activated	activate	VERB
bptjm-30	58	7	by	by	ADP
bptjm-30	58	8	glutamate	glutamate	NOUN
bptjm-30	58	9	,	,	PUNCT
bptjm-30	58	10	which	which	PRON
bptjm-30	58	11	causes	cause	VERB
bptjm-30	58	12	an	an	DET
bptjm-30	58	13	influx	influx	NOUN
bptjm-30	58	14	of	of	ADP
bptjm-30	58	15	calcium	calcium	NOUN
bptjm-30	58	16	ions	ion	NOUN
bptjm-30	58	17	and	and	CCONJ
bptjm-30	58	18	subsequent	subsequent	ADJ
bptjm-30	58	19	membrane	membrane	NOUN
bptjm-30	58	20	depolarization	depolarization	NOUN
bptjm-30	58	21	for	for	ADP
bptjm-30	58	22	an	an	DET
bptjm-30	58	23	action	action	NOUN
bptjm-30	58	24	potential18	potential18	NOUN
bptjm-30	58	25	.	.	PUNCT
bptjm-30	59	1	however	however	ADV
bptjm-30	59	2	,	,	PUNCT
bptjm-30	59	3	antagonists	antagonist	NOUN
bptjm-30	59	4	have	have	AUX
bptjm-30	59	5	been	be	AUX
bptjm-30	59	6	proposed	propose	VERB
bptjm-30	59	7	to	to	PART
bptjm-30	59	8	antagonize	antagonize	VERB
bptjm-30	59	9	nmda	nmda	ADJ
bptjm-30	59	10	receptors	receptor	NOUN
bptjm-30	59	11	on	on	ADP
bptjm-30	59	12	gabaergic	gabaergic	ADJ
bptjm-30	59	13	interneurons	interneuron	NOUN
bptjm-30	59	14	and	and	CCONJ
bptjm-30	59	15	broadly	broadly	ADV
bptjm-30	59	16	increase	increase	VERB
bptjm-30	59	17	levels	level	NOUN
bptjm-30	59	18	of	of	ADP
bptjm-30	59	19	glutamate	glutamate	NOUN
bptjm-30	59	20	,	,	PUNCT
bptjm-30	59	21	the	the	DET
bptjm-30	59	22	major	major	ADJ
bptjm-30	59	23	excitatory	excitatory	NOUN
bptjm-30	59	24	neurotransmitter	neurotransmitter	NOUN
bptjm-30	59	25	in	in	ADP
bptjm-30	59	26	the	the	DET
bptjm-30	59	27	nervous	nervous	ADJ
bptjm-30	59	28	system	system	NOUN
bptjm-30	59	29	.	.	PUNCT
bptjm-30	60	1	ampa	ampa	NOUN
bptjm-30	60	2	receptor	receptor	NOUN
bptjm-30	60	3	activation	activation	NOUN
bptjm-30	60	4	functions	function	NOUN
bptjm-30	60	5	in	in	ADP
bptjm-30	60	6	a	a	DET
bptjm-30	60	7	similar	similar	ADJ
bptjm-30	60	8	manner	manner	NOUN
bptjm-30	60	9	,	,	PUNCT
bptjm-30	60	10	except	except	SCONJ
bptjm-30	60	11	calcium	calcium	NOUN
bptjm-30	60	12	ions	ion	NOUN
bptjm-30	60	13	,	,	PUNCT
bptjm-30	60	14	are	be	AUX
bptjm-30	60	15	substituted	substitute	VERB
bptjm-30	60	16	for	for	ADP
bptjm-30	60	17	sodium	sodium	NOUN
bptjm-30	60	18	ions	ion	NOUN
bptjm-30	60	19	which	which	PRON
bptjm-30	60	20	allows	allow	VERB
bptjm-30	60	21	for	for	ADP
bptjm-30	60	22	faster	fast	ADJ
bptjm-30	60	23	action	action	NOUN
bptjm-30	60	24	potentials	potential	VERB
bptjm-30	60	25	.	.	PUNCT
bptjm-30	61	1	in	in	ADP
bptjm-30	61	2	recent	recent	ADJ
bptjm-30	61	3	studies	study	NOUN
bptjm-30	61	4	,	,	PUNCT
bptjm-30	61	5	compounds	compound	VERB
bptjm-30	61	6	that	that	PRON
bptjm-30	61	7	augment	augment	VERB
bptjm-30	61	8	signaling	signal	VERB
bptjm-30	61	9	through	through	ADP
bptjm-30	61	10	ampa	ampa	NOUN
bptjm-30	61	11	receptors	receptor	NOUN
bptjm-30	61	12	have	have	AUX
bptjm-30	61	13	been	be	AUX
bptjm-30	61	14	found	find	VERB
bptjm-30	61	15	to	to	PART
bptjm-30	61	16	promote	promote	VERB
bptjm-30	61	17	antidepressant	antidepressant	ADJ
bptjm-30	61	18	-	-	PUNCT
bptjm-30	61	19	like	like	ADJ
bptjm-30	61	20	behavioral	behavioral	ADJ
bptjm-30	61	21	effects	effect	NOUN
bptjm-30	61	22	in	in	ADP
bptjm-30	61	23	animal	animal	NOUN
bptjm-30	61	24	models19	models19	NOUN
bptjm-30	61	25	.	.	PUNCT
bptjm-30	62	1	4	4	X
bptjm-30	62	2	.	.	X
bptjm-30	62	3	molecular	molecular	ADJ
bptjm-30	62	4	mechanisms	mechanism	NOUN
bptjm-30	62	5	of	of	ADP
bptjm-30	62	6	antidepressants	antidepressant	NOUN
bptjm-30	62	7	most	most	ADJ
bptjm-30	62	8	current	current	ADJ
bptjm-30	62	9	antidepressant	antidepressant	ADJ
bptjm-30	62	10	medications	medication	NOUN
bptjm-30	62	11	fall	fall	VERB
bptjm-30	62	12	under	under	ADP
bptjm-30	62	13	the	the	DET
bptjm-30	62	14	category	category	NOUN
bptjm-30	62	15	of	of	ADP
bptjm-30	62	16	reuptake	reuptake	NOUN
bptjm-30	62	17	inhibitors	inhibitor	NOUN
bptjm-30	62	18	,	,	PUNCT
bptjm-30	62	19	namely	namely	ADV
bptjm-30	62	20	selective	selective	ADJ
bptjm-30	62	21	serotonin	serotonin	NOUN
bptjm-30	62	22	reuptake	reuptake	NOUN
bptjm-30	62	23	inhibitors	inhibitor	NOUN
bptjm-30	62	24	(	(	PUNCT
bptjm-30	62	25	ssris	ssris	NOUN
bptjm-30	62	26	)	)	PUNCT
bptjm-30	62	27	and	and	CCONJ
bptjm-30	62	28	serotonin	serotonin	VERB
bptjm-30	62	29	and	and	CCONJ
bptjm-30	62	30	norepinephrine	norepinephrine	ADJ
bptjm-30	62	31	reuptake	reuptake	NOUN
bptjm-30	62	32	inhibitors	inhibitor	NOUN
bptjm-30	62	33	(	(	PUNCT
bptjm-30	62	34	snris)20	snris)20	PROPN
bptjm-30	62	35	.	.	PUNCT
bptjm-30	63	1	these	these	DET
bptjm-30	63	2	medications	medication	NOUN
bptjm-30	63	3	function	function	NOUN
bptjm-30	63	4	by	by	ADP
bptjm-30	63	5	preventing	prevent	VERB
bptjm-30	63	6	neurotransmitters	neurotransmitter	NOUN
bptjm-30	63	7	(	(	PUNCT
bptjm-30	63	8	serotonin	serotonin	NOUN
bptjm-30	63	9	and	and	CCONJ
bptjm-30	63	10	norepinephrine	norepinephrine	NOUN
bptjm-30	63	11	)	)	PUNCT
bptjm-30	63	12	from	from	ADP
bptjm-30	63	13	being	be	AUX
bptjm-30	63	14	reabsorbed	reabsorb	VERB
bptjm-30	63	15	back	back	ADV
bptjm-30	63	16	into	into	ADP
bptjm-30	63	17	neurons	neuron	NOUN
bptjm-30	63	18	in	in	ADP
bptjm-30	63	19	the	the	DET
bptjm-30	63	20	brain	brain	NOUN
bptjm-30	63	21	after	after	SCONJ
bptjm-30	63	22	they	they	PRON
bptjm-30	63	23	are	be	AUX
bptjm-30	63	24	released	release	VERB
bptjm-30	63	25	.	.	PUNCT
bptjm-30	64	1	the	the	DET
bptjm-30	64	2	mechanism	mechanism	NOUN
bptjm-30	64	3	of	of	ADP
bptjm-30	64	4	these	these	DET
bptjm-30	64	5	drugs	drug	NOUN
bptjm-30	64	6	is	be	AUX
bptjm-30	64	7	based	base	VERB
bptjm-30	64	8	on	on	ADP
bptjm-30	64	9	the	the	DET
bptjm-30	64	10	monoamine	monoamine	NOUN
bptjm-30	64	11	hypothesis	hypothesis	NOUN
bptjm-30	64	12	,	,	PUNCT
bptjm-30	64	13	which	which	PRON
bptjm-30	64	14	states	state	VERB
bptjm-30	64	15	that	that	SCONJ
bptjm-30	64	16	depression	depression	NOUN
bptjm-30	64	17	is	be	AUX
bptjm-30	64	18	caused	cause	VERB
bptjm-30	64	19	by	by	ADP
bptjm-30	64	20	a	a	DET
bptjm-30	64	21	lack	lack	NOUN
bptjm-30	64	22	of	of	ADP
bptjm-30	64	23	available	available	ADJ
bptjm-30	64	24	monoamines	monoamine	NOUN
bptjm-30	64	25	.	.	PUNCT
bptjm-30	65	1	by	by	ADP
bptjm-30	65	2	blocking	block	VERB
bptjm-30	65	3	reuptake	reuptake	NOUN
bptjm-30	65	4	and	and	CCONJ
bptjm-30	65	5	increasing	increase	VERB
bptjm-30	65	6	the	the	DET
bptjm-30	65	7	extracellular	extracellular	ADJ
bptjm-30	65	8	berkeley	berkeley	PROPN
bptjm-30	65	9	pharma	pharma	PROPN
bptjm-30	65	10	tech	tech	NOUN
bptjm-30	65	11	journal	journal	NOUN
bptjm-30	65	12	of	of	ADP
bptjm-30	65	13	medicine	medicine	NOUN
bptjm-30	65	14	|	|	ADV
bptjm-30	65	15	25	25	NUM
bptjm-30	65	16	concentration	concentration	NOUN
bptjm-30	65	17	of	of	ADP
bptjm-30	65	18	monoamines	monoamine	NOUN
bptjm-30	65	19	,	,	PUNCT
bptjm-30	65	20	these	these	DET
bptjm-30	65	21	drugs	drug	NOUN
bptjm-30	65	22	are	be	AUX
bptjm-30	65	23	thought	think	VERB
bptjm-30	65	24	to	to	PART
bptjm-30	65	25	enhance	enhance	VERB
bptjm-30	65	26	and	and	CCONJ
bptjm-30	65	27	restore	restore	VERB
bptjm-30	65	28	connections	connection	NOUN
bptjm-30	65	29	between	between	ADP
bptjm-30	65	30	neurons	neuron	NOUN
bptjm-30	65	31	,	,	PUNCT
bptjm-30	65	32	ultimately	ultimately	ADV
bptjm-30	65	33	resulting	result	VERB
bptjm-30	65	34	in	in	ADP
bptjm-30	65	35	an	an	DET
bptjm-30	65	36	improved	improved	ADJ
bptjm-30	65	37	mood	mood	NOUN
bptjm-30	65	38	in	in	ADP
bptjm-30	65	39	patients21	patients21	NOUN
bptjm-30	65	40	.	.	PUNCT
bptjm-30	66	1	current	current	ADJ
bptjm-30	66	2	research	research	NOUN
bptjm-30	66	3	in	in	ADP
bptjm-30	66	4	antidepressants	antidepressant	NOUN
bptjm-30	66	5	,	,	PUNCT
bptjm-30	66	6	however	however	ADV
bptjm-30	66	7	,	,	PUNCT
bptjm-30	66	8	is	be	AUX
bptjm-30	66	9	not	not	PART
bptjm-30	66	10	based	base	VERB
bptjm-30	66	11	on	on	ADP
bptjm-30	66	12	the	the	DET
bptjm-30	66	13	monoamine	monoamine	ADJ
bptjm-30	66	14	hypothesis	hypothesis	NOUN
bptjm-30	66	15	and	and	CCONJ
bptjm-30	66	16	reuptake	reuptake	NOUN
bptjm-30	66	17	inhibition	inhibition	NOUN
bptjm-30	66	18	mechanism	mechanism	NOUN
bptjm-30	66	19	,	,	PUNCT
bptjm-30	66	20	largely	largely	ADV
bptjm-30	66	21	due	due	ADJ
bptjm-30	66	22	to	to	ADP
bptjm-30	66	23	the	the	DET
bptjm-30	66	24	inconsistent	inconsistent	ADJ
bptjm-30	66	25	results	result	NOUN
bptjm-30	66	26	and	and	CCONJ
bptjm-30	66	27	efficacy	efficacy	NOUN
bptjm-30	66	28	of	of	ADP
bptjm-30	66	29	the	the	DET
bptjm-30	66	30	current	current	ADJ
bptjm-30	66	31	antidepressant	antidepressant	ADJ
bptjm-30	66	32	medications	medication	NOUN
bptjm-30	66	33	.	.	PUNCT
bptjm-30	67	1	reuptake	reuptake	NOUN
bptjm-30	67	2	inhibitors	inhibitor	NOUN
bptjm-30	67	3	do	do	AUX
bptjm-30	67	4	not	not	PART
bptjm-30	67	5	directly	directly	ADV
bptjm-30	67	6	target	target	VERB
bptjm-30	67	7	the	the	DET
bptjm-30	67	8	glutamatergic	glutamatergic	ADJ
bptjm-30	67	9	system	system	NOUN
bptjm-30	67	10	,	,	PUNCT
bptjm-30	67	11	which	which	PRON
bptjm-30	67	12	plays	play	VERB
bptjm-30	67	13	a	a	DET
bptjm-30	67	14	significant	significant	ADJ
bptjm-30	67	15	role	role	NOUN
bptjm-30	67	16	in	in	ADP
bptjm-30	67	17	the	the	DET
bptjm-30	67	18	brain	brain	NOUN
bptjm-30	67	19	and	and	CCONJ
bptjm-30	67	20	is	be	AUX
bptjm-30	67	21	thought	think	VERB
bptjm-30	67	22	to	to	PART
bptjm-30	67	23	be	be	AUX
bptjm-30	67	24	a	a	DET
bptjm-30	67	25	vital	vital	ADJ
bptjm-30	67	26	system	system	NOUN
bptjm-30	67	27	regarding	regard	VERB
bptjm-30	67	28	depressive	depressive	ADJ
bptjm-30	67	29	symptoms20,21	symptoms20,21	NOUN
bptjm-30	67	30	.	.	PUNCT
bptjm-30	68	1	glutamate	glutamate	NOUN
bptjm-30	68	2	is	be	AUX
bptjm-30	68	3	an	an	DET
bptjm-30	68	4	important	important	ADJ
bptjm-30	68	5	neurotransmitter	neurotransmitter	NOUN
bptjm-30	68	6	of	of	ADP
bptjm-30	68	7	the	the	DET
bptjm-30	68	8	glutamatergic	glutamatergic	ADJ
bptjm-30	68	9	system	system	NOUN
bptjm-30	68	10	and	and	CCONJ
bptjm-30	68	11	is	be	AUX
bptjm-30	68	12	released	release	VERB
bptjm-30	68	13	in	in	ADP
bptjm-30	68	14	response	response	NOUN
bptjm-30	68	15	to	to	ADP
bptjm-30	68	16	increased	increase	VERB
bptjm-30	68	17	5	5	NUM
bptjm-30	68	18	-	-	PUNCT
bptjm-30	68	19	ht2a	ht2a	PROPN
bptjm-30	68	20	receptor	receptor	NOUN
bptjm-30	68	21	activation22	activation22	NOUN
bptjm-30	68	22	.	.	PUNCT
bptjm-30	69	1	while	while	SCONJ
bptjm-30	69	2	ssris	ssris	PROPN
bptjm-30	69	3	and	and	CCONJ
bptjm-30	69	4	snris	snris	PROPN
bptjm-30	69	5	indirectly	indirectly	ADV
bptjm-30	69	6	interact	interact	VERB
bptjm-30	69	7	with	with	ADP
bptjm-30	69	8	the	the	DET
bptjm-30	69	9	5	5	NUM
bptjm-30	69	10	-	-	PUNCT
bptjm-30	69	11	ht2a	ht2a	NOUN
bptjm-30	69	12	receptor	receptor	NOUN
bptjm-30	69	13	by	by	ADP
bptjm-30	69	14	increasing	increase	VERB
bptjm-30	69	15	neurotransmitter	neurotransmitter	NOUN
bptjm-30	69	16	concentrations	concentration	NOUN
bptjm-30	69	17	,	,	PUNCT
bptjm-30	69	18	they	they	PRON
bptjm-30	69	19	do	do	AUX
bptjm-30	69	20	not	not	PART
bptjm-30	69	21	impact	impact	VERB
bptjm-30	69	22	receptor	receptor	NOUN
bptjm-30	69	23	activation	activation	NOUN
bptjm-30	69	24	or	or	CCONJ
bptjm-30	69	25	functionality22	functionality22	NOUN
bptjm-30	69	26	.	.	PUNCT
bptjm-30	70	1	reuptake	reuptake	NOUN
bptjm-30	70	2	inhibitors	inhibitor	NOUN
bptjm-30	70	3	have	have	AUX
bptjm-30	70	4	instead	instead	ADV
bptjm-30	70	5	been	be	AUX
bptjm-30	70	6	found	find	VERB
bptjm-30	70	7	to	to	PART
bptjm-30	70	8	cause	cause	VERB
bptjm-30	70	9	postsynaptic	postsynaptic	ADJ
bptjm-30	70	10	receptor	receptor	NOUN
bptjm-30	70	11	downregulation	downregulation	NOUN
bptjm-30	70	12	,	,	PUNCT
bptjm-30	70	13	which	which	PRON
bptjm-30	70	14	explains	explain	VERB
bptjm-30	70	15	the	the	DET
bptjm-30	70	16	delayed	delay	VERB
bptjm-30	70	17	effects	effect	NOUN
bptjm-30	70	18	that	that	PRON
bptjm-30	70	19	patients	patient	NOUN
bptjm-30	70	20	often	often	ADV
bptjm-30	70	21	experience	experience	VERB
bptjm-30	70	22	with	with	ADP
bptjm-30	70	23	current	current	ADJ
bptjm-30	70	24	antidepressants23	antidepressants23	NOUN
bptjm-30	70	25	.	.	PUNCT
bptjm-30	71	1	ssris	ssris	PROPN
bptjm-30	71	2	have	have	AUX
bptjm-30	71	3	also	also	ADV
bptjm-30	71	4	been	be	AUX
bptjm-30	71	5	shown	show	VERB
bptjm-30	71	6	to	to	PART
bptjm-30	71	7	disrupt	disrupt	VERB
bptjm-30	71	8	k+	k+	NOUN
bptjm-30	71	9	channels	channel	NOUN
bptjm-30	71	10	that	that	PRON
bptjm-30	71	11	are	be	AUX
bptjm-30	71	12	necessary	necessary	ADJ
bptjm-30	71	13	for	for	ADP
bptjm-30	71	14	glutamate	glutamate	ADJ
bptjm-30	71	15	reuptake	reuptake	NOUN
bptjm-30	71	16	by	by	ADP
bptjm-30	71	17	astrocytes	astrocyte	NOUN
bptjm-30	71	18	,	,	PUNCT
bptjm-30	71	19	which	which	PRON
bptjm-30	71	20	are	be	AUX
bptjm-30	71	21	glutamate	glutamate	ADJ
bptjm-30	71	22	transporters	transporter	NOUN
bptjm-30	71	23	.	.	PUNCT
bptjm-30	72	1	blunted	blunt	VERB
bptjm-30	72	2	glutamate	glutamate	ADJ
bptjm-30	72	3	reuptake	reuptake	NOUN
bptjm-30	72	4	has	have	AUX
bptjm-30	72	5	recently	recently	ADV
bptjm-30	72	6	been	be	AUX
bptjm-30	72	7	found	find	VERB
bptjm-30	72	8	to	to	PART
bptjm-30	72	9	be	be	AUX
bptjm-30	72	10	associated	associate	VERB
bptjm-30	72	11	with	with	ADP
bptjm-30	72	12	mdd23,24	mdd23,24	PROPN
bptjm-30	72	13	.	.	PUNCT
bptjm-30	73	1	berkeley	berkeley	PROPN
bptjm-30	73	2	pharma	pharma	PROPN
bptjm-30	73	3	tech	tech	PROPN
bptjm-30	73	4	journal	journal	NOUN
bptjm-30	73	5	of	of	ADP
bptjm-30	73	6	medicine	medicine	NOUN
bptjm-30	73	7	|	|	ADV
bptjm-30	73	8	26	26	NUM
bptjm-30	73	9	figure	figure	NOUN
bptjm-30	73	10	1	1	NUM
bptjm-30	73	11	:	:	PUNCT
bptjm-30	73	12	mechanism	mechanism	NOUN
bptjm-30	73	13	of	of	ADP
bptjm-30	73	14	selective	selective	ADJ
bptjm-30	73	15	serotonin	serotonin	NOUN
bptjm-30	73	16	reuptake	reuptake	NOUN
bptjm-30	73	17	inhibitors	inhibitor	NOUN
bptjm-30	73	18	(	(	PUNCT
bptjm-30	73	19	ssris	ssris	NOUN
bptjm-30	73	20	)	)	PUNCT
bptjm-30	73	21	.	.	PUNCT
bptjm-30	74	1	when	when	SCONJ
bptjm-30	74	2	serotonin	serotonin	NOUN
bptjm-30	74	3	is	be	AUX
bptjm-30	74	4	released	release	VERB
bptjm-30	74	5	from	from	ADP
bptjm-30	74	6	a	a	DET
bptjm-30	74	7	presynaptic	presynaptic	ADJ
bptjm-30	74	8	cell	cell	NOUN
bptjm-30	74	9	into	into	ADP
bptjm-30	74	10	the	the	DET
bptjm-30	74	11	synapse	synapse	NOUN
bptjm-30	74	12	it	it	PRON
bptjm-30	74	13	can	can	AUX
bptjm-30	74	14	then	then	ADV
bptjm-30	74	15	bind	bind	VERB
bptjm-30	74	16	to	to	ADP
bptjm-30	74	17	5	5	NUM
bptjm-30	74	18	-	-	PUNCT
bptjm-30	74	19	ht	ht	NOUN
bptjm-30	74	20	receptors	receptor	NOUN
bptjm-30	74	21	on	on	ADP
bptjm-30	74	22	the	the	DET
bptjm-30	74	23	postsynaptic	postsynaptic	ADJ
bptjm-30	74	24	cell	cell	NOUN
bptjm-30	74	25	.	.	PUNCT
bptjm-30	75	1	this	this	DET
bptjm-30	75	2	pathway	pathway	NOUN
bptjm-30	75	3	,	,	PUNCT
bptjm-30	75	4	as	as	SCONJ
bptjm-30	75	5	mentioned	mention	VERB
bptjm-30	75	6	before	before	ADV
bptjm-30	75	7	,	,	PUNCT
bptjm-30	75	8	is	be	AUX
bptjm-30	75	9	involved	involve	VERB
bptjm-30	75	10	with	with	ADP
bptjm-30	75	11	important	important	ADJ
bptjm-30	75	12	brain	brain	NOUN
bptjm-30	75	13	functions	function	NOUN
bptjm-30	75	14	such	such	ADJ
bptjm-30	75	15	as	as	ADP
bptjm-30	75	16	mood	mood	NOUN
bptjm-30	75	17	regulation	regulation	NOUN
bptjm-30	75	18	,	,	PUNCT
bptjm-30	75	19	sleep	sleep	NOUN
bptjm-30	75	20	,	,	PUNCT
bptjm-30	75	21	reward	reward	NOUN
bptjm-30	75	22	processing	processing	NOUN
bptjm-30	75	23	,	,	PUNCT
bptjm-30	75	24	and	and	CCONJ
bptjm-30	75	25	cardiac	cardiac	ADJ
bptjm-30	75	26	rhythm	rhythm	NOUN
bptjm-30	75	27	.	.	PUNCT
bptjm-30	76	1	synaptic	synaptic	ADJ
bptjm-30	76	2	serotonin	serotonin	NOUN
bptjm-30	76	3	can	can	AUX
bptjm-30	76	4	also	also	ADV
bptjm-30	76	5	be	be	AUX
bptjm-30	76	6	reabsorbed	reabsorb	VERB
bptjm-30	76	7	by	by	ADP
bptjm-30	76	8	the	the	DET
bptjm-30	76	9	presynaptic	presynaptic	ADJ
bptjm-30	76	10	cell	cell	NOUN
bptjm-30	76	11	through	through	ADP
bptjm-30	76	12	5	5	NUM
bptjm-30	76	13	-	-	PUNCT
bptjm-30	76	14	ht	ht	PROPN
bptjm-30	76	15	transporters	transporter	NOUN
bptjm-30	76	16	,	,	PUNCT
bptjm-30	76	17	causing	cause	VERB
bptjm-30	76	18	a	a	DET
bptjm-30	76	19	decrease	decrease	NOUN
bptjm-30	76	20	of	of	ADP
bptjm-30	76	21	serotonin	serotonin	VERB
bptjm-30	76	22	available	available	ADJ
bptjm-30	76	23	to	to	PART
bptjm-30	76	24	bind	bind	VERB
bptjm-30	76	25	to	to	ADP
bptjm-30	76	26	the	the	DET
bptjm-30	76	27	postsynaptic	postsynaptic	ADJ
bptjm-30	76	28	5	5	NUM
bptjm-30	76	29	-	-	PUNCT
bptjm-30	76	30	ht	ht	NOUN
bptjm-30	76	31	receptors	receptor	NOUN
bptjm-30	76	32	.	.	PUNCT
bptjm-30	77	1	as	as	SCONJ
bptjm-30	77	2	seen	see	VERB
bptjm-30	77	3	in	in	ADP
bptjm-30	77	4	the	the	DET
bptjm-30	77	5	figure	figure	NOUN
bptjm-30	77	6	above	above	ADV
bptjm-30	77	7	,	,	PUNCT
bptjm-30	77	8	ssris	ssris	PROPN
bptjm-30	77	9	block	block	VERB
bptjm-30	77	10	the	the	DET
bptjm-30	77	11	5	5	NUM
bptjm-30	77	12	-	-	PUNCT
bptjm-30	77	13	ht	ht	NOUN
bptjm-30	77	14	transporter	transporter	NOUN
bptjm-30	77	15	from	from	ADP
bptjm-30	77	16	reabsorbing	reabsorb	VERB
bptjm-30	77	17	serotonin	serotonin	NOUN
bptjm-30	77	18	,	,	PUNCT
bptjm-30	77	19	therefore	therefore	ADV
bptjm-30	77	20	increasing	increase	VERB
bptjm-30	77	21	the	the	DET
bptjm-30	77	22	concentration	concentration	NOUN
bptjm-30	77	23	of	of	ADP
bptjm-30	77	24	serotonin	serotonin	NOUN
bptjm-30	77	25	in	in	ADP
bptjm-30	77	26	the	the	DET
bptjm-30	77	27	synapse	synapse	NOUN
bptjm-30	77	28	that	that	PRON
bptjm-30	77	29	can	can	AUX
bptjm-30	77	30	bind	bind	VERB
bptjm-30	77	31	to	to	ADP
bptjm-30	77	32	postsynaptic	postsynaptic	ADJ
bptjm-30	77	33	5	5	NUM
bptjm-30	77	34	-	-	PUNCT
bptjm-30	77	35	ht	ht	NOUN
bptjm-30	77	36	receptors	receptor	NOUN
bptjm-30	77	37	.	.	PUNCT
bptjm-30	78	1	novel	novel	ADJ
bptjm-30	78	2	antidepressant	antidepressant	ADJ
bptjm-30	78	3	therapies	therapy	NOUN
bptjm-30	78	4	currently	currently	ADV
bptjm-30	78	5	being	be	AUX
bptjm-30	78	6	researched	research	VERB
bptjm-30	78	7	,	,	PUNCT
bptjm-30	78	8	such	such	ADJ
bptjm-30	78	9	as	as	ADP
bptjm-30	78	10	ketamine	ketamine	PROPN
bptjm-30	78	11	and	and	CCONJ
bptjm-30	78	12	psilocybin	psilocybin	NOUN
bptjm-30	78	13	,	,	PUNCT
bptjm-30	78	14	largely	largely	ADV
bptjm-30	78	15	function	function	VERB
bptjm-30	78	16	as	as	ADP
bptjm-30	78	17	receptor	receptor	NOUN
bptjm-30	78	18	agonists	agonist	NOUN
bptjm-30	78	19	and	and	CCONJ
bptjm-30	78	20	antagonists	antagonist	NOUN
bptjm-30	78	21	.	.	PUNCT
bptjm-30	79	1	receptor	receptor	NOUN
bptjm-30	79	2	agonists	agonist	NOUN
bptjm-30	79	3	activate	activate	VERB
bptjm-30	79	4	a	a	DET
bptjm-30	79	5	receptor	receptor	NOUN
bptjm-30	79	6	to	to	PART
bptjm-30	79	7	produce	produce	VERB
bptjm-30	79	8	a	a	DET
bptjm-30	79	9	response	response	NOUN
bptjm-30	79	10	,	,	PUNCT
bptjm-30	79	11	which	which	PRON
bptjm-30	79	12	results	result	VERB
bptjm-30	79	13	in	in	ADP
bptjm-30	79	14	increased	increase	VERB
bptjm-30	79	15	receptor	receptor	NOUN
bptjm-30	79	16	functionality	functionality	NOUN
bptjm-30	79	17	/	/	SYM
bptjm-30	79	18	activation	activation	NOUN
bptjm-30	79	19	.	.	PUNCT
bptjm-30	80	1	psilocybin	psilocybin	NOUN
bptjm-30	80	2	is	be	AUX
bptjm-30	80	3	an	an	DET
bptjm-30	80	4	example	example	NOUN
bptjm-30	80	5	of	of	ADP
bptjm-30	80	6	a	a	DET
bptjm-30	80	7	receptor	receptor	NOUN
bptjm-30	80	8	agonist	agonist	NOUN
bptjm-30	80	9	,	,	PUNCT
bptjm-30	80	10	specifically	specifically	ADV
bptjm-30	80	11	activating	activate	VERB
bptjm-30	80	12	5	5	NUM
bptjm-30	80	13	-	-	PUNCT
bptjm-30	80	14	ht2a	ht2a	NUM
bptjm-30	80	15	receptors	receptor	NOUN
bptjm-30	80	16	.	.	PUNCT
bptjm-30	81	1	receptor	receptor	NOUN
bptjm-30	81	2	antagonists	antagonist	NOUN
bptjm-30	81	3	are	be	AUX
bptjm-30	81	4	molecules	molecule	NOUN
bptjm-30	81	5	that	that	PRON
bptjm-30	81	6	block	block	NOUN
bptjm-30	81	7	receptors	receptor	NOUN
bptjm-30	81	8	to	to	PART
bptjm-30	81	9	prevent	prevent	VERB
bptjm-30	81	10	a	a	DET
bptjm-30	81	11	response	response	NOUN
bptjm-30	81	12	,	,	PUNCT
bptjm-30	81	13	which	which	PRON
bptjm-30	81	14	in	in	ADP
bptjm-30	81	15	turn	turn	NOUN
bptjm-30	81	16	can	can	AUX
bptjm-30	81	17	increase	increase	VERB
bptjm-30	81	18	neurotransmitter	neurotransmitter	NOUN
bptjm-30	81	19	concentrations	concentration	NOUN
bptjm-30	81	20	in	in	ADP
bptjm-30	81	21	the	the	DET
bptjm-30	81	22	synapses	synapsis	NOUN
bptjm-30	81	23	and	and	CCONJ
bptjm-30	81	24	increase	increase	VERB
bptjm-30	81	25	the	the	DET
bptjm-30	81	26	activity	activity	NOUN
bptjm-30	81	27	of	of	ADP
bptjm-30	81	28	different	different	ADJ
bptjm-30	81	29	receptor	receptor	NOUN
bptjm-30	81	30	-	-	PUNCT
bptjm-30	81	31	mediated	mediate	VERB
bptjm-30	81	32	pathways	pathway	NOUN
bptjm-30	81	33	,	,	PUNCT
bptjm-30	81	34	as	as	SCONJ
bptjm-30	81	35	seen	see	VERB
bptjm-30	81	36	with	with	ADP
bptjm-30	81	37	ketamine	ketamine	PROPN
bptjm-30	81	38	and	and	CCONJ
bptjm-30	81	39	the	the	DET
bptjm-30	81	40	nmda	nmda	ADJ
bptjm-30	81	41	receptor25,26	receptor25,26	NOUN
bptjm-30	81	42	.	.	PUNCT
bptjm-30	82	1	while	while	SCONJ
bptjm-30	82	2	treatments	treatment	NOUN
bptjm-30	82	3	of	of	ADP
bptjm-30	82	4	this	this	DET
bptjm-30	82	5	nature	nature	NOUN
bptjm-30	82	6	show	show	VERB
bptjm-30	82	7	promise	promise	NOUN
bptjm-30	82	8	in	in	ADP
bptjm-30	82	9	effectively	effectively	ADV
bptjm-30	82	10	treating	treat	VERB
bptjm-30	82	11	depression	depression	NOUN
bptjm-30	82	12	both	both	DET
bptjm-30	82	13	shortand	shortand	NOUN
bptjm-30	82	14	long	long	ADJ
bptjm-30	82	15	-	-	PUNCT
bptjm-30	82	16	term	term	NOUN
bptjm-30	82	17	,	,	PUNCT
bptjm-30	82	18	much	much	ADJ
bptjm-30	82	19	is	be	AUX
bptjm-30	82	20	still	still	ADV
bptjm-30	82	21	unknown	unknown	ADJ
bptjm-30	82	22	regarding	regard	VERB
bptjm-30	82	23	the	the	DET
bptjm-30	82	24	long	long	ADJ
bptjm-30	82	25	-	-	PUNCT
bptjm-30	82	26	term	term	NOUN
bptjm-30	82	27	adverse	adverse	ADJ
bptjm-30	82	28	effects	effect	NOUN
bptjm-30	82	29	and	and	CCONJ
bptjm-30	82	30	the	the	DET
bptjm-30	82	31	overall	overall	ADJ
bptjm-30	82	32	efficacy	efficacy	NOUN
bptjm-30	82	33	of	of	ADP
bptjm-30	82	34	repeated	repeat	VERB
bptjm-30	82	35	exposure	exposure	NOUN
bptjm-30	82	36	to	to	ADP
bptjm-30	82	37	these	these	DET
bptjm-30	82	38	drugs	drug	NOUN
bptjm-30	82	39	.	.	PUNCT
bptjm-30	83	1	the	the	DET
bptjm-30	83	2	specific	specific	ADJ
bptjm-30	83	3	concerns	concern	NOUN
bptjm-30	83	4	and	and	CCONJ
bptjm-30	83	5	research	research	NOUN
bptjm-30	83	6	required	require	VERB
bptjm-30	83	7	for	for	ADP
bptjm-30	83	8	these	these	DET
bptjm-30	83	9	drugs	drug	NOUN
bptjm-30	83	10	are	be	AUX
bptjm-30	83	11	discussed	discuss	VERB
bptjm-30	83	12	below	below	ADV
bptjm-30	83	13	.	.	PUNCT
bptjm-30	84	1	berkeley	berkeley	PROPN
bptjm-30	84	2	pharma	pharma	PROPN
bptjm-30	84	3	tech	tech	PROPN
bptjm-30	84	4	journal	journal	NOUN
bptjm-30	84	5	of	of	ADP
bptjm-30	84	6	medicine	medicine	NOUN
bptjm-30	84	7	|	|	ADV
bptjm-30	84	8	27	27	NUM
bptjm-30	84	9	figure	figure	NOUN
bptjm-30	84	10	2	2	NUM
bptjm-30	84	11	:	:	PUNCT
bptjm-30	84	12	ketamine	ketamine	VERB
bptjm-30	84	13	as	as	ADP
bptjm-30	84	14	a	a	DET
bptjm-30	84	15	receptor	receptor	NOUN
bptjm-30	84	16	antagonist	antagonist	NOUN
bptjm-30	84	17	.	.	PUNCT
bptjm-30	85	1	ketamine	ketamine	PROPN
bptjm-30	85	2	functions	function	NOUN
bptjm-30	85	3	as	as	ADP
bptjm-30	85	4	an	an	DET
bptjm-30	85	5	nmda	nmda	ADJ
bptjm-30	85	6	receptor	receptor	NOUN
bptjm-30	85	7	antagonist	antagonist	NOUN
bptjm-30	85	8	,	,	PUNCT
bptjm-30	85	9	blocking	block	VERB
bptjm-30	85	10	molecules	molecule	NOUN
bptjm-30	85	11	,	,	PUNCT
bptjm-30	85	12	such	such	ADJ
bptjm-30	85	13	as	as	ADP
bptjm-30	85	14	glutamate	glutamate	NOUN
bptjm-30	85	15	,	,	PUNCT
bptjm-30	85	16	from	from	ADP
bptjm-30	85	17	activating	activate	VERB
bptjm-30	85	18	the	the	DET
bptjm-30	85	19	receptor	receptor	NOUN
bptjm-30	85	20	.	.	PUNCT
bptjm-30	86	1	when	when	SCONJ
bptjm-30	86	2	the	the	DET
bptjm-30	86	3	nmda	nmda	ADJ
bptjm-30	86	4	receptor	receptor	NOUN
bptjm-30	86	5	is	be	AUX
bptjm-30	86	6	activated	activate	VERB
bptjm-30	86	7	on	on	ADP
bptjm-30	86	8	inhibitory	inhibitory	ADJ
bptjm-30	86	9	gaba	gaba	NOUN
bptjm-30	86	10	interneurons	interneuron	NOUN
bptjm-30	86	11	(	(	PUNCT
bptjm-30	86	12	left	leave	VERB
bptjm-30	86	13	figure	figure	NOUN
bptjm-30	86	14	)	)	PUNCT
bptjm-30	86	15	,	,	PUNCT
bptjm-30	86	16	it	it	PRON
bptjm-30	86	17	blocks	block	VERB
bptjm-30	86	18	the	the	DET
bptjm-30	86	19	release	release	NOUN
bptjm-30	86	20	of	of	ADP
bptjm-30	86	21	glutamate	glutamate	NOUN
bptjm-30	86	22	from	from	ADP
bptjm-30	86	23	nearby	nearby	ADJ
bptjm-30	86	24	neurons	neuron	NOUN
bptjm-30	86	25	and	and	CCONJ
bptjm-30	86	26	from	from	ADP
bptjm-30	86	27	activating	activate	VERB
bptjm-30	86	28	ampa	ampa	NOUN
bptjm-30	86	29	receptors	receptor	NOUN
bptjm-30	86	30	in	in	ADP
bptjm-30	86	31	postsynaptic	postsynaptic	ADJ
bptjm-30	86	32	neurons	neuron	NOUN
bptjm-30	86	33	.	.	PUNCT
bptjm-30	87	1	glutamate	glutamate	NOUN
bptjm-30	87	2	and	and	CCONJ
bptjm-30	87	3	the	the	DET
bptjm-30	87	4	ampa	ampa	NOUN
bptjm-30	87	5	receptor	receptor	NOUN
bptjm-30	87	6	are	be	AUX
bptjm-30	87	7	important	important	ADJ
bptjm-30	87	8	components	component	NOUN
bptjm-30	87	9	of	of	ADP
bptjm-30	87	10	the	the	DET
bptjm-30	87	11	glutamatergic	glutamatergic	ADJ
bptjm-30	87	12	system	system	NOUN
bptjm-30	87	13	,	,	PUNCT
bptjm-30	87	14	which	which	PRON
bptjm-30	87	15	is	be	AUX
bptjm-30	87	16	heavily	heavily	ADV
bptjm-30	87	17	linked	link	VERB
bptjm-30	87	18	with	with	ADP
bptjm-30	87	19	processes	process	NOUN
bptjm-30	87	20	of	of	ADP
bptjm-30	87	21	mood	mood	NOUN
bptjm-30	87	22	regulation	regulation	NOUN
bptjm-30	87	23	.	.	PUNCT
bptjm-30	88	1	when	when	SCONJ
bptjm-30	88	2	ketamine	ketamine	PROPN
bptjm-30	88	3	is	be	AUX
bptjm-30	88	4	present	present	ADJ
bptjm-30	88	5	(	(	PUNCT
bptjm-30	88	6	right	right	ADJ
bptjm-30	88	7	figure	figure	NOUN
bptjm-30	88	8	)	)	PUNCT
bptjm-30	88	9	it	it	PRON
bptjm-30	88	10	functions	function	VERB
bptjm-30	88	11	by	by	ADP
bptjm-30	88	12	blocking	block	VERB
bptjm-30	88	13	the	the	DET
bptjm-30	88	14	nmda	nmda	ADJ
bptjm-30	88	15	receptor	receptor	NOUN
bptjm-30	88	16	,	,	PUNCT
bptjm-30	88	17	therefore	therefore	ADV
bptjm-30	88	18	preventing	prevent	VERB
bptjm-30	88	19	the	the	DET
bptjm-30	88	20	inhibitory	inhibitory	ADJ
bptjm-30	88	21	effect	effect	NOUN
bptjm-30	88	22	of	of	ADP
bptjm-30	88	23	the	the	DET
bptjm-30	88	24	gaba	gaba	PROPN
bptjm-30	88	25	interneuron	interneuron	PROPN
bptjm-30	88	26	.	.	PUNCT
bptjm-30	89	1	this	this	PRON
bptjm-30	89	2	increases	increase	VERB
bptjm-30	89	3	the	the	DET
bptjm-30	89	4	amount	amount	NOUN
bptjm-30	89	5	of	of	ADP
bptjm-30	89	6	glutamate	glutamate	NOUN
bptjm-30	89	7	that	that	PRON
bptjm-30	89	8	is	be	AUX
bptjm-30	89	9	released	release	VERB
bptjm-30	89	10	into	into	ADP
bptjm-30	89	11	the	the	DET
bptjm-30	89	12	synapse	synapse	NOUN
bptjm-30	89	13	and	and	CCONJ
bptjm-30	89	14	preferentially	preferentially	ADV
bptjm-30	89	15	activates	activate	VERB
bptjm-30	89	16	the	the	DET
bptjm-30	89	17	ampa	ampa	NOUN
bptjm-30	89	18	receptors	receptor	NOUN
bptjm-30	89	19	,	,	PUNCT
bptjm-30	89	20	which	which	PRON
bptjm-30	89	21	causes	cause	VERB
bptjm-30	89	22	a	a	DET
bptjm-30	89	23	more	more	ADV
bptjm-30	89	24	rapid	rapid	ADJ
bptjm-30	89	25	cascade	cascade	NOUN
bptjm-30	89	26	reaction	reaction	NOUN
bptjm-30	89	27	and	and	CCONJ
bptjm-30	89	28	antidepressant	antidepressant	ADJ
bptjm-30	89	29	effect	effect	NOUN
bptjm-30	89	30	.	.	PUNCT
bptjm-30	90	1	berkeley	berkeley	PROPN
bptjm-30	90	2	pharma	pharma	PROPN
bptjm-30	90	3	tech	tech	PROPN
bptjm-30	90	4	journal	journal	NOUN
bptjm-30	90	5	of	of	ADP
bptjm-30	90	6	medicine	medicine	NOUN
bptjm-30	90	7	|	|	ADV
bptjm-30	90	8	28	28	NUM
bptjm-30	90	9	figure	figure	NOUN
bptjm-30	90	10	3	3	NUM
bptjm-30	90	11	:	:	PUNCT
bptjm-30	90	12	basic	basic	ADJ
bptjm-30	90	13	mechanism	mechanism	NOUN
bptjm-30	90	14	of	of	ADP
bptjm-30	90	15	receptor	receptor	NOUN
bptjm-30	90	16	agonists	agonist	NOUN
bptjm-30	90	17	.	.	PUNCT
bptjm-30	91	1	receptor	receptor	NOUN
bptjm-30	91	2	agonists	agonist	NOUN
bptjm-30	91	3	are	be	AUX
bptjm-30	91	4	molecules	molecule	NOUN
bptjm-30	91	5	that	that	PRON
bptjm-30	91	6	can	can	AUX
bptjm-30	91	7	function	function	VERB
bptjm-30	91	8	like	like	ADP
bptjm-30	91	9	neurotransmitters	neurotransmitter	NOUN
bptjm-30	91	10	and	and	CCONJ
bptjm-30	91	11	activate	activate	VERB
bptjm-30	91	12	certain	certain	ADJ
bptjm-30	91	13	receptors	receptor	NOUN
bptjm-30	91	14	,	,	PUNCT
bptjm-30	91	15	causing	cause	VERB
bptjm-30	91	16	a	a	DET
bptjm-30	91	17	cascade	cascade	NOUN
bptjm-30	91	18	of	of	ADP
bptjm-30	91	19	reactions	reaction	NOUN
bptjm-30	91	20	that	that	PRON
bptjm-30	91	21	ultimately	ultimately	ADV
bptjm-30	91	22	lead	lead	VERB
bptjm-30	91	23	to	to	ADP
bptjm-30	91	24	activation	activation	NOUN
bptjm-30	91	25	of	of	ADP
bptjm-30	91	26	other	other	ADJ
bptjm-30	91	27	receptors	receptor	NOUN
bptjm-30	91	28	or	or	CCONJ
bptjm-30	91	29	expression	expression	NOUN
bptjm-30	91	30	of	of	ADP
bptjm-30	91	31	specific	specific	ADJ
bptjm-30	91	32	genes	gene	NOUN
bptjm-30	91	33	and	and	CCONJ
bptjm-30	91	34	proteins	protein	NOUN
bptjm-30	91	35	.	.	PUNCT
bptjm-30	92	1	psilocybin	psilocybin	NOUN
bptjm-30	92	2	is	be	AUX
bptjm-30	92	3	an	an	DET
bptjm-30	92	4	example	example	NOUN
bptjm-30	92	5	of	of	ADP
bptjm-30	92	6	a	a	DET
bptjm-30	92	7	receptor	receptor	NOUN
bptjm-30	92	8	agonist	agonist	NOUN
bptjm-30	92	9	,	,	PUNCT
bptjm-30	92	10	which	which	PRON
bptjm-30	92	11	is	be	AUX
bptjm-30	92	12	displayed	display	VERB
bptjm-30	92	13	as	as	ADP
bptjm-30	92	14	the	the	DET
bptjm-30	92	15	red	red	ADJ
bptjm-30	92	16	diamond	diamond	NOUN
bptjm-30	92	17	in	in	ADP
bptjm-30	92	18	the	the	DET
bptjm-30	92	19	figure	figure	NOUN
bptjm-30	92	20	above	above	ADV
bptjm-30	92	21	.	.	PUNCT
bptjm-30	93	1	5	5	X
bptjm-30	93	2	.	.	X
bptjm-30	93	3	treatments	treatment	NOUN
bptjm-30	93	4	of	of	ADP
bptjm-30	93	5	interest	interest	NOUN
bptjm-30	93	6	and	and	CCONJ
bptjm-30	93	7	their	their	PRON
bptjm-30	93	8	efficacy	efficacy	NOUN
bptjm-30	93	9	in	in	ADP
bptjm-30	93	10	treating	treat	VERB
bptjm-30	93	11	the	the	DET
bptjm-30	93	12	different	different	ADJ
bptjm-30	93	13	forms	form	NOUN
bptjm-30	93	14	of	of	ADP
bptjm-30	93	15	treatmentresistant	treatmentresistant	ADJ
bptjm-30	93	16	depression	depression	NOUN
bptjm-30	93	17	5.1	5.1	NUM
bptjm-30	93	18	.	.	PUNCT
bptjm-30	94	1	ketamine	ketamine	PROPN
bptjm-30	94	2	as	as	ADP
bptjm-30	94	3	a	a	DET
bptjm-30	94	4	short	short	ADJ
bptjm-30	94	5	-	-	PUNCT
bptjm-30	94	6	term	term	NOUN
bptjm-30	94	7	therapeutic	therapeutic	ADJ
bptjm-30	94	8	option	option	NOUN
bptjm-30	94	9	there	there	PRON
bptjm-30	94	10	has	have	AUX
bptjm-30	94	11	been	be	AUX
bptjm-30	94	12	a	a	DET
bptjm-30	94	13	lot	lot	NOUN
bptjm-30	94	14	of	of	ADP
bptjm-30	94	15	recent	recent	ADJ
bptjm-30	94	16	research	research	NOUN
bptjm-30	94	17	utilizing	utilize	VERB
bptjm-30	94	18	ketamine	ketamine	PROPN
bptjm-30	94	19	as	as	ADP
bptjm-30	94	20	a	a	DET
bptjm-30	94	21	shortterm	shortterm	NOUN
bptjm-30	94	22	therapeutic	therapeutic	ADJ
bptjm-30	94	23	option	option	NOUN
bptjm-30	94	24	.	.	PUNCT
bptjm-30	95	1	ketamine	ketamine	PROPN
bptjm-30	95	2	gained	gain	VERB
bptjm-30	95	3	popularity	popularity	NOUN
bptjm-30	95	4	with	with	ADP
bptjm-30	95	5	its	its	PRON
bptjm-30	95	6	efficacy	efficacy	NOUN
bptjm-30	95	7	for	for	ADP
bptjm-30	95	8	treatment	treatment	NOUN
bptjm-30	95	9	-	-	PUNCT
bptjm-30	95	10	resistant	resistant	ADJ
bptjm-30	95	11	depression	depression	NOUN
bptjm-30	95	12	.	.	PUNCT
bptjm-30	96	1	due	due	ADP
bptjm-30	96	2	to	to	ADP
bptjm-30	96	3	its	its	PRON
bptjm-30	96	4	rapid	rapid	ADJ
bptjm-30	96	5	onset	onset	NOUN
bptjm-30	96	6	and	and	CCONJ
bptjm-30	96	7	short	short	ADJ
bptjm-30	96	8	duration	duration	NOUN
bptjm-30	96	9	of	of	ADP
bptjm-30	96	10	action	action	NOUN
bptjm-30	96	11	,	,	PUNCT
bptjm-30	96	12	ketamine	ketamine	PROPN
bptjm-30	96	13	has	have	VERB
bptjm-30	96	14	a	a	DET
bptjm-30	96	15	strong	strong	ADJ
bptjm-30	96	16	antidepressant	antidepressant	ADJ
bptjm-30	96	17	effect	effect	NOUN
bptjm-30	96	18	.	.	PUNCT
bptjm-30	97	1	as	as	SCONJ
bptjm-30	97	2	mentioned	mention	VERB
bptjm-30	97	3	earlier	early	ADV
bptjm-30	97	4	,	,	PUNCT
bptjm-30	97	5	ketamine	ketamine	PROPN
bptjm-30	97	6	is	be	AUX
bptjm-30	97	7	an	an	DET
bptjm-30	97	8	nmda	nmda	ADJ
bptjm-30	97	9	receptor	receptor	NOUN
bptjm-30	97	10	antagonist	antagonist	NOUN
bptjm-30	97	11	,	,	PUNCT
bptjm-30	97	12	therefore	therefore	ADV
bptjm-30	97	13	keeping	keep	VERB
bptjm-30	97	14	glutamate	glutamate	ADJ
bptjm-30	97	15	levels	level	NOUN
bptjm-30	97	16	higher	high	ADJ
bptjm-30	97	17	.	.	PUNCT
bptjm-30	98	1	ketamine	ketamine	PROPN
bptjm-30	98	2	affects	affect	VERB
bptjm-30	98	3	glutamate	glutamate	ADJ
bptjm-30	98	4	levels	level	NOUN
bptjm-30	98	5	,	,	PUNCT
bptjm-30	98	6	essentially	essentially	ADV
bptjm-30	98	7	targeting	target	VERB
bptjm-30	98	8	a	a	DET
bptjm-30	98	9	neurotransmitter	neurotransmitter	NOUN
bptjm-30	98	10	different	different	ADJ
bptjm-30	98	11	from	from	ADP
bptjm-30	98	12	most	most	ADJ
bptjm-30	98	13	common	common	ADJ
bptjm-30	98	14	neurotransmitters	neurotransmitter	NOUN
bptjm-30	98	15	targeted	target	VERB
bptjm-30	98	16	with	with	ADP
bptjm-30	98	17	conventional	conventional	ADJ
bptjm-30	98	18	antidepressants27	antidepressants27	NOUN
bptjm-30	98	19	.	.	PUNCT
bptjm-30	99	1	increased	increase	VERB
bptjm-30	99	2	glutamate	glutamate	NOUN
bptjm-30	99	3	levels	level	NOUN
bptjm-30	99	4	result	result	VERB
bptjm-30	99	5	in	in	ADP
bptjm-30	99	6	berkeley	berkeley	PROPN
bptjm-30	99	7	pharma	pharma	PROPN
bptjm-30	99	8	tech	tech	NOUN
bptjm-30	99	9	journal	journal	NOUN
bptjm-30	99	10	of	of	ADP
bptjm-30	99	11	medicine	medicine	NOUN
bptjm-30	99	12	|	|	ADV
bptjm-30	99	13	29	29	NUM
bptjm-30	99	14	lessened	lessen	VERB
bptjm-30	99	15	depressive	depressive	ADJ
bptjm-30	99	16	effects	effect	NOUN
bptjm-30	99	17	as	as	SCONJ
bptjm-30	99	18	scientific	scientific	ADJ
bptjm-30	99	19	research	research	NOUN
bptjm-30	99	20	confirms	confirm	VERB
bptjm-30	99	21	the	the	DET
bptjm-30	99	22	involvement	involvement	NOUN
bptjm-30	99	23	of	of	ADP
bptjm-30	99	24	the	the	DET
bptjm-30	99	25	glutamatergic	glutamatergic	ADJ
bptjm-30	99	26	system	system	NOUN
bptjm-30	99	27	in	in	ADP
bptjm-30	99	28	the	the	DET
bptjm-30	99	29	processes	process	NOUN
bptjm-30	99	30	of	of	ADP
bptjm-30	99	31	mood	mood	NOUN
bptjm-30	99	32	regulation	regulation	NOUN
bptjm-30	99	33	.	.	PUNCT
bptjm-30	100	1	in	in	ADP
bptjm-30	100	2	addition	addition	NOUN
bptjm-30	100	3	,	,	PUNCT
bptjm-30	100	4	the	the	DET
bptjm-30	100	5	glutamatergic	glutamatergic	ADJ
bptjm-30	100	6	system	system	NOUN
bptjm-30	100	7	is	be	AUX
bptjm-30	100	8	involved	involve	VERB
bptjm-30	100	9	in	in	ADP
bptjm-30	100	10	neuroplasticity	neuroplasticity	NOUN
bptjm-30	100	11	processes28	processes28	NOUN
bptjm-30	100	12	,	,	PUNCT
bptjm-30	100	13	such	such	ADJ
bptjm-30	100	14	as	as	ADP
bptjm-30	100	15	the	the	DET
bptjm-30	100	16	formation	formation	NOUN
bptjm-30	100	17	of	of	ADP
bptjm-30	100	18	synapses	synapsis	NOUN
bptjm-30	100	19	and	and	CCONJ
bptjm-30	100	20	the	the	DET
bptjm-30	100	21	regulation	regulation	NOUN
bptjm-30	100	22	of	of	ADP
bptjm-30	100	23	memory	memory	NOUN
bptjm-30	100	24	.	.	PUNCT
bptjm-30	101	1	however	however	ADV
bptjm-30	101	2	,	,	PUNCT
bptjm-30	101	3	other	other	ADJ
bptjm-30	101	4	nmda	nmda	ADJ
bptjm-30	101	5	receptor	receptor	NOUN
bptjm-30	101	6	antagonists	antagonist	NOUN
bptjm-30	101	7	do	do	AUX
bptjm-30	101	8	not	not	PART
bptjm-30	101	9	have	have	VERB
bptjm-30	101	10	the	the	DET
bptjm-30	101	11	same	same	ADJ
bptjm-30	101	12	fast	fast	ADV
bptjm-30	101	13	-	-	PUNCT
bptjm-30	101	14	acting	act	VERB
bptjm-30	101	15	effects	effect	NOUN
bptjm-30	101	16	,	,	PUNCT
bptjm-30	101	17	which	which	PRON
bptjm-30	101	18	suggests	suggest	VERB
bptjm-30	101	19	something	something	PRON
bptjm-30	101	20	else	else	ADV
bptjm-30	101	21	makes	make	VERB
bptjm-30	101	22	ketamine	ketamine	PROPN
bptjm-30	101	23	successful	successful	ADJ
bptjm-30	101	24	–	–	PUNCT
bptjm-30	101	25	ketamine	ketamine	PROPN
bptjm-30	101	26	metabolites29	metabolites29	PROPN
bptjm-30	101	27	,	,	PUNCT
bptjm-30	101	28	depending	depend	VERB
bptjm-30	101	29	on	on	ADP
bptjm-30	101	30	its	its	PRON
bptjm-30	101	31	structure	structure	NOUN
bptjm-30	101	32	and	and	CCONJ
bptjm-30	101	33	chemistry	chemistry	NOUN
bptjm-30	101	34	.	.	PUNCT
bptjm-30	102	1	ketamine	ketamine	PROPN
bptjm-30	102	2	also	also	ADV
bptjm-30	102	3	acts	act	VERB
bptjm-30	102	4	on	on	ADP
bptjm-30	102	5	the	the	DET
bptjm-30	102	6	mtor	mtor	PROPN
bptjm-30	102	7	pathway30	pathway30	NOUN
bptjm-30	102	8	,	,	PUNCT
bptjm-30	102	9	ampa	ampa	NOUN
bptjm-30	102	10	receptors	receptor	NOUN
bptjm-30	102	11	and	and	CCONJ
bptjm-30	102	12	even	even	ADV
bptjm-30	102	13	the	the	DET
bptjm-30	102	14	opioid	opioid	ADJ
bptjm-30	102	15	receptors	receptor	NOUN
bptjm-30	102	16	in	in	ADP
bptjm-30	102	17	the	the	DET
bptjm-30	102	18	brain	brain	NOUN
bptjm-30	102	19	.	.	PUNCT
bptjm-30	103	1	the	the	DET
bptjm-30	103	2	mtor	mtor	PROPN
bptjm-30	103	3	pathway	pathway	NOUN
bptjm-30	103	4	is	be	AUX
bptjm-30	103	5	involved	involve	VERB
bptjm-30	103	6	in	in	ADP
bptjm-30	103	7	cell	cell	NOUN
bptjm-30	103	8	proliferation	proliferation	NOUN
bptjm-30	103	9	,	,	PUNCT
bptjm-30	103	10	mortality	mortality	NOUN
bptjm-30	103	11	,	,	PUNCT
bptjm-30	103	12	survival	survival	NOUN
bptjm-30	103	13	,	,	PUNCT
bptjm-30	103	14	and	and	CCONJ
bptjm-30	103	15	protein	protein	NOUN
bptjm-30	103	16	synthesis	synthesis	NOUN
bptjm-30	103	17	,	,	PUNCT
bptjm-30	103	18	resulting	result	VERB
bptjm-30	103	19	in	in	ADP
bptjm-30	103	20	the	the	DET
bptjm-30	103	21	growth	growth	NOUN
bptjm-30	103	22	of	of	ADP
bptjm-30	103	23	new	new	ADJ
bptjm-30	103	24	neural	neural	ADJ
bptjm-30	103	25	connections	connection	NOUN
bptjm-30	103	26	,	,	PUNCT
bptjm-30	103	27	and	and	CCONJ
bptjm-30	103	28	increasing	increase	VERB
bptjm-30	103	29	neuroplasticity	neuroplasticity	NOUN
bptjm-30	103	30	.	.	PUNCT
bptjm-30	104	1	clinical	clinical	ADJ
bptjm-30	104	2	trials	trial	NOUN
bptjm-30	104	3	have	have	AUX
bptjm-30	104	4	been	be	AUX
bptjm-30	104	5	done	do	VERB
bptjm-30	104	6	that	that	PRON
bptjm-30	104	7	show	show	VERB
bptjm-30	104	8	ketamine	ketamine	PROPN
bptjm-30	104	9	’s	’s	PART
bptjm-30	104	10	rapid	rapid	ADJ
bptjm-30	104	11	antidepressant	antidepressant	ADJ
bptjm-30	104	12	effects	effect	NOUN
bptjm-30	104	13	.	.	PUNCT
bptjm-30	105	1	in	in	ADP
bptjm-30	105	2	one	one	NUM
bptjm-30	105	3	study	study	NOUN
bptjm-30	105	4	,	,	PUNCT
bptjm-30	105	5	twenty	twenty	NUM
bptjm-30	105	6	-	-	PUNCT
bptjm-30	105	7	five	five	NUM
bptjm-30	105	8	males	male	NOUN
bptjm-30	105	9	were	be	AUX
bptjm-30	105	10	given	give	VERB
bptjm-30	105	11	one	one	NUM
bptjm-30	105	12	dose	dose	NOUN
bptjm-30	105	13	of	of	ADP
bptjm-30	105	14	ketamine	ketamine	PROPN
bptjm-30	105	15	and	and	CCONJ
bptjm-30	105	16	its	its	PRON
bptjm-30	105	17	changing	change	VERB
bptjm-30	105	18	effects	effect	NOUN
bptjm-30	105	19	were	be	AUX
bptjm-30	105	20	measured	measure	VERB
bptjm-30	105	21	over	over	ADP
bptjm-30	105	22	time	time	NOUN
bptjm-30	105	23	,	,	PUNCT
bptjm-30	105	24	starting	start	VERB
bptjm-30	105	25	baseline	baseline	NOUN
bptjm-30	105	26	at	at	ADP
bptjm-30	105	27	1	1	NUM
bptjm-30	105	28	h	h	NOUN
bptjm-30	105	29	and	and	CCONJ
bptjm-30	105	30	2	2	NUM
bptjm-30	105	31	weeks	week	NOUN
bptjm-30	105	32	after	after	ADP
bptjm-30	105	33	the	the	DET
bptjm-30	105	34	last	last	ADJ
bptjm-30	105	35	dose	dose	NOUN
bptjm-30	105	36	of	of	ADP
bptjm-30	105	37	ketamine	ketamine	PROPN
bptjm-30	105	38	,	,	PUNCT
bptjm-30	105	39	and	and	CCONJ
bptjm-30	105	40	1	1	NUM
bptjm-30	105	41	month	month	NOUN
bptjm-30	105	42	after	after	ADP
bptjm-30	105	43	the	the	DET
bptjm-30	105	44	last	last	ADJ
bptjm-30	105	45	dose31	dose31	NOUN
bptjm-30	105	46	.	.	PUNCT
bptjm-30	106	1	the	the	DET
bptjm-30	106	2	table	table	NOUN
bptjm-30	106	3	between	between	ADP
bptjm-30	106	4	the	the	DET
bptjm-30	106	5	three	three	NUM
bptjm-30	106	6	pairs	pair	NOUN
bptjm-30	106	7	are	be	AUX
bptjm-30	106	8	shown	show	VERB
bptjm-30	106	9	below	below	ADP
bptjm-30	106	10	.	.	PUNCT
bptjm-30	107	1	berkeley	berkeley	PROPN
bptjm-30	107	2	pharma	pharma	PROPN
bptjm-30	107	3	tech	tech	PROPN
bptjm-30	107	4	journal	journal	NOUN
bptjm-30	107	5	of	of	ADP
bptjm-30	107	6	medicine	medicine	NOUN
bptjm-30	107	7	|	|	ADV
bptjm-30	107	8	30	30	NUM
bptjm-30	107	9	hamilton	hamilton	NOUN
bptjm-30	107	10	rating	rating	NOUN
bptjm-30	107	11	depression	depression	NOUN
bptjm-30	107	12	scale	scale	NOUN
bptjm-30	107	13	mean	mean	NOUN
bptjm-30	107	14	±	±	NUM
bptjm-30	107	15	sd	sd	ADP
bptjm-30	107	16	pair	pair	NOUN
bptjm-30	107	17	1	1	NUM
bptjm-30	107	18	:	:	PUNCT
bptjm-30	107	19	depression	depression	NOUN
bptjm-30	107	20	baseline	baseline	VERB
bptjm-30	107	21	23.40	23.40	NUM
bptjm-30	107	22	±	±	NUM
bptjm-30	107	23	5.38	5.38	NUM
bptjm-30	107	24	after	after	ADP
bptjm-30	107	25	1	1	NUM
bptjm-30	107	26	hr	hr	NOUN
bptjm-30	107	27	.	.	PROPN
bptjm-30	107	28	of	of	ADP
bptjm-30	107	29	ketamine	ketamine	PROPN
bptjm-30	107	30	dose	dose	VERB
bptjm-30	107	31	21.20	21.20	NUM
bptjm-30	107	32	±	±	NUM
bptjm-30	107	33	6.34	6.34	NUM
bptjm-30	107	34	pair	pair	NOUN
bptjm-30	107	35	2	2	NUM
bptjm-30	107	36	:	:	PUNCT
bptjm-30	107	37	depression	depression	NOUN
bptjm-30	107	38	baseline	baseline	VERB
bptjm-30	107	39	23.40	23.40	NUM
bptjm-30	107	40	±	±	NUM
bptjm-30	107	41	5.38	5.38	NUM
bptjm-30	107	42	after	after	ADP
bptjm-30	107	43	2	2	NUM
bptjm-30	107	44	weeks	week	NOUN
bptjm-30	107	45	of	of	ADP
bptjm-30	107	46	ketamine	ketamine	PROPN
bptjm-30	107	47	dose	dose	VERB
bptjm-30	107	48	10.25	10.25	NUM
bptjm-30	107	49	±	±	NUM
bptjm-30	107	50	6.40	6.40	NUM
bptjm-30	107	51	pair	pair	NOUN
bptjm-30	107	52	3	3	NUM
bptjm-30	107	53	:	:	PUNCT
bptjm-30	107	54	depression	depression	NOUN
bptjm-30	107	55	baseline	baseline	VERB
bptjm-30	107	56	23.40	23.40	NUM
bptjm-30	107	57	±	±	NUM
bptjm-30	107	58	5.38	5.38	NUM
bptjm-30	107	59	after	after	ADP
bptjm-30	107	60	1	1	NUM
bptjm-30	107	61	month	month	NOUN
bptjm-30	107	62	of	of	ADP
bptjm-30	107	63	ketamine	ketamine	PROPN
bptjm-30	107	64	dose	dose	VERB
bptjm-30	107	65	10.45	10.45	NUM
bptjm-30	107	66	+8.47	+8.47	PROPN
bptjm-30	107	67	table	table	NOUN
bptjm-30	107	68	1	1	NUM
bptjm-30	107	69	:	:	PUNCT
bptjm-30	107	70	effect	effect	NOUN
bptjm-30	107	71	of	of	ADP
bptjm-30	107	72	ketamine	ketamine	PROPN
bptjm-30	107	73	treatment	treatment	NOUN
bptjm-30	107	74	over	over	ADP
bptjm-30	107	75	time	time	NOUN
bptjm-30	107	76	:	:	PUNCT
bptjm-30	107	77	changes	change	NOUN
bptjm-30	107	78	in	in	ADP
bptjm-30	107	79	the	the	DET
bptjm-30	107	80	hamilton	hamilton	PROPN
bptjm-30	107	81	rating	rating	NOUN
bptjm-30	107	82	scale	scale	NOUN
bptjm-30	107	83	for	for	ADP
bptjm-30	107	84	depression	depression	NOUN
bptjm-30	107	85	scores	score	NOUN
bptjm-30	107	86	.	.	PUNCT
bptjm-30	108	1	the	the	DET
bptjm-30	108	2	hamilton	hamilton	PROPN
bptjm-30	108	3	depression	depression	PROPN
bptjm-30	108	4	rating	rating	NOUN
bptjm-30	108	5	scale	scale	NOUN
bptjm-30	108	6	is	be	AUX
bptjm-30	108	7	the	the	DET
bptjm-30	108	8	most	most	ADV
bptjm-30	108	9	used	use	VERB
bptjm-30	108	10	administered	administer	VERB
bptjm-30	108	11	depression	depression	NOUN
bptjm-30	108	12	scale	scale	NOUN
bptjm-30	108	13	,	,	PUNCT
bptjm-30	108	14	with	with	ADP
bptjm-30	108	15	a	a	DET
bptjm-30	108	16	higher	high	ADJ
bptjm-30	108	17	rating	rating	NOUN
bptjm-30	108	18	indicating	indicate	VERB
bptjm-30	108	19	higher	high	ADJ
bptjm-30	108	20	depressive	depressive	ADJ
bptjm-30	108	21	levels	level	NOUN
bptjm-30	108	22	in	in	ADP
bptjm-30	108	23	a	a	DET
bptjm-30	108	24	patient31	patient31	NOUN
bptjm-30	108	25	.	.	PUNCT
bptjm-30	109	1	from	from	ADP
bptjm-30	109	2	the	the	DET
bptjm-30	109	3	table	table	NOUN
bptjm-30	109	4	,	,	PUNCT
bptjm-30	109	5	it	it	PRON
bptjm-30	109	6	is	be	AUX
bptjm-30	109	7	clear	clear	ADJ
bptjm-30	109	8	that	that	SCONJ
bptjm-30	109	9	the	the	DET
bptjm-30	109	10	mean	mean	ADJ
bptjm-30	109	11	reduction	reduction	NOUN
bptjm-30	109	12	of	of	ADP
bptjm-30	109	13	depression	depression	NOUN
bptjm-30	109	14	scores	score	NOUN
bptjm-30	109	15	decreased	decrease	VERB
bptjm-30	109	16	,	,	PUNCT
bptjm-30	109	17	with	with	ADP
bptjm-30	109	18	the	the	DET
bptjm-30	109	19	most	most	ADV
bptjm-30	109	20	notable	notable	ADJ
bptjm-30	109	21	change	change	NOUN
bptjm-30	109	22	being	be	AUX
bptjm-30	109	23	at	at	ADP
bptjm-30	109	24	the	the	DET
bptjm-30	109	25	two	two	NUM
bptjm-30	109	26	-	-	PUNCT
bptjm-30	109	27	week	week	NOUN
bptjm-30	109	28	mark31	mark31	NOUN
bptjm-30	109	29	.	.	PUNCT
bptjm-30	110	1	however	however	ADV
bptjm-30	110	2	,	,	PUNCT
bptjm-30	110	3	after	after	ADP
bptjm-30	110	4	one	one	NUM
bptjm-30	110	5	month	month	NOUN
bptjm-30	110	6	of	of	ADP
bptjm-30	110	7	ketamine	ketamine	PROPN
bptjm-30	110	8	doses	dose	NOUN
bptjm-30	110	9	,	,	PUNCT
bptjm-30	110	10	the	the	DET
bptjm-30	110	11	numbers	number	NOUN
bptjm-30	110	12	do	do	AUX
bptjm-30	110	13	not	not	PART
bptjm-30	110	14	drop	drop	VERB
bptjm-30	110	15	–	–	PUNCT
bptjm-30	110	16	they	they	PRON
bptjm-30	110	17	stay	stay	VERB
bptjm-30	110	18	roughly	roughly	ADV
bptjm-30	110	19	the	the	DET
bptjm-30	110	20	same	same	ADJ
bptjm-30	110	21	.	.	PUNCT
bptjm-30	111	1	this	this	DET
bptjm-30	111	2	data	datum	NOUN
bptjm-30	111	3	indicates	indicate	VERB
bptjm-30	111	4	that	that	SCONJ
bptjm-30	111	5	ketamine	ketamine	PROPN
bptjm-30	111	6	’s	’s	PART
bptjm-30	111	7	effects	effect	NOUN
bptjm-30	111	8	,	,	PUNCT
bptjm-30	111	9	though	though	SCONJ
bptjm-30	111	10	powerful	powerful	ADJ
bptjm-30	111	11	and	and	CCONJ
bptjm-30	111	12	promising	promising	ADJ
bptjm-30	111	13	,	,	PUNCT
bptjm-30	111	14	are	be	AUX
bptjm-30	111	15	relatively	relatively	ADV
bptjm-30	111	16	short	short	ADJ
bptjm-30	111	17	-	-	PUNCT
bptjm-30	111	18	term31	term31	NOUN
bptjm-30	111	19	.	.	PUNCT
bptjm-30	112	1	5.2	5.2	NUM
bptjm-30	112	2	.	.	PUNCT
bptjm-30	112	3	psilocybin	psilocybin	NOUN
bptjm-30	112	4	as	as	ADP
bptjm-30	112	5	a	a	DET
bptjm-30	112	6	long	long	ADJ
bptjm-30	112	7	-	-	PUNCT
bptjm-30	112	8	term	term	NOUN
bptjm-30	112	9	treatment	treatment	NOUN
bptjm-30	112	10	option	option	NOUN
bptjm-30	112	11	psilocybin	psilocybin	NOUN
bptjm-30	112	12	is	be	AUX
bptjm-30	112	13	a	a	DET
bptjm-30	112	14	naturally	naturally	ADV
bptjm-30	112	15	occurring	occur	VERB
bptjm-30	112	16	hallucinogen	hallucinogen	NOUN
bptjm-30	112	17	that	that	PRON
bptjm-30	112	18	has	have	AUX
bptjm-30	112	19	recently	recently	ADV
bptjm-30	112	20	been	be	AUX
bptjm-30	112	21	identified	identify	VERB
bptjm-30	112	22	as	as	ADP
bptjm-30	112	23	a	a	DET
bptjm-30	112	24	potential	potential	ADJ
bptjm-30	112	25	long	long	ADJ
bptjm-30	112	26	-	-	PUNCT
bptjm-30	112	27	term	term	NOUN
bptjm-30	112	28	therapeutic	therapeutic	ADJ
bptjm-30	112	29	option	option	NOUN
bptjm-30	112	30	for	for	ADP
bptjm-30	112	31	depression	depression	NOUN
bptjm-30	112	32	.	.	PUNCT
bptjm-30	113	1	psilocybin	psilocybin	NOUN
bptjm-30	113	2	acts	act	VERB
bptjm-30	113	3	as	as	ADP
bptjm-30	113	4	a	a	DET
bptjm-30	113	5	5	5	NUM
bptjm-30	113	6	-	-	PUNCT
bptjm-30	113	7	ht2a	ht2a	NOUN
bptjm-30	113	8	receptor	receptor	NOUN
bptjm-30	113	9	agonist	agonist	NOUN
bptjm-30	113	10	,	,	PUNCT
bptjm-30	113	11	activating	activate	VERB
bptjm-30	113	12	the	the	DET
bptjm-30	113	13	receptor	receptor	NOUN
bptjm-30	113	14	that	that	PRON
bptjm-30	113	15	is	be	AUX
bptjm-30	113	16	involved	involve	VERB
bptjm-30	113	17	with	with	ADP
bptjm-30	113	18	mood	mood	NOUN
bptjm-30	113	19	,	,	PUNCT
bptjm-30	113	20	emotions	emotion	NOUN
bptjm-30	113	21	,	,	PUNCT
bptjm-30	113	22	thoughts	thought	NOUN
bptjm-30	113	23	,	,	PUNCT
bptjm-30	113	24	perceptions	perception	NOUN
bptjm-30	113	25	,	,	PUNCT
bptjm-30	113	26	etc	etc	X
bptjm-30	113	27	.	.	X
bptjm-30	113	28	32	32	NUM
bptjm-30	113	29	.	.	PUNCT
bptjm-30	113	30	by	by	ADP
bptjm-30	113	31	stimulating	stimulate	VERB
bptjm-30	113	32	5	5	NUM
bptjm-30	113	33	-	-	PUNCT
bptjm-30	113	34	ht2a	ht2a	NUM
bptjm-30	113	35	receptors	receptor	NOUN
bptjm-30	113	36	on	on	ADP
bptjm-30	113	37	large	large	ADJ
bptjm-30	113	38	glutamatergic	glutamatergic	ADJ
bptjm-30	113	39	pyramidal	pyramidal	ADJ
bptjm-30	113	40	cells	cell	NOUN
bptjm-30	113	41	,	,	PUNCT
bptjm-30	113	42	psilocybin	psilocybin	NOUN
bptjm-30	113	43	also	also	ADV
bptjm-30	113	44	increases	increase	VERB
bptjm-30	113	45	the	the	DET
bptjm-30	113	46	synaptic	synaptic	ADJ
bptjm-30	113	47	concentration	concentration	NOUN
bptjm-30	113	48	of	of	ADP
bptjm-30	113	49	glutamate	glutamate	NOUN
bptjm-30	113	50	in	in	ADP
bptjm-30	113	51	the	the	DET
bptjm-30	113	52	prefrontal	prefrontal	ADJ
bptjm-30	113	53	cortex	cortex	NOUN
bptjm-30	113	54	(	(	PUNCT
bptjm-30	113	55	pfc	pfc	NOUN
bptjm-30	113	56	)	)	PUNCT
bptjm-30	113	57	33	33	NUM
bptjm-30	113	58	.	.	PUNCT
bptjm-30	114	1	rather	rather	ADV
bptjm-30	114	2	than	than	ADP
bptjm-30	114	3	blocking	block	VERB
bptjm-30	114	4	the	the	DET
bptjm-30	114	5	reuptake	reuptake	NOUN
bptjm-30	114	6	of	of	ADP
bptjm-30	114	7	berkeley	berkeley	PROPN
bptjm-30	114	8	pharma	pharma	PROPN
bptjm-30	114	9	tech	tech	NOUN
bptjm-30	114	10	journal	journal	NOUN
bptjm-30	114	11	of	of	ADP
bptjm-30	114	12	medicine	medicine	NOUN
bptjm-30	114	13	|	|	ADV
bptjm-30	114	14	31	31	NUM
bptjm-30	114	15	neurotransmitters	neurotransmitter	NOUN
bptjm-30	114	16	to	to	PART
bptjm-30	114	17	increase	increase	VERB
bptjm-30	114	18	synaptic	synaptic	ADJ
bptjm-30	114	19	concentrations	concentration	NOUN
bptjm-30	114	20	like	like	ADP
bptjm-30	114	21	current	current	ADJ
bptjm-30	114	22	antidepressant	antidepressant	ADJ
bptjm-30	114	23	medications	medication	NOUN
bptjm-30	114	24	,	,	PUNCT
bptjm-30	114	25	psilocybin	psilocybin	NOUN
bptjm-30	114	26	directly	directly	ADV
bptjm-30	114	27	interacts	interact	VERB
bptjm-30	114	28	and	and	CCONJ
bptjm-30	114	29	activates	activate	VERB
bptjm-30	114	30	the	the	DET
bptjm-30	114	31	5ht2a	5ht2a	NUM
bptjm-30	114	32	receptor	receptor	NOUN
bptjm-30	114	33	to	to	PART
bptjm-30	114	34	induce	induce	VERB
bptjm-30	114	35	changes	change	NOUN
bptjm-30	114	36	in	in	ADP
bptjm-30	114	37	mood	mood	NOUN
bptjm-30	114	38	and	and	CCONJ
bptjm-30	114	39	thoughts32	thoughts32	NOUN
bptjm-30	114	40	.	.	PUNCT
bptjm-30	115	1	in	in	ADP
bptjm-30	115	2	december	december	PROPN
bptjm-30	115	3	2016	2016	NUM
bptjm-30	115	4	,	,	PUNCT
bptjm-30	115	5	a	a	DET
bptjm-30	115	6	randomized	randomized	ADJ
bptjm-30	115	7	,	,	PUNCT
bptjm-30	115	8	double	double	ADJ
bptjm-30	115	9	-	-	PUNCT
bptjm-30	115	10	blind	blind	ADJ
bptjm-30	115	11	clinical	clinical	ADJ
bptjm-30	115	12	trial	trial	NOUN
bptjm-30	115	13	involving	involve	VERB
bptjm-30	115	14	psilocybin	psilocybin	NOUN
bptjm-30	115	15	administration	administration	NOUN
bptjm-30	115	16	to	to	ADP
bptjm-30	115	17	patients	patient	NOUN
bptjm-30	115	18	with	with	ADP
bptjm-30	115	19	life	life	NOUN
bptjm-30	115	20	-	-	PUNCT
bptjm-30	115	21	threatening	threaten	VERB
bptjm-30	115	22	cancer	cancer	NOUN
bptjm-30	115	23	found	find	VERB
bptjm-30	115	24	that	that	SCONJ
bptjm-30	115	25	treatment	treatment	NOUN
bptjm-30	115	26	with	with	ADP
bptjm-30	115	27	a	a	DET
bptjm-30	115	28	high	high	ADJ
bptjm-30	115	29	dose	dose	NOUN
bptjm-30	115	30	of	of	ADP
bptjm-30	115	31	psilocybin	psilocybin	NOUN
bptjm-30	115	32	administered	administer	VERB
bptjm-30	115	33	under	under	ADP
bptjm-30	115	34	supportive	supportive	ADJ
bptjm-30	115	35	conditions	condition	NOUN
bptjm-30	115	36	reduced	reduce	VERB
bptjm-30	115	37	depressive	depressive	ADJ
bptjm-30	115	38	symptoms	symptom	NOUN
bptjm-30	115	39	in	in	ADP
bptjm-30	115	40	patients	patient	NOUN
bptjm-30	115	41	as	as	ADV
bptjm-30	115	42	quickly	quickly	ADV
bptjm-30	115	43	as	as	ADP
bptjm-30	115	44	1	1	NUM
bptjm-30	115	45	week	week	NOUN
bptjm-30	115	46	,	,	PUNCT
bptjm-30	115	47	with	with	ADP
bptjm-30	115	48	effects	effect	NOUN
bptjm-30	115	49	lasting	last	VERB
bptjm-30	115	50	up	up	ADP
bptjm-30	115	51	to	to	PART
bptjm-30	115	52	3	3	NUM
bptjm-30	115	53	months	month	NOUN
bptjm-30	115	54	in	in	ADP
bptjm-30	115	55	12	12	NUM
bptjm-30	115	56	patients	patient	NOUN
bptjm-30	115	57	.	.	PUNCT
bptjm-30	116	1	there	there	PRON
bptjm-30	116	2	was	be	VERB
bptjm-30	116	3	also	also	ADV
bptjm-30	116	4	a	a	DET
bptjm-30	116	5	decrease	decrease	NOUN
bptjm-30	116	6	in	in	ADP
bptjm-30	116	7	depressed	depressed	ADJ
bptjm-30	116	8	mood	mood	NOUN
bptjm-30	116	9	in	in	ADP
bptjm-30	116	10	some	some	DET
bptjm-30	116	11	patients	patient	NOUN
bptjm-30	116	12	at	at	ADP
bptjm-30	116	13	a	a	DET
bptjm-30	116	14	6	6	NUM
bptjm-30	116	15	month	month	NOUN
bptjm-30	116	16	follow	follow	NOUN
bptjm-30	116	17	-	-	PUNCT
bptjm-30	116	18	up34	up34	PROPN
bptjm-30	116	19	.	.	PUNCT
bptjm-30	117	1	numerous	numerous	ADJ
bptjm-30	117	2	adverse	adverse	ADJ
bptjm-30	117	3	effects	effect	NOUN
bptjm-30	117	4	were	be	AUX
bptjm-30	117	5	observed	observe	VERB
bptjm-30	117	6	,	,	PUNCT
bptjm-30	117	7	but	but	CCONJ
bptjm-30	117	8	none	none	NOUN
bptjm-30	117	9	were	be	AUX
bptjm-30	117	10	deemed	deem	VERB
bptjm-30	117	11	life	life	NOUN
bptjm-30	117	12	-	-	PUNCT
bptjm-30	117	13	threatening	threatening	ADJ
bptjm-30	117	14	.	.	PUNCT
bptjm-30	118	1	no	no	DET
bptjm-30	118	2	adverse	adverse	ADJ
bptjm-30	118	3	effects	effect	NOUN
bptjm-30	118	4	were	be	AUX
bptjm-30	118	5	displayed	display	VERB
bptjm-30	118	6	in	in	ADP
bptjm-30	118	7	patients	patient	NOUN
bptjm-30	118	8	after	after	SCONJ
bptjm-30	118	9	the	the	DET
bptjm-30	118	10	study	study	NOUN
bptjm-30	118	11	was	be	AUX
bptjm-30	118	12	concluded34	concluded34	NOUN
bptjm-30	118	13	.	.	PUNCT
bptjm-30	119	1	the	the	DET
bptjm-30	119	2	table	table	NOUN
bptjm-30	119	3	below	below	ADV
bptjm-30	119	4	shows	show	VERB
bptjm-30	119	5	the	the	DET
bptjm-30	119	6	results	result	NOUN
bptjm-30	119	7	of	of	ADP
bptjm-30	119	8	this	this	DET
bptjm-30	119	9	study	study	NOUN
bptjm-30	119	10	,	,	PUNCT
bptjm-30	119	11	with	with	ADP
bptjm-30	119	12	numerous	numerous	ADJ
bptjm-30	119	13	different	different	ADJ
bptjm-30	119	14	outcome	outcome	NOUN
bptjm-30	119	15	measures	measure	NOUN
bptjm-30	119	16	used	use	VERB
bptjm-30	119	17	to	to	PART
bptjm-30	119	18	evaluate	evaluate	VERB
bptjm-30	119	19	symptoms	symptom	NOUN
bptjm-30	119	20	of	of	ADP
bptjm-30	119	21	depression	depression	NOUN
bptjm-30	119	22	,	,	PUNCT
bptjm-30	119	23	anxiety	anxiety	NOUN
bptjm-30	119	24	,	,	PUNCT
bptjm-30	119	25	and	and	CCONJ
bptjm-30	119	26	overall	overall	ADJ
bptjm-30	119	27	mood	mood	NOUN
bptjm-30	119	28	.	.	PUNCT
bptjm-30	120	1	each	each	PRON
bptjm-30	120	2	of	of	ADP
bptjm-30	120	3	the	the	DET
bptjm-30	120	4	outcome	outcome	NOUN
bptjm-30	120	5	measures	measure	NOUN
bptjm-30	120	6	used	use	VERB
bptjm-30	120	7	is	be	AUX
bptjm-30	120	8	briefly	briefly	ADV
bptjm-30	120	9	explained	explain	VERB
bptjm-30	120	10	in	in	ADP
bptjm-30	120	11	the	the	DET
bptjm-30	120	12	table	table	NOUN
bptjm-30	120	13	.	.	PUNCT
bptjm-30	121	1	this	this	PRON
bptjm-30	121	2	was	be	AUX
bptjm-30	121	3	a	a	DET
bptjm-30	121	4	9month	9month	NUM
bptjm-30	121	5	study	study	NOUN
bptjm-30	121	6	performed	perform	VERB
bptjm-30	121	7	with	with	ADP
bptjm-30	121	8	56	56	NUM
bptjm-30	121	9	participants	participant	NOUN
bptjm-30	121	10	randomly	randomly	ADV
bptjm-30	121	11	assigned	assign	VERB
bptjm-30	121	12	to	to	ADP
bptjm-30	121	13	two	two	NUM
bptjm-30	121	14	groups	group	NOUN
bptjm-30	121	15	either	either	CCONJ
bptjm-30	121	16	receiving	receive	VERB
bptjm-30	121	17	high	high	ADJ
bptjm-30	121	18	doses	dose	NOUN
bptjm-30	121	19	or	or	CCONJ
bptjm-30	121	20	low	low	ADJ
bptjm-30	121	21	doses	dose	NOUN
bptjm-30	121	22	of	of	ADP
bptjm-30	121	23	psilocybin	psilocybin	NOUN
bptjm-30	121	24	;	;	PUNCT
bptjm-30	121	25	while	while	SCONJ
bptjm-30	121	26	the	the	DET
bptjm-30	121	27	results	result	NOUN
bptjm-30	121	28	of	of	ADP
bptjm-30	121	29	this	this	DET
bptjm-30	121	30	study	study	NOUN
bptjm-30	121	31	are	be	AUX
bptjm-30	121	32	promising	promise	VERB
bptjm-30	121	33	,	,	PUNCT
bptjm-30	121	34	there	there	PRON
bptjm-30	121	35	is	be	VERB
bptjm-30	121	36	a	a	DET
bptjm-30	121	37	need	need	NOUN
bptjm-30	121	38	for	for	SCONJ
bptjm-30	121	39	a	a	DET
bptjm-30	121	40	larger	large	ADJ
bptjm-30	121	41	and	and	CCONJ
bptjm-30	121	42	more	more	ADV
bptjm-30	121	43	diverse	diverse	ADJ
bptjm-30	121	44	patient	patient	ADJ
bptjm-30	121	45	population	population	NOUN
bptjm-30	121	46	to	to	PART
bptjm-30	121	47	fully	fully	ADV
bptjm-30	121	48	examine	examine	VERB
bptjm-30	121	49	the	the	DET
bptjm-30	121	50	effects	effect	NOUN
bptjm-30	121	51	of	of	ADP
bptjm-30	121	52	psilocybin	psilocybin	NOUN
bptjm-30	121	53	as	as	ADP
bptjm-30	121	54	an	an	DET
bptjm-30	121	55	antidepressant	antidepressant	NOUN
bptjm-30	121	56	.	.	PUNCT
bptjm-30	122	1	berkeley	berkeley	PROPN
bptjm-30	122	2	pharma	pharma	PROPN
bptjm-30	122	3	tech	tech	PROPN
bptjm-30	122	4	journal	journal	NOUN
bptjm-30	122	5	of	of	ADP
bptjm-30	122	6	medicine	medicine	NOUN
bptjm-30	122	7	|	|	ADV
bptjm-30	122	8	32	32	NUM
bptjm-30	122	9	measure	measure	NOUN
bptjm-30	122	10	group	group	NOUN
bptjm-30	122	11	baseline	baseline	VERB
bptjm-30	122	12	post	post	ADJ
bptjm-30	122	13	-	-	ADJ
bptjm-30	122	14	session	session	ADJ
bptjm-30	122	15	1	1	NUM
bptjm-30	122	16	post	post	NOUN
bptjm-30	122	17	-	-	NOUN
bptjm-30	122	18	session	session	ADJ
bptjm-30	122	19	2	2	NUM
bptjm-30	122	20	6	6	NUM
bptjm-30	122	21	months	month	NOUN
bptjm-30	122	22	grid	grid	NOUN
bptjm-30	122	23	-	-	PUNCT
bptjm-30	122	24	hamd-17	hamd-17	PROPN
bptjm-30	122	25	(	(	PUNCT
bptjm-30	122	26	depression)a	depression)a	NOUN
bptjm-30	122	27	low	low	ADV
bptjm-30	122	28	-	-	PUNCT
bptjm-30	122	29	dose	dose	NOUN
bptjm-30	122	30	1st	1st	NOUN
bptjm-30	122	31	22.32	22.32	NUM
bptjm-30	122	32	14.80	14.80	NUM
bptjm-30	122	33	6.50	6.50	NUM
bptjm-30	122	34	6.95	6.95	NUM
bptjm-30	122	35	high	high	ADV
bptjm-30	122	36	-	-	PUNCT
bptjm-30	122	37	dose	dose	NOUN
bptjm-30	122	38	1st	1st	NOUN
bptjm-30	122	39	22.84	22.84	NUM
bptjm-30	122	40	6.64	6.64	NUM
bptjm-30	122	41	6.52	6.52	NUM
bptjm-30	122	42	6.23	6.23	NUM
bptjm-30	122	43	beck	beck	NOUN
bptjm-30	122	44	depression	depression	NOUN
bptjm-30	122	45	inventory	inventory	NOUN
bptjm-30	122	46	(	(	PUNCT
bptjm-30	122	47	bdi)b	bdi)b	PROPN
bptjm-30	122	48	low	low	ADV
bptjm-30	122	49	-	-	PUNCT
bptjm-30	122	50	dose	dose	NOUN
bptjm-30	122	51	1st	1st	NOUN
bptjm-30	122	52	18.40	18.40	NUM
bptjm-30	122	53	12.92	12.92	NUM
bptjm-30	122	54	8.17	8.17	NUM
bptjm-30	122	55	8.00	8.00	NUM
bptjm-30	122	56	high	high	ADJ
bptjm-30	122	57	-	-	PUNCT
bptjm-30	122	58	dose	dose	NOUN
bptjm-30	122	59	1st	1st	NOUN
bptjm-30	122	60	17.77	17.77	NUM
bptjm-30	122	61	7.00	7.00	NUM
bptjm-30	122	62	5.80	5.80	NUM
bptjm-30	122	63	6.17	6.17	NUM
bptjm-30	122	64	hads	had	NOUN
bptjm-30	122	65	depressionc	depressionc	VERB
bptjm-30	122	66	low	low	ADJ
bptjm-30	122	67	-	-	PUNCT
bptjm-30	122	68	dose	dose	NOUN
bptjm-30	122	69	1st	1st	NOUN
bptjm-30	122	70	9.48	9.48	NUM
bptjm-30	122	71	6.04	6.04	NUM
bptjm-30	122	72	4.57	4.57	NUM
bptjm-30	122	73	4.64	4.64	NUM
bptjm-30	122	74	high	high	ADV
bptjm-30	122	75	-	-	PUNCT
bptjm-30	122	76	dose	dose	NOUN
bptjm-30	122	77	1st	1st	NOUN
bptjm-30	122	78	9.81	9.81	NUM
bptjm-30	122	79	3.92	3.92	NUM
bptjm-30	122	80	4.28	4.28	NUM
bptjm-30	122	81	3.46	3.46	NUM
bptjm-30	122	82	ham	ham	NOUN
bptjm-30	122	83	-	-	PUNCT
bptjm-30	122	84	a	a	PRON
bptjm-30	122	85	(	(	PUNCT
bptjm-30	122	86	anxiety)d	anxiety)d	SYM
bptjm-30	122	87	low	low	ADJ
bptjm-30	122	88	-	-	PUNCT
bptjm-30	122	89	dose	dose	NOUN
bptjm-30	122	90	1st	1st	NOUN
bptjm-30	122	91	25.68	25.68	NUM
bptjm-30	122	92	16.64	16.64	NUM
bptjm-30	122	93	8.92	8.92	NUM
bptjm-30	122	94	7.95	7.95	NUM
bptjm-30	122	95	high	high	ADJ
bptjm-30	122	96	-	-	PUNCT
bptjm-30	122	97	dose	dose	NOUN
bptjm-30	122	98	1st	1st	NOUN
bptjm-30	122	99	25.73	25.73	NUM
bptjm-30	122	100	8.48	8.48	NUM
bptjm-30	122	101	7.52	7.52	NUM
bptjm-30	122	102	7.04	7.04	NUM
bptjm-30	122	103	stai	stai	X
bptjm-30	122	104	-	-	PUNCT
bptjm-30	122	105	trait	trait	NOUN
bptjm-30	122	106	anxietye	anxietye	ADJ
bptjm-30	122	107	low	low	ADV
bptjm-30	122	108	-	-	PUNCT
bptjm-30	122	109	dose	dose	NOUN
bptjm-30	122	110	1st	1st	NOUN
bptjm-30	122	111	47.46	47.46	NUM
bptjm-30	122	112	40.48	40.48	NUM
bptjm-30	122	113	35.48	35.48	NUM
bptjm-30	122	114	36.83	36.83	NUM
bptjm-30	122	115	high	high	ADJ
bptjm-30	122	116	-	-	PUNCT
bptjm-30	122	117	dose	dose	NOUN
bptjm-30	122	118	1st	1st	NOUN
bptjm-30	122	119	47.73	47.73	NUM
bptjm-30	122	120	34.64	34.64	NUM
bptjm-30	122	121	34.28	34.28	NUM
bptjm-30	122	122	35.32	35.32	NUM
bptjm-30	122	123	poms	pom	NOUN
bptjm-30	122	124	total	total	VERB
bptjm-30	122	125	low	low	ADV
bptjm-30	122	126	-	-	PUNCT
bptjm-30	122	127	dose	dose	NOUN
bptjm-30	122	128	1st	1st	NOUN
bptjm-30	122	129	51.72	51.72	NUM
bptjm-30	122	130	42.48	42.48	NUM
bptjm-30	122	131	21.09	21.09	NUM
bptjm-30	122	132	23.50	23.50	NUM
bptjm-30	122	133	mood	mood	NOUN
bptjm-30	122	134	disturbancef	disturbancef	NOUN
bptjm-30	122	135	high	high	ADV
bptjm-30	122	136	-	-	PUNCT
bptjm-30	122	137	dose	dose	NOUN
bptjm-30	122	138	1st	1st	NOUN
bptjm-30	122	139	56.93	56.93	NUM
bptjm-30	122	140	18.96	18.96	NUM
bptjm-30	122	141	17.14	17.14	NUM
bptjm-30	122	142	12.52	12.52	NUM
bptjm-30	122	143	brief	brief	ADJ
bptjm-30	122	144	symptom	symptom	NOUN
bptjm-30	122	145	inventory	inventory	NOUN
bptjm-30	122	146	(	(	PUNCT
bptjm-30	122	147	bsi)g	bsi)g	ADP
bptjm-30	122	148	low	low	ADV
bptjm-30	122	149	-	-	PUNCT
bptjm-30	122	150	dose	dose	NOUN
bptjm-30	122	151	1st	1st	NOUN
bptjm-30	122	152	41.76	41.76	NUM
bptjm-30	122	153	33.74	33.74	NUM
bptjm-30	122	154	26.08	26.08	NUM
bptjm-30	122	155	23.50	23.50	NUM
bptjm-30	122	156	high	high	ADJ
bptjm-30	122	157	-	-	PUNCT
bptjm-30	122	158	dose	dose	NOUN
bptjm-30	122	159	1st	1st	NOUN
bptjm-30	122	160	40.19	40.19	NUM
bptjm-30	122	161	18.08	18.08	NUM
bptjm-30	122	162	16.48	16.48	NUM
bptjm-30	122	163	14.35	14.35	NUM
bptjm-30	122	164	mqol	mqol	NOUN
bptjm-30	122	165	(	(	PUNCT
bptjm-30	122	166	overall	overall	ADJ
bptjm-30	122	167	quality	quality	NOUN
bptjm-30	122	168	of	of	ADP
bptjm-30	122	169	life)h	life)h	NOUN
bptjm-30	122	170	low	low	ADV
bptjm-30	122	171	-	-	PUNCT
bptjm-30	122	172	dose	dose	NOUN
bptjm-30	122	173	1st	1st	NOUN
bptjm-30	122	174	5.69	5.69	NUM
bptjm-30	122	175	6.17	6.17	NUM
bptjm-30	122	176	6.90	6.90	NUM
bptjm-30	122	177	6.88	6.88	NUM
bptjm-30	122	178	high	high	ADJ
bptjm-30	122	179	-	-	PUNCT
bptjm-30	122	180	dose	dose	NOUN
bptjm-30	122	181	1st	1st	NOUN
bptjm-30	122	182	5.32	5.32	NUM
bptjm-30	122	183	7.14	7.14	NUM
bptjm-30	122	184	7.46	7.46	NUM
bptjm-30	122	185	7.65	7.65	NUM
bptjm-30	122	186	mqol	mqol	NOUN
bptjm-30	122	187	(	(	PUNCT
bptjm-30	122	188	meaningful	meaningful	ADJ
bptjm-30	122	189	existence)i	existence)i	NOUN
bptjm-30	122	190	low	low	ADV
bptjm-30	122	191	-	-	PUNCT
bptjm-30	122	192	dose	dose	NOUN
bptjm-30	122	193	1st	1st	NOUN
bptjm-30	122	194	6.03	6.03	NUM
bptjm-30	122	195	6.10	6.10	NUM
bptjm-30	122	196	7.30	7.30	NUM
bptjm-30	122	197	7.29	7.29	NUM
bptjm-30	122	198	high	high	ADJ
bptjm-30	122	199	-	-	PUNCT
bptjm-30	122	200	dose	dose	NOUN
bptjm-30	122	201	1st	1st	NOUN
bptjm-30	122	202	5.43	5.43	NUM
bptjm-30	122	203	7.23	7.23	NUM
bptjm-30	122	204	7.30	7.30	NUM
bptjm-30	122	205	7.62	7.62	NUM
bptjm-30	122	206	lot	lot	NOUN
bptjm-30	122	207	-	-	PUNCT
bptjm-30	122	208	r	r	NOUN
bptjm-30	122	209	optimismj	optimismj	NOUN
bptjm-30	122	210	low	low	ADV
bptjm-30	122	211	-	-	PUNCT
bptjm-30	122	212	dose	dose	NOUN
bptjm-30	122	213	1st	1st	NOUN
bptjm-30	122	214	13.56	13.56	NUM
bptjm-30	122	215	13.60	13.60	NUM
bptjm-30	122	216	15.96	15.96	NUM
bptjm-30	122	217	16.68	16.68	NUM
bptjm-30	122	218	high	high	ADJ
bptjm-30	122	219	-	-	PUNCT
bptjm-30	122	220	dose	dose	NOUN
bptjm-30	122	221	1st	1st	NOUN
bptjm-30	122	222	14.15	14.15	NUM
bptjm-30	122	223	17.23	17.23	NUM
bptjm-30	122	224	17.16	17.16	NUM
bptjm-30	122	225	17.43	17.43	NUM
bptjm-30	122	226	table	table	NOUN
bptjm-30	122	227	2	2	NUM
bptjm-30	122	228	:	:	PUNCT
bptjm-30	122	229	effects	effect	NOUN
bptjm-30	122	230	of	of	ADP
bptjm-30	122	231	psilocybin	psilocybin	NOUN
bptjm-30	122	232	.	.	PUNCT
bptjm-30	123	1	changes	change	NOUN
bptjm-30	123	2	in	in	ADP
bptjm-30	123	3	10	10	NUM
bptjm-30	123	4	different	different	ADJ
bptjm-30	123	5	outcome	outcome	NOUN
bptjm-30	123	6	measures	measure	NOUN
bptjm-30	123	7	/	/	SYM
bptjm-30	123	8	scales	scale	NOUN
bptjm-30	123	9	after	after	ADP
bptjm-30	123	10	session	session	NOUN
bptjm-30	123	11	1	1	NUM
bptjm-30	123	12	,	,	PUNCT
bptjm-30	123	13	2	2	NUM
bptjm-30	123	14	,	,	PUNCT
bptjm-30	123	15	and	and	CCONJ
bptjm-30	123	16	at	at	ADP
bptjm-30	123	17	a	a	DET
bptjm-30	123	18	6month	6month	NUM
bptjm-30	123	19	follow	follow	NOUN
bptjm-30	123	20	-	-	PUNCT
bptjm-30	123	21	up	up	NOUN
bptjm-30	123	22	in	in	ADP
bptjm-30	123	23	two	two	NUM
bptjm-30	123	24	groups	group	NOUN
bptjm-30	123	25	receiving	receive	VERB
bptjm-30	123	26	different	different	ADJ
bptjm-30	123	27	dosages	dosage	NOUN
bptjm-30	123	28	of	of	ADP
bptjm-30	123	29	psilocybin	psilocybin	NOUN
bptjm-30	123	30	.	.	PUNCT
bptjm-30	124	1	_	_	PUNCT
bptjm-30	125	1	_	_	PUNCT
bptjm-30	126	1	_	_	PUNCT
bptjm-30	127	1	_	_	PUNCT
bptjm-30	128	1	_	_	PUNCT
bptjm-30	129	1	_	_	PUNCT
bptjm-30	130	1	_	_	PUNCT
bptjm-30	131	1	_	_	PUNCT
bptjm-30	132	1	_	_	PUNCT
bptjm-30	133	1	_	_	PUNCT
bptjm-30	134	1	_	_	PUNCT
bptjm-30	135	1	_	_	PUNCT
bptjm-30	136	1	_	_	PUNCT
bptjm-30	137	1	_	_	PUNCT
bptjm-30	138	1	_	_	PUNCT
bptjm-30	139	1	_	_	PUNCT
bptjm-30	140	1	_	_	PUNCT
bptjm-30	140	2	_	_	PUNCT
bptjm-30	141	1	a	a	DET
bptjm-30	141	2	the	the	DET
bptjm-30	141	3	grid	grid	NOUN
bptjm-30	141	4	-	-	PUNCT
bptjm-30	141	5	hamd-17	hamd-17	PROPN
bptjm-30	141	6	is	be	AUX
bptjm-30	141	7	a	a	DET
bptjm-30	141	8	clinician	clinician	NOUN
bptjm-30	141	9	-	-	PUNCT
bptjm-30	141	10	rated	rate	VERB
bptjm-30	141	11	measure	measure	NOUN
bptjm-30	141	12	of	of	ADP
bptjm-30	141	13	depression	depression	NOUN
bptjm-30	141	14	,	,	PUNCT
bptjm-30	141	15	with	with	ADP
bptjm-30	141	16	lower	low	ADJ
bptjm-30	141	17	scores	score	NOUN
bptjm-30	141	18	correlating	correlate	VERB
bptjm-30	141	19	to	to	ADP
bptjm-30	141	20	fewer	few	ADJ
bptjm-30	141	21	symptoms	symptom	NOUN
bptjm-30	141	22	of	of	ADP
bptjm-30	141	23	depression34	depression34	NOUN
bptjm-30	141	24	.	.	PUNCT
bptjm-30	142	1	berkeley	berkeley	PROPN
bptjm-30	142	2	pharma	pharma	PROPN
bptjm-30	142	3	tech	tech	PROPN
bptjm-30	142	4	journal	journal	NOUN
bptjm-30	142	5	of	of	ADP
bptjm-30	142	6	medicine	medicine	NOUN
bptjm-30	142	7	|	|	ADV
bptjm-30	142	8	33	33	NUM
bptjm-30	142	9	b	b	NOUN
bptjm-30	142	10	,	,	PUNCT
bptjm-30	142	11	c	c	PROPN
bptjm-30	142	12	the	the	DET
bptjm-30	142	13	bdi	bdi	PROPN
bptjm-30	142	14	and	and	CCONJ
bptjm-30	142	15	hads	had	NOUN
bptjm-30	142	16	tests	test	NOUN
bptjm-30	142	17	are	be	AUX
bptjm-30	142	18	self	self	NOUN
bptjm-30	142	19	-	-	PUNCT
bptjm-30	142	20	rated	rate	VERB
bptjm-30	142	21	measures	measure	NOUN
bptjm-30	142	22	of	of	ADP
bptjm-30	142	23	depression	depression	NOUN
bptjm-30	142	24	,	,	PUNCT
bptjm-30	142	25	with	with	ADP
bptjm-30	142	26	lower	low	ADJ
bptjm-30	142	27	scores	score	NOUN
bptjm-30	142	28	indicating	indicate	VERB
bptjm-30	142	29	fewer	few	ADJ
bptjm-30	142	30	depressive	depressive	ADJ
bptjm-30	142	31	symptoms34	symptoms34	NOUN
bptjm-30	142	32	.	.	PUNCT
bptjm-30	143	1	d	d	X
bptjm-30	143	2	the	the	DET
bptjm-30	143	3	ham	ham	NOUN
bptjm-30	143	4	-	-	PUNCT
bptjm-30	143	5	a	a	NOUN
bptjm-30	143	6	is	be	AUX
bptjm-30	143	7	a	a	DET
bptjm-30	143	8	clinician	clinician	NOUN
bptjm-30	143	9	-	-	PUNCT
bptjm-30	143	10	rated	rate	VERB
bptjm-30	143	11	measure	measure	NOUN
bptjm-30	143	12	of	of	ADP
bptjm-30	143	13	anxiety	anxiety	NOUN
bptjm-30	143	14	,	,	PUNCT
bptjm-30	143	15	with	with	ADP
bptjm-30	143	16	lower	low	ADJ
bptjm-30	143	17	scores	score	NOUN
bptjm-30	143	18	signifying	signify	VERB
bptjm-30	143	19	less	less	ADJ
bptjm-30	143	20	anxiety	anxiety	NOUN
bptjm-30	143	21	in	in	ADP
bptjm-30	143	22	patients34	patients34	ADV
bptjm-30	143	23	.	.	PUNCT
bptjm-30	144	1	e	e	X
bptjm-30	144	2	the	the	DET
bptjm-30	144	3	stai	stai	PROPN
bptjm-30	144	4	test	test	NOUN
bptjm-30	144	5	is	be	AUX
bptjm-30	144	6	a	a	DET
bptjm-30	144	7	self	self	NOUN
bptjm-30	144	8	-	-	PUNCT
bptjm-30	144	9	rated	rate	VERB
bptjm-30	144	10	measure	measure	NOUN
bptjm-30	144	11	of	of	ADP
bptjm-30	144	12	anxiety	anxiety	NOUN
bptjm-30	144	13	,	,	PUNCT
bptjm-30	144	14	with	with	ADP
bptjm-30	144	15	lower	low	ADJ
bptjm-30	144	16	scores	score	NOUN
bptjm-30	144	17	signifying	signify	VERB
bptjm-30	144	18	less	less	ADJ
bptjm-30	144	19	anxiety34	anxiety34	NOUN
bptjm-30	144	20	.	.	PUNCT
bptjm-30	145	1	f	f	PUNCT
bptjm-30	146	1	the	the	DET
bptjm-30	146	2	poms	pom	NOUN
bptjm-30	146	3	test	test	NOUN
bptjm-30	146	4	is	be	AUX
bptjm-30	146	5	a	a	DET
bptjm-30	146	6	self	self	NOUN
bptjm-30	146	7	-	-	PUNCT
bptjm-30	146	8	rated	rate	VERB
bptjm-30	146	9	mood	mood	NOUN
bptjm-30	146	10	measure	measure	NOUN
bptjm-30	146	11	,	,	PUNCT
bptjm-30	146	12	with	with	ADP
bptjm-30	146	13	lower	low	ADJ
bptjm-30	146	14	scores	score	NOUN
bptjm-30	146	15	indicating	indicate	VERB
bptjm-30	146	16	an	an	DET
bptjm-30	146	17	overall	overall	ADV
bptjm-30	146	18	better	well	ADJ
bptjm-30	146	19	mood34	mood34	NOUN
bptjm-30	146	20	.	.	PUNCT
bptjm-30	147	1	g	g	PROPN
bptjm-30	147	2	the	the	DET
bptjm-30	147	3	bsi	bsi	PROPN
bptjm-30	147	4	score	score	NOUN
bptjm-30	147	5	is	be	AUX
bptjm-30	147	6	a	a	DET
bptjm-30	147	7	self	self	NOUN
bptjm-30	147	8	-	-	PUNCT
bptjm-30	147	9	rated	rate	VERB
bptjm-30	147	10	measure	measure	NOUN
bptjm-30	147	11	of	of	ADP
bptjm-30	147	12	psychiatric	psychiatric	ADJ
bptjm-30	147	13	symptoms	symptom	NOUN
bptjm-30	147	14	,	,	PUNCT
bptjm-30	147	15	with	with	ADP
bptjm-30	147	16	lower	low	ADJ
bptjm-30	147	17	scores	score	NOUN
bptjm-30	147	18	indicating	indicate	VERB
bptjm-30	147	19	fewer	few	ADJ
bptjm-30	147	20	feelings	feeling	NOUN
bptjm-30	147	21	of	of	ADP
bptjm-30	147	22	distress34	distress34	ADV
bptjm-30	147	23	.	.	PUNCT
bptjm-30	148	1	h	h	NOUN
bptjm-30	148	2	,	,	PUNCT
bptjm-30	148	3	i	i	PRON
bptjm-30	148	4	the	the	DET
bptjm-30	148	5	mqol	mqol	NOUN
bptjm-30	148	6	test	test	NOUN
bptjm-30	148	7	is	be	AUX
bptjm-30	148	8	a	a	DET
bptjm-30	148	9	self	self	NOUN
bptjm-30	148	10	-	-	PUNCT
bptjm-30	148	11	rated	rate	VERB
bptjm-30	148	12	measure	measure	NOUN
bptjm-30	148	13	of	of	ADP
bptjm-30	148	14	the	the	DET
bptjm-30	148	15	overall	overall	ADJ
bptjm-30	148	16	quality	quality	NOUN
bptjm-30	148	17	of	of	ADP
bptjm-30	148	18	life	life	NOUN
bptjm-30	148	19	,	,	PUNCT
bptjm-30	148	20	with	with	ADP
bptjm-30	148	21	higher	high	ADJ
bptjm-30	148	22	scores	score	NOUN
bptjm-30	148	23	indicating	indicate	VERB
bptjm-30	148	24	a	a	DET
bptjm-30	148	25	better	well	ADJ
bptjm-30	148	26	quality	quality	NOUN
bptjm-30	148	27	of	of	ADP
bptjm-30	148	28	life34	life34	NOUN
bptjm-30	148	29	.	.	PUNCT
bptjm-30	149	1	j	j	NOUN
bptjm-30	150	1	the	the	DET
bptjm-30	150	2	lot	lot	NOUN
bptjm-30	150	3	-	-	PUNCT
bptjm-30	150	4	r	r	NOUN
bptjm-30	150	5	test	test	NOUN
bptjm-30	150	6	is	be	AUX
bptjm-30	150	7	a	a	DET
bptjm-30	150	8	self	self	NOUN
bptjm-30	150	9	-	-	PUNCT
bptjm-30	150	10	rated	rate	VERB
bptjm-30	150	11	optimism	optimism	NOUN
bptjm-30	150	12	measure	measure	NOUN
bptjm-30	150	13	,	,	PUNCT
bptjm-30	150	14	with	with	ADP
bptjm-30	150	15	higher	high	ADJ
bptjm-30	150	16	scores	score	NOUN
bptjm-30	150	17	correlating	correlate	VERB
bptjm-30	150	18	to	to	ADP
bptjm-30	150	19	more	more	ADJ
bptjm-30	150	20	feelings	feeling	NOUN
bptjm-30	150	21	of	of	ADP
bptjm-30	150	22	optimism34	optimism34	NOUN
bptjm-30	150	23	.	.	PUNCT
bptjm-30	151	1	psilocybin	psilocybin	NOUN
bptjm-30	151	2	also	also	ADV
bptjm-30	151	3	differs	differ	VERB
bptjm-30	151	4	from	from	ADP
bptjm-30	151	5	current	current	ADJ
bptjm-30	151	6	antidepressants	antidepressant	NOUN
bptjm-30	151	7	in	in	ADP
bptjm-30	151	8	that	that	DET
bptjm-30	151	9	limited	limit	VERB
bptjm-30	151	10	exposure	exposure	NOUN
bptjm-30	151	11	or	or	CCONJ
bptjm-30	151	12	administration	administration	NOUN
bptjm-30	151	13	of	of	ADP
bptjm-30	151	14	the	the	DET
bptjm-30	151	15	drug	drug	NOUN
bptjm-30	151	16	has	have	VERB
bptjm-30	151	17	the	the	DET
bptjm-30	151	18	potential	potential	NOUN
bptjm-30	151	19	for	for	ADP
bptjm-30	151	20	longer	long	ADV
bptjm-30	151	21	-	-	PUNCT
bptjm-30	151	22	lasting	last	VERB
bptjm-30	151	23	effects	effect	NOUN
bptjm-30	151	24	.	.	PUNCT
bptjm-30	152	1	recent	recent	ADJ
bptjm-30	152	2	studies	study	NOUN
bptjm-30	152	3	also	also	ADV
bptjm-30	152	4	show	show	VERB
bptjm-30	152	5	signs	sign	NOUN
bptjm-30	152	6	of	of	ADP
bptjm-30	152	7	high	high	ADJ
bptjm-30	152	8	transient	transient	ADJ
bptjm-30	152	9	neuroplasticity	neuroplasticity	NOUN
bptjm-30	152	10	after	after	ADP
bptjm-30	152	11	a	a	DET
bptjm-30	152	12	single	single	ADJ
bptjm-30	152	13	dose	dose	NOUN
bptjm-30	152	14	of	of	ADP
bptjm-30	152	15	psilocybin	psilocybin	NOUN
bptjm-30	152	16	,	,	PUNCT
bptjm-30	152	17	which	which	PRON
bptjm-30	152	18	is	be	AUX
bptjm-30	152	19	a	a	DET
bptjm-30	152	20	possible	possible	ADJ
bptjm-30	152	21	source	source	NOUN
bptjm-30	152	22	of	of	ADP
bptjm-30	152	23	the	the	DET
bptjm-30	152	24	longer	long	ADV
bptjm-30	152	25	-	-	PUNCT
bptjm-30	152	26	lasting	last	VERB
bptjm-30	152	27	effects	effect	NOUN
bptjm-30	152	28	associated	associate	VERB
bptjm-30	152	29	with	with	ADP
bptjm-30	152	30	psilocybin33,34	psilocybin33,34	NOUN
bptjm-30	152	31	.	.	PUNCT
bptjm-30	153	1	psilocybin	psilocybin	NOUN
bptjm-30	153	2	targets	target	NOUN
bptjm-30	153	3	inflammatory	inflammatory	ADJ
bptjm-30	153	4	and	and	CCONJ
bptjm-30	153	5	oxidative	oxidative	ADJ
bptjm-30	153	6	stress	stress	NOUN
bptjm-30	153	7	pathways	pathway	NOUN
bptjm-30	153	8	that	that	PRON
bptjm-30	153	9	lead	lead	VERB
bptjm-30	153	10	to	to	ADP
bptjm-30	153	11	an	an	DET
bptjm-30	153	12	increase	increase	NOUN
bptjm-30	153	13	in	in	ADP
bptjm-30	153	14	brain	brain	NOUN
bptjm-30	153	15	plasticity	plasticity	NOUN
bptjm-30	153	16	and	and	CCONJ
bptjm-30	153	17	cognitive	cognitive	ADJ
bptjm-30	153	18	flexibility	flexibility	NOUN
bptjm-30	153	19	,	,	PUNCT
bptjm-30	153	20	both	both	PRON
bptjm-30	153	21	of	of	ADP
bptjm-30	153	22	which	which	PRON
bptjm-30	153	23	are	be	AUX
bptjm-30	153	24	important	important	ADJ
bptjm-30	153	25	gauges	gauge	NOUN
bptjm-30	153	26	of	of	ADP
bptjm-30	153	27	neuroplasticity33	neuroplasticity33	NOUN
bptjm-30	153	28	.	.	PUNCT
bptjm-30	154	1	a	a	DET
bptjm-30	154	2	study	study	NOUN
bptjm-30	154	3	published	publish	VERB
bptjm-30	154	4	in	in	ADP
bptjm-30	154	5	november	november	PROPN
bptjm-30	154	6	2021	2021	NUM
bptjm-30	154	7	also	also	ADV
bptjm-30	154	8	found	find	VERB
bptjm-30	154	9	that	that	SCONJ
bptjm-30	154	10	psilocybin	psilocybin	NOUN
bptjm-30	154	11	increases	increase	VERB
bptjm-30	154	12	the	the	DET
bptjm-30	154	13	expression	expression	NOUN
bptjm-30	154	14	of	of	ADP
bptjm-30	154	15	genes	gene	NOUN
bptjm-30	154	16	related	relate	VERB
bptjm-30	154	17	to	to	ADP
bptjm-30	154	18	neuroplasticity	neuroplasticity	NOUN
bptjm-30	154	19	(	(	PUNCT
bptjm-30	154	20	c	c	NOUN
bptjm-30	154	21	-	-	PUNCT
bptjm-30	154	22	fos	fos	NOUN
bptjm-30	154	23	,	,	PUNCT
bptjm-30	154	24	junb	junb	NOUN
bptjm-30	154	25	,	,	PUNCT
bptjm-30	154	26	dusp1)33,34	dusp1)33,34	PROPN
bptjm-30	154	27	.	.	PUNCT
bptjm-30	155	1	this	this	DET
bptjm-30	155	2	study	study	NOUN
bptjm-30	155	3	refers	refer	VERB
bptjm-30	155	4	to	to	ADP
bptjm-30	155	5	a	a	DET
bptjm-30	155	6	clinical	clinical	ADJ
bptjm-30	155	7	trial	trial	NOUN
bptjm-30	155	8	involving	involve	VERB
bptjm-30	155	9	mice	mouse	NOUN
bptjm-30	155	10	in	in	ADP
bptjm-30	155	11	which	which	PRON
bptjm-30	155	12	it	it	PRON
bptjm-30	155	13	finds	find	VERB
bptjm-30	155	14	that	that	SCONJ
bptjm-30	155	15	mice	mouse	NOUN
bptjm-30	155	16	treated	treat	VERB
bptjm-30	155	17	with	with	ADP
bptjm-30	155	18	psilocybin	psilocybin	NOUN
bptjm-30	155	19	experienced	experience	VERB
bptjm-30	155	20	increased	increase	VERB
bptjm-30	155	21	density	density	NOUN
bptjm-30	155	22	and	and	CCONJ
bptjm-30	155	23	strength	strength	NOUN
bptjm-30	155	24	of	of	ADP
bptjm-30	155	25	neural	neural	ADJ
bptjm-30	155	26	connections	connection	NOUN
bptjm-30	155	27	by	by	ADP
bptjm-30	155	28	10	10	NUM
bptjm-30	155	29	percent33	percent33	NOUN
bptjm-30	155	30	.	.	PUNCT
bptjm-30	156	1	the	the	DET
bptjm-30	156	2	same	same	ADJ
bptjm-30	156	3	study	study	NOUN
bptjm-30	156	4	published	publish	VERB
bptjm-30	156	5	in	in	ADP
bptjm-30	156	6	2021	2021	NUM
bptjm-30	156	7	also	also	ADV
bptjm-30	156	8	finds	find	VERB
bptjm-30	156	9	that	that	SCONJ
bptjm-30	156	10	suicidal	suicidal	ADJ
bptjm-30	156	11	behaviors	behavior	NOUN
bptjm-30	156	12	are	be	AUX
bptjm-30	156	13	associated	associate	VERB
bptjm-30	156	14	with	with	ADP
bptjm-30	156	15	neuroplastic	neuroplastic	ADJ
bptjm-30	156	16	dysfunction	dysfunction	NOUN
bptjm-30	156	17	and	and	CCONJ
bptjm-30	156	18	that	that	SCONJ
bptjm-30	156	19	those	those	PRON
bptjm-30	156	20	that	that	PRON
bptjm-30	156	21	die	die	VERB
bptjm-30	156	22	from	from	ADP
bptjm-30	156	23	suicide	suicide	NOUN
bptjm-30	156	24	have	have	VERB
bptjm-30	156	25	low	low	ADJ
bptjm-30	156	26	levels	level	NOUN
bptjm-30	156	27	of	of	ADP
bptjm-30	156	28	brain	brain	NOUN
bptjm-30	156	29	-	-	PUNCT
bptjm-30	156	30	derived	derive	VERB
bptjm-30	156	31	neurotrophic	neurotrophic	ADJ
bptjm-30	156	32	factor	factor	NOUN
bptjm-30	156	33	(	(	PUNCT
bptjm-30	156	34	bdnf	bdnf	PROPN
bptjm-30	156	35	)	)	PUNCT
bptjm-30	156	36	in	in	ADP
bptjm-30	156	37	certain	certain	ADJ
bptjm-30	156	38	regions	region	NOUN
bptjm-30	156	39	of	of	ADP
bptjm-30	156	40	the	the	DET
bptjm-30	156	41	brain33	brain33	NOUN
bptjm-30	156	42	.	.	PUNCT
bptjm-30	157	1	psilocybin	psilocybin	NOUN
bptjm-30	157	2	’s	’s	PART
bptjm-30	157	3	ability	ability	NOUN
bptjm-30	157	4	to	to	PART
bptjm-30	157	5	increase	increase	VERB
bptjm-30	157	6	neuroplasticity	neuroplasticity	NOUN
bptjm-30	157	7	in	in	ADP
bptjm-30	157	8	patients	patient	NOUN
bptjm-30	157	9	suggests	suggest	VERB
bptjm-30	157	10	that	that	SCONJ
bptjm-30	157	11	it	it	PRON
bptjm-30	157	12	could	could	AUX
bptjm-30	157	13	be	be	AUX
bptjm-30	157	14	used	use	VERB
bptjm-30	157	15	to	to	PART
bptjm-30	157	16	treat	treat	VERB
bptjm-30	157	17	patients	patient	NOUN
bptjm-30	157	18	at	at	ADP
bptjm-30	157	19	high	high	ADJ
bptjm-30	157	20	risk	risk	NOUN
bptjm-30	157	21	of	of	ADP
bptjm-30	157	22	suicidal	suicidal	ADJ
bptjm-30	157	23	behaviors	behavior	NOUN
bptjm-30	157	24	.	.	PUNCT
bptjm-30	158	1	however	however	ADV
bptjm-30	158	2	,	,	PUNCT
bptjm-30	158	3	more	more	ADJ
bptjm-30	158	4	research	research	NOUN
bptjm-30	158	5	is	be	AUX
bptjm-30	158	6	needed	need	VERB
bptjm-30	158	7	to	to	PART
bptjm-30	158	8	fully	fully	ADV
bptjm-30	158	9	evaluate	evaluate	VERB
bptjm-30	158	10	its	its	PRON
bptjm-30	158	11	efficacy	efficacy	NOUN
bptjm-30	158	12	for	for	ADP
bptjm-30	158	13	these	these	DET
bptjm-30	158	14	conditions	condition	NOUN
bptjm-30	158	15	.	.	PUNCT
bptjm-30	159	1	while	while	SCONJ
bptjm-30	159	2	psilocybin	psilocybin	NOUN
bptjm-30	159	3	has	have	AUX
bptjm-30	159	4	shown	show	VERB
bptjm-30	159	5	promise	promise	NOUN
bptjm-30	159	6	as	as	ADP
bptjm-30	159	7	a	a	DET
bptjm-30	159	8	novel	novel	ADJ
bptjm-30	159	9	therapeutic	therapeutic	ADJ
bptjm-30	159	10	option	option	NOUN
bptjm-30	159	11	to	to	PART
bptjm-30	159	12	treat	treat	VERB
bptjm-30	159	13	depressive	depressive	ADJ
bptjm-30	159	14	symptoms	symptom	NOUN
bptjm-30	159	15	due	due	ADP
bptjm-30	159	16	to	to	ADP
bptjm-30	159	17	its	its	PRON
bptjm-30	159	18	prolonged	prolonged	ADJ
bptjm-30	159	19	effects	effect	NOUN
bptjm-30	159	20	on	on	ADP
bptjm-30	159	21	neuroplasticity	neuroplasticity	NOUN
bptjm-30	159	22	,	,	PUNCT
bptjm-30	159	23	there	there	PRON
bptjm-30	159	24	is	be	VERB
bptjm-30	159	25	still	still	ADV
bptjm-30	159	26	much	much	ADV
bptjm-30	159	27	unknown	unknown	ADJ
bptjm-30	159	28	.	.	PUNCT
bptjm-30	160	1	many	many	ADJ
bptjm-30	160	2	studies	study	NOUN
bptjm-30	160	3	and	and	CCONJ
bptjm-30	160	4	trials	trial	NOUN
bptjm-30	160	5	performed	perform	VERB
bptjm-30	160	6	involved	involve	VERB
bptjm-30	160	7	small	small	ADJ
bptjm-30	160	8	sample	sample	NOUN
bptjm-30	160	9	sizes	size	NOUN
bptjm-30	160	10	,	,	PUNCT
bptjm-30	160	11	so	so	SCONJ
bptjm-30	160	12	their	their	PRON
bptjm-30	160	13	findings	finding	NOUN
bptjm-30	160	14	can	can	AUX
bptjm-30	160	15	not	not	PART
bptjm-30	160	16	be	be	AUX
bptjm-30	160	17	applied	apply	VERB
bptjm-30	160	18	to	to	ADP
bptjm-30	160	19	a	a	DET
bptjm-30	160	20	larger	large	ADJ
bptjm-30	160	21	population33	population33	NOUN
bptjm-30	160	22	.	.	PUNCT
bptjm-30	161	1	there	there	PRON
bptjm-30	161	2	is	be	VERB
bptjm-30	161	3	a	a	DET
bptjm-30	161	4	need	need	NOUN
bptjm-30	161	5	for	for	ADP
bptjm-30	161	6	a	a	DET
bptjm-30	161	7	trial	trial	NOUN
bptjm-30	161	8	involving	involve	VERB
bptjm-30	161	9	administration	administration	NOUN
bptjm-30	161	10	in	in	ADP
bptjm-30	161	11	a	a	DET
bptjm-30	161	12	clinical	clinical	ADJ
bptjm-30	161	13	setting	setting	NOUN
bptjm-30	161	14	,	,	PUNCT
bptjm-30	161	15	which	which	PRON
bptjm-30	161	16	is	be	AUX
bptjm-30	161	17	not	not	PART
bptjm-30	161	18	as	as	ADV
bptjm-30	161	19	ideal	ideal	ADJ
bptjm-30	161	20	and	and	CCONJ
bptjm-30	161	21	accessible	accessible	ADJ
bptjm-30	161	22	.	.	PUNCT
bptjm-30	162	1	berkeley	berkeley	PROPN
bptjm-30	162	2	pharma	pharma	PROPN
bptjm-30	162	3	tech	tech	PROPN
bptjm-30	162	4	journal	journal	NOUN
bptjm-30	162	5	of	of	ADP
bptjm-30	162	6	medicine	medicine	NOUN
bptjm-30	162	7	|	|	ADV
bptjm-30	162	8	34	34	NUM
bptjm-30	162	9	5.3	5.3	NUM
bptjm-30	162	10	.	.	PUNCT
bptjm-30	163	1	psychedelic	psychedelic	ADJ
bptjm-30	163	2	-	-	PUNCT
bptjm-30	163	3	related	relate	VERB
bptjm-30	163	4	drugs	drug	NOUN
bptjm-30	163	5	we	we	PRON
bptjm-30	163	6	have	have	AUX
bptjm-30	163	7	already	already	ADV
bptjm-30	163	8	seen	see	VERB
bptjm-30	163	9	an	an	DET
bptjm-30	163	10	example	example	NOUN
bptjm-30	163	11	of	of	ADP
bptjm-30	163	12	a	a	DET
bptjm-30	163	13	popular	popular	ADJ
bptjm-30	163	14	,	,	PUNCT
bptjm-30	163	15	effective	effective	ADJ
bptjm-30	163	16	psychedelic	psychedelic	ADJ
bptjm-30	163	17	-	-	PUNCT
bptjm-30	163	18	related	relate	VERB
bptjm-30	163	19	drug	drug	NOUN
bptjm-30	163	20	–	–	PUNCT
bptjm-30	163	21	psilocybin	psilocybin	NOUN
bptjm-30	163	22	.	.	PUNCT
bptjm-30	164	1	other	other	ADJ
bptjm-30	164	2	drugs	drug	NOUN
bptjm-30	164	3	of	of	ADP
bptjm-30	164	4	similar	similar	ADJ
bptjm-30	164	5	properties	property	NOUN
bptjm-30	164	6	will	will	AUX
bptjm-30	164	7	be	be	AUX
bptjm-30	164	8	discussed	discuss	VERB
bptjm-30	164	9	in	in	ADP
bptjm-30	164	10	this	this	DET
bptjm-30	164	11	section	section	NOUN
bptjm-30	164	12	.	.	PUNCT
bptjm-30	165	1	ayahuasca	ayahuasca	PROPN
bptjm-30	165	2	is	be	AUX
bptjm-30	165	3	a	a	DET
bptjm-30	165	4	psychoactive	psychoactive	ADJ
bptjm-30	165	5	drink	drink	NOUN
bptjm-30	165	6	shown	show	VERB
bptjm-30	165	7	to	to	PART
bptjm-30	165	8	have	have	VERB
bptjm-30	165	9	medicinal	medicinal	ADJ
bptjm-30	165	10	potential	potential	NOUN
bptjm-30	165	11	in	in	ADP
bptjm-30	165	12	treating	treat	VERB
bptjm-30	165	13	psychological	psychological	ADJ
bptjm-30	165	14	disorders	disorder	NOUN
bptjm-30	165	15	.	.	PUNCT
bptjm-30	166	1	in	in	ADP
bptjm-30	166	2	recent	recent	ADJ
bptjm-30	166	3	clinical	clinical	ADJ
bptjm-30	166	4	trials	trial	NOUN
bptjm-30	166	5	,	,	PUNCT
bptjm-30	166	6	the	the	DET
bptjm-30	166	7	drug	drug	NOUN
bptjm-30	166	8	has	have	AUX
bptjm-30	166	9	been	be	AUX
bptjm-30	166	10	proven	prove	VERB
bptjm-30	166	11	to	to	PART
bptjm-30	166	12	decrease	decrease	VERB
bptjm-30	166	13	activity	activity	NOUN
bptjm-30	166	14	in	in	ADP
bptjm-30	166	15	the	the	DET
bptjm-30	166	16	precuneus	precuneus	NOUN
bptjm-30	166	17	and	and	CCONJ
bptjm-30	166	18	medial	medial	ADJ
bptjm-30	166	19	prefrontal	prefrontal	ADJ
bptjm-30	166	20	cortex35	cortex35	NOUN
bptjm-30	166	21	.	.	PUNCT
bptjm-30	167	1	these	these	DET
bptjm-30	167	2	regions	region	NOUN
bptjm-30	167	3	have	have	AUX
bptjm-30	167	4	also	also	ADV
bptjm-30	167	5	been	be	AUX
bptjm-30	167	6	implicated	implicate	VERB
bptjm-30	167	7	in	in	ADP
bptjm-30	167	8	the	the	DET
bptjm-30	167	9	default	default	NOUN
bptjm-30	167	10	mode	mode	NOUN
bptjm-30	167	11	network	network	NOUN
bptjm-30	167	12	a	a	DET
bptjm-30	167	13	brain	brain	NOUN
bptjm-30	167	14	pathway	pathway	NOUN
bptjm-30	167	15	most	most	ADV
bptjm-30	167	16	active	active	ADJ
bptjm-30	167	17	during	during	ADP
bptjm-30	167	18	periods	period	NOUN
bptjm-30	167	19	of	of	ADP
bptjm-30	167	20	introspection	introspection	NOUN
bptjm-30	167	21	.	.	PUNCT
bptjm-30	168	1	unsurprisingly	unsurprisingly	ADV
bptjm-30	168	2	,	,	PUNCT
bptjm-30	168	3	overstimulation	overstimulation	NOUN
bptjm-30	168	4	of	of	ADP
bptjm-30	168	5	the	the	DET
bptjm-30	168	6	default	default	NOUN
bptjm-30	168	7	mode	mode	NOUN
bptjm-30	168	8	network	network	NOUN
bptjm-30	168	9	has	have	AUX
bptjm-30	168	10	been	be	AUX
bptjm-30	168	11	associated	associate	VERB
bptjm-30	168	12	with	with	ADP
bptjm-30	168	13	higher	high	ADJ
bptjm-30	168	14	rates	rate	NOUN
bptjm-30	168	15	of	of	ADP
bptjm-30	168	16	depression	depression	NOUN
bptjm-30	168	17	and	and	CCONJ
bptjm-30	168	18	anxiety36	anxiety36	NOUN
bptjm-30	168	19	.	.	PUNCT
bptjm-30	169	1	ayahuasca	ayahuasca	PROPN
bptjm-30	169	2	combats	combat	VERB
bptjm-30	169	3	stress	stress	NOUN
bptjm-30	169	4	-	-	PUNCT
bptjm-30	169	5	induced	induce	VERB
bptjm-30	169	6	depression	depression	NOUN
bptjm-30	169	7	and	and	CCONJ
bptjm-30	169	8	anxiety	anxiety	NOUN
bptjm-30	169	9	through	through	ADP
bptjm-30	169	10	its	its	PRON
bptjm-30	169	11	composition	composition	NOUN
bptjm-30	169	12	of	of	ADP
bptjm-30	169	13	dmt	dmt	PROPN
bptjm-30	169	14	and	and	CCONJ
bptjm-30	169	15	b	b	NOUN
bptjm-30	169	16	-	-	PUNCT
bptjm-30	169	17	carboline37	carboline37	NOUN
bptjm-30	169	18	.	.	PUNCT
bptjm-30	170	1	dmt	dmt	PROPN
bptjm-30	170	2	activates	activate	VERB
bptjm-30	170	3	the	the	DET
bptjm-30	170	4	sig-1r	sig-1r	ADJ
bptjm-30	170	5	receptor	receptor	NOUN
bptjm-30	170	6	,	,	PUNCT
bptjm-30	170	7	which	which	PRON
bptjm-30	170	8	blocks	block	VERB
bptjm-30	170	9	neurodegeneration	neurodegeneration	NOUN
bptjm-30	170	10	and	and	CCONJ
bptjm-30	170	11	regulates	regulate	VERB
bptjm-30	170	12	the	the	DET
bptjm-30	170	13	production	production	NOUN
bptjm-30	170	14	of	of	ADP
bptjm-30	170	15	protective	protective	ADJ
bptjm-30	170	16	antioxidants	antioxidant	NOUN
bptjm-30	170	17	.	.	PUNCT
bptjm-30	171	1	b	b	X
bptjm-30	171	2	-	-	PUNCT
bptjm-30	171	3	carboline	carboline	NOUN
bptjm-30	171	4	,	,	PUNCT
bptjm-30	171	5	meanwhile	meanwhile	ADV
bptjm-30	171	6	,	,	PUNCT
bptjm-30	171	7	has	have	AUX
bptjm-30	171	8	been	be	AUX
bptjm-30	171	9	shown	show	VERB
bptjm-30	171	10	to	to	PART
bptjm-30	171	11	increase	increase	VERB
bptjm-30	171	12	bdnf38	bdnf38	NOUN
bptjm-30	171	13	.	.	PUNCT
bptjm-30	172	1	the	the	DET
bptjm-30	172	2	drug	drug	NOUN
bptjm-30	172	3	ultimately	ultimately	ADV
bptjm-30	172	4	leads	lead	VERB
bptjm-30	172	5	to	to	ADP
bptjm-30	172	6	anti	anti	ADJ
bptjm-30	172	7	-	-	ADJ
bptjm-30	172	8	inflammatory	inflammatory	ADJ
bptjm-30	172	9	,	,	PUNCT
bptjm-30	172	10	neuroprotective	neuroprotective	ADJ
bptjm-30	172	11	,	,	PUNCT
bptjm-30	172	12	and	and	CCONJ
bptjm-30	172	13	potentially	potentially	ADV
bptjm-30	172	14	memory	memory	NOUN
bptjm-30	172	15	-	-	PUNCT
bptjm-30	172	16	boosting	boost	VERB
bptjm-30	172	17	effects	effect	NOUN
bptjm-30	172	18	because	because	SCONJ
bptjm-30	172	19	of	of	ADP
bptjm-30	172	20	its	its	PRON
bptjm-30	172	21	focus	focus	NOUN
bptjm-30	172	22	on	on	ADP
bptjm-30	172	23	promoting	promote	VERB
bptjm-30	172	24	nerve	nerve	NOUN
bptjm-30	172	25	cell	cell	NOUN
bptjm-30	172	26	survival	survival	NOUN
bptjm-30	172	27	.	.	PUNCT
bptjm-30	173	1	ayahuasca	ayahuasca	PROPN
bptjm-30	173	2	has	have	AUX
bptjm-30	173	3	added	add	VERB
bptjm-30	173	4	utility	utility	NOUN
bptjm-30	173	5	compared	compare	VERB
bptjm-30	173	6	to	to	ADP
bptjm-30	173	7	traditional	traditional	ADJ
bptjm-30	173	8	antidepressants	antidepressant	NOUN
bptjm-30	173	9	due	due	ADP
bptjm-30	173	10	to	to	ADP
bptjm-30	173	11	its	its	PRON
bptjm-30	173	12	multifaceted	multifaceted	ADJ
bptjm-30	173	13	approach	approach	NOUN
bptjm-30	173	14	to	to	ADP
bptjm-30	173	15	mental	mental	ADJ
bptjm-30	173	16	disorders	disorder	NOUN
bptjm-30	173	17	:	:	PUNCT
bptjm-30	173	18	the	the	DET
bptjm-30	173	19	drug	drug	NOUN
bptjm-30	173	20	has	have	AUX
bptjm-30	173	21	been	be	AUX
bptjm-30	173	22	shown	show	VERB
bptjm-30	173	23	to	to	PART
bptjm-30	173	24	combat	combat	VERB
bptjm-30	173	25	depression	depression	NOUN
bptjm-30	173	26	,	,	PUNCT
bptjm-30	173	27	anxiety	anxiety	NOUN
bptjm-30	173	28	,	,	PUNCT
bptjm-30	173	29	ptsd	ptsd	NOUN
bptjm-30	173	30	,	,	PUNCT
bptjm-30	173	31	and	and	CCONJ
bptjm-30	173	32	drug	drug	NOUN
bptjm-30	173	33	dependence39,40	dependence39,40	VERB
bptjm-30	173	34	.	.	PUNCT
bptjm-30	174	1	additionally	additionally	ADV
bptjm-30	174	2	,	,	PUNCT
bptjm-30	174	3	the	the	DET
bptjm-30	174	4	psychedelic	psychedelic	ADJ
bptjm-30	174	5	is	be	AUX
bptjm-30	174	6	faster	fast	ADV
bptjm-30	174	7	-	-	PUNCT
bptjm-30	174	8	acting	act	VERB
bptjm-30	174	9	and	and	CCONJ
bptjm-30	174	10	lasts	last	VERB
bptjm-30	174	11	longer	long	ADV
bptjm-30	174	12	than	than	ADP
bptjm-30	174	13	other	other	ADJ
bptjm-30	174	14	antidepressants	antidepressant	NOUN
bptjm-30	174	15	that	that	PRON
bptjm-30	174	16	also	also	ADV
bptjm-30	174	17	target	target	VERB
bptjm-30	174	18	serotonin	serotonin	NOUN
bptjm-30	174	19	receptors	receptor	NOUN
bptjm-30	174	20	37	37	NUM
bptjm-30	174	21	.	.	PUNCT
bptjm-30	175	1	a	a	DET
bptjm-30	175	2	recent	recent	ADJ
bptjm-30	175	3	clinical	clinical	ADJ
bptjm-30	175	4	trial	trial	NOUN
bptjm-30	175	5	focused	focus	VERB
bptjm-30	175	6	on	on	ADP
bptjm-30	175	7	ayahuasca	ayahuasca	PROPN
bptjm-30	175	8	’s	’s	PART
bptjm-30	175	9	effects	effect	NOUN
bptjm-30	175	10	on	on	ADP
bptjm-30	175	11	treatment	treatment	NOUN
bptjm-30	175	12	-	-	PUNCT
bptjm-30	175	13	resistant	resistant	ADJ
bptjm-30	175	14	depression35	depression35	NOUN
bptjm-30	175	15	.	.	PUNCT
bptjm-30	176	1	twenty	twenty	NUM
bptjm-30	176	2	-	-	PUNCT
bptjm-30	176	3	nine	nine	NUM
bptjm-30	176	4	patients	patient	NOUN
bptjm-30	176	5	with	with	ADP
bptjm-30	176	6	persistent	persistent	ADJ
bptjm-30	176	7	,	,	PUNCT
bptjm-30	176	8	moderate	moderate	ADJ
bptjm-30	176	9	-	-	PUNCT
bptjm-30	176	10	to	to	ADP
bptjm-30	176	11	-	-	PUNCT
bptjm-30	176	12	severe	severe	ADJ
bptjm-30	176	13	depressive	depressive	ADJ
bptjm-30	176	14	symptoms	symptom	NOUN
bptjm-30	176	15	received	receive	VERB
bptjm-30	176	16	either	either	CCONJ
bptjm-30	176	17	a	a	DET
bptjm-30	176	18	single	single	ADJ
bptjm-30	176	19	dose	dose	NOUN
bptjm-30	176	20	of	of	ADP
bptjm-30	176	21	a	a	DET
bptjm-30	176	22	placebo	placebo	NOUN
bptjm-30	176	23	or	or	CCONJ
bptjm-30	176	24	ayahuasca	ayahuasca	NOUN
bptjm-30	176	25	.	.	PUNCT
bptjm-30	177	1	the	the	DET
bptjm-30	177	2	results	result	NOUN
bptjm-30	177	3	of	of	ADP
bptjm-30	177	4	the	the	DET
bptjm-30	177	5	study	study	NOUN
bptjm-30	177	6	indicated	indicate	VERB
bptjm-30	177	7	that	that	SCONJ
bptjm-30	177	8	when	when	SCONJ
bptjm-30	177	9	compared	compare	VERB
bptjm-30	177	10	to	to	ADP
bptjm-30	177	11	the	the	DET
bptjm-30	177	12	placebo	placebo	NOUN
bptjm-30	177	13	,	,	PUNCT
bptjm-30	177	14	ayahuasca	ayahuasca	PROPN
bptjm-30	177	15	generated	generate	VERB
bptjm-30	177	16	significant	significant	ADJ
bptjm-30	177	17	antidepressant	antidepressant	ADJ
bptjm-30	177	18	effects	effect	NOUN
bptjm-30	177	19	.	.	PUNCT
bptjm-30	178	1	statistical	statistical	ADJ
bptjm-30	178	2	analyses	analysis	NOUN
bptjm-30	178	3	proved	prove	VERB
bptjm-30	178	4	that	that	SCONJ
bptjm-30	178	5	the	the	DET
bptjm-30	178	6	effects	effect	NOUN
bptjm-30	178	7	were	be	AUX
bptjm-30	178	8	rapid	rapid	ADJ
bptjm-30	178	9	,	,	PUNCT
bptjm-30	178	10	and	and	CCONJ
bptjm-30	178	11	the	the	DET
bptjm-30	178	12	positive	positive	ADJ
bptjm-30	178	13	outcomes	outcome	NOUN
bptjm-30	178	14	persisted	persist	VERB
bptjm-30	178	15	for	for	ADP
bptjm-30	178	16	at	at	ADV
bptjm-30	178	17	least	least	ADV
bptjm-30	178	18	seven	seven	NUM
bptjm-30	178	19	days	day	NOUN
bptjm-30	178	20	.	.	PUNCT
bptjm-30	179	1	although	although	SCONJ
bptjm-30	179	2	ayahuasca	ayahuasca	NOUN
bptjm-30	179	3	is	be	AUX
bptjm-30	179	4	especially	especially	ADV
bptjm-30	179	5	promising	promising	ADJ
bptjm-30	179	6	as	as	ADP
bptjm-30	179	7	an	an	DET
bptjm-30	179	8	antidepressant	antidepressant	ADJ
bptjm-30	179	9	medicine	medicine	NOUN
bptjm-30	179	10	due	due	ADP
bptjm-30	179	11	to	to	ADP
bptjm-30	179	12	its	its	PRON
bptjm-30	179	13	rapid	rapid	ADJ
bptjm-30	179	14	effect	effect	NOUN
bptjm-30	179	15	in	in	ADP
bptjm-30	179	16	combating	combat	VERB
bptjm-30	179	17	depressive	depressive	ADJ
bptjm-30	179	18	symptoms	symptom	NOUN
bptjm-30	179	19	,	,	PUNCT
bptjm-30	179	20	some	some	DET
bptjm-30	179	21	other	other	ADJ
bptjm-30	179	22	key	key	ADJ
bptjm-30	179	23	features	feature	NOUN
bptjm-30	179	24	contribute	contribute	VERB
bptjm-30	179	25	to	to	ADP
bptjm-30	179	26	its	its	PRON
bptjm-30	179	27	potential	potential	NOUN
bptjm-30	179	28	.	.	PUNCT
bptjm-30	180	1	the	the	DET
bptjm-30	180	2	drug	drug	NOUN
bptjm-30	180	3	has	have	VERB
bptjm-30	180	4	a	a	DET
bptjm-30	180	5	rare	rare	ADJ
bptjm-30	180	6	capability	capability	NOUN
bptjm-30	180	7	of	of	ADP
bptjm-30	180	8	improving	improve	VERB
bptjm-30	180	9	depression	depression	NOUN
bptjm-30	180	10	in	in	ADP
bptjm-30	180	11	patients	patient	NOUN
bptjm-30	180	12	resistant	resistant	ADJ
bptjm-30	180	13	to	to	ADP
bptjm-30	180	14	traditional	traditional	ADJ
bptjm-30	180	15	antidepressant	antidepressant	ADJ
bptjm-30	180	16	therapies35	therapies35	NOUN
bptjm-30	180	17	.	.	PUNCT
bptjm-30	181	1	additionally	additionally	ADV
bptjm-30	181	2	,	,	PUNCT
bptjm-30	181	3	ayahuasca	ayahuasca	PROPN
bptjm-30	181	4	’s	’s	PART
bptjm-30	181	5	focus	focus	NOUN
bptjm-30	181	6	on	on	ADP
bptjm-30	181	7	the	the	DET
bptjm-30	181	8	default	default	NOUN
bptjm-30	181	9	mode	mode	NOUN
bptjm-30	181	10	network	network	NOUN
bptjm-30	181	11	provides	provide	VERB
bptjm-30	181	12	a	a	DET
bptjm-30	181	13	direct	direct	ADJ
bptjm-30	181	14	focus	focus	NOUN
bptjm-30	181	15	on	on	ADP
bptjm-30	181	16	reducing	reduce	VERB
bptjm-30	181	17	the	the	DET
bptjm-30	181	18	source	source	NOUN
bptjm-30	181	19	of	of	ADP
bptjm-30	181	20	depressive	depressive	ADJ
bptjm-30	181	21	berkeley	berkeley	PROPN
bptjm-30	181	22	pharma	pharma	PROPN
bptjm-30	181	23	tech	tech	NOUN
bptjm-30	181	24	journal	journal	NOUN
bptjm-30	181	25	of	of	ADP
bptjm-30	181	26	medicine	medicine	NOUN
bptjm-30	181	27	|	|	ADV
bptjm-30	181	28	35	35	NUM
bptjm-30	181	29	thoughts	thought	NOUN
bptjm-30	181	30	and	and	CCONJ
bptjm-30	181	31	instead	instead	ADV
bptjm-30	181	32	increases	increase	VERB
bptjm-30	181	33	blood	blood	NOUN
bptjm-30	181	34	flow	flow	NOUN
bptjm-30	181	35	to	to	ADP
bptjm-30	181	36	areas	area	NOUN
bptjm-30	181	37	that	that	PRON
bptjm-30	181	38	regulate	regulate	VERB
bptjm-30	181	39	emotions	emotion	NOUN
bptjm-30	181	40	and	and	CCONJ
bptjm-30	181	41	memory	memory	NOUN
bptjm-30	181	42	.	.	PUNCT
bptjm-30	182	1	despite	despite	SCONJ
bptjm-30	182	2	these	these	DET
bptjm-30	182	3	encouraging	encouraging	ADJ
bptjm-30	182	4	findings	finding	NOUN
bptjm-30	182	5	,	,	PUNCT
bptjm-30	182	6	more	more	ADJ
bptjm-30	182	7	studies	study	NOUN
bptjm-30	182	8	must	must	AUX
bptjm-30	182	9	be	be	AUX
bptjm-30	182	10	conducted	conduct	VERB
bptjm-30	182	11	to	to	PART
bptjm-30	182	12	prove	prove	VERB
bptjm-30	182	13	ayahuasca	ayahuasca	PROPN
bptjm-30	182	14	’s	’s	PART
bptjm-30	182	15	efficacy	efficacy	NOUN
bptjm-30	182	16	in	in	ADP
bptjm-30	182	17	other	other	ADJ
bptjm-30	182	18	mood	mood	NOUN
bptjm-30	182	19	and	and	CCONJ
bptjm-30	182	20	behavioral	behavioral	ADJ
bptjm-30	182	21	disorders	disorder	NOUN
bptjm-30	182	22	.	.	PUNCT
bptjm-30	183	1	lysergic	lysergic	ADJ
bptjm-30	183	2	acid	acid	NOUN
bptjm-30	183	3	diethylamide	diethylamide	NOUN
bptjm-30	183	4	(	(	PUNCT
bptjm-30	183	5	lsd	lsd	NOUN
bptjm-30	183	6	)	)	PUNCT
bptjm-30	183	7	is	be	AUX
bptjm-30	183	8	a	a	DET
bptjm-30	183	9	classical	classical	ADJ
bptjm-30	183	10	hallucinogen	hallucinogen	NOUN
bptjm-30	183	11	more	more	ADV
bptjm-30	183	12	specifically	specifically	ADV
bptjm-30	183	13	characterized	characterize	VERB
bptjm-30	183	14	as	as	ADP
bptjm-30	183	15	an	an	DET
bptjm-30	183	16	entheogen	entheogen	NOUN
bptjm-30	183	17	.	.	PUNCT
bptjm-30	184	1	some	some	PRON
bptjm-30	184	2	of	of	ADP
bptjm-30	184	3	its	its	PRON
bptjm-30	184	4	characteristic	characteristic	ADJ
bptjm-30	184	5	mental	mental	ADJ
bptjm-30	184	6	effects	effect	NOUN
bptjm-30	184	7	include	include	VERB
bptjm-30	184	8	distortion	distortion	NOUN
bptjm-30	184	9	of	of	ADP
bptjm-30	184	10	the	the	DET
bptjm-30	184	11	sense	sense	NOUN
bptjm-30	184	12	of	of	ADP
bptjm-30	184	13	time	time	NOUN
bptjm-30	184	14	and	and	CCONJ
bptjm-30	184	15	identity	identity	NOUN
bptjm-30	184	16	,	,	PUNCT
bptjm-30	184	17	visual	visual	ADJ
bptjm-30	184	18	hallucinations	hallucination	NOUN
bptjm-30	184	19	,	,	PUNCT
bptjm-30	184	20	and	and	CCONJ
bptjm-30	184	21	states	state	NOUN
bptjm-30	184	22	of	of	ADP
bptjm-30	184	23	euphoria	euphoria	NOUN
bptjm-30	184	24	or	or	CCONJ
bptjm-30	184	25	dysphoria	dysphoria	NOUN
bptjm-30	184	26	.	.	PUNCT
bptjm-30	185	1	beyond	beyond	ADP
bptjm-30	185	2	these	these	DET
bptjm-30	185	3	short	short	ADJ
bptjm-30	185	4	-	-	PUNCT
bptjm-30	185	5	term	term	NOUN
bptjm-30	185	6	effects	effect	NOUN
bptjm-30	185	7	on	on	ADP
bptjm-30	185	8	the	the	DET
bptjm-30	185	9	brain	brain	NOUN
bptjm-30	185	10	,	,	PUNCT
bptjm-30	185	11	lsd	lsd	NOUN
bptjm-30	185	12	may	may	AUX
bptjm-30	185	13	play	play	VERB
bptjm-30	185	14	an	an	DET
bptjm-30	185	15	overlooked	overlook	VERB
bptjm-30	185	16	role	role	NOUN
bptjm-30	185	17	in	in	ADP
bptjm-30	185	18	neurogenesis	neurogenesis	NOUN
bptjm-30	185	19	and	and	CCONJ
bptjm-30	185	20	possible	possible	ADJ
bptjm-30	185	21	long	long	ADJ
bptjm-30	185	22	-	-	PUNCT
bptjm-30	185	23	term	term	NOUN
bptjm-30	185	24	nervous	nervous	ADJ
bptjm-30	185	25	system	system	NOUN
bptjm-30	185	26	health	health	NOUN
bptjm-30	185	27	.	.	PUNCT
bptjm-30	186	1	a	a	DET
bptjm-30	186	2	recent	recent	ADJ
bptjm-30	186	3	clinical	clinical	ADJ
bptjm-30	186	4	study	study	NOUN
bptjm-30	186	5	indicates	indicate	VERB
bptjm-30	186	6	that	that	SCONJ
bptjm-30	186	7	the	the	DET
bptjm-30	186	8	drug	drug	NOUN
bptjm-30	186	9	may	may	AUX
bptjm-30	186	10	help	help	VERB
bptjm-30	186	11	the	the	DET
bptjm-30	186	12	brain	brain	NOUN
bptjm-30	186	13	grow	grow	VERB
bptjm-30	186	14	cells	cell	NOUN
bptjm-30	186	15	and	and	CCONJ
bptjm-30	186	16	construct	construct	VERB
bptjm-30	186	17	novel	novel	ADJ
bptjm-30	186	18	connections	connection	NOUN
bptjm-30	186	19	in	in	ADP
bptjm-30	186	20	brain	brain	NOUN
bptjm-30	186	21	regions	region	NOUN
bptjm-30	186	22	that	that	PRON
bptjm-30	186	23	typically	typically	ADV
bptjm-30	186	24	exhibit	exhibit	VERB
bptjm-30	186	25	cell	cell	NOUN
bptjm-30	186	26	death	death	NOUN
bptjm-30	186	27	in	in	ADP
bptjm-30	186	28	mental	mental	ADJ
bptjm-30	186	29	health	health	NOUN
bptjm-30	186	30	disorders	disorder	NOUN
bptjm-30	186	31	such	such	ADJ
bptjm-30	186	32	as	as	ADP
bptjm-30	186	33	anxiety	anxiety	NOUN
bptjm-30	186	34	and	and	CCONJ
bptjm-30	186	35	depression41	depression41	NOUN
bptjm-30	186	36	.	.	PUNCT
bptjm-30	187	1	the	the	DET
bptjm-30	187	2	drug	drug	NOUN
bptjm-30	187	3	acts	act	VERB
bptjm-30	187	4	on	on	ADP
bptjm-30	187	5	the	the	DET
bptjm-30	187	6	brain	brain	NOUN
bptjm-30	187	7	by	by	ADP
bptjm-30	187	8	interacting	interact	VERB
bptjm-30	187	9	with	with	ADP
bptjm-30	187	10	the	the	DET
bptjm-30	187	11	serotonin	serotonin	ADJ
bptjm-30	187	12	5	5	NUM
bptjm-30	187	13	-	-	PUNCT
bptjm-30	187	14	ht2a	ht2a	NOUN
bptjm-30	187	15	receptor	receptor	NOUN
bptjm-30	187	16	in	in	ADP
bptjm-30	187	17	an	an	DET
bptjm-30	187	18	agonist	agonist	NOUN
bptjm-30	187	19	capacity42	capacity42	NOUN
bptjm-30	187	20	.	.	PUNCT
bptjm-30	188	1	thus	thus	ADV
bptjm-30	188	2	,	,	PUNCT
bptjm-30	188	3	the	the	DET
bptjm-30	188	4	drug	drug	NOUN
bptjm-30	188	5	is	be	AUX
bptjm-30	188	6	analogous	analogous	ADJ
bptjm-30	188	7	to	to	PART
bptjm-30	188	8	serotonin	serotonin	VERB
bptjm-30	188	9	chemically	chemically	ADV
bptjm-30	188	10	,	,	PUNCT
bptjm-30	188	11	which	which	PRON
bptjm-30	188	12	has	have	AUX
bptjm-30	188	13	been	be	AUX
bptjm-30	188	14	associated	associate	VERB
bptjm-30	188	15	with	with	ADP
bptjm-30	188	16	numerous	numerous	ADJ
bptjm-30	188	17	brain	brain	NOUN
bptjm-30	188	18	-	-	PUNCT
bptjm-30	188	19	boosting	boost	VERB
bptjm-30	188	20	and	and	CCONJ
bptjm-30	188	21	physiologically	physiologically	ADV
bptjm-30	188	22	regulating	regulate	VERB
bptjm-30	188	23	benefits	benefit	NOUN
bptjm-30	188	24	.	.	PUNCT
bptjm-30	189	1	studies	study	NOUN
bptjm-30	189	2	have	have	AUX
bptjm-30	189	3	implicated	implicate	VERB
bptjm-30	189	4	serotonin	serotonin	NOUN
bptjm-30	189	5	receptors	receptor	NOUN
bptjm-30	189	6	specifically	specifically	ADV
bptjm-30	189	7	in	in	ADP
bptjm-30	189	8	promoting	promote	VERB
bptjm-30	189	9	promnesic	promnesic	ADJ
bptjm-30	189	10	effects	effect	NOUN
bptjm-30	189	11	and	and	CCONJ
bptjm-30	189	12	regulating	regulate	VERB
bptjm-30	189	13	emotional	emotional	ADJ
bptjm-30	189	14	behaviors43	behaviors43	NOUN
bptjm-30	189	15	.	.	PUNCT
bptjm-30	190	1	compared	compare	VERB
bptjm-30	190	2	to	to	ADP
bptjm-30	190	3	other	other	ADJ
bptjm-30	190	4	traditional	traditional	ADJ
bptjm-30	190	5	antidepressant	antidepressant	ADJ
bptjm-30	190	6	drugs	drug	NOUN
bptjm-30	190	7	that	that	PRON
bptjm-30	190	8	focus	focus	VERB
bptjm-30	190	9	on	on	ADP
bptjm-30	190	10	inhibiting	inhibit	VERB
bptjm-30	190	11	serotonin	serotonin	NOUN
bptjm-30	190	12	reuptake	reuptake	NOUN
bptjm-30	190	13	,	,	PUNCT
bptjm-30	190	14	lsd	lsd	NOUN
bptjm-30	190	15	is	be	AUX
bptjm-30	190	16	both	both	PRON
bptjm-30	190	17	faster	fast	ADV
bptjm-30	190	18	-	-	PUNCT
bptjm-30	190	19	acting	act	VERB
bptjm-30	190	20	and	and	CCONJ
bptjm-30	190	21	longer	long	ADV
bptjm-30	190	22	-	-	PUNCT
bptjm-30	190	23	lasting	last	VERB
bptjm-30	190	24	in	in	ADP
bptjm-30	190	25	the	the	DET
bptjm-30	190	26	human	human	ADJ
bptjm-30	190	27	body44	body44	NOUN
bptjm-30	190	28	.	.	PUNCT
bptjm-30	191	1	one	one	NUM
bptjm-30	191	2	current	current	ADJ
bptjm-30	191	3	research	research	NOUN
bptjm-30	191	4	trial	trial	NOUN
bptjm-30	191	5	presents	present	NOUN
bptjm-30	191	6	that	that	PRON
bptjm-30	191	7	lsd	lsd	NOUN
bptjm-30	191	8	promotes	promote	VERB
bptjm-30	191	9	social	social	ADJ
bptjm-30	191	10	behavior	behavior	NOUN
bptjm-30	191	11	through	through	ADP
bptjm-30	191	12	mtorc1	mtorc1	NOUN
bptjm-30	191	13	,	,	PUNCT
bptjm-30	191	14	a	a	DET
bptjm-30	191	15	protein	protein	NOUN
bptjm-30	191	16	complex	complex	NOUN
bptjm-30	191	17	activating	activate	VERB
bptjm-30	191	18	the	the	DET
bptjm-30	191	19	translation	translation	NOUN
bptjm-30	191	20	of	of	ADP
bptjm-30	191	21	other	other	ADJ
bptjm-30	191	22	proteinsin	proteinsin	NOUN
bptjm-30	191	23	excitatory	excitatory	NOUN
bptjm-30	191	24	neurotransmission45.lsd	neurotransmission45.lsd	NOUN
bptjm-30	191	25	was	be	AUX
bptjm-30	191	26	shown	show	VERB
bptjm-30	191	27	to	to	PART
bptjm-30	191	28	potential	potential	VERB
bptjm-30	191	29	both	both	CCONJ
bptjm-30	191	30	ampa	ampa	NOUN
bptjm-30	191	31	and	and	CCONJ
bptjm-30	191	32	5	5	NUM
bptjm-30	191	33	-	-	PUNCT
bptjm-30	191	34	ht2a	ht2a	NOUN
bptjm-30	191	35	synaptic	synaptic	ADJ
bptjm-30	191	36	responses	response	NOUN
bptjm-30	191	37	in	in	ADP
bptjm-30	191	38	the	the	DET
bptjm-30	191	39	mpfc	mpfc	NOUN
bptjm-30	191	40	(	(	PUNCT
bptjm-30	191	41	medial	medial	ADJ
bptjm-30	191	42	prefrontal	prefrontal	ADJ
bptjm-30	191	43	cortex	cortex	NOUN
bptjm-30	191	44	)	)	PUNCT
bptjm-30	191	45	and	and	CCONJ
bptjm-30	191	46	increase	increase	VERB
bptjm-30	191	47	the	the	DET
bptjm-30	191	48	phosphorylation	phosphorylation	NOUN
bptjm-30	191	49	of	of	ADP
bptjm-30	191	50	protein	protein	NOUN
bptjm-30	191	51	kinases	kinase	NOUN
bptjm-30	191	52	akt	akt	PROPN
bptjm-30	191	53	and	and	CCONJ
bptjm-30	191	54	mtor	mtor	PROPN
bptjm-30	191	55	in	in	ADP
bptjm-30	191	56	a	a	DET
bptjm-30	191	57	rodent	rodent	ADJ
bptjm-30	191	58	model	model	NOUN
bptjm-30	191	59	.	.	PUNCT
bptjm-30	192	1	this	this	DET
bptjm-30	192	2	effect	effect	NOUN
bptjm-30	192	3	on	on	ADP
bptjm-30	192	4	signaling	signal	VERB
bptjm-30	192	5	in	in	ADP
bptjm-30	192	6	the	the	DET
bptjm-30	192	7	mtor	mtor	PROPN
bptjm-30	192	8	pathway	pathway	NOUN
bptjm-30	192	9	was	be	AUX
bptjm-30	192	10	hypothesized	hypothesize	VERB
bptjm-30	192	11	as	as	ADP
bptjm-30	192	12	the	the	DET
bptjm-30	192	13	rationale	rationale	NOUN
bptjm-30	192	14	behind	behind	ADP
bptjm-30	192	15	the	the	DET
bptjm-30	192	16	increase	increase	NOUN
bptjm-30	192	17	in	in	ADP
bptjm-30	192	18	prosocial	prosocial	ADJ
bptjm-30	192	19	behaviors	behavior	NOUN
bptjm-30	192	20	like	like	ADP
bptjm-30	192	21	ketamine	ketamine	PROPN
bptjm-30	192	22	.	.	PUNCT
bptjm-30	193	1	another	another	DET
bptjm-30	193	2	recent	recent	ADJ
bptjm-30	193	3	clinical	clinical	ADJ
bptjm-30	193	4	trial	trial	NOUN
bptjm-30	193	5	utilized	utilize	VERB
bptjm-30	193	6	the	the	DET
bptjm-30	193	7	administration	administration	NOUN
bptjm-30	193	8	of	of	ADP
bptjm-30	193	9	lsd	lsd	NOUN
bptjm-30	193	10	and	and	CCONJ
bptjm-30	193	11	placebo	placebo	NOUN
bptjm-30	193	12	to	to	ADP
bptjm-30	193	13	20	20	NUM
bptjm-30	193	14	healthy	healthy	ADJ
bptjm-30	193	15	volunteers	volunteer	NOUN
bptjm-30	193	16	and	and	CCONJ
bptjm-30	193	17	subsequently	subsequently	ADV
bptjm-30	193	18	measured	measure	VERB
bptjm-30	193	19	the	the	DET
bptjm-30	193	20	emotional	emotional	ADJ
bptjm-30	193	21	behaviors	behavior	NOUN
bptjm-30	193	22	of	of	ADP
bptjm-30	193	23	the	the	DET
bptjm-30	193	24	participants	participant	NOUN
bptjm-30	193	25	2	2	NUM
bptjm-30	193	26	weeks	week	NOUN
bptjm-30	193	27	after	after	ADP
bptjm-30	193	28	administration46	administration46	NOUN
bptjm-30	193	29	.	.	PUNCT
bptjm-30	194	1	the	the	DET
bptjm-30	194	2	results	result	NOUN
bptjm-30	194	3	indicated	indicate	VERB
bptjm-30	194	4	that	that	SCONJ
bptjm-30	194	5	lsd	lsd	NOUN
bptjm-30	194	6	was	be	AUX
bptjm-30	194	7	responsible	responsible	ADJ
bptjm-30	194	8	for	for	ADP
bptjm-30	194	9	the	the	DET
bptjm-30	194	10	heightened	heighten	VERB
bptjm-30	194	11	mood	mood	NOUN
bptjm-30	194	12	,	,	PUNCT
bptjm-30	194	13	optimism	optimism	NOUN
bptjm-30	194	14	,	,	PUNCT
bptjm-30	194	15	and	and	CCONJ
bptjm-30	194	16	trait	trait	NOUN
bptjm-30	194	17	optimism	optimism	NOUN
bptjm-30	194	18	of	of	ADP
bptjm-30	194	19	the	the	DET
bptjm-30	194	20	participants	participant	NOUN
bptjm-30	194	21	.	.	PUNCT
bptjm-30	195	1	another	another	DET
bptjm-30	195	2	important	important	ADJ
bptjm-30	195	3	ongoing	ongoing	ADJ
bptjm-30	195	4	clinical	clinical	ADJ
bptjm-30	195	5	trial	trial	NOUN
bptjm-30	195	6	will	will	AUX
bptjm-30	195	7	measure	measure	VERB
bptjm-30	195	8	the	the	DET
bptjm-30	195	9	efficacy	efficacy	NOUN
bptjm-30	195	10	of	of	ADP
bptjm-30	195	11	lsd	lsd	PROPN
bptjm-30	195	12	administration	administration	NOUN
bptjm-30	195	13	in	in	ADP
bptjm-30	195	14	patients	patient	NOUN
bptjm-30	195	15	suffering	suffer	VERB
bptjm-30	195	16	from	from	ADP
bptjm-30	195	17	mdd	mdd	PROPN
bptjm-30	195	18	.	.	PROPN
bptjm-30	195	19	berkeley	berkeley	PROPN
bptjm-30	195	20	pharma	pharma	PROPN
bptjm-30	195	21	tech	tech	PROPN
bptjm-30	195	22	journal	journal	NOUN
bptjm-30	195	23	of	of	ADP
bptjm-30	195	24	medicine	medicine	NOUN
bptjm-30	195	25	|	|	ADV
bptjm-30	195	26	36	36	NUM
bptjm-30	195	27	by	by	ADP
bptjm-30	195	28	targeting	target	VERB
bptjm-30	195	29	the	the	DET
bptjm-30	195	30	5	5	NUM
bptjm-30	195	31	-	-	PUNCT
bptjm-30	195	32	ht2a	ht2a	NOUN
bptjm-30	195	33	receptor	receptor	NOUN
bptjm-30	195	34	,	,	PUNCT
bptjm-30	195	35	lsd	lsd	NOUN
bptjm-30	195	36	functions	function	NOUN
bptjm-30	195	37	as	as	ADP
bptjm-30	195	38	a	a	DET
bptjm-30	195	39	serotonin	serotonin	NOUN
bptjm-30	195	40	-	-	PUNCT
bptjm-30	195	41	like	like	ADJ
bptjm-30	195	42	chemical	chemical	NOUN
bptjm-30	195	43	in	in	ADP
bptjm-30	195	44	an	an	DET
bptjm-30	195	45	agonist	agonist	NOUN
bptjm-30	195	46	role	role	NOUN
bptjm-30	195	47	.	.	PUNCT
bptjm-30	196	1	this	this	PRON
bptjm-30	196	2	may	may	AUX
bptjm-30	196	3	be	be	AUX
bptjm-30	196	4	advantageous	advantageous	ADJ
bptjm-30	196	5	to	to	ADP
bptjm-30	196	6	other	other	ADJ
bptjm-30	196	7	antidepressants	antidepressant	NOUN
bptjm-30	196	8	due	due	ADP
bptjm-30	196	9	to	to	ADP
bptjm-30	196	10	its	its	PRON
bptjm-30	196	11	rapid	rapid	ADJ
bptjm-30	196	12	and	and	CCONJ
bptjm-30	196	13	longer	long	ADV
bptjm-30	196	14	-	-	PUNCT
bptjm-30	196	15	lasting	last	VERB
bptjm-30	196	16	effects	effect	NOUN
bptjm-30	196	17	.	.	PUNCT
bptjm-30	197	1	lsd	lsd	PROPN
bptjm-30	197	2	also	also	ADV
bptjm-30	197	3	affects	affect	VERB
bptjm-30	197	4	the	the	DET
bptjm-30	197	5	mtorc1	mtorc1	NOUN
bptjm-30	197	6	pathway	pathway	NOUN
bptjm-30	197	7	,	,	PUNCT
bptjm-30	197	8	which	which	PRON
bptjm-30	197	9	has	have	AUX
bptjm-30	197	10	been	be	AUX
bptjm-30	197	11	implicated	implicate	VERB
bptjm-30	197	12	in	in	ADP
bptjm-30	197	13	increasing	increase	VERB
bptjm-30	197	14	sociality	sociality	NOUN
bptjm-30	197	15	.	.	PUNCT
bptjm-30	198	1	although	although	SCONJ
bptjm-30	198	2	much	much	ADJ
bptjm-30	198	3	research	research	NOUN
bptjm-30	198	4	was	be	AUX
bptjm-30	198	5	conducted	conduct	VERB
bptjm-30	198	6	regarding	regard	VERB
bptjm-30	198	7	lsd	lsd	NOUN
bptjm-30	198	8	’s	’s	PART
bptjm-30	198	9	therapeutic	therapeutic	ADJ
bptjm-30	198	10	effects	effect	NOUN
bptjm-30	198	11	in	in	ADP
bptjm-30	198	12	the	the	DET
bptjm-30	198	13	1970s	1970	NOUN
bptjm-30	198	14	,	,	PUNCT
bptjm-30	198	15	government	government	NOUN
bptjm-30	198	16	restrictions	restriction	NOUN
bptjm-30	198	17	on	on	ADP
bptjm-30	198	18	psychedelic	psychedelic	ADJ
bptjm-30	198	19	research	research	NOUN
bptjm-30	198	20	have	have	AUX
bptjm-30	198	21	curtailed	curtail	VERB
bptjm-30	198	22	efforts	effort	NOUN
bptjm-30	198	23	in	in	ADP
bptjm-30	198	24	the	the	DET
bptjm-30	198	25	past	past	ADJ
bptjm-30	198	26	few	few	ADJ
bptjm-30	198	27	decades46	decades46	NOUN
bptjm-30	198	28	.	.	PUNCT
bptjm-30	199	1	the	the	DET
bptjm-30	199	2	increasing	increase	VERB
bptjm-30	199	3	rate	rate	NOUN
bptjm-30	199	4	of	of	ADP
bptjm-30	199	5	clinical	clinical	ADJ
bptjm-30	199	6	trials	trial	NOUN
bptjm-30	199	7	,	,	PUNCT
bptjm-30	199	8	including	include	VERB
bptjm-30	199	9	psychedelics	psychedelic	NOUN
bptjm-30	199	10	and	and	CCONJ
bptjm-30	199	11	lsd	lsd	NOUN
bptjm-30	199	12	in	in	ADP
bptjm-30	199	13	psychiatric	psychiatric	ADJ
bptjm-30	199	14	disorders	disorder	NOUN
bptjm-30	199	15	,	,	PUNCT
bptjm-30	199	16	must	must	AUX
bptjm-30	199	17	continue	continue	VERB
bptjm-30	199	18	to	to	PART
bptjm-30	199	19	gather	gather	VERB
bptjm-30	199	20	evidence	evidence	NOUN
bptjm-30	199	21	of	of	ADP
bptjm-30	199	22	reproducibility	reproducibility	NOUN
bptjm-30	199	23	and	and	CCONJ
bptjm-30	199	24	validity	validity	NOUN
bptjm-30	199	25	.	.	PUNCT
bptjm-30	200	1	because	because	SCONJ
bptjm-30	200	2	of	of	ADP
bptjm-30	200	3	the	the	DET
bptjm-30	200	4	prevalence	prevalence	NOUN
bptjm-30	200	5	of	of	ADP
bptjm-30	200	6	“	"	PUNCT
bptjm-30	200	7	bad	bad	ADJ
bptjm-30	200	8	trips	trip	NOUN
bptjm-30	200	9	”	"	PUNCT
bptjm-30	200	10	and	and	CCONJ
bptjm-30	200	11	the	the	DET
bptjm-30	200	12	tendency	tendency	NOUN
bptjm-30	200	13	of	of	ADP
bptjm-30	200	14	the	the	DET
bptjm-30	200	15	drug	drug	NOUN
bptjm-30	200	16	to	to	PART
bptjm-30	200	17	sometimes	sometimes	ADV
bptjm-30	200	18	exacerbate	exacerbate	VERB
bptjm-30	200	19	existing	exist	VERB
bptjm-30	200	20	psychiatric	psychiatric	ADJ
bptjm-30	200	21	predispositions	predisposition	NOUN
bptjm-30	200	22	,	,	PUNCT
bptjm-30	200	23	trials	trial	NOUN
bptjm-30	200	24	testing	test	VERB
bptjm-30	200	25	the	the	DET
bptjm-30	200	26	drug	drug	NOUN
bptjm-30	200	27	,	,	PUNCT
bptjm-30	200	28	in	in	ADP
bptjm-30	200	29	combination	combination	NOUN
bptjm-30	200	30	with	with	ADP
bptjm-30	200	31	therapy	therapy	NOUN
bptjm-30	200	32	or	or	CCONJ
bptjm-30	200	33	trials	trial	NOUN
bptjm-30	200	34	focusing	focus	VERB
bptjm-30	200	35	on	on	ADP
bptjm-30	200	36	micro	micro	ADJ
bptjm-30	200	37	-	-	ADJ
bptjm-30	200	38	dosing	dose	VERB
bptjm-30	200	39	the	the	DET
bptjm-30	200	40	drug	drug	NOUN
bptjm-30	200	41	,	,	PUNCT
bptjm-30	200	42	may	may	AUX
bptjm-30	200	43	be	be	AUX
bptjm-30	200	44	an	an	DET
bptjm-30	200	45	optimal	optimal	ADJ
bptjm-30	200	46	focus47	focus47	NOUN
bptjm-30	200	47	.	.	PUNCT
bptjm-30	201	1	5.4	5.4	NUM
bptjm-30	201	2	.	.	PUNCT
bptjm-30	201	3	natural	natural	ADJ
bptjm-30	201	4	products	product	NOUN
bptjm-30	201	5	natural	natural	ADJ
bptjm-30	201	6	products	product	NOUN
bptjm-30	201	7	encompass	encompass	VERB
bptjm-30	201	8	many	many	ADJ
bptjm-30	201	9	possible	possible	ADJ
bptjm-30	201	10	treatment	treatment	NOUN
bptjm-30	201	11	options	option	NOUN
bptjm-30	201	12	,	,	PUNCT
bptjm-30	201	13	which	which	PRON
bptjm-30	201	14	all	all	DET
bptjm-30	201	15	work	work	VERB
bptjm-30	201	16	to	to	PART
bptjm-30	201	17	cure	cure	VERB
bptjm-30	201	18	depression	depression	NOUN
bptjm-30	201	19	through	through	ADP
bptjm-30	201	20	different	different	ADJ
bptjm-30	201	21	mechanisms	mechanism	NOUN
bptjm-30	201	22	.	.	PUNCT
bptjm-30	202	1	most	most	ADJ
bptjm-30	202	2	natural	natural	ADJ
bptjm-30	202	3	products	product	NOUN
bptjm-30	202	4	act	act	VERB
bptjm-30	202	5	prophylactically	prophylactically	ADV
bptjm-30	202	6	and	and	CCONJ
bptjm-30	202	7	help	help	VERB
bptjm-30	202	8	to	to	PART
bptjm-30	202	9	alleviate	alleviate	VERB
bptjm-30	202	10	symptoms	symptom	NOUN
bptjm-30	202	11	of	of	ADP
bptjm-30	202	12	depression	depression	NOUN
bptjm-30	202	13	while	while	SCONJ
bptjm-30	202	14	also	also	ADV
bptjm-30	202	15	benefiting	benefit	VERB
bptjm-30	202	16	internal	internal	ADJ
bptjm-30	202	17	organ	organ	NOUN
bptjm-30	202	18	functions7	functions7	NOUN
bptjm-30	202	19	.	.	PUNCT
bptjm-30	203	1	current	current	ADJ
bptjm-30	203	2	natural	natural	ADJ
bptjm-30	203	3	products	product	NOUN
bptjm-30	203	4	investigated	investigate	VERB
bptjm-30	203	5	as	as	ADP
bptjm-30	203	6	potential	potential	ADJ
bptjm-30	203	7	depression	depression	NOUN
bptjm-30	203	8	treatments	treatment	NOUN
bptjm-30	203	9	include	include	VERB
bptjm-30	203	10	traditional	traditional	ADJ
bptjm-30	203	11	chinese	chinese	ADJ
bptjm-30	203	12	medicine	medicine	NOUN
bptjm-30	203	13	formula	formula	NOUN
bptjm-30	203	14	,	,	PUNCT
bptjm-30	203	15	herbs	herb	NOUN
bptjm-30	203	16	or	or	CCONJ
bptjm-30	203	17	their	their	PRON
bptjm-30	203	18	parts	part	NOUN
bptjm-30	203	19	,	,	PUNCT
bptjm-30	203	20	and	and	CCONJ
bptjm-30	203	21	natural	natural	ADJ
bptjm-30	203	22	products	product	NOUN
bptjm-30	203	23	that	that	PRON
bptjm-30	203	24	are	be	AUX
bptjm-30	203	25	either	either	CCONJ
bptjm-30	203	26	extracts	extract	NOUN
bptjm-30	203	27	or	or	CCONJ
bptjm-30	203	28	isolated	isolated	ADJ
bptjm-30	203	29	compounds7	compounds7	NOUN
bptjm-30	203	30	.	.	PUNCT
bptjm-30	204	1	there	there	PRON
bptjm-30	204	2	are	be	VERB
bptjm-30	204	3	different	different	ADJ
bptjm-30	204	4	types	type	NOUN
bptjm-30	204	5	of	of	ADP
bptjm-30	204	6	natural	natural	ADJ
bptjm-30	204	7	products	product	NOUN
bptjm-30	204	8	available	available	ADJ
bptjm-30	204	9	for	for	ADP
bptjm-30	204	10	different	different	ADJ
bptjm-30	204	11	types	type	NOUN
bptjm-30	204	12	of	of	ADP
bptjm-30	204	13	depression	depression	NOUN
bptjm-30	204	14	,	,	PUNCT
bptjm-30	204	15	such	such	ADJ
bptjm-30	204	16	as	as	ADP
bptjm-30	204	17	stress	stress	NOUN
bptjm-30	204	18	-	-	PUNCT
bptjm-30	204	19	induced	induce	VERB
bptjm-30	204	20	depression	depression	NOUN
bptjm-30	204	21	,	,	PUNCT
bptjm-30	204	22	post	post	ADJ
bptjm-30	204	23	-	-	ADJ
bptjm-30	204	24	stroke	stroke	ADJ
bptjm-30	204	25	depression	depression	NOUN
bptjm-30	204	26	,	,	PUNCT
bptjm-30	204	27	comorbidity	comorbidity	NOUN
bptjm-30	204	28	depression	depression	NOUN
bptjm-30	204	29	,	,	PUNCT
bptjm-30	204	30	and	and	CCONJ
bptjm-30	204	31	more	more	ADJ
bptjm-30	204	32	.	.	PUNCT
bptjm-30	205	1	some	some	DET
bptjm-30	205	2	products	product	NOUN
bptjm-30	205	3	work	work	VERB
bptjm-30	205	4	well	well	ADV
bptjm-30	205	5	in	in	ADP
bptjm-30	205	6	conjunction	conjunction	NOUN
bptjm-30	205	7	with	with	ADP
bptjm-30	205	8	a	a	DET
bptjm-30	205	9	good	good	ADJ
bptjm-30	205	10	diet	diet	NOUN
bptjm-30	205	11	to	to	PART
bptjm-30	205	12	prevent	prevent	VERB
bptjm-30	205	13	depression	depression	NOUN
bptjm-30	205	14	because	because	SCONJ
bptjm-30	205	15	some	some	DET
bptjm-30	205	16	food	food	NOUN
bptjm-30	205	17	components	component	NOUN
bptjm-30	205	18	,	,	PUNCT
bptjm-30	205	19	such	such	ADJ
bptjm-30	205	20	as	as	ADP
bptjm-30	205	21	omega-3	omega-3	NUM
bptjm-30	205	22	fatty	fatty	NOUN
bptjm-30	205	23	acids	acid	NOUN
bptjm-30	205	24	and	and	CCONJ
bptjm-30	205	25	vitamin	vitamin	NOUN
bptjm-30	205	26	l1	l1	PROPN
bptjm-30	205	27	,	,	PUNCT
bptjm-30	205	28	can	can	AUX
bptjm-30	205	29	improve	improve	VERB
bptjm-30	205	30	mood	mood	NOUN
bptjm-30	205	31	.	.	PUNCT
bptjm-30	206	1	traditional	traditional	ADJ
bptjm-30	206	2	herbal	herbal	ADJ
bptjm-30	206	3	medicine	medicine	NOUN
bptjm-30	206	4	has	have	AUX
bptjm-30	206	5	been	be	AUX
bptjm-30	206	6	used	use	VERB
bptjm-30	206	7	with	with	ADP
bptjm-30	206	8	multitargets	multitarget	NOUN
bptjm-30	206	9	,	,	PUNCT
bptjm-30	206	10	multi	multi	NOUN
bptjm-30	206	11	-	-	NOUN
bptjm-30	206	12	levels	level	NOUN
bptjm-30	206	13	,	,	PUNCT
bptjm-30	206	14	and	and	CCONJ
bptjm-30	206	15	multi	multi	ADJ
bptjm-30	206	16	-	-	NOUN
bptjm-30	206	17	ways48	ways48	ADJ
bptjm-30	206	18	.	.	PUNCT
bptjm-30	207	1	natural	natural	ADJ
bptjm-30	207	2	products	product	NOUN
bptjm-30	207	3	differ	differ	VERB
bptjm-30	207	4	from	from	ADP
bptjm-30	207	5	commonly	commonly	ADV
bptjm-30	207	6	prescribed	prescribe	VERB
bptjm-30	207	7	antidepressants	antidepressant	NOUN
bptjm-30	207	8	because	because	SCONJ
bptjm-30	207	9	they	they	PRON
bptjm-30	207	10	tend	tend	VERB
bptjm-30	207	11	to	to	PART
bptjm-30	207	12	originate	originate	VERB
bptjm-30	207	13	from	from	ADP
bptjm-30	207	14	non	non	ADJ
bptjm-30	207	15	-	-	ADJ
bptjm-30	207	16	western	western	ADJ
bptjm-30	207	17	medicine	medicine	NOUN
bptjm-30	207	18	and	and	CCONJ
bptjm-30	207	19	focus	focus	VERB
bptjm-30	207	20	on	on	ADP
bptjm-30	207	21	treating	treat	VERB
bptjm-30	207	22	other	other	ADJ
bptjm-30	207	23	mechanisms	mechanism	NOUN
bptjm-30	207	24	in	in	ADP
bptjm-30	207	25	the	the	DET
bptjm-30	207	26	brain	brain	NOUN
bptjm-30	207	27	.	.	PUNCT
bptjm-30	208	1	for	for	ADP
bptjm-30	208	2	example	example	NOUN
bptjm-30	208	3	,	,	PUNCT
bptjm-30	208	4	suppressing	suppress	VERB
bptjm-30	208	5	signaling	signal	VERB
bptjm-30	208	6	pathways	pathway	NOUN
bptjm-30	208	7	,	,	PUNCT
bptjm-30	208	8	treating	treat	VERB
bptjm-30	208	9	internal	internal	ADJ
bptjm-30	208	10	heat	heat	NOUN
bptjm-30	208	11	depression	depression	NOUN
bptjm-30	208	12	,	,	PUNCT
bptjm-30	208	13	and	and	CCONJ
bptjm-30	208	14	protecting	protect	VERB
bptjm-30	208	15	brain	brain	NOUN
bptjm-30	208	16	glial	glial	ADJ
bptjm-30	208	17	loss	loss	NOUN
bptjm-30	208	18	.	.	PUNCT
bptjm-30	208	19	natural	natural	ADJ
bptjm-30	208	20	products	product	NOUN
bptjm-30	208	21	also	also	ADV
bptjm-30	208	22	tend	tend	VERB
bptjm-30	208	23	to	to	PART
bptjm-30	208	24	be	be	AUX
bptjm-30	208	25	produced	produce	VERB
bptjm-30	208	26	naturally	naturally	ADV
bptjm-30	208	27	,	,	PUNCT
bptjm-30	208	28	compared	compare	VERB
bptjm-30	208	29	to	to	ADP
bptjm-30	208	30	most	most	ADJ
bptjm-30	208	31	berkeley	berkeley	PROPN
bptjm-30	208	32	pharma	pharma	PROPN
bptjm-30	208	33	tech	tech	NOUN
bptjm-30	208	34	journal	journal	NOUN
bptjm-30	208	35	of	of	ADP
bptjm-30	208	36	medicine	medicine	NOUN
bptjm-30	208	37	|	|	ADV
bptjm-30	208	38	37	37	NUM
bptjm-30	208	39	antidepressants	antidepressant	NOUN
bptjm-30	208	40	which	which	PRON
bptjm-30	208	41	are	be	AUX
bptjm-30	208	42	produced	produce	VERB
bptjm-30	208	43	in	in	ADP
bptjm-30	208	44	a	a	DET
bptjm-30	208	45	laboratory	laboratory	NOUN
bptjm-30	208	46	environment	environment	NOUN
bptjm-30	208	47	.	.	PUNCT
bptjm-30	209	1	some	some	DET
bptjm-30	209	2	natural	natural	ADJ
bptjm-30	209	3	products	product	NOUN
bptjm-30	209	4	have	have	VERB
bptjm-30	209	5	fewer	few	ADJ
bptjm-30	209	6	adverse	adverse	ADJ
bptjm-30	209	7	effects	effect	NOUN
bptjm-30	209	8	compared	compare	VERB
bptjm-30	209	9	to	to	ADP
bptjm-30	209	10	conventional	conventional	ADJ
bptjm-30	209	11	depression	depression	NOUN
bptjm-30	209	12	medication	medication	NOUN
bptjm-30	209	13	and	and	CCONJ
bptjm-30	209	14	can	can	AUX
bptjm-30	209	15	also	also	ADV
bptjm-30	209	16	reduce	reduce	VERB
bptjm-30	209	17	medication	medication	NOUN
bptjm-30	209	18	load	load	NOUN
bptjm-30	209	19	and	and	CCONJ
bptjm-30	209	20	undesirable	undesirable	ADJ
bptjm-30	209	21	side	side	NOUN
bptjm-30	209	22	effects49	effects49	NOUN
bptjm-30	209	23	.	.	PUNCT
bptjm-30	210	1	natural	natural	ADJ
bptjm-30	210	2	products	product	NOUN
bptjm-30	210	3	provide	provide	VERB
bptjm-30	210	4	many	many	ADJ
bptjm-30	210	5	compounds	compound	NOUN
bptjm-30	210	6	with	with	ADP
bptjm-30	210	7	antidepressant	antidepressant	ADJ
bptjm-30	210	8	-	-	PUNCT
bptjm-30	210	9	like	like	ADJ
bptjm-30	210	10	effects	effect	NOUN
bptjm-30	210	11	,	,	PUNCT
bptjm-30	210	12	and	and	CCONJ
bptjm-30	210	13	their	their	PRON
bptjm-30	210	14	therapeutic	therapeutic	ADJ
bptjm-30	210	15	impacts	impact	NOUN
bptjm-30	210	16	have	have	AUX
bptjm-30	210	17	been	be	AUX
bptjm-30	210	18	highlighted	highlight	VERB
bptjm-30	210	19	for	for	ADP
bptjm-30	210	20	a	a	DET
bptjm-30	210	21	long	long	ADJ
bptjm-30	210	22	time	time	NOUN
bptjm-30	210	23	.	.	PUNCT
bptjm-30	211	1	apart	apart	ADV
bptjm-30	211	2	from	from	ADP
bptjm-30	211	3	using	use	VERB
bptjm-30	211	4	as	as	ADP
bptjm-30	211	5	-	-	PUNCT
bptjm-30	211	6	is	be	AUX
bptjm-30	211	7	,	,	PUNCT
bptjm-30	211	8	natural	natural	ADJ
bptjm-30	211	9	products	product	NOUN
bptjm-30	211	10	are	be	AUX
bptjm-30	211	11	also	also	ADV
bptjm-30	211	12	a	a	DET
bptjm-30	211	13	great	great	ADJ
bptjm-30	211	14	source	source	NOUN
bptjm-30	211	15	for	for	ADP
bptjm-30	211	16	future	future	ADJ
bptjm-30	211	17	antidepressant	antidepressant	ADJ
bptjm-30	211	18	drug	drug	NOUN
bptjm-30	211	19	discovery	discovery	NOUN
bptjm-30	211	20	.	.	PUNCT
bptjm-30	212	1	there	there	PRON
bptjm-30	212	2	are	be	VERB
bptjm-30	212	3	in	in	ADP
bptjm-30	212	4	vitro	vitro	NOUN
bptjm-30	212	5	,	,	PUNCT
bptjm-30	212	6	in	in	ADP
bptjm-30	212	7	vivo	vivo	NOUN
bptjm-30	212	8	,	,	PUNCT
bptjm-30	212	9	nonclinical	nonclinical	ADJ
bptjm-30	212	10	,	,	PUNCT
bptjm-30	212	11	and	and	CCONJ
bptjm-30	212	12	clinical	clinical	ADJ
bptjm-30	212	13	/	/	SYM
bptjm-30	212	14	translational	translational	ADJ
bptjm-30	212	15	studies	study	NOUN
bptjm-30	212	16	looking	look	VERB
bptjm-30	212	17	at	at	ADP
bptjm-30	212	18	the	the	DET
bptjm-30	212	19	effectiveness	effectiveness	NOUN
bptjm-30	212	20	of	of	ADP
bptjm-30	212	21	natural	natural	ADJ
bptjm-30	212	22	products	product	NOUN
bptjm-30	212	23	in	in	ADP
bptjm-30	212	24	depression	depression	NOUN
bptjm-30	212	25	treatment	treatment	NOUN
bptjm-30	212	26	.	.	PUNCT
bptjm-30	213	1	the	the	DET
bptjm-30	213	2	potential	potential	NOUN
bptjm-30	213	3	of	of	ADP
bptjm-30	213	4	tetragonia	tetragonia	NOUN
bptjm-30	213	5	tetragonioides	tetragonioide	NOUN
bptjm-30	213	6	(	(	PUNCT
bptjm-30	213	7	ttk	ttk	PROPN
bptjm-30	213	8	)	)	PUNCT
bptjm-30	213	9	was	be	AUX
bptjm-30	213	10	examined	examine	VERB
bptjm-30	213	11	through	through	ADP
bptjm-30	213	12	a	a	DET
bptjm-30	213	13	trial	trial	NOUN
bptjm-30	213	14	involving	involve	VERB
bptjm-30	213	15	the	the	DET
bptjm-30	213	16	animal	animal	NOUN
bptjm-30	213	17	model	model	NOUN
bptjm-30	213	18	brain	brain	NOUN
bptjm-30	213	19	of	of	ADP
bptjm-30	213	20	depression50	depression50	NOUN
bptjm-30	213	21	.	.	PUNCT
bptjm-30	214	1	glial	glial	ADJ
bptjm-30	214	2	cells	cell	NOUN
bptjm-30	214	3	have	have	VERB
bptjm-30	214	4	a	a	DET
bptjm-30	214	5	protective	protective	ADJ
bptjm-30	214	6	role	role	NOUN
bptjm-30	214	7	within	within	ADP
bptjm-30	214	8	the	the	DET
bptjm-30	214	9	cns	cns	NOUN
bptjm-30	214	10	and	and	CCONJ
bptjm-30	214	11	pns	pns	NOUN
bptjm-30	214	12	by	by	ADP
bptjm-30	214	13	helping	help	VERB
bptjm-30	214	14	to	to	PART
bptjm-30	214	15	maintain	maintain	VERB
bptjm-30	214	16	homeostasis	homeostasis	NOUN
bptjm-30	214	17	.	.	PUNCT
bptjm-30	215	1	essentially	essentially	ADV
bptjm-30	215	2	,	,	PUNCT
bptjm-30	215	3	glial	glial	ADJ
bptjm-30	215	4	cells	cell	NOUN
bptjm-30	215	5	help	help	VERB
bptjm-30	215	6	to	to	PART
bptjm-30	215	7	hold	hold	VERB
bptjm-30	215	8	nerve	nerve	NOUN
bptjm-30	215	9	cells	cell	NOUN
bptjm-30	215	10	in	in	ADP
bptjm-30	215	11	place	place	NOUN
bptjm-30	215	12	so	so	SCONJ
bptjm-30	215	13	nerve	nerve	NOUN
bptjm-30	215	14	cells	cell	NOUN
bptjm-30	215	15	can	can	AUX
bptjm-30	215	16	produce	produce	VERB
bptjm-30	215	17	their	their	PRON
bptjm-30	215	18	appropriate	appropriate	ADJ
bptjm-30	215	19	function	function	NOUN
bptjm-30	215	20	.	.	PUNCT
bptjm-30	216	1	glial	glial	ADJ
bptjm-30	216	2	cells	cell	NOUN
bptjm-30	216	3	play	play	VERB
bptjm-30	216	4	a	a	DET
bptjm-30	216	5	role	role	NOUN
bptjm-30	216	6	in	in	ADP
bptjm-30	216	7	depression	depression	NOUN
bptjm-30	216	8	because	because	SCONJ
bptjm-30	216	9	the	the	DET
bptjm-30	216	10	loss	loss	NOUN
bptjm-30	216	11	of	of	ADP
bptjm-30	216	12	glial	glial	ADJ
bptjm-30	216	13	functions	function	NOUN
bptjm-30	216	14	has	have	AUX
bptjm-30	216	15	been	be	AUX
bptjm-30	216	16	shown	show	VERB
bptjm-30	216	17	to	to	PART
bptjm-30	216	18	contribute	contribute	VERB
bptjm-30	216	19	to	to	ADP
bptjm-30	216	20	the	the	DET
bptjm-30	216	21	pathophysiology	pathophysiology	NOUN
bptjm-30	216	22	of	of	ADP
bptjm-30	216	23	depression50	depression50	NOUN
bptjm-30	216	24	.	.	PUNCT
bptjm-30	217	1	ttk	ttk	PROPN
bptjm-30	217	2	is	be	AUX
bptjm-30	217	3	commonly	commonly	ADV
bptjm-30	217	4	called	call	VERB
bptjm-30	217	5	the	the	DET
bptjm-30	217	6	new	new	PROPN
bptjm-30	217	7	zealand	zealand	PROPN
bptjm-30	217	8	spinach	spinach	NOUN
bptjm-30	217	9	and	and	CCONJ
bptjm-30	217	10	other	other	ADJ
bptjm-30	217	11	local	local	ADJ
bptjm-30	217	12	names	name	NOUN
bptjm-30	217	13	.	.	PUNCT
bptjm-30	218	1	ttk	ttk	PROPN
bptjm-30	218	2	is	be	AUX
bptjm-30	218	3	edible	edible	ADJ
bptjm-30	218	4	,	,	PUNCT
bptjm-30	218	5	both	both	CCONJ
bptjm-30	218	6	raw	raw	ADJ
bptjm-30	218	7	and	and	CCONJ
bptjm-30	218	8	cooked	cook	VERB
bptjm-30	218	9	,	,	PUNCT
bptjm-30	218	10	and	and	CCONJ
bptjm-30	218	11	looks	look	VERB
bptjm-30	218	12	like	like	ADP
bptjm-30	218	13	a	a	DET
bptjm-30	218	14	leafy	leafy	ADJ
bptjm-30	218	15	plant51	plant51	NOUN
bptjm-30	218	16	.	.	PUNCT
bptjm-30	219	1	in	in	ADP
bptjm-30	219	2	the	the	DET
bptjm-30	219	3	research	research	NOUN
bptjm-30	219	4	article	article	NOUN
bptjm-30	219	5	,	,	PUNCT
bptjm-30	219	6	the	the	DET
bptjm-30	219	7	team	team	NOUN
bptjm-30	219	8	was	be	AUX
bptjm-30	219	9	able	able	ADJ
bptjm-30	219	10	to	to	PART
bptjm-30	219	11	protect	protect	VERB
bptjm-30	219	12	glial	glial	ADJ
bptjm-30	219	13	loss	loss	NOUN
bptjm-30	219	14	(	(	PUNCT
bptjm-30	219	15	and	and	CCONJ
bptjm-30	219	16	hence	hence	ADV
bptjm-30	219	17	loss	loss	NOUN
bptjm-30	219	18	of	of	ADP
bptjm-30	219	19	glial	glial	ADJ
bptjm-30	219	20	function	function	NOUN
bptjm-30	219	21	)	)	PUNCT
bptjm-30	219	22	in	in	ADP
bptjm-30	219	23	the	the	DET
bptjm-30	219	24	prefrontal	prefrontal	ADJ
bptjm-30	219	25	cortex	cortex	NOUN
bptjm-30	219	26	of	of	ADP
bptjm-30	219	27	a	a	DET
bptjm-30	219	28	mouse	mouse	NOUN
bptjm-30	219	29	brain	brain	NOUN
bptjm-30	219	30	by	by	ADP
bptjm-30	219	31	using	use	VERB
bptjm-30	219	32	tkk52	tkk52	NOUN
bptjm-30	219	33	,	,	PUNCT
bptjm-30	219	34	demonstrating	demonstrate	VERB
bptjm-30	219	35	that	that	SCONJ
bptjm-30	219	36	tkk	tkk	PROPN
bptjm-30	219	37	is	be	AUX
bptjm-30	219	38	a	a	DET
bptjm-30	219	39	potential	potential	ADJ
bptjm-30	219	40	candidate	candidate	NOUN
bptjm-30	219	41	for	for	ADP
bptjm-30	219	42	depression	depression	NOUN
bptjm-30	219	43	treatment	treatment	NOUN
bptjm-30	219	44	.	.	PUNCT
bptjm-30	220	1	however	however	ADV
bptjm-30	220	2	,	,	PUNCT
bptjm-30	220	3	further	further	ADJ
bptjm-30	220	4	research	research	NOUN
bptjm-30	220	5	is	be	AUX
bptjm-30	220	6	necessary	necessary	ADJ
bptjm-30	220	7	.	.	PUNCT
bptjm-30	221	1	xiaoyaosan	xiaoyaosan	PROPN
bptjm-30	221	2	,	,	PUNCT
bptjm-30	221	3	a	a	DET
bptjm-30	221	4	mixture	mixture	NOUN
bptjm-30	221	5	of	of	ADP
bptjm-30	221	6	dried	dry	VERB
bptjm-30	221	7	plants	plant	NOUN
bptjm-30	221	8	and	and	CCONJ
bptjm-30	221	9	herbs	herb	NOUN
bptjm-30	221	10	,	,	PUNCT
bptjm-30	221	11	was	be	AUX
bptjm-30	221	12	shown	show	VERB
bptjm-30	221	13	to	to	PART
bptjm-30	221	14	improve	improve	VERB
bptjm-30	221	15	depressive	depressive	ADJ
bptjm-30	221	16	-	-	PUNCT
bptjm-30	221	17	like	like	ADJ
bptjm-30	221	18	behavior	behavior	NOUN
bptjm-30	221	19	in	in	ADP
bptjm-30	221	20	rats52	rats52	ADJ
bptjm-30	221	21	.	.	PUNCT
bptjm-30	222	1	xiaoyaosan	xiaoyaosan	PROPN
bptjm-30	222	2	works	work	VERB
bptjm-30	222	3	by	by	ADP
bptjm-30	222	4	inhibiting	inhibit	VERB
bptjm-30	222	5	immunoinflammatory	immunoinflammatory	ADJ
bptjm-30	222	6	activation	activation	NOUN
bptjm-30	222	7	and	and	CCONJ
bptjm-30	222	8	reducing	reduce	VERB
bptjm-30	222	9	the	the	DET
bptjm-30	222	10	levels	level	NOUN
bptjm-30	222	11	of	of	ADP
bptjm-30	222	12	inflammatory	inflammatory	ADJ
bptjm-30	222	13	cytokines	cytokine	NOUN
bptjm-30	222	14	in	in	ADP
bptjm-30	222	15	the	the	DET
bptjm-30	222	16	colon	colon	NOUN
bptjm-30	222	17	by	by	ADP
bptjm-30	222	18	suppressing	suppress	VERB
bptjm-30	222	19	the	the	DET
bptjm-30	222	20	activation	activation	NOUN
bptjm-30	222	21	of	of	ADP
bptjm-30	222	22	the	the	DET
bptjm-30	222	23	tlr4	tlr4	NOUN
bptjm-30	222	24	/	/	SYM
bptjm-30	222	25	nlrp3	nlrp3	NOUN
bptjm-30	222	26	inflammasome	inflammasome	NOUN
bptjm-30	222	27	signaling	signal	VERB
bptjm-30	222	28	pathway	pathway	NOUN
bptjm-30	222	29	.	.	PUNCT
bptjm-30	223	1	improvement	improvement	NOUN
bptjm-30	223	2	in	in	ADP
bptjm-30	223	3	depression	depression	NOUN
bptjm-30	223	4	is	be	AUX
bptjm-30	223	5	likely	likely	ADJ
bptjm-30	223	6	due	due	ADP
bptjm-30	223	7	to	to	ADP
bptjm-30	223	8	the	the	DET
bptjm-30	223	9	decrease	decrease	NOUN
bptjm-30	223	10	in	in	ADP
bptjm-30	223	11	levels	level	NOUN
bptjm-30	223	12	of	of	ADP
bptjm-30	223	13	various	various	ADJ
bptjm-30	223	14	proteins	protein	NOUN
bptjm-30	223	15	,	,	PUNCT
bptjm-30	223	16	such	such	ADJ
bptjm-30	223	17	as	as	ADP
bptjm-30	223	18	tlr4	tlr4	PROPN
bptjm-30	223	19	,	,	PUNCT
bptjm-30	223	20	tak1	tak1	PROPN
bptjm-30	223	21	,	,	PUNCT
bptjm-30	223	22	and	and	CCONJ
bptjm-30	223	23	irak1	irak1	PROPN
bptjm-30	223	24	,	,	PUNCT
bptjm-30	223	25	which	which	PRON
bptjm-30	223	26	lead	lead	VERB
bptjm-30	223	27	to	to	ADP
bptjm-30	223	28	a	a	DET
bptjm-30	223	29	subsequent	subsequent	ADJ
bptjm-30	223	30	decrease	decrease	NOUN
bptjm-30	223	31	in	in	ADP
bptjm-30	223	32	inflammatory	inflammatory	ADJ
bptjm-30	223	33	cytokines	cytokine	NOUN
bptjm-30	223	34	,	,	PUNCT
bptjm-30	223	35	including	include	VERB
bptjm-30	223	36	il-6	il-6	NUM
bptjm-30	223	37	,	,	PUNCT
bptjm-30	223	38	il-1β	il-1β	PROPN
bptjm-30	223	39	,	,	PUNCT
bptjm-30	223	40	and	and	CCONJ
bptjm-30	223	41	tnf	tnf	PROPN
bptjm-30	223	42	-	-	PUNCT
bptjm-30	223	43	α	α	PROPN
bptjm-30	223	44	.	.	PUNCT
bptjm-30	224	1	evidence	evidence	NOUN
bptjm-30	224	2	shows	show	VERB
bptjm-30	224	3	that	that	SCONJ
bptjm-30	224	4	inflammatory	inflammatory	ADJ
bptjm-30	224	5	cytokines	cytokine	NOUN
bptjm-30	224	6	contribute	contribute	VERB
bptjm-30	224	7	to	to	ADP
bptjm-30	224	8	the	the	DET
bptjm-30	224	9	development	development	NOUN
bptjm-30	224	10	of	of	ADP
bptjm-30	224	11	depression	depression	NOUN
bptjm-30	224	12	,	,	PUNCT
bptjm-30	224	13	and	and	CCONJ
bptjm-30	224	14	reducing	reduce	VERB
bptjm-30	224	15	the	the	DET
bptjm-30	224	16	concentration	concentration	NOUN
bptjm-30	224	17	of	of	ADP
bptjm-30	224	18	inflammatory	inflammatory	ADJ
bptjm-30	224	19	cytokines	cytokine	NOUN
bptjm-30	224	20	alleviates	alleviate	VERB
bptjm-30	224	21	depression	depression	NOUN
bptjm-30	224	22	symptoms52,53	symptoms52,53	PROPN
bptjm-30	224	23	.	.	PROPN
bptjm-30	225	1	berkeley	berkeley	PROPN
bptjm-30	225	2	pharma	pharma	PROPN
bptjm-30	225	3	tech	tech	PROPN
bptjm-30	225	4	journal	journal	NOUN
bptjm-30	225	5	of	of	ADP
bptjm-30	225	6	medicine	medicine	NOUN
bptjm-30	225	7	|	|	ADV
bptjm-30	225	8	38	38	NUM
bptjm-30	225	9	several	several	ADJ
bptjm-30	225	10	natural	natural	ADJ
bptjm-30	225	11	products	product	NOUN
bptjm-30	225	12	are	be	AUX
bptjm-30	225	13	effective	effective	ADJ
bptjm-30	225	14	in	in	ADP
bptjm-30	225	15	treating	treat	VERB
bptjm-30	225	16	depression	depression	NOUN
bptjm-30	225	17	by	by	ADP
bptjm-30	225	18	reducing	reduce	VERB
bptjm-30	225	19	the	the	DET
bptjm-30	225	20	likelihood	likelihood	NOUN
bptjm-30	225	21	of	of	ADP
bptjm-30	225	22	depression	depression	NOUN
bptjm-30	225	23	development	development	NOUN
bptjm-30	225	24	,	,	PUNCT
bptjm-30	225	25	alleviating	alleviate	VERB
bptjm-30	225	26	depressive	depressive	ADJ
bptjm-30	225	27	symptoms	symptom	NOUN
bptjm-30	225	28	,	,	PUNCT
bptjm-30	225	29	or	or	CCONJ
bptjm-30	225	30	accompanying	accompany	VERB
bptjm-30	225	31	conventional	conventional	ADJ
bptjm-30	225	32	western	western	ADJ
bptjm-30	225	33	medicine	medicine	NOUN
bptjm-30	225	34	.	.	PUNCT
bptjm-30	226	1	however	however	ADV
bptjm-30	226	2	,	,	PUNCT
bptjm-30	226	3	natural	natural	ADJ
bptjm-30	226	4	products	product	NOUN
bptjm-30	226	5	are	be	AUX
bptjm-30	226	6	generally	generally	ADV
bptjm-30	226	7	grouped	group	VERB
bptjm-30	226	8	under	under	ADP
bptjm-30	226	9	“	"	PUNCT
bptjm-30	226	10	alternative	alternative	ADJ
bptjm-30	226	11	treatment	treatment	NOUN
bptjm-30	226	12	,	,	PUNCT
bptjm-30	226	13	"	"	PUNCT
bptjm-30	226	14	a	a	DET
bptjm-30	226	15	treatment	treatment	NOUN
bptjm-30	226	16	option	option	NOUN
bptjm-30	226	17	used	use	VERB
bptjm-30	226	18	when	when	SCONJ
bptjm-30	226	19	western	western	ADJ
bptjm-30	226	20	medicine	medicine	NOUN
bptjm-30	226	21	proves	prove	VERB
bptjm-30	226	22	inadequate54	inadequate54	NOUN
bptjm-30	226	23	.	.	PUNCT
bptjm-30	227	1	for	for	SCONJ
bptjm-30	227	2	natural	natural	ADJ
bptjm-30	227	3	products	product	NOUN
bptjm-30	227	4	to	to	PART
bptjm-30	227	5	gain	gain	VERB
bptjm-30	227	6	more	more	ADV
bptjm-30	227	7	potential	potential	ADJ
bptjm-30	227	8	as	as	ADP
bptjm-30	227	9	novel	novel	ADJ
bptjm-30	227	10	therapeutic	therapeutic	ADJ
bptjm-30	227	11	strategies	strategy	NOUN
bptjm-30	227	12	,	,	PUNCT
bptjm-30	227	13	it	it	PRON
bptjm-30	227	14	is	be	AUX
bptjm-30	227	15	important	important	ADJ
bptjm-30	227	16	for	for	ADP
bptjm-30	227	17	welldesigned	welldesigne	VERB
bptjm-30	227	18	,	,	PUNCT
bptjm-30	227	19	more	more	ADV
bptjm-30	227	20	extensive	extensive	ADJ
bptjm-30	227	21	clinical	clinical	ADJ
bptjm-30	227	22	trials	trial	NOUN
bptjm-30	227	23	to	to	PART
bptjm-30	227	24	be	be	AUX
bptjm-30	227	25	carried	carry	VERB
bptjm-30	227	26	out	out	ADP
bptjm-30	227	27	.	.	PUNCT
bptjm-30	228	1	only	only	ADV
bptjm-30	228	2	then	then	ADV
bptjm-30	228	3	more	more	ADV
bptjm-30	228	4	clinical	clinical	ADJ
bptjm-30	228	5	trials	trial	NOUN
bptjm-30	228	6	using	use	VERB
bptjm-30	228	7	natural	natural	ADJ
bptjm-30	228	8	products	product	NOUN
bptjm-30	228	9	can	can	AUX
bptjm-30	228	10	be	be	AUX
bptjm-30	228	11	carried	carry	VERB
bptjm-30	228	12	out	out	ADP
bptjm-30	228	13	to	to	PART
bptjm-30	228	14	prove	prove	VERB
bptjm-30	228	15	the	the	DET
bptjm-30	228	16	efficacy	efficacy	NOUN
bptjm-30	228	17	of	of	ADP
bptjm-30	228	18	natural	natural	ADJ
bptjm-30	228	19	products	product	NOUN
bptjm-30	228	20	in	in	ADP
bptjm-30	228	21	depression	depression	NOUN
bptjm-30	228	22	treatment	treatment	NOUN
bptjm-30	228	23	.	.	PUNCT
bptjm-30	229	1	better	well	ADJ
bptjm-30	229	2	integration	integration	NOUN
bptjm-30	229	3	of	of	ADP
bptjm-30	229	4	natural	natural	ADJ
bptjm-30	229	5	products	product	NOUN
bptjm-30	229	6	in	in	ADP
bptjm-30	229	7	western	western	ADJ
bptjm-30	229	8	medicinal	medicinal	ADJ
bptjm-30	229	9	research	research	NOUN
bptjm-30	229	10	is	be	AUX
bptjm-30	229	11	recommended	recommend	VERB
bptjm-30	229	12	.	.	PUNCT
bptjm-30	230	1	5.5	5.5	NUM
bptjm-30	230	2	.	.	PUNCT
bptjm-30	230	3	hormonal	hormonal	ADJ
bptjm-30	230	4	treatment	treatment	NOUN
bptjm-30	230	5	thyroid	thyroid	NOUN
bptjm-30	230	6	,	,	PUNCT
bptjm-30	230	7	gonadal	gonadal	NOUN
bptjm-30	230	8	,	,	PUNCT
bptjm-30	230	9	pineal	pineal	NOUN
bptjm-30	230	10	gland	gland	NOUN
bptjm-30	230	11	,	,	PUNCT
bptjm-30	230	12	and	and	CCONJ
bptjm-30	230	13	adrenal	adrenal	ADJ
bptjm-30	230	14	axis	axis	NOUN
bptjm-30	230	15	hormones	hormone	NOUN
bptjm-30	230	16	are	be	AUX
bptjm-30	230	17	the	the	DET
bptjm-30	230	18	four	four	NUM
bptjm-30	230	19	hormonal	hormonal	ADJ
bptjm-30	230	20	groups	group	NOUN
bptjm-30	230	21	that	that	PRON
bptjm-30	230	22	have	have	AUX
bptjm-30	230	23	garnered	garner	VERB
bptjm-30	230	24	the	the	DET
bptjm-30	230	25	most	most	ADV
bptjm-30	230	26	recent	recent	ADJ
bptjm-30	230	27	attention	attention	NOUN
bptjm-30	230	28	in	in	ADP
bptjm-30	230	29	depression	depression	NOUN
bptjm-30	230	30	research	research	NOUN
bptjm-30	230	31	.	.	PUNCT
bptjm-30	231	1	some	some	DET
bptjm-30	231	2	hormones	hormone	NOUN
bptjm-30	231	3	play	play	VERB
bptjm-30	231	4	a	a	DET
bptjm-30	231	5	direct	direct	ADJ
bptjm-30	231	6	role	role	NOUN
bptjm-30	231	7	in	in	ADP
bptjm-30	231	8	the	the	DET
bptjm-30	231	9	nervous	nervous	ADJ
bptjm-30	231	10	system	system	NOUN
bptjm-30	231	11	by	by	ADP
bptjm-30	231	12	acting	act	VERB
bptjm-30	231	13	as	as	ADP
bptjm-30	231	14	neurotransmitters	neurotransmitter	NOUN
bptjm-30	231	15	and	and	CCONJ
bptjm-30	231	16	affecting	affect	VERB
bptjm-30	231	17	neuronal	neuronal	ADJ
bptjm-30	231	18	signaling8	signaling8	NOUN
bptjm-30	231	19	.	.	PUNCT
bptjm-30	232	1	other	other	ADJ
bptjm-30	232	2	hormones	hormone	NOUN
bptjm-30	232	3	regulate	regulate	VERB
bptjm-30	232	4	the	the	DET
bptjm-30	232	5	production	production	NOUN
bptjm-30	232	6	of	of	ADP
bptjm-30	232	7	proteins	protein	NOUN
bptjm-30	232	8	that	that	PRON
bptjm-30	232	9	affect	affect	VERB
bptjm-30	232	10	both	both	DET
bptjm-30	232	11	brain	brain	NOUN
bptjm-30	232	12	cell	cell	NOUN
bptjm-30	232	13	structure	structure	NOUN
bptjm-30	232	14	and	and	CCONJ
bptjm-30	232	15	synaptic	synaptic	ADJ
bptjm-30	232	16	neurotransmission	neurotransmission	NOUN
bptjm-30	232	17	.	.	PUNCT
bptjm-30	233	1	sex	sex	NOUN
bptjm-30	233	2	hormones	hormone	NOUN
bptjm-30	233	3	have	have	AUX
bptjm-30	233	4	even	even	ADV
bptjm-30	233	5	been	be	AUX
bptjm-30	233	6	proven	prove	VERB
bptjm-30	233	7	to	to	PART
bptjm-30	233	8	stimulate	stimulate	VERB
bptjm-30	233	9	neuroprotection	neuroprotection	NOUN
bptjm-30	233	10	.	.	PUNCT
bptjm-30	234	1	thyrotropin	thyrotropin	NOUN
bptjm-30	234	2	-	-	PUNCT
bptjm-30	234	3	releasing	release	VERB
bptjm-30	234	4	hormone	hormone	NOUN
bptjm-30	234	5	,	,	PUNCT
bptjm-30	234	6	associated	associate	VERB
bptjm-30	234	7	with	with	ADP
bptjm-30	234	8	the	the	DET
bptjm-30	234	9	thyroid	thyroid	NOUN
bptjm-30	234	10	hormonal	hormonal	NOUN
bptjm-30	234	11	group	group	NOUN
bptjm-30	234	12	,	,	PUNCT
bptjm-30	234	13	has	have	AUX
bptjm-30	234	14	been	be	AUX
bptjm-30	234	15	proven	prove	VERB
bptjm-30	234	16	to	to	PART
bptjm-30	234	17	stimulate	stimulate	VERB
bptjm-30	234	18	locomotor	locomotor	NOUN
bptjm-30	234	19	activity	activity	NOUN
bptjm-30	234	20	,	,	PUNCT
bptjm-30	234	21	amongst	amongst	ADP
bptjm-30	234	22	other	other	ADJ
bptjm-30	234	23	behavioral	behavioral	ADJ
bptjm-30	234	24	effects55	effects55	NOUN
bptjm-30	234	25	.	.	PUNCT
bptjm-30	235	1	additionally	additionally	ADV
bptjm-30	235	2	,	,	PUNCT
bptjm-30	235	3	thyrotropin	thyrotropin	PROPN
bptjm-30	235	4	is	be	AUX
bptjm-30	235	5	a	a	DET
bptjm-30	235	6	pituitary	pituitary	ADJ
bptjm-30	235	7	hormone	hormone	NOUN
bptjm-30	235	8	that	that	PRON
bptjm-30	235	9	stimulates	stimulate	VERB
bptjm-30	235	10	the	the	DET
bptjm-30	235	11	thyroid	thyroid	NOUN
bptjm-30	235	12	gland	gland	NOUN
bptjm-30	235	13	,	,	PUNCT
bptjm-30	235	14	and	and	CCONJ
bptjm-30	235	15	t4	t4	PROPN
bptjm-30	235	16	and	and	CCONJ
bptjm-30	235	17	t3	t3	PROPN
bptjm-30	235	18	are	be	AUX
bptjm-30	235	19	hormones	hormone	NOUN
bptjm-30	235	20	secreted	secrete	VERB
bptjm-30	235	21	from	from	ADP
bptjm-30	235	22	the	the	DET
bptjm-30	235	23	thyroid	thyroid	NOUN
bptjm-30	235	24	gland	gland	NOUN
bptjm-30	235	25	.	.	PUNCT
bptjm-30	236	1	research	research	NOUN
bptjm-30	236	2	studies	study	NOUN
bptjm-30	236	3	have	have	AUX
bptjm-30	236	4	indicated	indicate	VERB
bptjm-30	236	5	that	that	SCONJ
bptjm-30	236	6	deficiency	deficiency	NOUN
bptjm-30	236	7	of	of	ADP
bptjm-30	236	8	these	these	DET
bptjm-30	236	9	hormones	hormone	NOUN
bptjm-30	236	10	in	in	ADP
bptjm-30	236	11	the	the	DET
bptjm-30	236	12	central	central	ADJ
bptjm-30	236	13	nervous	nervous	ADJ
bptjm-30	236	14	system	system	NOUN
bptjm-30	236	15	can	can	AUX
bptjm-30	236	16	result	result	VERB
bptjm-30	236	17	in	in	ADP
bptjm-30	236	18	fatigue	fatigue	NOUN
bptjm-30	236	19	,	,	PUNCT
bptjm-30	236	20	weight	weight	NOUN
bptjm-30	236	21	gain	gain	NOUN
bptjm-30	236	22	,	,	PUNCT
bptjm-30	236	23	and	and	CCONJ
bptjm-30	236	24	lack	lack	NOUN
bptjm-30	236	25	of	of	ADP
bptjm-30	236	26	energy	energy	NOUN
bptjm-30	236	27	-	-	PUNCT
bptjm-30	236	28	all	all	DET
bptjm-30	236	29	common	common	ADJ
bptjm-30	236	30	symptoms	symptom	NOUN
bptjm-30	236	31	of	of	ADP
bptjm-30	236	32	depression56	depression56	NOUN
bptjm-30	236	33	.	.	PUNCT
bptjm-30	237	1	the	the	DET
bptjm-30	237	2	gonadal	gonadal	NOUN
bptjm-30	237	3	steroids	steroid	NOUN
bptjm-30	237	4	estrogen	estrogen	NOUN
bptjm-30	237	5	and	and	CCONJ
bptjm-30	237	6	progesterone	progesterone	NOUN
bptjm-30	237	7	,	,	PUNCT
bptjm-30	237	8	beyond	beyond	ADP
bptjm-30	237	9	their	their	PRON
bptjm-30	237	10	neuroprotective	neuroprotective	ADJ
bptjm-30	237	11	effects	effect	NOUN
bptjm-30	237	12	,	,	PUNCT
bptjm-30	237	13	have	have	AUX
bptjm-30	237	14	been	be	AUX
bptjm-30	237	15	shown	show	VERB
bptjm-30	237	16	to	to	PART
bptjm-30	237	17	affect	affect	VERB
bptjm-30	237	18	brain	brain	NOUN
bptjm-30	237	19	regions	region	NOUN
bptjm-30	237	20	involved	involve	VERB
bptjm-30	237	21	in	in	ADP
bptjm-30	237	22	mood	mood	NOUN
bptjm-30	237	23	and	and	CCONJ
bptjm-30	237	24	behavior	behavior	NOUN
bptjm-30	237	25	regulation57	regulation57	NOUN
bptjm-30	237	26	.	.	PUNCT
bptjm-30	238	1	furthermore	furthermore	ADV
bptjm-30	238	2	,	,	PUNCT
bptjm-30	238	3	melatonin	melatonin	NOUN
bptjm-30	238	4	,	,	PUNCT
bptjm-30	238	5	the	the	DET
bptjm-30	238	6	“	"	PUNCT
bptjm-30	238	7	sleep	sleep	NOUN
bptjm-30	238	8	hormone	hormone	NOUN
bptjm-30	238	9	,	,	PUNCT
bptjm-30	238	10	”	"	PUNCT
bptjm-30	238	11	has	have	AUX
bptjm-30	238	12	been	be	AUX
bptjm-30	238	13	implicated	implicate	VERB
bptjm-30	238	14	in	in	ADP
bptjm-30	238	15	mediating	mediate	VERB
bptjm-30	238	16	the	the	DET
bptjm-30	238	17	circadian	circadian	ADJ
bptjm-30	238	18	rhythm	rhythm	NOUN
bptjm-30	238	19	.	.	PUNCT
bptjm-30	239	1	given	give	VERB
bptjm-30	239	2	the	the	DET
bptjm-30	239	3	common	common	ADJ
bptjm-30	239	4	occurrence	occurrence	NOUN
bptjm-30	239	5	of	of	ADP
bptjm-30	239	6	sleep	sleep	NOUN
bptjm-30	239	7	disturbance	disturbance	NOUN
bptjm-30	239	8	and	and	CCONJ
bptjm-30	239	9	irregular	irregular	ADJ
bptjm-30	239	10	sleeping	sleeping	NOUN
bptjm-30	239	11	patterns	pattern	NOUN
bptjm-30	239	12	in	in	ADP
bptjm-30	239	13	mdd	mdd	PROPN
bptjm-30	239	14	,	,	PUNCT
bptjm-30	239	15	melatonin	melatonin	NOUN
bptjm-30	239	16	replacement	replacement	NOUN
bptjm-30	239	17	therapies	therapy	NOUN
bptjm-30	239	18	have	have	AUX
bptjm-30	239	19	been	be	AUX
bptjm-30	239	20	gaining	gain	VERB
bptjm-30	239	21	popularity58	popularity58	NOUN
bptjm-30	239	22	.	.	PUNCT
bptjm-30	240	1	additionally	additionally	ADV
bptjm-30	240	2	,	,	PUNCT
bptjm-30	240	3	a	a	DET
bptjm-30	240	4	link	link	NOUN
bptjm-30	240	5	between	between	ADP
bptjm-30	240	6	hypersecretion	hypersecretion	NOUN
bptjm-30	240	7	of	of	ADP
bptjm-30	240	8	corticotropin	corticotropin	NOUN
bptjm-30	240	9	-	-	PUNCT
bptjm-30	240	10	releasing	release	VERB
bptjm-30	240	11	hormone	hormone	NOUN
bptjm-30	240	12	(	(	PUNCT
bptjm-30	240	13	crh	crh	PROPN
bptjm-30	240	14	)	)	PUNCT
bptjm-30	240	15	and	and	CCONJ
bptjm-30	240	16	depression	depression	NOUN
bptjm-30	240	17	has	have	AUX
bptjm-30	240	18	been	be	AUX
bptjm-30	240	19	established	establish	VERB
bptjm-30	240	20	.	.	PUNCT
bptjm-30	241	1	higher	high	ADJ
bptjm-30	241	2	levels	level	NOUN
bptjm-30	241	3	of	of	ADP
bptjm-30	241	4	this	this	DET
bptjm-30	241	5	berkeley	berkeley	PROPN
bptjm-30	241	6	pharma	pharma	PROPN
bptjm-30	241	7	tech	tech	NOUN
bptjm-30	241	8	journal	journal	NOUN
bptjm-30	241	9	of	of	ADP
bptjm-30	241	10	medicine	medicine	NOUN
bptjm-30	241	11	|	|	ADV
bptjm-30	241	12	39	39	NUM
bptjm-30	241	13	hormone	hormone	NOUN
bptjm-30	241	14	have	have	AUX
bptjm-30	241	15	been	be	AUX
bptjm-30	241	16	shown	show	VERB
bptjm-30	241	17	to	to	PART
bptjm-30	241	18	reduce	reduce	VERB
bptjm-30	241	19	free	free	ADJ
bptjm-30	241	20	cortisol	cortisol	ADJ
bptjm-30	241	21	levels	level	NOUN
bptjm-30	241	22	and	and	CCONJ
bptjm-30	241	23	may	may	AUX
bptjm-30	241	24	be	be	AUX
bptjm-30	241	25	a	a	DET
bptjm-30	241	26	therapeutic	therapeutic	ADJ
bptjm-30	241	27	option	option	NOUN
bptjm-30	241	28	for	for	ADP
bptjm-30	241	29	stress	stress	NOUN
bptjm-30	241	30	-	-	PUNCT
bptjm-30	241	31	induced	induce	VERB
bptjm-30	241	32	depression59	depression59	NOUN
bptjm-30	241	33	.	.	PUNCT
bptjm-30	242	1	hormone	hormone	NOUN
bptjm-30	242	2	therapy	therapy	NOUN
bptjm-30	242	3	targets	target	NOUN
bptjm-30	242	4	differ	differ	VERB
bptjm-30	242	5	from	from	ADP
bptjm-30	242	6	traditional	traditional	ADJ
bptjm-30	242	7	antidepressants	antidepressant	NOUN
bptjm-30	242	8	as	as	SCONJ
bptjm-30	242	9	they	they	PRON
bptjm-30	242	10	focus	focus	VERB
bptjm-30	242	11	on	on	ADP
bptjm-30	242	12	replacement	replacement	NOUN
bptjm-30	242	13	therapies	therapy	NOUN
bptjm-30	242	14	that	that	PRON
bptjm-30	242	15	increase	increase	VERB
bptjm-30	242	16	levels	level	NOUN
bptjm-30	242	17	of	of	ADP
bptjm-30	242	18	chemicals	chemical	NOUN
bptjm-30	242	19	found	find	VERB
bptjm-30	242	20	naturally	naturally	ADV
bptjm-30	242	21	in	in	ADP
bptjm-30	242	22	the	the	DET
bptjm-30	242	23	body8	body8	NOUN
bptjm-30	242	24	.	.	PUNCT
bptjm-30	243	1	although	although	SCONJ
bptjm-30	243	2	hormone	hormone	NOUN
bptjm-30	243	3	replacement	replacement	NOUN
bptjm-30	243	4	therapies	therapy	NOUN
bptjm-30	243	5	often	often	ADV
bptjm-30	243	6	have	have	VERB
bptjm-30	243	7	indirect	indirect	ADJ
bptjm-30	243	8	effects	effect	NOUN
bptjm-30	243	9	on	on	ADP
bptjm-30	243	10	brain	brain	NOUN
bptjm-30	243	11	function	function	NOUN
bptjm-30	243	12	and	and	CCONJ
bptjm-30	243	13	can	can	AUX
bptjm-30	243	14	thus	thus	ADV
bptjm-30	243	15	result	result	VERB
bptjm-30	243	16	in	in	ADP
bptjm-30	243	17	unintended	unintended	ADJ
bptjm-30	243	18	secondary	secondary	ADJ
bptjm-30	243	19	effects	effect	NOUN
bptjm-30	243	20	,	,	PUNCT
bptjm-30	243	21	these	these	DET
bptjm-30	243	22	therapies	therapy	NOUN
bptjm-30	243	23	are	be	AUX
bptjm-30	243	24	much	much	ADV
bptjm-30	243	25	more	more	ADV
bptjm-30	243	26	targeted	target	VERB
bptjm-30	243	27	than	than	ADP
bptjm-30	243	28	novel	novel	ADJ
bptjm-30	243	29	drug	drug	NOUN
bptjm-30	243	30	treatments	treatment	NOUN
bptjm-30	243	31	due	due	ADP
bptjm-30	243	32	to	to	ADP
bptjm-30	243	33	their	their	PRON
bptjm-30	243	34	natural	natural	ADJ
bptjm-30	243	35	prevalence	prevalence	NOUN
bptjm-30	243	36	in	in	ADP
bptjm-30	243	37	the	the	DET
bptjm-30	243	38	human	human	ADJ
bptjm-30	243	39	body	body	NOUN
bptjm-30	243	40	.	.	PUNCT
bptjm-30	244	1	furthermore	furthermore	ADV
bptjm-30	244	2	,	,	PUNCT
bptjm-30	244	3	because	because	SCONJ
bptjm-30	244	4	such	such	ADJ
bptjm-30	244	5	therapies	therapy	NOUN
bptjm-30	244	6	often	often	ADV
bptjm-30	244	7	focus	focus	VERB
bptjm-30	244	8	on	on	ADP
bptjm-30	244	9	the	the	DET
bptjm-30	244	10	replacement	replacement	NOUN
bptjm-30	244	11	of	of	ADP
bptjm-30	244	12	natural	natural	ADJ
bptjm-30	244	13	chemicals	chemical	NOUN
bptjm-30	244	14	,	,	PUNCT
bptjm-30	244	15	they	they	PRON
bptjm-30	244	16	are	be	AUX
bptjm-30	244	17	much	much	ADV
bptjm-30	244	18	safer	safe	ADJ
bptjm-30	244	19	and	and	CCONJ
bptjm-30	244	20	likely	likely	ADJ
bptjm-30	244	21	to	to	PART
bptjm-30	244	22	be	be	AUX
bptjm-30	244	23	approved	approve	VERB
bptjm-30	244	24	for	for	ADP
bptjm-30	244	25	funding	funding	NOUN
bptjm-30	244	26	and	and	CCONJ
bptjm-30	244	27	distribution	distribution	NOUN
bptjm-30	244	28	.	.	PUNCT
bptjm-30	245	1	in	in	ADP
bptjm-30	245	2	future	future	ADJ
bptjm-30	245	3	research	research	NOUN
bptjm-30	245	4	efforts	effort	NOUN
bptjm-30	245	5	,	,	PUNCT
bptjm-30	245	6	the	the	DET
bptjm-30	245	7	three	three	NUM
bptjm-30	245	8	major	major	ADJ
bptjm-30	245	9	endocrine	endocrine	NOUN
bptjm-30	245	10	systems	system	NOUN
bptjm-30	245	11	—	—	PUNCT
bptjm-30	245	12	the	the	DET
bptjm-30	245	13	hypothalamic	hypothalamic	ADJ
bptjm-30	245	14	-	-	PUNCT
bptjm-30	245	15	pituitary	pituitary	ADJ
bptjm-30	245	16	-	-	PUNCT
bptjm-30	245	17	adrenal	adrenal	ADJ
bptjm-30	245	18	(	(	PUNCT
bptjm-30	245	19	hpa	hpa	NOUN
bptjm-30	245	20	)	)	PUNCT
bptjm-30	245	21	axis	axis	NOUN
bptjm-30	245	22	,	,	PUNCT
bptjm-30	245	23	the	the	DET
bptjm-30	245	24	hypothalamic	hypothalamic	NOUN
bptjm-30	245	25	-	-	PUNCT
bptjm-30	245	26	pituitarythyroid	pituitarythyroid	NOUN
bptjm-30	245	27	(	(	PUNCT
bptjm-30	245	28	hpt	hpt	NOUN
bptjm-30	245	29	)	)	PUNCT
bptjm-30	245	30	axis	axis	NOUN
bptjm-30	245	31	,	,	PUNCT
bptjm-30	245	32	and	and	CCONJ
bptjm-30	245	33	the	the	DET
bptjm-30	245	34	hypothalamic	hypothalamic	ADJ
bptjm-30	245	35	-	-	PUNCT
bptjm-30	245	36	pituitary	pituitary	ADJ
bptjm-30	245	37	-	-	PUNCT
bptjm-30	245	38	gonadal	gonadal	NOUN
bptjm-30	245	39	axis	axis	NOUN
bptjm-30	245	40	—	—	PUNCT
bptjm-30	245	41	should	should	AUX
bptjm-30	245	42	be	be	AUX
bptjm-30	245	43	studied	study	VERB
bptjm-30	245	44	more	more	ADV
bptjm-30	245	45	to	to	PART
bptjm-30	245	46	enable	enable	VERB
bptjm-30	245	47	hormones	hormone	NOUN
bptjm-30	245	48	as	as	ADP
bptjm-30	245	49	research	research	NOUN
bptjm-30	245	50	targets	target	NOUN
bptjm-30	245	51	in	in	ADP
bptjm-30	245	52	depression	depression	NOUN
bptjm-30	245	53	.	.	PUNCT
bptjm-30	246	1	table	table	NOUN
bptjm-30	246	2	3	3	NUM
bptjm-30	246	3	:	:	PUNCT
bptjm-30	246	4	summary	summary	NOUN
bptjm-30	246	5	table	table	NOUN
bptjm-30	246	6	that	that	PRON
bptjm-30	246	7	displays	display	VERB
bptjm-30	246	8	all	all	DET
bptjm-30	246	9	forms	form	NOUN
bptjm-30	246	10	of	of	ADP
bptjm-30	246	11	antidepressants	antidepressant	NOUN
bptjm-30	246	12	discussed	discuss	VERB
bptjm-30	246	13	–	–	PUNCT
bptjm-30	246	14	both	both	CCONJ
bptjm-30	246	15	conventional	conventional	ADJ
bptjm-30	246	16	and	and	CCONJ
bptjm-30	246	17	novel	novel	NOUN
bptjm-30	246	18	.	.	PUNCT
bptjm-30	247	1	berkeley	berkeley	PROPN
bptjm-30	247	2	pharma	pharma	PROPN
bptjm-30	247	3	tech	tech	PROPN
bptjm-30	247	4	journal	journal	NOUN
bptjm-30	247	5	of	of	ADP
bptjm-30	247	6	medicine	medicine	NOUN
bptjm-30	247	7	|	|	ADV
bptjm-30	247	8	40	40	NUM
bptjm-30	247	9	6	6	NUM
bptjm-30	247	10	.	.	PUNCT
bptjm-30	248	1	practical	practical	ADJ
bptjm-30	248	2	considerations	consideration	NOUN
bptjm-30	248	3	ketamine	ketamine	VERB
bptjm-30	248	4	and	and	CCONJ
bptjm-30	248	5	psilocybin	psilocybin	NOUN
bptjm-30	248	6	are	be	AUX
bptjm-30	248	7	the	the	DET
bptjm-30	248	8	most	most	ADV
bptjm-30	248	9	thoroughly	thoroughly	ADV
bptjm-30	248	10	researched	research	VERB
bptjm-30	248	11	and	and	CCONJ
bptjm-30	248	12	promising	promise	VERB
bptjm-30	248	13	therapeutic	therapeutic	ADJ
bptjm-30	248	14	options	option	NOUN
bptjm-30	248	15	for	for	ADP
bptjm-30	248	16	treating	treat	VERB
bptjm-30	248	17	depression	depression	NOUN
bptjm-30	248	18	.	.	PUNCT
bptjm-30	249	1	before	before	ADP
bptjm-30	249	2	their	their	PRON
bptjm-30	249	3	widespread	widespread	ADJ
bptjm-30	249	4	implementation	implementation	NOUN
bptjm-30	249	5	,	,	PUNCT
bptjm-30	249	6	however	however	ADV
bptjm-30	249	7	,	,	PUNCT
bptjm-30	249	8	greater	great	ADJ
bptjm-30	249	9	efforts	effort	NOUN
bptjm-30	249	10	must	must	AUX
bptjm-30	249	11	be	be	AUX
bptjm-30	249	12	undertaken	undertake	VERB
bptjm-30	249	13	to	to	PART
bptjm-30	249	14	reduce	reduce	VERB
bptjm-30	249	15	stigmas	stigma	NOUN
bptjm-30	249	16	and	and	CCONJ
bptjm-30	249	17	influence	influence	VERB
bptjm-30	249	18	public	public	ADJ
bptjm-30	249	19	perceptions	perception	NOUN
bptjm-30	249	20	surrounding	surround	VERB
bptjm-30	249	21	psychedelic	psychedelic	ADJ
bptjm-30	249	22	treatments	treatment	NOUN
bptjm-30	249	23	.	.	PUNCT
bptjm-30	250	1	governmental	governmental	ADJ
bptjm-30	250	2	action	action	NOUN
bptjm-30	250	3	is	be	AUX
bptjm-30	250	4	needed	need	VERB
bptjm-30	250	5	to	to	PART
bptjm-30	250	6	ease	ease	VERB
bptjm-30	250	7	medicinal	medicinal	ADJ
bptjm-30	250	8	restrictions	restriction	NOUN
bptjm-30	250	9	on	on	ADP
bptjm-30	250	10	psychedelic	psychedelic	ADJ
bptjm-30	250	11	,	,	PUNCT
bptjm-30	250	12	natural	natural	ADJ
bptjm-30	250	13	,	,	PUNCT
bptjm-30	250	14	and	and	CCONJ
bptjm-30	250	15	hormonal	hormonal	ADJ
bptjm-30	250	16	treatments	treatment	NOUN
bptjm-30	250	17	for	for	ADP
bptjm-30	250	18	mental	mental	ADJ
bptjm-30	250	19	disorders60	disorders60	NOUN
bptjm-30	250	20	.	.	PUNCT
bptjm-30	251	1	reputable	reputable	ADJ
bptjm-30	251	2	scientific	scientific	ADJ
bptjm-30	251	3	journals	journal	NOUN
bptjm-30	251	4	and	and	CCONJ
bptjm-30	251	5	agencies	agency	NOUN
bptjm-30	251	6	should	should	AUX
bptjm-30	251	7	continue	continue	VERB
bptjm-30	251	8	to	to	PART
bptjm-30	251	9	publish	publish	VERB
bptjm-30	251	10	and	and	CCONJ
bptjm-30	251	11	advertise	advertise	VERB
bptjm-30	251	12	content	content	NOUN
bptjm-30	251	13	displaying	display	VERB
bptjm-30	251	14	the	the	DET
bptjm-30	251	15	efficacy	efficacy	NOUN
bptjm-30	251	16	of	of	ADP
bptjm-30	251	17	these	these	DET
bptjm-30	251	18	novel	novel	ADJ
bptjm-30	251	19	treatments	treatment	NOUN
bptjm-30	251	20	to	to	PART
bptjm-30	251	21	change	change	VERB
bptjm-30	251	22	public	public	ADJ
bptjm-30	251	23	perception	perception	NOUN
bptjm-30	251	24	.	.	PUNCT
bptjm-30	252	1	however	however	ADV
bptjm-30	252	2	,	,	PUNCT
bptjm-30	252	3	some	some	DET
bptjm-30	252	4	concerns	concern	NOUN
bptjm-30	252	5	regarding	regard	VERB
bptjm-30	252	6	these	these	DET
bptjm-30	252	7	treatments	treatment	NOUN
bptjm-30	252	8	are	be	AUX
bptjm-30	252	9	valid	valid	ADJ
bptjm-30	252	10	—	—	PUNCT
bptjm-30	252	11	as	as	SCONJ
bptjm-30	252	12	high	high	ADJ
bptjm-30	252	13	doses	dose	NOUN
bptjm-30	252	14	of	of	ADP
bptjm-30	252	15	certain	certain	ADJ
bptjm-30	252	16	drugs	drug	NOUN
bptjm-30	252	17	may	may	AUX
bptjm-30	252	18	cause	cause	VERB
bptjm-30	252	19	adverse	adverse	ADJ
bptjm-30	252	20	side	side	NOUN
bptjm-30	252	21	effects	effect	NOUN
bptjm-30	252	22	and	and	CCONJ
bptjm-30	252	23	set	set	VERB
bptjm-30	252	24	back	back	ADP
bptjm-30	252	25	research	research	NOUN
bptjm-30	252	26	efforts60	efforts60	NOUN
bptjm-30	252	27	.	.	PUNCT
bptjm-30	253	1	thus	thus	ADV
bptjm-30	253	2	,	,	PUNCT
bptjm-30	253	3	researchers	researcher	NOUN
bptjm-30	253	4	must	must	AUX
bptjm-30	253	5	continue	continue	VERB
bptjm-30	253	6	to	to	PART
bptjm-30	253	7	prove	prove	VERB
bptjm-30	253	8	the	the	DET
bptjm-30	253	9	reproducibility	reproducibility	NOUN
bptjm-30	253	10	of	of	ADP
bptjm-30	253	11	their	their	PRON
bptjm-30	253	12	clinical	clinical	ADJ
bptjm-30	253	13	trials	trial	NOUN
bptjm-30	253	14	and	and	CCONJ
bptjm-30	253	15	consider	consider	VERB
bptjm-30	253	16	the	the	DET
bptjm-30	253	17	implementation	implementation	NOUN
bptjm-30	253	18	of	of	ADP
bptjm-30	253	19	natural	natural	ADJ
bptjm-30	253	20	products	product	NOUN
bptjm-30	253	21	in	in	ADP
bptjm-30	253	22	conjunction	conjunction	NOUN
bptjm-30	253	23	with	with	ADP
bptjm-30	253	24	conventional	conventional	ADJ
bptjm-30	253	25	drugs	drug	NOUN
bptjm-30	253	26	.	.	PUNCT
bptjm-30	254	1	such	such	DET
bptjm-30	254	2	a	a	DET
bptjm-30	254	3	strategy	strategy	NOUN
bptjm-30	254	4	may	may	AUX
bptjm-30	254	5	prove	prove	VERB
bptjm-30	254	6	to	to	PART
bptjm-30	254	7	make	make	VERB
bptjm-30	254	8	therapeutic	therapeutic	ADJ
bptjm-30	254	9	options	option	NOUN
bptjm-30	254	10	more	more	ADV
bptjm-30	254	11	accessible	accessible	ADJ
bptjm-30	254	12	for	for	ADP
bptjm-30	254	13	patients	patient	NOUN
bptjm-30	254	14	and	and	CCONJ
bptjm-30	254	15	more	more	ADV
bptjm-30	254	16	likely	likely	ADJ
bptjm-30	254	17	to	to	PART
bptjm-30	254	18	be	be	AUX
bptjm-30	254	19	approved	approve	VERB
bptjm-30	254	20	for	for	ADP
bptjm-30	254	21	medicinal	medicinal	ADJ
bptjm-30	254	22	use	use	NOUN
bptjm-30	254	23	.	.	PUNCT
bptjm-30	255	1	7	7	X
bptjm-30	255	2	.	.	X
bptjm-30	255	3	future	future	ADJ
bptjm-30	255	4	directions	direction	NOUN
bptjm-30	255	5	ketamine	ketamine	VERB
bptjm-30	255	6	and	and	CCONJ
bptjm-30	255	7	psilocybin	psilocybin	NOUN
bptjm-30	255	8	have	have	AUX
bptjm-30	255	9	emerged	emerge	VERB
bptjm-30	255	10	as	as	ADP
bptjm-30	255	11	potential	potential	ADJ
bptjm-30	255	12	antidepressant	antidepressant	ADJ
bptjm-30	255	13	therapeutic	therapeutic	ADJ
bptjm-30	255	14	options	option	NOUN
bptjm-30	255	15	through	through	ADP
bptjm-30	255	16	mechanisms	mechanism	NOUN
bptjm-30	255	17	that	that	PRON
bptjm-30	255	18	promote	promote	VERB
bptjm-30	255	19	increased	increase	VERB
bptjm-30	255	20	neuroplasticity	neuroplasticity	NOUN
bptjm-30	255	21	.	.	PUNCT
bptjm-30	256	1	we	we	PRON
bptjm-30	256	2	have	have	AUX
bptjm-30	256	3	seen	see	VERB
bptjm-30	256	4	similar	similar	ADJ
bptjm-30	256	5	mechanisms	mechanism	NOUN
bptjm-30	256	6	in	in	ADP
bptjm-30	256	7	other	other	ADJ
bptjm-30	256	8	psychedelic	psychedelic	ADJ
bptjm-30	256	9	drugs	drug	NOUN
bptjm-30	256	10	,	,	PUNCT
bptjm-30	256	11	such	such	ADJ
bptjm-30	256	12	as	as	ADP
bptjm-30	256	13	interaction	interaction	NOUN
bptjm-30	256	14	with	with	ADP
bptjm-30	256	15	the	the	DET
bptjm-30	256	16	5	5	NUM
bptjm-30	256	17	-	-	PUNCT
bptjm-30	256	18	ht2a	ht2a	NOUN
bptjm-30	256	19	receptor	receptor	NOUN
bptjm-30	256	20	and	and	CCONJ
bptjm-30	256	21	signaling	signal	VERB
bptjm-30	256	22	on	on	ADP
bptjm-30	256	23	the	the	DET
bptjm-30	256	24	mtor	mtor	NOUN
bptjm-30	256	25	pathway30,32	pathway30,32	VERB
bptjm-30	256	26	.	.	PUNCT
bptjm-30	257	1	by	by	ADP
bptjm-30	257	2	better	well	ADJ
bptjm-30	257	3	understanding	understanding	NOUN
bptjm-30	257	4	what	what	PRON
bptjm-30	257	5	specifically	specifically	ADV
bptjm-30	257	6	contributes	contribute	VERB
bptjm-30	257	7	to	to	ADP
bptjm-30	257	8	psilocybin	psilocybin	NOUN
bptjm-30	257	9	’s	’s	PART
bptjm-30	257	10	long	long	ADJ
bptjm-30	257	11	-	-	PUNCT
bptjm-30	257	12	term	term	NOUN
bptjm-30	257	13	success	success	NOUN
bptjm-30	257	14	,	,	PUNCT
bptjm-30	257	15	ketamine	ketamine	PROPN
bptjm-30	257	16	’s	’s	PART
bptjm-30	257	17	rapid	rapid	ADJ
bptjm-30	257	18	action	action	NOUN
bptjm-30	257	19	,	,	PUNCT
bptjm-30	257	20	hormonal	hormonal	ADJ
bptjm-30	257	21	treatments	treatment	NOUN
bptjm-30	257	22	’	'	PUNCT
bptjm-30	257	23	direct	direct	ADJ
bptjm-30	257	24	targeted	target	VERB
bptjm-30	257	25	approach	approach	NOUN
bptjm-30	257	26	,	,	PUNCT
bptjm-30	257	27	and	and	CCONJ
bptjm-30	257	28	natural	natural	ADJ
bptjm-30	257	29	products	product	NOUN
bptjm-30	257	30	’	'	PUNCT
bptjm-30	257	31	reduction	reduction	NOUN
bptjm-30	257	32	of	of	ADP
bptjm-30	257	33	neurotoxic	neurotoxic	ADJ
bptjm-30	257	34	side	side	NOUN
bptjm-30	257	35	effects	effect	NOUN
bptjm-30	257	36	,	,	PUNCT
bptjm-30	257	37	researchers	researcher	NOUN
bptjm-30	257	38	can	can	AUX
bptjm-30	257	39	not	not	PART
bptjm-30	257	40	only	only	ADV
bptjm-30	257	41	guide	guide	VERB
bptjm-30	257	42	the	the	DET
bptjm-30	257	43	development	development	NOUN
bptjm-30	257	44	of	of	ADP
bptjm-30	257	45	novel	novel	ADJ
bptjm-30	257	46	antidepressants	antidepressant	NOUN
bptjm-30	257	47	with	with	ADP
bptjm-30	257	48	similar	similar	ADJ
bptjm-30	257	49	properties	property	NOUN
bptjm-30	257	50	,	,	PUNCT
bptjm-30	257	51	but	but	CCONJ
bptjm-30	257	52	we	we	PRON
bptjm-30	257	53	can	can	AUX
bptjm-30	257	54	even	even	ADV
bptjm-30	257	55	perhaps	perhaps	ADV
bptjm-30	257	56	go	go	VERB
bptjm-30	257	57	into	into	ADP
bptjm-30	257	58	how	how	SCONJ
bptjm-30	257	59	to	to	PART
bptjm-30	257	60	personalize	personalize	VERB
bptjm-30	257	61	antidepressants	antidepressant	NOUN
bptjm-30	257	62	to	to	PART
bptjm-30	257	63	meet	meet	VERB
bptjm-30	257	64	individual	individual	ADJ
bptjm-30	257	65	needs	need	NOUN
bptjm-30	257	66	.	.	PUNCT
bptjm-30	258	1	we	we	PRON
bptjm-30	258	2	can	can	AUX
bptjm-30	258	3	also	also	ADV
bptjm-30	258	4	expand	expand	VERB
bptjm-30	258	5	this	this	DET
bptjm-30	258	6	study	study	NOUN
bptjm-30	258	7	of	of	ADP
bptjm-30	258	8	depression	depression	NOUN
bptjm-30	258	9	to	to	ADP
bptjm-30	258	10	other	other	ADJ
bptjm-30	258	11	neurological	neurological	ADJ
bptjm-30	258	12	disorders	disorder	NOUN
bptjm-30	258	13	as	as	ADV
bptjm-30	258	14	well	well	ADV
bptjm-30	258	15	,	,	PUNCT
bptjm-30	258	16	such	such	ADJ
bptjm-30	258	17	as	as	ADP
bptjm-30	258	18	post	post	ADJ
bptjm-30	258	19	-	-	ADJ
bptjm-30	258	20	traumatic	traumatic	ADJ
bptjm-30	258	21	stress	stress	NOUN
bptjm-30	258	22	disorder	disorder	NOUN
bptjm-30	258	23	,	,	PUNCT
bptjm-30	258	24	which	which	PRON
bptjm-30	258	25	could	could	AUX
bptjm-30	258	26	benefit	benefit	VERB
bptjm-30	258	27	from	from	ADP
bptjm-30	258	28	similar	similar	ADJ
bptjm-30	258	29	novel	novel	ADJ
bptjm-30	258	30	antidepressant	antidepressant	ADJ
bptjm-30	258	31	mechanisms	mechanism	NOUN
bptjm-30	258	32	.	.	PUNCT
bptjm-30	259	1	berkeley	berkeley	PROPN
bptjm-30	259	2	pharma	pharma	PROPN
bptjm-30	259	3	tech	tech	PROPN
bptjm-30	259	4	journal	journal	NOUN
bptjm-30	259	5	of	of	ADP
bptjm-30	259	6	medicine	medicine	NOUN
bptjm-30	259	7	|	|	ADV
bptjm-30	259	8	41	41	NUM
bptjm-30	259	9	8	8	NUM
bptjm-30	259	10	.	.	PUNCT
bptjm-30	260	1	conclusion	conclusion	NOUN
bptjm-30	260	2	research	research	NOUN
bptjm-30	260	3	on	on	ADP
bptjm-30	260	4	antidepressant	antidepressant	ADJ
bptjm-30	260	5	therapies	therapy	NOUN
bptjm-30	260	6	has	have	AUX
bptjm-30	260	7	significantly	significantly	ADV
bptjm-30	260	8	advanced	advance	VERB
bptjm-30	260	9	in	in	ADP
bptjm-30	260	10	recent	recent	ADJ
bptjm-30	260	11	years	year	NOUN
bptjm-30	260	12	while	while	SCONJ
bptjm-30	260	13	taking	take	VERB
bptjm-30	260	14	on	on	ADP
bptjm-30	260	15	a	a	DET
bptjm-30	260	16	new	new	ADJ
bptjm-30	260	17	approach	approach	NOUN
bptjm-30	260	18	to	to	ADP
bptjm-30	260	19	treating	treat	VERB
bptjm-30	260	20	depressive	depressive	ADJ
bptjm-30	260	21	symptoms	symptom	NOUN
bptjm-30	260	22	in	in	ADP
bptjm-30	260	23	patients	patient	NOUN
bptjm-30	260	24	.	.	PUNCT
bptjm-30	261	1	while	while	SCONJ
bptjm-30	261	2	current	current	ADJ
bptjm-30	261	3	antidepressant	antidepressant	ADJ
bptjm-30	261	4	medications	medication	NOUN
bptjm-30	261	5	increase	increase	VERB
bptjm-30	261	6	concentrations	concentration	NOUN
bptjm-30	261	7	of	of	ADP
bptjm-30	261	8	serotonin	serotonin	NOUN
bptjm-30	261	9	and	and	CCONJ
bptjm-30	261	10	norepinephrine	norepinephrine	NOUN
bptjm-30	261	11	through	through	ADP
bptjm-30	261	12	reuptake	reuptake	NOUN
bptjm-30	261	13	inhibition	inhibition	NOUN
bptjm-30	261	14	,	,	PUNCT
bptjm-30	261	15	new	new	ADJ
bptjm-30	261	16	research	research	NOUN
bptjm-30	261	17	focuses	focus	VERB
bptjm-30	261	18	on	on	ADP
bptjm-30	261	19	the	the	DET
bptjm-30	261	20	direct	direct	ADJ
bptjm-30	261	21	manipulation	manipulation	NOUN
bptjm-30	261	22	of	of	ADP
bptjm-30	261	23	receptors	receptor	NOUN
bptjm-30	261	24	,	,	PUNCT
bptjm-30	261	25	specifically	specifically	ADV
bptjm-30	261	26	targeting	target	VERB
bptjm-30	261	27	and	and	CCONJ
bptjm-30	261	28	improving	improve	VERB
bptjm-30	261	29	neuroplasticity	neuroplasticity	NOUN
bptjm-30	261	30	,	,	PUNCT
bptjm-30	261	31	which	which	PRON
bptjm-30	261	32	has	have	AUX
bptjm-30	261	33	emerged	emerge	VERB
bptjm-30	261	34	as	as	ADP
bptjm-30	261	35	a	a	DET
bptjm-30	261	36	promising	promising	ADJ
bptjm-30	261	37	approach	approach	NOUN
bptjm-30	261	38	to	to	ADP
bptjm-30	261	39	treating	treat	VERB
bptjm-30	261	40	depressive	depressive	ADJ
bptjm-30	261	41	symptoms	symptom	NOUN
bptjm-30	261	42	.	.	PUNCT
bptjm-30	262	1	ketamine	ketamine	PROPN
bptjm-30	262	2	has	have	AUX
bptjm-30	262	3	been	be	AUX
bptjm-30	262	4	shown	show	VERB
bptjm-30	262	5	to	to	PART
bptjm-30	262	6	rapidly	rapidly	ADV
bptjm-30	262	7	reduce	reduce	VERB
bptjm-30	262	8	depressive	depressive	ADJ
bptjm-30	262	9	symptoms	symptom	NOUN
bptjm-30	262	10	by	by	ADP
bptjm-30	262	11	targeting	target	VERB
bptjm-30	262	12	glutamate	glutamate	NOUN
bptjm-30	262	13	,	,	PUNCT
bptjm-30	262	14	promoting	promote	VERB
bptjm-30	262	15	the	the	DET
bptjm-30	262	16	formation	formation	NOUN
bptjm-30	262	17	of	of	ADP
bptjm-30	262	18	synapses	synapsis	NOUN
bptjm-30	262	19	and	and	CCONJ
bptjm-30	262	20	new	new	ADJ
bptjm-30	262	21	neural	neural	ADJ
bptjm-30	262	22	connections	connection	NOUN
bptjm-30	262	23	.	.	PUNCT
bptjm-30	263	1	psilocybin	psilocybin	NOUN
bptjm-30	263	2	has	have	AUX
bptjm-30	263	3	also	also	ADV
bptjm-30	263	4	shown	show	VERB
bptjm-30	263	5	numerous	numerous	ADJ
bptjm-30	263	6	signs	sign	NOUN
bptjm-30	263	7	of	of	ADP
bptjm-30	263	8	improving	improve	VERB
bptjm-30	263	9	neuroplasticity	neuroplasticity	NOUN
bptjm-30	263	10	in	in	ADP
bptjm-30	263	11	clinical	clinical	ADJ
bptjm-30	263	12	trials	trial	NOUN
bptjm-30	263	13	,	,	PUNCT
bptjm-30	263	14	with	with	ADP
bptjm-30	263	15	the	the	DET
bptjm-30	263	16	potential	potential	NOUN
bptjm-30	263	17	for	for	ADP
bptjm-30	263	18	longer	long	ADV
bptjm-30	263	19	-	-	PUNCT
bptjm-30	263	20	lasting	last	VERB
bptjm-30	263	21	effects	effect	NOUN
bptjm-30	263	22	.	.	PUNCT
bptjm-30	264	1	while	while	SCONJ
bptjm-30	264	2	ketamine	ketamine	PROPN
bptjm-30	264	3	and	and	CCONJ
bptjm-30	264	4	psilocybin	psilocybin	NOUN
bptjm-30	264	5	are	be	AUX
bptjm-30	264	6	at	at	ADP
bptjm-30	264	7	the	the	DET
bptjm-30	264	8	forefront	forefront	NOUN
bptjm-30	264	9	of	of	ADP
bptjm-30	264	10	current	current	ADJ
bptjm-30	264	11	antidepressant	antidepressant	ADJ
bptjm-30	264	12	research	research	NOUN
bptjm-30	264	13	,	,	PUNCT
bptjm-30	264	14	much	much	ADJ
bptjm-30	264	15	information	information	NOUN
bptjm-30	264	16	remains	remain	VERB
bptjm-30	264	17	to	to	PART
bptjm-30	264	18	be	be	AUX
bptjm-30	264	19	known	know	VERB
bptjm-30	264	20	about	about	ADP
bptjm-30	264	21	the	the	DET
bptjm-30	264	22	impact	impact	NOUN
bptjm-30	264	23	of	of	ADP
bptjm-30	264	24	long	long	ADJ
bptjm-30	264	25	-	-	PUNCT
bptjm-30	264	26	term	term	NOUN
bptjm-30	264	27	and	and	CCONJ
bptjm-30	264	28	repeated	repeat	VERB
bptjm-30	264	29	exposure	exposure	NOUN
bptjm-30	264	30	to	to	ADP
bptjm-30	264	31	these	these	DET
bptjm-30	264	32	drugs	drug	NOUN
bptjm-30	264	33	,	,	PUNCT
bptjm-30	264	34	and	and	CCONJ
bptjm-30	264	35	larger	large	ADJ
bptjm-30	264	36	clinical	clinical	ADJ
bptjm-30	264	37	trials	trial	NOUN
bptjm-30	264	38	are	be	AUX
bptjm-30	264	39	necessary	necessary	ADJ
bptjm-30	264	40	to	to	PART
bptjm-30	264	41	evaluate	evaluate	VERB
bptjm-30	264	42	their	their	PRON
bptjm-30	264	43	efficacy	efficacy	NOUN
bptjm-30	264	44	.	.	PUNCT
bptjm-30	265	1	psychedelic	psychedelic	ADJ
bptjm-30	265	2	-	-	PUNCT
bptjm-30	265	3	related	relate	VERB
bptjm-30	265	4	drugs	drug	NOUN
bptjm-30	265	5	,	,	PUNCT
bptjm-30	265	6	such	such	ADJ
bptjm-30	265	7	as	as	ADP
bptjm-30	265	8	ayahuasca	ayahuasca	NOUN
bptjm-30	265	9	and	and	CCONJ
bptjm-30	265	10	lsd	lsd	NOUN
bptjm-30	265	11	,	,	PUNCT
bptjm-30	265	12	display	display	VERB
bptjm-30	265	13	the	the	DET
bptjm-30	265	14	potential	potential	NOUN
bptjm-30	265	15	to	to	PART
bptjm-30	265	16	treat	treat	VERB
bptjm-30	265	17	depressive	depressive	ADJ
bptjm-30	265	18	symptoms	symptom	NOUN
bptjm-30	265	19	as	as	ADV
bptjm-30	265	20	well	well	ADV
bptjm-30	265	21	.	.	PUNCT
bptjm-30	266	1	ayahuasca	ayahuasca	PROPN
bptjm-30	266	2	inhibits	inhibit	VERB
bptjm-30	266	3	default	default	NOUN
bptjm-30	266	4	mode	mode	NOUN
bptjm-30	266	5	network	network	NOUN
bptjm-30	266	6	activity	activity	NOUN
bptjm-30	266	7	to	to	PART
bptjm-30	266	8	reduce	reduce	VERB
bptjm-30	266	9	stress	stress	NOUN
bptjm-30	266	10	-	-	PUNCT
bptjm-30	266	11	induced	induce	VERB
bptjm-30	266	12	depression	depression	NOUN
bptjm-30	266	13	and	and	CCONJ
bptjm-30	266	14	anxiety	anxiety	NOUN
bptjm-30	266	15	,	,	PUNCT
bptjm-30	266	16	while	while	SCONJ
bptjm-30	266	17	lsd	lsd	NOUN
bptjm-30	266	18	functions	function	NOUN
bptjm-30	266	19	similarly	similarly	ADV
bptjm-30	266	20	to	to	ADP
bptjm-30	266	21	psilocybin	psilocybin	NOUN
bptjm-30	266	22	and	and	CCONJ
bptjm-30	266	23	promotes	promote	VERB
bptjm-30	266	24	cell	cell	NOUN
bptjm-30	266	25	growth	growth	NOUN
bptjm-30	266	26	and	and	CCONJ
bptjm-30	266	27	connections	connection	NOUN
bptjm-30	266	28	to	to	PART
bptjm-30	266	29	improve	improve	VERB
bptjm-30	266	30	neuroplasticity	neuroplasticity	NOUN
bptjm-30	266	31	.	.	PUNCT
bptjm-30	267	1	however	however	ADV
bptjm-30	267	2	,	,	PUNCT
bptjm-30	267	3	concerns	concern	NOUN
bptjm-30	267	4	over	over	ADP
bptjm-30	267	5	side	side	NOUN
bptjm-30	267	6	effects	effect	NOUN
bptjm-30	267	7	and	and	CCONJ
bptjm-30	267	8	government	government	NOUN
bptjm-30	267	9	restrictions	restriction	NOUN
bptjm-30	267	10	have	have	AUX
bptjm-30	267	11	limited	limit	VERB
bptjm-30	267	12	research	research	NOUN
bptjm-30	267	13	on	on	ADP
bptjm-30	267	14	the	the	DET
bptjm-30	267	15	psychedelic	psychedelic	ADJ
bptjm-30	267	16	approach	approach	NOUN
bptjm-30	267	17	.	.	PUNCT
bptjm-30	268	1	natural	natural	ADJ
bptjm-30	268	2	products	product	NOUN
bptjm-30	268	3	have	have	AUX
bptjm-30	268	4	also	also	ADV
bptjm-30	268	5	been	be	AUX
bptjm-30	268	6	found	find	VERB
bptjm-30	268	7	to	to	PART
bptjm-30	268	8	work	work	VERB
bptjm-30	268	9	well	well	ADV
bptjm-30	268	10	in	in	ADP
bptjm-30	268	11	conjunction	conjunction	NOUN
bptjm-30	268	12	with	with	ADP
bptjm-30	268	13	current	current	ADJ
bptjm-30	268	14	antidepressant	antidepressant	ADJ
bptjm-30	268	15	drugs	drug	NOUN
bptjm-30	268	16	and	and	CCONJ
bptjm-30	268	17	therapies	therapy	NOUN
bptjm-30	268	18	due	due	ADJ
bptjm-30	268	19	to	to	ADP
bptjm-30	268	20	reduced	reduce	VERB
bptjm-30	268	21	side	side	NOUN
bptjm-30	268	22	effects	effect	NOUN
bptjm-30	268	23	and	and	CCONJ
bptjm-30	268	24	medication	medication	NOUN
bptjm-30	268	25	loads	load	NOUN
bptjm-30	268	26	.	.	PUNCT
bptjm-30	269	1	while	while	SCONJ
bptjm-30	269	2	recent	recent	ADJ
bptjm-30	269	3	clinical	clinical	ADJ
bptjm-30	269	4	trials	trial	NOUN
bptjm-30	269	5	show	show	VERB
bptjm-30	269	6	signs	sign	NOUN
bptjm-30	269	7	of	of	ADP
bptjm-30	269	8	antidepressant	antidepressant	ADJ
bptjm-30	269	9	effects	effect	NOUN
bptjm-30	269	10	,	,	PUNCT
bptjm-30	269	11	there	there	PRON
bptjm-30	269	12	is	be	VERB
bptjm-30	269	13	still	still	ADV
bptjm-30	269	14	an	an	DET
bptjm-30	269	15	overall	overall	ADJ
bptjm-30	269	16	lack	lack	NOUN
bptjm-30	269	17	of	of	ADP
bptjm-30	269	18	research	research	NOUN
bptjm-30	269	19	surrounding	surround	VERB
bptjm-30	269	20	these	these	DET
bptjm-30	269	21	products	product	NOUN
bptjm-30	269	22	and	and	CCONJ
bptjm-30	269	23	their	their	PRON
bptjm-30	269	24	potential	potential	NOUN
bptjm-30	269	25	to	to	PART
bptjm-30	269	26	treat	treat	VERB
bptjm-30	269	27	depression	depression	NOUN
bptjm-30	269	28	.	.	PUNCT
bptjm-30	270	1	hormonal	hormonal	ADJ
bptjm-30	270	2	treatment	treatment	NOUN
bptjm-30	270	3	,	,	PUNCT
bptjm-30	270	4	which	which	PRON
bptjm-30	270	5	has	have	AUX
bptjm-30	270	6	been	be	AUX
bptjm-30	270	7	used	use	VERB
bptjm-30	270	8	for	for	ADP
bptjm-30	270	9	years	year	NOUN
bptjm-30	270	10	to	to	PART
bptjm-30	270	11	treat	treat	VERB
bptjm-30	270	12	a	a	DET
bptjm-30	270	13	variety	variety	NOUN
bptjm-30	270	14	of	of	ADP
bptjm-30	270	15	disorders	disorder	NOUN
bptjm-30	270	16	,	,	PUNCT
bptjm-30	270	17	has	have	AUX
bptjm-30	270	18	recently	recently	ADV
bptjm-30	270	19	emerged	emerge	VERB
bptjm-30	270	20	as	as	ADP
bptjm-30	270	21	a	a	DET
bptjm-30	270	22	potential	potential	ADJ
bptjm-30	270	23	antidepressant	antidepressant	ADJ
bptjm-30	270	24	therapy	therapy	NOUN
bptjm-30	270	25	.	.	PUNCT
bptjm-30	271	1	replacement	replacement	NOUN
bptjm-30	271	2	therapies	therapy	NOUN
bptjm-30	271	3	involving	involve	VERB
bptjm-30	271	4	thyroid	thyroid	NOUN
bptjm-30	271	5	,	,	PUNCT
bptjm-30	271	6	gonadal	gonadal	NOUN
bptjm-30	271	7	,	,	PUNCT
bptjm-30	271	8	pineal	pineal	NOUN
bptjm-30	271	9	gland	gland	NOUN
bptjm-30	271	10	,	,	PUNCT
bptjm-30	271	11	and	and	CCONJ
bptjm-30	271	12	adrenal	adrenal	ADJ
bptjm-30	271	13	axis	axis	NOUN
bptjm-30	271	14	hormones	hormone	NOUN
bptjm-30	271	15	specifically	specifically	ADV
bptjm-30	271	16	have	have	AUX
bptjm-30	271	17	shown	show	VERB
bptjm-30	271	18	signs	sign	NOUN
bptjm-30	271	19	of	of	ADP
bptjm-30	271	20	reducing	reduce	VERB
bptjm-30	271	21	depressive	depressive	ADJ
bptjm-30	271	22	symptoms	symptom	NOUN
bptjm-30	271	23	by	by	ADP
bptjm-30	271	24	adjusting	adjust	VERB
bptjm-30	271	25	the	the	DET
bptjm-30	271	26	naturally	naturally	ADV
bptjm-30	271	27	occurring	occur	VERB
bptjm-30	271	28	chemicals	chemical	NOUN
bptjm-30	271	29	to	to	ADP
bptjm-30	271	30	their	their	PRON
bptjm-30	271	31	optimum	optimum	ADJ
bptjm-30	271	32	levels	level	NOUN
bptjm-30	271	33	.	.	PUNCT
bptjm-30	272	1	while	while	SCONJ
bptjm-30	272	2	hormonal	hormonal	ADJ
bptjm-30	272	3	treatment	treatment	NOUN
bptjm-30	272	4	offers	offer	VERB
bptjm-30	272	5	a	a	DET
bptjm-30	272	6	targeted	targeted	ADJ
bptjm-30	272	7	approach	approach	NOUN
bptjm-30	272	8	due	due	ADP
bptjm-30	272	9	to	to	ADP
bptjm-30	272	10	the	the	DET
bptjm-30	272	11	knowledge	knowledge	NOUN
bptjm-30	272	12	surrounding	surround	VERB
bptjm-30	272	13	hormones	hormone	NOUN
bptjm-30	272	14	and	and	CCONJ
bptjm-30	272	15	their	their	PRON
bptjm-30	272	16	effect	effect	NOUN
bptjm-30	272	17	on	on	ADP
bptjm-30	272	18	the	the	DET
bptjm-30	272	19	body	body	NOUN
bptjm-30	272	20	,	,	PUNCT
bptjm-30	272	21	there	there	PRON
bptjm-30	272	22	are	be	VERB
bptjm-30	272	23	concerns	concern	NOUN
bptjm-30	272	24	about	about	ADP
bptjm-30	272	25	unintended	unintended	ADJ
bptjm-30	272	26	secondary	secondary	ADJ
bptjm-30	272	27	effects	effect	NOUN
bptjm-30	272	28	that	that	PRON
bptjm-30	272	29	can	can	AUX
bptjm-30	272	30	occur	occur	VERB
bptjm-30	272	31	.	.	PUNCT
bptjm-30	273	1	due	due	ADP
bptjm-30	273	2	to	to	ADP
bptjm-30	273	3	the	the	DET
bptjm-30	273	4	relative	relative	ADJ
bptjm-30	273	5	inconsistency	inconsistency	NOUN
bptjm-30	273	6	and	and	CCONJ
bptjm-30	273	7	inefficiency	inefficiency	NOUN
bptjm-30	273	8	of	of	ADP
bptjm-30	273	9	current	current	ADJ
bptjm-30	273	10	berkeley	berkeley	PROPN
bptjm-30	273	11	pharma	pharma	PROPN
bptjm-30	273	12	tech	tech	NOUN
bptjm-30	273	13	journal	journal	NOUN
bptjm-30	273	14	of	of	ADP
bptjm-30	273	15	medicine	medicine	NOUN
bptjm-30	273	16	|	|	ADV
bptjm-30	273	17	42	42	NUM
bptjm-30	273	18	antidepressants	antidepressant	NOUN
bptjm-30	273	19	,	,	PUNCT
bptjm-30	273	20	many	many	ADJ
bptjm-30	273	21	novel	novel	ADJ
bptjm-30	273	22	therapeutic	therapeutic	ADJ
bptjm-30	273	23	strategies	strategy	NOUN
bptjm-30	273	24	,	,	PUNCT
bptjm-30	273	25	and	and	CCONJ
bptjm-30	273	26	approaches	approach	NOUN
bptjm-30	273	27	to	to	PART
bptjm-30	273	28	treat	treat	VERB
bptjm-30	273	29	depression	depression	NOUN
bptjm-30	273	30	have	have	AUX
bptjm-30	273	31	emerged	emerge	VERB
bptjm-30	273	32	in	in	ADP
bptjm-30	273	33	recent	recent	ADJ
bptjm-30	273	34	years	year	NOUN
bptjm-30	273	35	.	.	PUNCT
bptjm-30	274	1	larger	large	ADJ
bptjm-30	274	2	and	and	CCONJ
bptjm-30	274	3	more	more	ADV
bptjm-30	274	4	diverse	diverse	ADJ
bptjm-30	274	5	clinical	clinical	ADJ
bptjm-30	274	6	trials	trial	NOUN
bptjm-30	274	7	are	be	AUX
bptjm-30	274	8	needed	need	VERB
bptjm-30	274	9	for	for	ADP
bptjm-30	274	10	all	all	DET
bptjm-30	274	11	the	the	DET
bptjm-30	274	12	potential	potential	ADJ
bptjm-30	274	13	therapies	therapy	NOUN
bptjm-30	274	14	discussed	discuss	VERB
bptjm-30	274	15	in	in	ADP
bptjm-30	274	16	this	this	DET
bptjm-30	274	17	review	review	NOUN
bptjm-30	274	18	to	to	PART
bptjm-30	274	19	determine	determine	VERB
bptjm-30	274	20	their	their	PRON
bptjm-30	274	21	efficacy	efficacy	NOUN
bptjm-30	274	22	in	in	ADP
bptjm-30	274	23	treating	treat	VERB
bptjm-30	274	24	depression	depression	NOUN
bptjm-30	274	25	and	and	CCONJ
bptjm-30	274	26	whether	whether	SCONJ
bptjm-30	274	27	they	they	PRON
bptjm-30	274	28	offer	offer	VERB
bptjm-30	274	29	significant	significant	ADJ
bptjm-30	274	30	improvements	improvement	NOUN
bptjm-30	274	31	compared	compare	VERB
bptjm-30	274	32	to	to	ADP
bptjm-30	274	33	current	current	ADJ
bptjm-30	274	34	reuptake	reuptake	NOUN
bptjm-30	274	35	inhibitors	inhibitor	NOUN
bptjm-30	274	36	.	.	PUNCT
bptjm-30	275	1	conflicts	conflict	NOUN
bptjm-30	275	2	of	of	ADP
bptjm-30	275	3	interest	interest	NOUN
bptjm-30	275	4	the	the	DET
bptjm-30	275	5	authors	author	NOUN
bptjm-30	275	6	declare	declare	VERB
bptjm-30	275	7	that	that	SCONJ
bptjm-30	275	8	there	there	PRON
bptjm-30	275	9	is	be	VERB
bptjm-30	275	10	no	no	DET
bptjm-30	275	11	conflict	conflict	NOUN
bptjm-30	275	12	of	of	ADP
bptjm-30	275	13	interest	interest	NOUN
bptjm-30	275	14	regarding	regard	VERB
bptjm-30	275	15	the	the	DET
bptjm-30	275	16	publication	publication	NOUN
bptjm-30	275	17	of	of	ADP
bptjm-30	275	18	this	this	DET
bptjm-30	275	19	paper	paper	NOUN
bptjm-30	275	20	.	.	PUNCT
bptjm-30	276	1	berkeley	berkeley	PROPN
bptjm-30	276	2	pharma	pharma	PROPN
bptjm-30	276	3	tech	tech	PROPN
bptjm-30	276	4	journal	journal	NOUN
bptjm-30	276	5	of	of	ADP
bptjm-30	276	6	medicine	medicine	NOUN
bptjm-30	276	7	|	|	ADV
bptjm-30	276	8	43	43	NUM
bptjm-30	276	9	references	reference	NOUN
bptjm-30	276	10	1	1	NUM
bptjm-30	276	11	.	.	PUNCT
bptjm-30	276	12	depression	depression	NOUN
bptjm-30	276	13	.	.	PUNCT
bptjm-30	277	1	national	national	PROPN
bptjm-30	277	2	institute	institute	PROPN
bptjm-30	277	3	of	of	ADP
bptjm-30	277	4	mental	mental	ADJ
bptjm-30	277	5	health	health	NOUN
bptjm-30	277	6	.	.	PUNCT
bptjm-30	278	1	https://www.nimh.nih.gov/health/topics/depres	https://www.nimh.nih.gov/health/topics/depre	NOUN
bptjm-30	278	2	sion	sion	PROPN
bptjm-30	278	3	.	.	PUNCT
bptjm-30	279	1	accessed	access	VERB
bptjm-30	279	2	july	july	PROPN
bptjm-30	279	3	24	24	NUM
bptjm-30	279	4	,	,	PUNCT
bptjm-30	279	5	2022	2022	NUM
bptjm-30	279	6	.	.	PUNCT
bptjm-30	280	1	2	2	NUM
bptjm-30	280	2	.	.	X
bptjm-30	280	3	penn	penn	PROPN
bptjm-30	280	4	e	e	PROPN
bptjm-30	280	5	,	,	PUNCT
bptjm-30	280	6	tracy	tracy	PROPN
bptjm-30	280	7	dk	dk	PROPN
bptjm-30	280	8	.	.	PUNCT
bptjm-30	281	1	the	the	DET
bptjm-30	281	2	drugs	drug	NOUN
bptjm-30	281	3	do	do	AUX
bptjm-30	281	4	n't	not	PART
bptjm-30	281	5	work	work	VERB
bptjm-30	281	6	?	?	PUNCT
bptjm-30	282	1	antidepressants	antidepressant	NOUN
bptjm-30	282	2	and	and	CCONJ
bptjm-30	282	3	the	the	DET
bptjm-30	282	4	current	current	ADJ
bptjm-30	282	5	and	and	CCONJ
bptjm-30	282	6	future	future	ADJ
bptjm-30	282	7	pharmacological	pharmacological	ADJ
bptjm-30	282	8	management	management	NOUN
bptjm-30	282	9	of	of	ADP
bptjm-30	282	10	depression	depression	NOUN
bptjm-30	282	11	.	.	PUNCT
bptjm-30	283	1	ther	ther	VERB
bptjm-30	283	2	adv	adv	PROPN
bptjm-30	283	3	psychopharmacol	psychopharmacol	PROPN
bptjm-30	283	4	.	.	PUNCT
bptjm-30	284	1	2012;2(5):179	2012;2(5):179	NUM
bptjm-30	284	2	-	-	SYM
bptjm-30	284	3	188	188	NUM
bptjm-30	284	4	.	.	PUNCT
bptjm-30	284	5	doi:10.1177/2045125312445469	doi:10.1177/2045125312445469	NOUN
bptjm-30	285	1	3	3	X
bptjm-30	285	2	.	.	PUNCT
bptjm-30	285	3	al	al	PROPN
bptjm-30	285	4	-	-	PUNCT
bptjm-30	285	5	harbi	harbi	PROPN
bptjm-30	285	6	ks	ks	PROPN
bptjm-30	285	7	.	.	PROPN
bptjm-30	285	8	treatment	treatment	NOUN
bptjm-30	285	9	-	-	PUNCT
bptjm-30	285	10	resistant	resistant	ADJ
bptjm-30	285	11	depression	depression	NOUN
bptjm-30	285	12	:	:	PUNCT
bptjm-30	285	13	therapeutic	therapeutic	ADJ
bptjm-30	285	14	trends	trend	NOUN
bptjm-30	285	15	,	,	PUNCT
bptjm-30	285	16	challenges	challenge	NOUN
bptjm-30	285	17	,	,	PUNCT
bptjm-30	285	18	and	and	CCONJ
bptjm-30	285	19	future	future	ADJ
bptjm-30	285	20	directions	direction	NOUN
bptjm-30	285	21	.	.	PUNCT
bptjm-30	286	1	patient	patient	ADJ
bptjm-30	286	2	prefer	prefer	NOUN
bptjm-30	286	3	adherence	adherence	NOUN
bptjm-30	286	4	.	.	PUNCT
bptjm-30	287	1	2012;6:369388	2012;6:369388	NUM
bptjm-30	287	2	.	.	PUNCT
bptjm-30	287	3	doi:10.2147	doi:10.2147	NOUN
bptjm-30	287	4	/	/	SYM
bptjm-30	287	5	ppa.s29716	ppa.s29716	PROPN
bptjm-30	287	6	4	4	NUM
bptjm-30	287	7	.	.	PUNCT
bptjm-30	288	1	szarmach	szarmach	PROPN
bptjm-30	288	2	j	j	PROPN
bptjm-30	288	3	,	,	PUNCT
bptjm-30	288	4	cubała	cubała	PROPN
bptjm-30	288	5	wj	wj	PROPN
bptjm-30	288	6	,	,	PUNCT
bptjm-30	288	7	włodarczyk	włodarczyk	INTJ
bptjm-30	288	8	a	a	PRON
bptjm-30	288	9	,	,	PUNCT
bptjm-30	288	10	wiglusz	wiglusz	PROPN
bptjm-30	288	11	ms	ms	PROPN
bptjm-30	288	12	.	.	PROPN
bptjm-30	288	13	short	short	ADJ
bptjm-30	288	14	-	-	PUNCT
bptjm-30	288	15	term	term	NOUN
bptjm-30	288	16	ketamine	ketamine	PROPN
bptjm-30	288	17	administration	administration	NOUN
bptjm-30	288	18	in	in	ADP
bptjm-30	288	19	treatment	treatment	NOUN
bptjm-30	288	20	-	-	PUNCT
bptjm-30	288	21	resistant	resistant	ADJ
bptjm-30	288	22	depression	depression	NOUN
bptjm-30	288	23	:	:	PUNCT
bptjm-30	288	24	focus	focus	VERB
bptjm-30	288	25	on	on	ADP
bptjm-30	288	26	cardiovascular	cardiovascular	ADJ
bptjm-30	288	27	safety	safety	NOUN
bptjm-30	288	28	.	.	PUNCT
bptjm-30	289	1	psychiatr	psychiatr	ADJ
bptjm-30	289	2	danub	danub	NOUN
bptjm-30	289	3	.	.	PUNCT
bptjm-30	290	1	2019;31(suppl	2019;31(suppl	PROPN
bptjm-30	290	2	3):585	3):585	NUM
bptjm-30	290	3	-	-	SYM
bptjm-30	290	4	590	590	NUM
bptjm-30	290	5	.	.	PUNCT
bptjm-30	291	1	5	5	NUM
bptjm-30	291	2	.	.	X
bptjm-30	291	3	johnson	johnson	PROPN
bptjm-30	291	4	mw	mw	PROPN
bptjm-30	291	5	,	,	PUNCT
bptjm-30	291	6	griffiths	griffiths	PROPN
bptjm-30	291	7	rr	rr	PROPN
bptjm-30	291	8	.	.	PUNCT
bptjm-30	292	1	potential	potential	ADJ
bptjm-30	292	2	therapeutic	therapeutic	ADJ
bptjm-30	292	3	effects	effect	NOUN
bptjm-30	292	4	of	of	ADP
bptjm-30	292	5	psilocybin	psilocybin	NOUN
bptjm-30	292	6	.	.	PUNCT
bptjm-30	293	1	neurotherapeutics	neurotherapeutics	PROPN
bptjm-30	293	2	.	.	PUNCT
bptjm-30	294	1	2017;14(3):734	2017;14(3):734	NUM
bptjm-30	294	2	-	-	PUNCT
bptjm-30	294	3	740	740	NUM
bptjm-30	294	4	.	.	PUNCT
bptjm-30	295	1	doi:10.1007	doi:10.1007	VERB
bptjm-30	295	2	/	/	SYM
bptjm-30	295	3	s13311	s13311	NOUN
bptjm-30	295	4	-	-	PUNCT
bptjm-30	295	5	017	017	NUM
bptjm-30	295	6	-	-	PUNCT
bptjm-30	295	7	0542	0542	NUM
bptjm-30	295	8	-	-	PUNCT
bptjm-30	295	9	y	y	PROPN
bptjm-30	295	10	6	6	NUM
bptjm-30	295	11	.	.	PUNCT
bptjm-30	296	1	tupper	tupper	PROPN
bptjm-30	296	2	kw	kw	PROPN
bptjm-30	296	3	,	,	PUNCT
bptjm-30	296	4	wood	wood	NOUN
bptjm-30	296	5	e	e	NOUN
bptjm-30	296	6	,	,	PUNCT
bptjm-30	296	7	yensen	yensen	ADJ
bptjm-30	296	8	r	r	NOUN
bptjm-30	296	9	,	,	PUNCT
bptjm-30	296	10	johnson	johnson	PROPN
bptjm-30	296	11	mw	mw	PROPN
bptjm-30	296	12	.	.	PROPN
bptjm-30	296	13	psychedelic	psychedelic	ADJ
bptjm-30	296	14	medicine	medicine	NOUN
bptjm-30	296	15	:	:	PUNCT
bptjm-30	296	16	a	a	DET
bptjm-30	296	17	re	re	ADJ
bptjm-30	296	18	-	-	VERB
bptjm-30	296	19	emerging	emerge	VERB
bptjm-30	296	20	therapeutic	therapeutic	ADJ
bptjm-30	296	21	paradigm	paradigm	NOUN
bptjm-30	296	22	.	.	PUNCT
bptjm-30	297	1	cmaj	cmaj	PROPN
bptjm-30	297	2	.	.	PUNCT
bptjm-30	298	1	2015;187(14):1054	2015;187(14):1054	NUM
bptjm-30	298	2	-	-	SYM
bptjm-30	298	3	1059	1059	NUM
bptjm-30	298	4	.	.	PUNCT
bptjm-30	299	1	doi:10.1503	doi:10.1503	NOUN
bptjm-30	299	2	/	/	SYM
bptjm-30	299	3	cmaj.141124	cmaj.141124	NOUN
bptjm-30	299	4	7	7	NUM
bptjm-30	299	5	.	.	NOUN
bptjm-30	299	6	mischoulon	mischoulon	PROPN
bptjm-30	299	7	d.	d.	PROPN
bptjm-30	299	8	update	update	NOUN
bptjm-30	299	9	and	and	CCONJ
bptjm-30	299	10	critique	critique	NOUN
bptjm-30	299	11	of	of	ADP
bptjm-30	299	12	natural	natural	ADJ
bptjm-30	299	13	remedies	remedy	NOUN
bptjm-30	299	14	as	as	ADP
bptjm-30	299	15	antidepressant	antidepressant	ADJ
bptjm-30	299	16	treatments	treatment	NOUN
bptjm-30	299	17	.	.	PUNCT
bptjm-30	300	1	obstet	obstet	PROPN
bptjm-30	300	2	gynecol	gynecol	PROPN
bptjm-30	300	3	clin	clin	PROPN
bptjm-30	300	4	north	north	PROPN
bptjm-30	300	5	am	be	AUX
bptjm-30	300	6	.	.	PUNCT
bptjm-30	301	1	2009;36(4):789	2009;36(4):789	ADV
bptjm-30	301	2	-	-	PUNCT
bptjm-30	301	3	x.	x.	NOUN
bptjm-30	301	4	doi:10.1016	doi:10.1016	PROPN
bptjm-30	301	5	/	/	SYM
bptjm-30	301	6	j.ogc.2009.10.005	j.ogc.2009.10.005	PROPN
bptjm-30	301	7	8	8	NUM
bptjm-30	301	8	.	.	PUNCT
bptjm-30	302	1	joffe	joffe	PROPN
bptjm-30	302	2	rt	rt	PROPN
bptjm-30	302	3	.	.	PROPN
bptjm-30	302	4	hormone	hormone	NOUN
bptjm-30	302	5	treatment	treatment	NOUN
bptjm-30	302	6	of	of	ADP
bptjm-30	302	7	depression	depression	NOUN
bptjm-30	302	8	.	.	PUNCT
bptjm-30	303	1	dialogues	dialogue	NOUN
bptjm-30	303	2	clin	clin	PROPN
bptjm-30	303	3	neurosci	neurosci	PROPN
bptjm-30	303	4	.	.	PUNCT
bptjm-30	304	1	2011;13(1):127	2011;13(1):127	NUM
bptjm-30	304	2	-	-	SYM
bptjm-30	304	3	138	138	NUM
bptjm-30	304	4	.	.	PUNCT
bptjm-30	305	1	doi:10.31887	doi:10.31887	VERB
bptjm-30	305	2	/	/	SYM
bptjm-30	305	3	dcns.2011.13.1	dcns.2011.13.1	ADJ
bptjm-30	305	4	/	/	SYM
bptjm-30	305	5	rjoffe	rjoffe	NOUN
bptjm-30	305	6	9	9	NUM
bptjm-30	305	7	.	.	PUNCT
bptjm-30	306	1	hasler	hasler	PROPN
bptjm-30	306	2	g.	g.	PROPN
bptjm-30	306	3	pathophysiology	pathophysiology	PROPN
bptjm-30	306	4	of	of	ADP
bptjm-30	306	5	depression	depression	NOUN
bptjm-30	306	6	:	:	PUNCT
bptjm-30	306	7	do	do	AUX
bptjm-30	306	8	we	we	PRON
bptjm-30	306	9	have	have	VERB
bptjm-30	306	10	any	any	DET
bptjm-30	306	11	solid	solid	ADJ
bptjm-30	306	12	evidence	evidence	NOUN
bptjm-30	306	13	of	of	ADP
bptjm-30	306	14	interest	interest	NOUN
bptjm-30	306	15	to	to	ADP
bptjm-30	306	16	clinicians	clinician	NOUN
bptjm-30	306	17	?	?	PUNCT
bptjm-30	306	18	.	.	PUNCT
bptjm-30	307	1	world	world	NOUN
bptjm-30	307	2	psychiatry	psychiatry	PROPN
bptjm-30	307	3	.	.	PUNCT
bptjm-30	308	1	2010;9(3):155	2010;9(3):155	X
bptjm-30	308	2	-	-	SYM
bptjm-30	308	3	161	161	NUM
bptjm-30	308	4	.	.	PUNCT
bptjm-30	309	1	doi:10.1002	doi:10.1002	NOUN
bptjm-30	309	2	/	/	SYM
bptjm-30	309	3	j.2051	j.2051	PROPN
bptjm-30	309	4	-	-	ADJ
bptjm-30	309	5	5545.2010.tb00298.x	5545.2010.tb00298.x	NUM
bptjm-30	309	6	10	10	NUM
bptjm-30	309	7	.	.	PUNCT
bptjm-30	310	1	luscher	luscher	PROPN
bptjm-30	310	2	b	b	PROPN
bptjm-30	310	3	,	,	PUNCT
bptjm-30	310	4	shen	shen	PROPN
bptjm-30	310	5	q	q	PROPN
bptjm-30	310	6	,	,	PUNCT
bptjm-30	310	7	sahir	sahir	PROPN
bptjm-30	310	8	n.	n.	PROPN
bptjm-30	311	1	the	the	DET
bptjm-30	311	2	gabaergic	gabaergic	ADJ
bptjm-30	311	3	deficit	deficit	NOUN
bptjm-30	311	4	hypothesis	hypothesis	NOUN
bptjm-30	311	5	of	of	ADP
bptjm-30	311	6	major	major	ADJ
bptjm-30	311	7	depressive	depressive	ADJ
bptjm-30	311	8	disorder	disorder	NOUN
bptjm-30	311	9	.	.	PUNCT
bptjm-30	312	1	mol	mol	ADP
bptjm-30	312	2	psychiatry	psychiatry	NOUN
bptjm-30	312	3	.	.	PUNCT
bptjm-30	313	1	2011;16(4):383	2011;16(4):383	NUM
bptjm-30	313	2	-	-	PUNCT
bptjm-30	313	3	406	406	NUM
bptjm-30	313	4	.	.	PUNCT
bptjm-30	314	1	doi:10.1038	doi:10.1038	NOUN
bptjm-30	314	2	/	/	SYM
bptjm-30	314	3	mp.2010.120	mp.2010.120	PROPN
bptjm-30	314	4	11	11	NUM
bptjm-30	314	5	.	.	PUNCT
bptjm-30	315	1	national	national	PROPN
bptjm-30	315	2	institute	institute	PROPN
bptjm-30	315	3	of	of	ADP
bptjm-30	315	4	general	general	PROPN
bptjm-30	315	5	medical	medical	ADJ
bptjm-30	315	6	sciences	science	NOUN
bptjm-30	315	7	.	.	PUNCT
bptjm-30	316	1	circadian	circadian	ADJ
bptjm-30	316	2	rhythms	rhythm	NOUN
bptjm-30	316	3	.	.	PUNCT
bptjm-30	317	1	www.nigms.nih.gov	www.nigms.nih.gov	ADJ
bptjm-30	317	2	.	.	PUNCT
bptjm-30	318	1	published	publish	VERB
bptjm-30	318	2	september	september	PROPN
bptjm-30	318	3	9	9	NUM
bptjm-30	318	4	,	,	PUNCT
bptjm-30	318	5	2021	2021	NUM
bptjm-30	318	6	.	.	PUNCT
bptjm-30	319	1	https://www.nigms.nih.gov/education/factsheets/pages/circadian-rhythms.aspx#:~:text=	https://www.nigms.nih.gov/education/factsheets/pages/circadian-rhythms.aspx#:~:text=	PROPN
bptjm-30	319	2	circadian%20rhythms%20are%20physical%2c%	circadian%20rhythms%20are%20physical%2c%	PROPN
bptjm-30	319	3	20mental	20mental	NOUN
bptjm-30	319	4	12	12	NUM
bptjm-30	319	5	.	.	PUNCT
bptjm-30	320	1	nautiyal	nautiyal	PROPN
bptjm-30	320	2	km	km	PROPN
bptjm-30	320	3	,	,	PUNCT
bptjm-30	320	4	hen	hen	PROPN
bptjm-30	320	5	r.	r.	PROPN
bptjm-30	320	6	serotonin	serotonin	NOUN
bptjm-30	320	7	receptors	receptor	NOUN
bptjm-30	320	8	in	in	ADP
bptjm-30	320	9	depression	depression	NOUN
bptjm-30	320	10	:	:	PUNCT
bptjm-30	320	11	from	from	ADP
bptjm-30	320	12	a	a	PRON
bptjm-30	320	13	to	to	ADP
bptjm-30	320	14	b.	b.	PROPN
bptjm-30	320	15	f1000research	f1000research	PROPN
bptjm-30	320	16	.	.	PUNCT
bptjm-30	321	1	2017;6:123	2017;6:123	NOUN
bptjm-30	321	2	.	.	PUNCT
bptjm-30	322	1	doi:10.12688	doi:10.12688	PROPN
bptjm-30	322	2	/	/	PUNCT
bptjm-30	322	3	f1000research.9736.1	f1000research.9736.1	PROPN
bptjm-30	322	4	13	13	NUM
bptjm-30	322	5	.	.	PUNCT
bptjm-30	323	1	garcia	garcia	PROPN
bptjm-30	323	2	-	-	PUNCT
bptjm-30	323	3	garcia	garcia	PROPN
bptjm-30	323	4	al	al	PROPN
bptjm-30	323	5	,	,	PUNCT
bptjm-30	323	6	newman	newman	PROPN
bptjm-30	323	7	-	-	PUNCT
bptjm-30	323	8	tancredi	tancredi	PROPN
bptjm-30	323	9	a	a	X
bptjm-30	323	10	,	,	PUNCT
bptjm-30	323	11	leonardo	leonardo	PROPN
bptjm-30	323	12	ed	ed	PROPN
bptjm-30	323	13	.	.	PUNCT
bptjm-30	324	1	p5	p5	PROPN
bptjm-30	324	2	-	-	PUNCT
bptjm-30	324	3	ht1a	ht1a	PROPN
bptjm-30	324	4	receptors	receptor	NOUN
bptjm-30	324	5	in	in	ADP
bptjm-30	324	6	mood	mood	NOUN
bptjm-30	324	7	and	and	CCONJ
bptjm-30	324	8	anxiety	anxiety	NOUN
bptjm-30	324	9	:	:	PUNCT
bptjm-30	324	10	recent	recent	ADJ
bptjm-30	324	11	insights	insight	NOUN
bptjm-30	324	12	into	into	ADP
bptjm-30	324	13	autoreceptor	autoreceptor	NOUN
bptjm-30	324	14	versus	versus	ADP
bptjm-30	324	15	heteroreceptor	heteroreceptor	PROPN
bptjm-30	324	16	function	function	PROPN
bptjm-30	324	17	.	.	PUNCT
bptjm-30	325	1	psychopharmacology	psychopharmacology	NOUN
bptjm-30	325	2	.	.	PUNCT
bptjm-30	326	1	2013;231(4):623	2013;231(4):623	NUM
bptjm-30	326	2	-	-	SYM
bptjm-30	326	3	636	636	NUM
bptjm-30	326	4	.	.	PUNCT
bptjm-30	326	5	doi:10.1007	doi:10.1007	NOUN
bptjm-30	326	6	/	/	SYM
bptjm-30	326	7	s00213	s00213	NOUN
bptjm-30	326	8	-	-	PUNCT
bptjm-30	326	9	013	013	NUM
bptjm-30	326	10	-	-	PUNCT
bptjm-30	326	11	3389	3389	NUM
bptjm-30	326	12	-	-	PUNCT
bptjm-30	326	13	x	x	SYM
bptjm-30	326	14	14	14	NUM
bptjm-30	326	15	.	.	PUNCT
bptjm-30	327	1	frazer	frazer	PROPN
bptjm-30	327	2	a	a	PRON
bptjm-30	327	3	,	,	PUNCT
bptjm-30	327	4	hensler	hensler	NOUN
bptjm-30	327	5	jg	jg	PROPN
bptjm-30	327	6	.	.	PROPN
bptjm-30	327	7	serotonin	serotonin	NOUN
bptjm-30	327	8	receptors	receptor	NOUN
bptjm-30	327	9	.	.	PUNCT
bptjm-30	328	1	nih.gov	nih.gov	NOUN
bptjm-30	328	2	.	.	PUNCT
bptjm-30	329	1	published	publish	VERB
bptjm-30	329	2	2016	2016	NUM
bptjm-30	329	3	.	.	PUNCT
bptjm-30	330	1	https://www.ncbi.nlm.nih.gov/books/nbk282	https://www.ncbi.nlm.nih.gov/books/nbk282	PROPN
bptjm-30	330	2	34/	34/	NUM
bptjm-30	330	3	15	15	NUM
bptjm-30	330	4	.	.	PUNCT
bptjm-30	331	1	jenkins	jenkins	PROPN
bptjm-30	331	2	t	t	PROPN
bptjm-30	331	3	,	,	PUNCT
bptjm-30	331	4	nguyen	nguyen	PROPN
bptjm-30	331	5	j	j	PROPN
bptjm-30	331	6	,	,	PUNCT
bptjm-30	331	7	polglaze	polglaze	PROPN
bptjm-30	331	8	k	k	PROPN
bptjm-30	331	9	,	,	PUNCT
bptjm-30	331	10	bertrand	bertrand	PROPN
bptjm-30	331	11	p.	p.	PROPN
bptjm-30	331	12	influence	influence	NOUN
bptjm-30	331	13	of	of	ADP
bptjm-30	331	14	tryptophan	tryptophan	NOUN
bptjm-30	331	15	and	and	CCONJ
bptjm-30	331	16	serotonin	serotonin	VERB
bptjm-30	331	17	on	on	ADP
bptjm-30	331	18	mood	mood	NOUN
bptjm-30	331	19	and	and	CCONJ
bptjm-30	331	20	cognition	cognition	NOUN
bptjm-30	331	21	with	with	ADP
bptjm-30	331	22	a	a	DET
bptjm-30	331	23	possible	possible	ADJ
bptjm-30	331	24	role	role	NOUN
bptjm-30	331	25	of	of	ADP
bptjm-30	331	26	the	the	DET
bptjm-30	331	27	https://www.nimh.nih.gov/health/topics/depression	https://www.nimh.nih.gov/health/topics/depression	NOUN
bptjm-30	331	28	https://www.nimh.nih.gov/health/topics/depression	https://www.nimh.nih.gov/health/topics/depression	NOUN
bptjm-30	331	29	http://www.nigms.nih.gov/	http://www.nigms.nih.gov/	PROPN
bptjm-30	331	30	http://www.nigms.nih.gov/	http://www.nigms.nih.gov/	ADJ
bptjm-30	331	31	http://www.nigms.nih.gov/	http://www.nigms.nih.gov/	ADJ
bptjm-30	331	32	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	ADJ
bptjm-30	331	33	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	ADJ
bptjm-30	331	34	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	ADJ
bptjm-30	331	35	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	ADJ
bptjm-30	331	36	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	https://www.nigms.nih.gov/education/fact-sheets/pages/circadian-rhythms.aspx#:~:text=circadian%20rhythms%20are%20physical%2c%20mental	NOUN
bptjm-30	331	37	https://www.ncbi.nlm.nih.gov/books/nbk28234/	https://www.ncbi.nlm.nih.gov/books/nbk28234/	PROPN
bptjm-30	331	38	https://www.ncbi.nlm.nih.gov/books/nbk28234/	https://www.ncbi.nlm.nih.gov/books/nbk28234/	PROPN
bptjm-30	331	39	https://www.ncbi.nlm.nih.gov/books/nbk28234/	https://www.ncbi.nlm.nih.gov/books/nbk28234/	PROPN
bptjm-30	331	40	berkeley	berkeley	PROPN
bptjm-30	331	41	pharma	pharma	PROPN
bptjm-30	331	42	tech	tech	NOUN
bptjm-30	331	43	journal	journal	NOUN
bptjm-30	331	44	of	of	ADP
bptjm-30	331	45	medicine	medicine	NOUN
bptjm-30	331	46	|	|	ADV
bptjm-30	331	47	44	44	NUM
bptjm-30	331	48	gut	gut	NOUN
bptjm-30	331	49	-	-	PUNCT
bptjm-30	331	50	brain	brain	NOUN
bptjm-30	331	51	axis	axis	NOUN
bptjm-30	331	52	.	.	PUNCT
bptjm-30	332	1	nutrients	nutrient	NOUN
bptjm-30	332	2	.	.	PUNCT
bptjm-30	333	1	2016;8(1):56	2016;8(1):56	NUM
bptjm-30	333	2	.	.	PUNCT
bptjm-30	333	3	doi:10.3390	doi:10.3390	PROPN
bptjm-30	333	4	/	/	SYM
bptjm-30	333	5	nu8010056	nu8010056	PROPN
bptjm-30	333	6	16	16	NUM
bptjm-30	333	7	.	.	PUNCT
bptjm-30	334	1	dale	dale	PROPN
bptjm-30	334	2	e	e	PROPN
bptjm-30	334	3	,	,	PUNCT
bptjm-30	334	4	pehrson	pehrson	PROPN
bptjm-30	334	5	al	al	PROPN
bptjm-30	334	6	,	,	PUNCT
bptjm-30	334	7	jeyarajah	jeyarajah	PROPN
bptjm-30	334	8	t	t	PROPN
bptjm-30	334	9	,	,	PUNCT
bptjm-30	334	10	et	et	PROPN
bptjm-30	334	11	al	al	PROPN
bptjm-30	334	12	.	.	PUNCT
bptjm-30	334	13	effects	effect	NOUN
bptjm-30	334	14	of	of	ADP
bptjm-30	334	15	serotonin	serotonin	NOUN
bptjm-30	334	16	in	in	ADP
bptjm-30	334	17	the	the	DET
bptjm-30	334	18	hippocampus	hippocampus	NOUN
bptjm-30	334	19	:	:	PUNCT
bptjm-30	334	20	how	how	SCONJ
bptjm-30	334	21	ssris	ssris	NOUN
bptjm-30	334	22	and	and	CCONJ
bptjm-30	334	23	multimodal	multimodal	NOUN
bptjm-30	334	24	antidepressants	antidepressant	NOUN
bptjm-30	334	25	might	might	AUX
bptjm-30	334	26	regulate	regulate	VERB
bptjm-30	334	27	pyramidal	pyramidal	ADJ
bptjm-30	334	28	cell	cell	NOUN
bptjm-30	334	29	function	function	NOUN
bptjm-30	334	30	.	.	PUNCT
bptjm-30	335	1	cns	cns	NOUN
bptjm-30	335	2	spectrums	spectrum	NOUN
bptjm-30	335	3	.	.	PUNCT
bptjm-30	336	1	2015;21(2):143	2015;21(2):143	NUM
bptjm-30	336	2	-	-	SYM
bptjm-30	336	3	161	161	NUM
bptjm-30	336	4	.	.	PUNCT
bptjm-30	337	1	doi:10.1017	doi:10.1017	NOUN
bptjm-30	337	2	/	/	SYM
bptjm-30	337	3	s1092852915000425	s1092852915000425	ADJ
bptjm-30	337	4	17	17	NUM
bptjm-30	337	5	.	.	PUNCT
bptjm-30	337	6	niciu	niciu	PROPN
bptjm-30	337	7	mj	mj	PROPN
bptjm-30	337	8	,	,	PUNCT
bptjm-30	337	9	henter	henter	VERB
bptjm-30	337	10	i	i	PROPN
bptjm-30	337	11	d	d	PROPN
bptjm-30	337	12	,	,	PUNCT
bptjm-30	337	13	luckenbaugh	luckenbaugh	NOUN
bptjm-30	337	14	da	da	PROPN
bptjm-30	337	15	,	,	PUNCT
bptjm-30	337	16	zarate	zarate	PROPN
bptjm-30	337	17	ca	ca	PROPN
bptjm-30	337	18	,	,	PUNCT
bptjm-30	337	19	charney	charney	PROPN
bptjm-30	337	20	ds	ds	PROPN
bptjm-30	337	21	.	.	PROPN
bptjm-30	337	22	glutamate	glutamate	ADJ
bptjm-30	337	23	receptor	receptor	NOUN
bptjm-30	337	24	antagonists	antagonist	NOUN
bptjm-30	337	25	as	as	ADP
bptjm-30	337	26	fast	fast	ADV
bptjm-30	337	27	-	-	PUNCT
bptjm-30	337	28	acting	act	VERB
bptjm-30	337	29	therapeutic	therapeutic	ADJ
bptjm-30	337	30	alternatives	alternative	NOUN
bptjm-30	337	31	for	for	ADP
bptjm-30	337	32	the	the	DET
bptjm-30	337	33	treatment	treatment	NOUN
bptjm-30	337	34	of	of	ADP
bptjm-30	337	35	depression	depression	NOUN
bptjm-30	337	36	:	:	PUNCT
bptjm-30	337	37	ketamine	ketamine	PROPN
bptjm-30	337	38	and	and	CCONJ
bptjm-30	337	39	other	other	ADJ
bptjm-30	337	40	compounds	compound	NOUN
bptjm-30	337	41	.	.	PUNCT
bptjm-30	338	1	annual	annual	ADJ
bptjm-30	338	2	review	review	NOUN
bptjm-30	338	3	of	of	ADP
bptjm-30	338	4	pharmacology	pharmacology	NOUN
bptjm-30	338	5	and	and	CCONJ
bptjm-30	338	6	toxicology	toxicology	NOUN
bptjm-30	338	7	.	.	PUNCT
bptjm-30	339	1	2014;54(1):119	2014;54(1):119	NUM
bptjm-30	339	2	-	-	SYM
bptjm-30	339	3	139	139	NUM
bptjm-30	339	4	.	.	PUNCT
bptjm-30	340	1	doi:10.1146	doi:10.1146	NOUN
bptjm-30	340	2	/	/	SYM
bptjm-30	340	3	annurevpharmtox-011613	annurevpharmtox-011613	NOUN
bptjm-30	340	4	-	-	PUNCT
bptjm-30	340	5	135950	135950	NUM
bptjm-30	340	6	18	18	NUM
bptjm-30	340	7	.	.	PUNCT
bptjm-30	341	1	lüscher	lüscher	PROPN
bptjm-30	341	2	c	c	PROPN
bptjm-30	341	3	,	,	PUNCT
bptjm-30	341	4	malenka	malenka	PROPN
bptjm-30	341	5	rc	rc	PROPN
bptjm-30	341	6	.	.	PROPN
bptjm-30	341	7	nmda	nmda	PROPN
bptjm-30	341	8	receptordependent	receptordependent	PROPN
bptjm-30	341	9	long	long	ADJ
bptjm-30	341	10	-	-	PUNCT
bptjm-30	341	11	term	term	NOUN
bptjm-30	341	12	potentiation	potentiation	NOUN
bptjm-30	341	13	and	and	CCONJ
bptjm-30	341	14	long	long	ADJ
bptjm-30	341	15	-	-	PUNCT
bptjm-30	341	16	term	term	NOUN
bptjm-30	341	17	depression	depression	NOUN
bptjm-30	341	18	(	(	PUNCT
bptjm-30	341	19	ltp	ltp	PROPN
bptjm-30	341	20	/	/	SYM
bptjm-30	341	21	ltd	ltd	PROPN
bptjm-30	341	22	)	)	PUNCT
bptjm-30	341	23	.	.	PUNCT
bptjm-30	342	1	cold	cold	ADJ
bptjm-30	342	2	spring	spring	NOUN
bptjm-30	342	3	harb	harb	PROPN
bptjm-30	342	4	perspect	perspect	VERB
bptjm-30	342	5	biol	biol	PROPN
bptjm-30	342	6	.	.	PUNCT
bptjm-30	343	1	2012;4(6):a005710	2012;4(6):a005710	X
bptjm-30	343	2	.	.	PUNCT
bptjm-30	344	1	published	publish	VERB
bptjm-30	344	2	2012	2012	NUM
bptjm-30	344	3	jun	jun	PROPN
bptjm-30	344	4	1	1	NUM
bptjm-30	344	5	.	.	PUNCT
bptjm-30	344	6	doi:10.1101	doi:10.1101	NOUN
bptjm-30	344	7	/	/	SYM
bptjm-30	344	8	cshperspect.a005710	cshperspect.a005710	NOUN
bptjm-30	344	9	19	19	NUM
bptjm-30	344	10	.	.	PUNCT
bptjm-30	344	11	bleakman	bleakman	PROPN
bptjm-30	344	12	d	d	PROPN
bptjm-30	344	13	,	,	PUNCT
bptjm-30	344	14	alt	alt	VERB
bptjm-30	344	15	a	a	PRON
bptjm-30	344	16	,	,	PUNCT
bptjm-30	344	17	witkin	witkin	PROPN
bptjm-30	344	18	j.	j.	PROPN
bptjm-30	344	19	ampa	ampa	PROPN
bptjm-30	344	20	receptors	receptor	NOUN
bptjm-30	344	21	in	in	ADP
bptjm-30	344	22	the	the	DET
bptjm-30	344	23	therapeutic	therapeutic	ADJ
bptjm-30	344	24	management	management	NOUN
bptjm-30	344	25	of	of	ADP
bptjm-30	344	26	depression	depression	NOUN
bptjm-30	344	27	.	.	PUNCT
bptjm-30	345	1	cns	cns	PROPN
bptjm-30	345	2	&	&	CCONJ
bptjm-30	345	3	neurological	neurological	ADJ
bptjm-30	345	4	disorders	disorder	NOUN
bptjm-30	345	5	drug	drug	NOUN
bptjm-30	345	6	targets	target	NOUN
bptjm-30	345	7	.	.	PUNCT
bptjm-30	346	1	2007;6(2):117	2007;6(2):117	NUM
bptjm-30	346	2	-	-	SYM
bptjm-30	346	3	126	126	NUM
bptjm-30	346	4	.	.	PUNCT
bptjm-30	347	1	doi:10.2174/187152707780363258	doi:10.2174/187152707780363258	NOUN
bptjm-30	347	2	20	20	NUM
bptjm-30	347	3	.	.	PUNCT
bptjm-30	348	1	braund	braund	PROPN
bptjm-30	348	2	ta	ta	PROPN
bptjm-30	348	3	,	,	PUNCT
bptjm-30	348	4	tillman	tillman	NOUN
bptjm-30	348	5	g	g	PROPN
bptjm-30	348	6	,	,	PUNCT
bptjm-30	348	7	palmer	palmer	PROPN
bptjm-30	348	8	dm	dm	PROPN
bptjm-30	348	9	,	,	PUNCT
bptjm-30	348	10	gordon	gordon	PROPN
bptjm-30	348	11	e	e	PROPN
bptjm-30	348	12	,	,	PUNCT
bptjm-30	348	13	rush	rush	PROPN
bptjm-30	348	14	aj	aj	PROPN
bptjm-30	348	15	,	,	PUNCT
bptjm-30	348	16	harris	harris	PROPN
bptjm-30	348	17	aw	aw	INTJ
bptjm-30	348	18	.	.	PROPN
bptjm-30	348	19	antidepressant	antidepressant	ADJ
bptjm-30	348	20	side	side	NOUN
bptjm-30	348	21	effects	effect	NOUN
bptjm-30	348	22	and	and	CCONJ
bptjm-30	348	23	their	their	PRON
bptjm-30	348	24	impact	impact	NOUN
bptjm-30	348	25	on	on	ADP
bptjm-30	348	26	treatment	treatment	NOUN
bptjm-30	348	27	outcome	outcome	NOUN
bptjm-30	348	28	in	in	ADP
bptjm-30	348	29	people	people	NOUN
bptjm-30	348	30	with	with	ADP
bptjm-30	348	31	major	major	ADJ
bptjm-30	348	32	depressive	depressive	ADJ
bptjm-30	348	33	disorder	disorder	NOUN
bptjm-30	348	34	:	:	PUNCT
bptjm-30	348	35	an	an	DET
bptjm-30	348	36	ispot	ispot	NOUN
bptjm-30	348	37	-	-	PUNCT
bptjm-30	348	38	d	d	PROPN
bptjm-30	348	39	report	report	NOUN
bptjm-30	348	40	.	.	PUNCT
bptjm-30	349	1	translational	translational	ADJ
bptjm-30	349	2	psychiatry	psychiatry	NOUN
bptjm-30	349	3	.	.	PUNCT
bptjm-30	350	1	2021;11(1	2021;11(1	NUM
bptjm-30	350	2	)	)	PUNCT
bptjm-30	350	3	.	.	PUNCT
bptjm-30	351	1	doi:10.1038	doi:10.1038	NOUN
bptjm-30	351	2	/	/	SYM
bptjm-30	351	3	s41398	s41398	NOUN
bptjm-30	351	4	-	-	PUNCT
bptjm-30	351	5	021	021	NUM
bptjm-30	351	6	-	-	PUNCT
bptjm-30	351	7	01533	01533	NUM
bptjm-30	351	8	-	-	SYM
bptjm-30	351	9	1	1	NUM
bptjm-30	351	10	21	21	NUM
bptjm-30	351	11	.	.	PUNCT
bptjm-30	352	1	cellular	cellular	ADJ
bptjm-30	352	2	and	and	CCONJ
bptjm-30	352	3	molecular	molecular	ADJ
bptjm-30	352	4	mechanisms	mechanism	NOUN
bptjm-30	352	5	in	in	ADP
bptjm-30	352	6	the	the	DET
bptjm-30	352	7	long	long	ADJ
bptjm-30	352	8	-	-	PUNCT
bptjm-30	352	9	term	term	NOUN
bptjm-30	352	10	action	action	NOUN
bptjm-30	352	11	of	of	ADP
bptjm-30	352	12	antidepressants	antidepressant	NOUN
bptjm-30	352	13	.	.	PUNCT
bptjm-30	353	1	remission	remission	NOUN
bptjm-30	353	2	in	in	ADP
bptjm-30	353	3	depression	depression	NOUN
bptjm-30	353	4	.	.	PUNCT
bptjm-30	354	1	2008;10(4):385	2008;10(4):385	NUM
bptjm-30	354	2	-	-	PUNCT
bptjm-30	354	3	400	400	NUM
bptjm-30	354	4	.	.	PUNCT
bptjm-30	355	1	doi:10.31887	doi:10.31887	VERB
bptjm-30	355	2	/	/	SYM
bptjm-30	355	3	dcns.2008.10.4	dcns.2008.10.4	NOUN
bptjm-30	355	4	/	/	SYM
bptjm-30	355	5	gracagni	gracagni	NOUN
bptjm-30	355	6	22	22	NUM
bptjm-30	355	7	.	.	PUNCT
bptjm-30	356	1	murnane	murnane	PROPN
bptjm-30	356	2	ks	ks	AUX
bptjm-30	356	3	.	.	PROPN
bptjm-30	356	4	serotonin	serotonin	VERB
bptjm-30	356	5	2a	2a	NUM
bptjm-30	356	6	receptors	receptor	NOUN
bptjm-30	356	7	are	be	AUX
bptjm-30	356	8	a	a	DET
bptjm-30	356	9	stress	stress	ADJ
bptjm-30	356	10	response	response	NOUN
bptjm-30	356	11	system	system	NOUN
bptjm-30	356	12	.	.	PUNCT
bptjm-30	357	1	behavioural	behavioural	ADJ
bptjm-30	357	2	pharmacology	pharmacology	NOUN
bptjm-30	357	3	.	.	PUNCT
bptjm-30	358	1	2019;30:151	2019;30:151	NUM
bptjm-30	358	2	-	-	SYM
bptjm-30	358	3	162	162	NUM
bptjm-30	358	4	.	.	PUNCT
bptjm-30	359	1	doi:10.1097	doi:10.1097	PROPN
bptjm-30	359	2	/	/	SYM
bptjm-30	359	3	fbp.000000000000045	fbp.000000000000045	PROPN
bptjm-30	359	4	23	23	NUM
bptjm-30	359	5	.	.	PUNCT
bptjm-30	360	1	hasselmann	hasselmann	PROPN
bptjm-30	360	2	h.	h.	PROPN
bptjm-30	360	3	ketamine	ketamine	PROPN
bptjm-30	360	4	as	as	ADP
bptjm-30	360	5	antidepressant	antidepressant	ADJ
bptjm-30	360	6	?	?	PUNCT
bptjm-30	361	1	current	current	ADJ
bptjm-30	361	2	state	state	NOUN
bptjm-30	361	3	and	and	CCONJ
bptjm-30	361	4	future	future	ADJ
bptjm-30	361	5	perspectives	perspective	NOUN
bptjm-30	361	6	.	.	PUNCT
bptjm-30	362	1	current	current	ADJ
bptjm-30	362	2	neuropharmacology	neuropharmacology	NOUN
bptjm-30	362	3	.	.	PUNCT
bptjm-30	363	1	2014;12(1):57	2014;12(1):57	NUM
bptjm-30	363	2	-	-	SYM
bptjm-30	363	3	70	70	NUM
bptjm-30	363	4	.	.	PUNCT
bptjm-30	364	1	doi:10.2174/1570159x113119990043	doi:10.2174/1570159x113119990043	ADP
bptjm-30	364	2	24	24	NUM
bptjm-30	364	3	.	.	PUNCT
bptjm-30	364	4	frizzo	frizzo	VERB
bptjm-30	364	5	me	i	PRON
bptjm-30	364	6	.	.	PUNCT
bptjm-30	365	1	can	can	AUX
bptjm-30	365	2	a	a	DET
bptjm-30	365	3	selective	selective	ADJ
bptjm-30	365	4	serotonin	serotonin	NOUN
bptjm-30	365	5	reuptake	reuptake	NOUN
bptjm-30	365	6	inhibitor	inhibitor	NOUN
bptjm-30	365	7	act	act	NOUN
bptjm-30	365	8	as	as	ADP
bptjm-30	365	9	a	a	DET
bptjm-30	365	10	glutamatergic	glutamatergic	ADJ
bptjm-30	365	11	modulator	modulator	NOUN
bptjm-30	365	12	?	?	PUNCT
bptjm-30	366	1	current	current	ADJ
bptjm-30	366	2	therapeutic	therapeutic	ADJ
bptjm-30	366	3	research	research	NOUN
bptjm-30	366	4	.	.	PUNCT
bptjm-30	367	1	2017;87:9	2017;87:9	NUM
bptjm-30	367	2	-	-	SYM
bptjm-30	367	3	12	12	NUM
bptjm-30	367	4	.	.	PUNCT
bptjm-30	368	1	doi:10.1016	doi:10.1016	PROPN
bptjm-30	368	2	/	/	SYM
bptjm-30	368	3	j.curtheres.2017.07.001	j.curtheres.2017.07.001	PROPN
bptjm-30	368	4	25	25	NUM
bptjm-30	368	5	.	.	PUNCT
bptjm-30	369	1	newcomer	newcomer	PROPN
bptjm-30	369	2	jw	jw	PROPN
bptjm-30	369	3	,	,	PUNCT
bptjm-30	369	4	farber	farber	PROPN
bptjm-30	369	5	nb	nb	PROPN
bptjm-30	369	6	,	,	PUNCT
bptjm-30	369	7	olney	olney	PROPN
bptjm-30	369	8	jw	jw	PROPN
bptjm-30	369	9	.	.	PROPN
bptjm-30	369	10	nmda	nmda	ADJ
bptjm-30	369	11	receptor	receptor	NOUN
bptjm-30	369	12	function	function	NOUN
bptjm-30	369	13	,	,	PUNCT
bptjm-30	369	14	memory	memory	NOUN
bptjm-30	369	15	,	,	PUNCT
bptjm-30	369	16	and	and	CCONJ
bptjm-30	369	17	brain	brain	NOUN
bptjm-30	369	18	aging	aging	NOUN
bptjm-30	369	19	.	.	PUNCT
bptjm-30	370	1	dialogues	dialogue	NOUN
bptjm-30	370	2	clin	clin	PROPN
bptjm-30	370	3	neurosci	neurosci	PROPN
bptjm-30	370	4	.	.	PUNCT
bptjm-30	371	1	2000;2(3):219232	2000;2(3):219232	X
bptjm-30	371	2	.	.	PUNCT
bptjm-30	372	1	doi:10.31887	doi:10.31887	VERB
bptjm-30	372	2	/	/	SYM
bptjm-30	372	3	dcns.2000.2.3	dcns.2000.2.3	PROPN
bptjm-30	372	4	/	/	SYM
bptjm-30	372	5	jnewcomer	jnewcomer	PROPN
bptjm-30	372	6	26	26	NUM
bptjm-30	372	7	.	.	PUNCT
bptjm-30	373	1	aleksandrova	aleksandrova	PROPN
bptjm-30	373	2	lr	lr	PROPN
bptjm-30	373	3	,	,	PUNCT
bptjm-30	373	4	phillips	phillips	PROPN
bptjm-30	373	5	ag	ag	PROPN
bptjm-30	373	6	,	,	PUNCT
bptjm-30	373	7	wang	wang	PROPN
bptjm-30	373	8	yt	yt	PROPN
bptjm-30	373	9	.	.	PROPN
bptjm-30	373	10	antidepressant	antidepressant	ADJ
bptjm-30	373	11	effects	effect	NOUN
bptjm-30	373	12	of	of	ADP
bptjm-30	373	13	ketamine	ketamine	PROPN
bptjm-30	373	14	and	and	CCONJ
bptjm-30	373	15	the	the	DET
bptjm-30	373	16	roles	role	NOUN
bptjm-30	373	17	of	of	ADP
bptjm-30	373	18	ampa	ampa	NOUN
bptjm-30	373	19	glutamate	glutamate	NOUN
bptjm-30	373	20	receptors	receptor	NOUN
bptjm-30	373	21	and	and	CCONJ
bptjm-30	373	22	other	other	ADJ
bptjm-30	373	23	mechanisms	mechanism	NOUN
bptjm-30	373	24	beyond	beyond	ADP
bptjm-30	373	25	nmda	nmda	ADJ
bptjm-30	373	26	receptor	receptor	NOUN
bptjm-30	373	27	antagonism	antagonism	NOUN
bptjm-30	373	28	.	.	PUNCT
bptjm-30	374	1	j	j	PROPN
bptjm-30	374	2	psychiatry	psychiatry	PROPN
bptjm-30	374	3	neurosci	neurosci	PROPN
bptjm-30	374	4	.	.	PUNCT
bptjm-30	375	1	2017;42(4):222	2017;42(4):222	NUM
bptjm-30	375	2	-	-	SYM
bptjm-30	375	3	229	229	NUM
bptjm-30	375	4	.	.	PUNCT
bptjm-30	376	1	doi:10.1503	doi:10.1503	PROPN
bptjm-30	376	2	/	/	SYM
bptjm-30	377	1	jpn.160175	jpn.160175	PROPN
bptjm-30	377	2	27	27	NUM
bptjm-30	377	3	.	.	PUNCT
bptjm-30	378	1	kowalczyk	kowalczyk	PROPN
bptjm-30	378	2	m	m	PROPN
bptjm-30	378	3	,	,	PUNCT
bptjm-30	378	4	kowalczyk	kowalczyk	X
bptjm-30	378	5	e	e	NOUN
bptjm-30	378	6	,	,	PUNCT
bptjm-30	378	7	kwiatkowski	kwiatkowski	VERB
bptjm-30	378	8	p	p	PRON
bptjm-30	378	9	,	,	PUNCT
bptjm-30	378	10	łopusiewicz	łopusiewicz	ADJ
bptjm-30	378	11	ł	ł	PROPN
bptjm-30	378	12	,	,	PUNCT
bptjm-30	378	13	sienkiewicz	sienkiewicz	PROPN
bptjm-30	378	14	m	m	PROPN
bptjm-30	378	15	,	,	PUNCT
bptjm-30	378	16	talarowska	talarowska	PROPN
bptjm-30	378	17	m.	m.	PROPN
bptjm-30	378	18	ketamine	ketamine	PROPN
bptjm-30	378	19	-	-	PUNCT
bptjm-30	378	20	new	new	ADJ
bptjm-30	378	21	possibilities	possibility	NOUN
bptjm-30	378	22	in	in	ADP
bptjm-30	378	23	the	the	DET
bptjm-30	378	24	treatment	treatment	NOUN
bptjm-30	378	25	of	of	ADP
bptjm-30	378	26	depression	depression	NOUN
bptjm-30	378	27	:	:	PUNCT
bptjm-30	378	28	a	a	DET
bptjm-30	378	29	narrative	narrative	NOUN
bptjm-30	378	30	review	review	NOUN
bptjm-30	378	31	.	.	PUNCT
bptjm-30	379	1	life	life	NOUN
bptjm-30	379	2	(	(	PUNCT
bptjm-30	379	3	basel	basel	PROPN
bptjm-30	379	4	)	)	PUNCT
bptjm-30	379	5	.	.	PUNCT
bptjm-30	380	1	2021;11(11):1186	2021;11(11):1186	NUM
bptjm-30	380	2	.	.	PUNCT
bptjm-30	380	3	published	publish	VERB
bptjm-30	380	4	2021	2021	NUM
bptjm-30	380	5	nov	nov	NOUN
bptjm-30	380	6	5	5	NUM
bptjm-30	380	7	.	.	PUNCT
bptjm-30	380	8	doi:10.3390	doi:10.3390	PROPN
bptjm-30	380	9	/	/	SYM
bptjm-30	380	10	life11111186	life11111186	PROPN
bptjm-30	380	11	28	28	NUM
bptjm-30	380	12	.	.	PUNCT
bptjm-30	381	1	d'sa	d'sa	PROPN
bptjm-30	381	2	c	c	X
bptjm-30	381	3	,	,	PUNCT
bptjm-30	381	4	duman	duman	PROPN
bptjm-30	381	5	rs	rs	PROPN
bptjm-30	381	6	.	.	PUNCT
bptjm-30	381	7	antidepressants	antidepressant	NOUN
bptjm-30	381	8	and	and	CCONJ
bptjm-30	381	9	neuroplasticity	neuroplasticity	NOUN
bptjm-30	381	10	.	.	PUNCT
bptjm-30	382	1	bipolar	bipolar	ADJ
bptjm-30	382	2	disord	disord	NOUN
bptjm-30	382	3	.	.	PUNCT
bptjm-30	383	1	2002;4(3):183	2002;4(3):183	NUM
bptjm-30	383	2	-	-	SYM
bptjm-30	383	3	194	194	NUM
bptjm-30	383	4	.	.	PUNCT
bptjm-30	383	5	doi:10.1034	doi:10.1034	PROPN
bptjm-30	383	6	/	/	SYM
bptjm-30	383	7	j.13995618.2002.01203.x	j.13995618.2002.01203.x	PROPN
bptjm-30	383	8	29	29	NUM
bptjm-30	383	9	.	.	PUNCT
bptjm-30	384	1	dimitrov	dimitrov	PROPN
bptjm-30	384	2	iv	iv	PROPN
bptjm-30	384	3	,	,	PUNCT
bptjm-30	384	4	harvey	harvey	PROPN
bptjm-30	384	5	mg	mg	PROPN
bptjm-30	384	6	,	,	PUNCT
bptjm-30	384	7	voss	voss	PROPN
bptjm-30	384	8	lj	lj	PROPN
bptjm-30	384	9	,	,	PUNCT
bptjm-30	384	10	sleigh	sleigh	PROPN
bptjm-30	384	11	berkeley	berkeley	PROPN
bptjm-30	384	12	pharma	pharma	PROPN
bptjm-30	384	13	tech	tech	NOUN
bptjm-30	384	14	journal	journal	NOUN
bptjm-30	384	15	of	of	ADP
bptjm-30	384	16	medicine	medicine	NOUN
bptjm-30	384	17	|	|	ADV
bptjm-30	384	18	45	45	NUM
bptjm-30	384	19	jw	jw	PROPN
bptjm-30	384	20	,	,	PUNCT
bptjm-30	384	21	bickerdike	bickerdike	PROPN
bptjm-30	384	22	mj	mj	PROPN
bptjm-30	384	23	,	,	PUNCT
bptjm-30	384	24	denny	denny	PROPN
bptjm-30	384	25	wa	wa	PROPN
bptjm-30	384	26	.	.	PROPN
bptjm-30	384	27	structureactivity	structureactivity	NOUN
bptjm-30	384	28	relationships	relationship	NOUN
bptjm-30	384	29	for	for	ADP
bptjm-30	384	30	the	the	DET
bptjm-30	384	31	anaesthetic	anaesthetic	ADJ
bptjm-30	384	32	and	and	CCONJ
bptjm-30	384	33	analgaesic	analgaesic	ADJ
bptjm-30	384	34	properties	property	NOUN
bptjm-30	384	35	of	of	ADP
bptjm-30	384	36	aromatic	aromatic	ADJ
bptjm-30	384	37	ringsubstituted	ringsubstitute	VERB
bptjm-30	384	38	ketamine	ketamine	PROPN
bptjm-30	384	39	esters	ester	NOUN
bptjm-30	384	40	.	.	PUNCT
bptjm-30	385	1	molecules	molecule	NOUN
bptjm-30	385	2	.	.	PUNCT
bptjm-30	386	1	2020;25(12):2950	2020;25(12):2950	X
bptjm-30	386	2	.	.	NUM
bptjm-30	386	3	published	publish	VERB
bptjm-30	386	4	2020	2020	NUM
bptjm-30	386	5	jun	jun	PROPN
bptjm-30	386	6	26	26	NUM
bptjm-30	386	7	.	.	PUNCT
bptjm-30	387	1	doi:10.3390	doi:10.3390	NOUN
bptjm-30	387	2	/	/	SYM
bptjm-30	387	3	molecules25122950	molecules25122950	PROPN
bptjm-30	387	4	30	30	NUM
bptjm-30	387	5	.	.	PUNCT
bptjm-30	388	1	harraz	harraz	PROPN
bptjm-30	388	2	mm	mm	PROPN
bptjm-30	388	3	,	,	PUNCT
bptjm-30	388	4	tyagi	tyagi	PROPN
bptjm-30	388	5	r	r	PROPN
bptjm-30	388	6	,	,	PUNCT
bptjm-30	388	7	cortés	cortés	NOUN
bptjm-30	388	8	p	p	NOUN
bptjm-30	388	9	,	,	PUNCT
bptjm-30	388	10	snyder	snyder	PROPN
bptjm-30	388	11	sh	sh	PROPN
bptjm-30	388	12	.	.	PROPN
bptjm-30	388	13	antidepressant	antidepressant	ADJ
bptjm-30	388	14	action	action	NOUN
bptjm-30	388	15	of	of	ADP
bptjm-30	388	16	ketamine	ketamine	PROPN
bptjm-30	388	17	via	via	ADP
bptjm-30	388	18	mtor	mtor	PROPN
bptjm-30	388	19	is	be	AUX
bptjm-30	388	20	mediated	mediate	VERB
bptjm-30	388	21	by	by	ADP
bptjm-30	388	22	inhibition	inhibition	NOUN
bptjm-30	388	23	of	of	ADP
bptjm-30	388	24	nitrergic	nitrergic	ADJ
bptjm-30	388	25	rheb	rheb	ADJ
bptjm-30	388	26	degradation	degradation	NOUN
bptjm-30	388	27	.	.	PUNCT
bptjm-30	389	1	mol	mol	ADP
bptjm-30	389	2	psychiatry	psychiatry	NOUN
bptjm-30	389	3	.	.	PUNCT
bptjm-30	390	1	2016;21(3):313	2016;21(3):313	NUM
bptjm-30	390	2	-	-	PUNCT
bptjm-30	390	3	319	319	PROPN
bptjm-30	390	4	.	.	PUNCT
bptjm-30	391	1	doi:10.1038	doi:10.1038	PROPN
bptjm-30	391	2	/	/	SYM
bptjm-30	391	3	mp.2015.211	mp.2015.211	PROPN
bptjm-30	392	1	31	31	NUM
bptjm-30	392	2	.	.	PUNCT
bptjm-30	393	1	mandal	mandal	PROPN
bptjm-30	393	2	s	s	PROPN
bptjm-30	393	3	,	,	PUNCT
bptjm-30	393	4	sinha	sinha	PROPN
bptjm-30	393	5	vk	vk	PROPN
bptjm-30	393	6	,	,	PUNCT
bptjm-30	393	7	goyal	goyal	PROPN
bptjm-30	393	8	n.	n.	PROPN
bptjm-30	393	9	efficacy	efficacy	PROPN
bptjm-30	393	10	of	of	ADP
bptjm-30	393	11	ketamine	ketamine	PROPN
bptjm-30	393	12	therapy	therapy	NOUN
bptjm-30	393	13	in	in	ADP
bptjm-30	393	14	the	the	DET
bptjm-30	393	15	treatment	treatment	NOUN
bptjm-30	393	16	of	of	ADP
bptjm-30	393	17	depression	depression	NOUN
bptjm-30	393	18	.	.	PUNCT
bptjm-30	394	1	indian	indian	PROPN
bptjm-30	394	2	j	j	PROPN
bptjm-30	394	3	psychiatry	psychiatry	PROPN
bptjm-30	394	4	.	.	PUNCT
bptjm-30	395	1	2019;61(5):480	2019;61(5):480	NUM
bptjm-30	395	2	-	-	PUNCT
bptjm-30	395	3	485	485	NUM
bptjm-30	395	4	.	.	PUNCT
bptjm-30	395	5	doi:10.4103	doi:10.4103	ADJ
bptjm-30	395	6	/	/	SYM
bptjm-30	395	7	psychiatry.indianjpsychiatry_484_1	psychiatry.indianjpsychiatry_484_1	NOUN
bptjm-30	395	8	8	8	NUM
bptjm-30	395	9	32	32	NUM
bptjm-30	395	10	.	.	PUNCT
bptjm-30	396	1	davis	davis	PROPN
bptjm-30	396	2	ak	ak	PROPN
bptjm-30	396	3	,	,	PUNCT
bptjm-30	396	4	so	so	PROPN
bptjm-30	396	5	s	s	PROPN
bptjm-30	396	6	,	,	PUNCT
bptjm-30	396	7	lancelotta	lancelotta	ADJ
bptjm-30	396	8	r	r	NOUN
bptjm-30	396	9	,	,	PUNCT
bptjm-30	396	10	barsuglia	barsuglia	PROPN
bptjm-30	396	11	jp	jp	PROPN
bptjm-30	396	12	,	,	PUNCT
bptjm-30	396	13	griffiths	griffiths	PROPN
bptjm-30	396	14	rr	rr	PROPN
bptjm-30	396	15	.	.	PROPN
bptjm-30	397	1	5	5	NUM
bptjm-30	397	2	-	-	PUNCT
bptjm-30	397	3	methoxy	methoxy	ADJ
bptjm-30	397	4	-	-	PUNCT
bptjm-30	397	5	n	n	CCONJ
bptjm-30	397	6	,	,	PUNCT
bptjm-30	397	7	n	n	CCONJ
bptjm-30	397	8	-	-	PUNCT
bptjm-30	397	9	dimethyltryptamine	dimethyltryptamine	ADJ
bptjm-30	397	10	(	(	PUNCT
bptjm-30	397	11	5	5	NUM
bptjm-30	397	12	-	-	PUNCT
bptjm-30	397	13	meodmt	meodmt	NOUN
bptjm-30	397	14	)	)	PUNCT
bptjm-30	397	15	used	use	VERB
bptjm-30	397	16	in	in	ADP
bptjm-30	397	17	a	a	DET
bptjm-30	397	18	naturalistic	naturalistic	ADJ
bptjm-30	397	19	group	group	NOUN
bptjm-30	397	20	setting	setting	NOUN
bptjm-30	397	21	is	be	AUX
bptjm-30	397	22	associated	associate	VERB
bptjm-30	397	23	with	with	ADP
bptjm-30	397	24	unintended	unintended	ADJ
bptjm-30	397	25	improvements	improvement	NOUN
bptjm-30	397	26	in	in	ADP
bptjm-30	397	27	depression	depression	NOUN
bptjm-30	397	28	and	and	CCONJ
bptjm-30	397	29	anxiety	anxiety	NOUN
bptjm-30	397	30	.	.	PUNCT
bptjm-30	398	1	the	the	DET
bptjm-30	398	2	american	american	PROPN
bptjm-30	398	3	journal	journal	PROPN
bptjm-30	398	4	of	of	ADP
bptjm-30	398	5	drug	drug	NOUN
bptjm-30	398	6	and	and	CCONJ
bptjm-30	398	7	alcohol	alcohol	NOUN
bptjm-30	398	8	abuse	abuse	NOUN
bptjm-30	398	9	.	.	PUNCT
bptjm-30	399	1	2019;45(2):161	2019;45(2):161	NUM
bptjm-30	399	2	-	-	SYM
bptjm-30	399	3	169	169	NUM
bptjm-30	399	4	.	.	PUNCT
bptjm-30	400	1	doi:10.1080/00952990.2018.1545024	doi:10.1080/00952990.2018.1545024	PROPN
bptjm-30	400	2	33	33	NUM
bptjm-30	400	3	.	.	PUNCT
bptjm-30	401	1	strumila	strumila	PROPN
bptjm-30	401	2	r	r	NOUN
bptjm-30	401	3	,	,	PUNCT
bptjm-30	401	4	nobile	nobile	PROPN
bptjm-30	401	5	b	b	PROPN
bptjm-30	401	6	,	,	PUNCT
bptjm-30	401	7	korsakova	korsakova	X
bptjm-30	401	8	l	l	NOUN
bptjm-30	401	9	,	,	PUNCT
bptjm-30	401	10	et	et	PROPN
bptjm-30	401	11	al	al	PROPN
bptjm-30	401	12	.	.	PROPN
bptjm-30	401	13	psilocybin	psilocybin	PROPN
bptjm-30	401	14	,	,	PUNCT
bptjm-30	401	15	a	a	DET
bptjm-30	401	16	naturally	naturally	ADV
bptjm-30	401	17	occurring	occur	VERB
bptjm-30	401	18	indoleamine	indoleamine	NOUN
bptjm-30	401	19	compound	compound	NOUN
bptjm-30	401	20	,	,	PUNCT
bptjm-30	401	21	could	could	AUX
bptjm-30	401	22	be	be	AUX
bptjm-30	401	23	useful	useful	ADJ
bptjm-30	401	24	to	to	PART
bptjm-30	401	25	prevent	prevent	VERB
bptjm-30	401	26	suicidal	suicidal	ADJ
bptjm-30	401	27	behaviors	behavior	NOUN
bptjm-30	401	28	.	.	PUNCT
bptjm-30	402	1	pharmaceuticals	pharmaceutical	NOUN
bptjm-30	402	2	.	.	PUNCT
bptjm-30	403	1	2021;14(12):1213	2021;14(12):1213	NUM
bptjm-30	403	2	.	.	PUNCT
bptjm-30	403	3	doi:10.3390	doi:10.3390	NOUN
bptjm-30	403	4	/	/	SYM
bptjm-30	403	5	ph14121213	ph14121213	PROPN
bptjm-30	403	6	34	34	NUM
bptjm-30	403	7	.	.	PUNCT
bptjm-30	404	1	griffiths	griffiths	PROPN
bptjm-30	404	2	rr	rr	PROPN
bptjm-30	404	3	,	,	PUNCT
bptjm-30	404	4	johnson	johnson	PROPN
bptjm-30	404	5	mw	mw	PROPN
bptjm-30	404	6	,	,	PUNCT
bptjm-30	404	7	carducci	carducci	PROPN
bptjm-30	404	8	ma	ma	PROPN
bptjm-30	404	9	,	,	PUNCT
bptjm-30	404	10	et	et	PROPN
bptjm-30	404	11	al	al	PROPN
bptjm-30	404	12	.	.	PUNCT
bptjm-30	404	13	psilocybin	psilocybin	NOUN
bptjm-30	404	14	produces	produce	VERB
bptjm-30	404	15	substantial	substantial	ADJ
bptjm-30	404	16	and	and	CCONJ
bptjm-30	404	17	sustained	sustained	ADJ
bptjm-30	404	18	decreases	decrease	NOUN
bptjm-30	404	19	in	in	ADP
bptjm-30	404	20	depression	depression	NOUN
bptjm-30	404	21	and	and	CCONJ
bptjm-30	404	22	anxiety	anxiety	NOUN
bptjm-30	404	23	in	in	ADP
bptjm-30	404	24	patients	patient	NOUN
bptjm-30	404	25	with	with	ADP
bptjm-30	404	26	life	life	NOUN
bptjm-30	404	27	-	-	PUNCT
bptjm-30	404	28	threatening	threaten	VERB
bptjm-30	404	29	cancer	cancer	NOUN
bptjm-30	404	30	:	:	PUNCT
bptjm-30	404	31	a	a	DET
bptjm-30	404	32	randomized	randomized	ADJ
bptjm-30	404	33	double	double	ADJ
bptjm-30	404	34	-	-	PUNCT
bptjm-30	404	35	blind	blind	ADJ
bptjm-30	404	36	trial	trial	NOUN
bptjm-30	404	37	.	.	PUNCT
bptjm-30	405	1	journal	journal	NOUN
bptjm-30	405	2	of	of	ADP
bptjm-30	405	3	psychopharmacology	psychopharmacology	NOUN
bptjm-30	405	4	.	.	PUNCT
bptjm-30	406	1	2016;30(12):1181	2016;30(12):1181	NUM
bptjm-30	406	2	-	-	SYM
bptjm-30	406	3	1197	1197	NUM
bptjm-30	406	4	.	.	PUNCT
bptjm-30	407	1	doi:10.1177/0269881116675513	doi:10.1177/0269881116675513	PROPN
bptjm-30	408	1	35	35	NUM
bptjm-30	408	2	.	.	PUNCT
bptjm-30	409	1	palhano	palhano	PROPN
bptjm-30	409	2	-	-	PUNCT
bptjm-30	409	3	fontes	fontes	PROPN
bptjm-30	409	4	f	f	PROPN
bptjm-30	409	5	,	,	PUNCT
bptjm-30	409	6	barreto	barreto	PROPN
bptjm-30	409	7	d	d	PROPN
bptjm-30	409	8	,	,	PUNCT
bptjm-30	409	9	onias	onia	NOUN
bptjm-30	409	10	h	h	NOUN
bptjm-30	409	11	,	,	PUNCT
bptjm-30	409	12	et	et	PROPN
bptjm-30	409	13	al	al	PROPN
bptjm-30	409	14	.	.	PROPN
bptjm-30	410	1	rapid	rapid	ADJ
bptjm-30	410	2	antidepressant	antidepressant	ADJ
bptjm-30	410	3	effects	effect	NOUN
bptjm-30	410	4	of	of	ADP
bptjm-30	410	5	the	the	DET
bptjm-30	410	6	psychedelic	psychedelic	ADJ
bptjm-30	410	7	ayahuasca	ayahuasca	NOUN
bptjm-30	410	8	in	in	ADP
bptjm-30	410	9	treatment	treatment	NOUN
bptjm-30	410	10	-	-	PUNCT
bptjm-30	410	11	resistant	resistant	ADJ
bptjm-30	410	12	depression	depression	NOUN
bptjm-30	410	13	:	:	PUNCT
bptjm-30	410	14	a	a	DET
bptjm-30	410	15	randomized	randomized	ADJ
bptjm-30	410	16	placebo	placebo	NOUN
bptjm-30	410	17	-	-	PUNCT
bptjm-30	410	18	controlled	control	VERB
bptjm-30	410	19	trial	trial	NOUN
bptjm-30	410	20	.	.	PUNCT
bptjm-30	411	1	psychological	psychological	ADJ
bptjm-30	411	2	medicine	medicine	NOUN
bptjm-30	411	3	.	.	PUNCT
bptjm-30	412	1	2018;49(4):655	2018;49(4):655	NUM
bptjm-30	412	2	-	-	PUNCT
bptjm-30	412	3	663	663	NUM
bptjm-30	412	4	.	.	PUNCT
bptjm-30	413	1	doi:10.1017	doi:10.1017	NOUN
bptjm-30	413	2	/	/	SYM
bptjm-30	413	3	s0033291718001356	s0033291718001356	PROPN
bptjm-30	413	4	36	36	NUM
bptjm-30	413	5	.	.	PUNCT
bptjm-30	414	1	hamilton	hamilton	PROPN
bptjm-30	414	2	jp	jp	PROPN
bptjm-30	414	3	,	,	PUNCT
bptjm-30	414	4	farmer	farmer	PROPN
bptjm-30	414	5	m	m	PROPN
bptjm-30	414	6	,	,	PUNCT
bptjm-30	414	7	fogelman	fogelman	ADJ
bptjm-30	414	8	p	p	NOUN
bptjm-30	414	9	,	,	PUNCT
bptjm-30	414	10	gotlib	gotlib	X
bptjm-30	414	11	ih	ih	X
bptjm-30	414	12	.	.	PUNCT
bptjm-30	414	13	depressive	depressive	ADJ
bptjm-30	414	14	rumination	rumination	NOUN
bptjm-30	414	15	,	,	PUNCT
bptjm-30	414	16	the	the	DET
bptjm-30	414	17	default	default	NOUN
bptjm-30	414	18	-	-	PUNCT
bptjm-30	414	19	mode	mode	NOUN
bptjm-30	414	20	network	network	NOUN
bptjm-30	414	21	,	,	PUNCT
bptjm-30	414	22	and	and	CCONJ
bptjm-30	414	23	the	the	DET
bptjm-30	414	24	dark	dark	ADJ
bptjm-30	414	25	matter	matter	NOUN
bptjm-30	414	26	of	of	ADP
bptjm-30	414	27	clinical	clinical	ADJ
bptjm-30	414	28	neuroscience	neuroscience	NOUN
bptjm-30	414	29	.	.	PUNCT
bptjm-30	415	1	biological	biological	ADJ
bptjm-30	415	2	psychiatry	psychiatry	NOUN
bptjm-30	415	3	.	.	PUNCT
bptjm-30	416	1	2015;78(4):224	2015;78(4):224	NUM
bptjm-30	416	2	-	-	SYM
bptjm-30	416	3	230	230	NUM
bptjm-30	416	4	.	.	PUNCT
bptjm-30	416	5	doi:10.1016	doi:10.1016	PROPN
bptjm-30	416	6	/	/	SYM
bptjm-30	416	7	j.biopsych.2015.02.020	j.biopsych.2015.02.020	PROPN
bptjm-30	416	8	37	37	NUM
bptjm-30	416	9	.	.	PUNCT
bptjm-30	417	1	jiménez	jiménez	PROPN
bptjm-30	417	2	-	-	PUNCT
bptjm-30	417	3	garrido	garrido	PROPN
bptjm-30	417	4	df	df	PROPN
bptjm-30	417	5	,	,	PUNCT
bptjm-30	417	6	gómez	gómez	NOUN
bptjm-30	417	7	-	-	PUNCT
bptjm-30	417	8	sousa	sousa	NOUN
bptjm-30	417	9	m	m	PROPN
bptjm-30	417	10	,	,	PUNCT
bptjm-30	417	11	ona	ona	PROPN
bptjm-30	417	12	g	g	PROPN
bptjm-30	417	13	,	,	PUNCT
bptjm-30	417	14	et	et	PROPN
bptjm-30	417	15	al	al	PROPN
bptjm-30	417	16	.	.	PUNCT
bptjm-30	417	17	effects	effect	NOUN
bptjm-30	417	18	of	of	ADP
bptjm-30	417	19	ayahuasca	ayahuasca	NOUN
bptjm-30	417	20	on	on	ADP
bptjm-30	417	21	mental	mental	ADJ
bptjm-30	417	22	health	health	NOUN
bptjm-30	417	23	and	and	CCONJ
bptjm-30	417	24	quality	quality	NOUN
bptjm-30	417	25	of	of	ADP
bptjm-30	417	26	life	life	NOUN
bptjm-30	417	27	in	in	ADP
bptjm-30	417	28	naïve	naïve	ADJ
bptjm-30	417	29	users	user	NOUN
bptjm-30	417	30	:	:	PUNCT
bptjm-30	417	31	a	a	DET
bptjm-30	417	32	longitudinal	longitudinal	ADJ
bptjm-30	417	33	and	and	CCONJ
bptjm-30	417	34	cross	cross	ADJ
bptjm-30	417	35	-	-	ADJ
bptjm-30	417	36	sectional	sectional	ADJ
bptjm-30	417	37	study	study	NOUN
bptjm-30	417	38	combination	combination	NOUN
bptjm-30	417	39	.	.	PUNCT
bptjm-30	418	1	scientific	scientific	ADJ
bptjm-30	418	2	reports	report	NOUN
bptjm-30	418	3	.	.	PUNCT
bptjm-30	419	1	2020;10(1	2020;10(1	NUM
bptjm-30	419	2	)	)	PUNCT
bptjm-30	419	3	.	.	PUNCT
bptjm-30	420	1	doi:10.1038	doi:10.1038	NOUN
bptjm-30	420	2	/	/	SYM
bptjm-30	420	3	s41598	s41598	NOUN
bptjm-30	420	4	-	-	PUNCT
bptjm-30	420	5	02061169	02061169	NUM
bptjm-30	420	6	-	-	PUNCT
bptjm-30	420	7	x	x	SYM
bptjm-30	420	8	38	38	NUM
bptjm-30	420	9	.	.	PUNCT
bptjm-30	421	1	szilágyi	szilágyi	PROPN
bptjm-30	421	2	a	a	DET
bptjm-30	421	3	,	,	PUNCT
bptjm-30	421	4	takács	takács	PROPN
bptjm-30	421	5	b	b	PROPN
bptjm-30	421	6	,	,	PUNCT
bptjm-30	421	7	szekeres	szekere	VERB
bptjm-30	421	8	r	r	NOUN
bptjm-30	421	9	,	,	PUNCT
bptjm-30	421	10	et	et	PROPN
bptjm-30	421	11	al	al	PROPN
bptjm-30	421	12	.	.	PUNCT
bptjm-30	422	1	therapeutic	therapeutic	ADJ
bptjm-30	422	2	properties	property	NOUN
bptjm-30	422	3	of	of	ADP
bptjm-30	422	4	ayahuasca	ayahuasca	PROPN
bptjm-30	422	5	components	component	NOUN
bptjm-30	422	6	in	in	ADP
bptjm-30	422	7	ischemia	ischemia	NOUN
bptjm-30	422	8	/	/	SYM
bptjm-30	422	9	reperfusion	reperfusion	NOUN
bptjm-30	422	10	injury	injury	NOUN
bptjm-30	422	11	of	of	ADP
bptjm-30	422	12	the	the	DET
bptjm-30	422	13	eye	eye	NOUN
bptjm-30	422	14	.	.	PUNCT
bptjm-30	423	1	biomedicines	biomedicine	NOUN
bptjm-30	423	2	.	.	PUNCT
bptjm-30	424	1	2022;10(5):997	2022;10(5):997	NUM
bptjm-30	424	2	.	.	PUNCT
bptjm-30	425	1	published	publish	VERB
bptjm-30	425	2	2022	2022	NUM
bptjm-30	425	3	apr	apr	NOUN
bptjm-30	425	4	26	26	NUM
bptjm-30	425	5	.	.	PUNCT
bptjm-30	426	1	doi:10.3390	doi:10.3390	NOUN
bptjm-30	426	2	/	/	SYM
bptjm-30	426	3	biomedicines10050997	biomedicines10050997	PROPN
bptjm-30	426	4	39	39	NUM
bptjm-30	426	5	.	.	PUNCT
bptjm-30	427	1	davis	davis	PROPN
bptjm-30	427	2	ak	ak	PROPN
bptjm-30	427	3	,	,	PUNCT
bptjm-30	427	4	averill	averill	PROPN
bptjm-30	427	5	la	la	PROPN
bptjm-30	427	6	,	,	PUNCT
bptjm-30	427	7	sepeda	sepeda	PROPN
bptjm-30	427	8	nd	nd	NUM
bptjm-30	427	9	,	,	PUNCT
bptjm-30	427	10	barsuglia	barsuglia	PROPN
bptjm-30	427	11	jp	jp	PROPN
bptjm-30	427	12	,	,	PUNCT
bptjm-30	427	13	amoroso	amoroso	PROPN
bptjm-30	427	14	t.	t.	ADJ
bptjm-30	427	15	psychedelic	psychedelic	ADJ
bptjm-30	427	16	treatment	treatment	NOUN
bptjm-30	427	17	for	for	ADP
bptjm-30	427	18	trauma	trauma	NOUN
bptjm-30	427	19	-	-	PUNCT
bptjm-30	427	20	related	relate	VERB
bptjm-30	427	21	psychological	psychological	ADJ
bptjm-30	427	22	and	and	CCONJ
bptjm-30	427	23	cognitive	cognitive	ADJ
bptjm-30	427	24	impairment	impairment	NOUN
bptjm-30	427	25	among	among	ADP
bptjm-30	427	26	us	we	PRON
bptjm-30	427	27	special	special	ADJ
bptjm-30	427	28	operations	operation	NOUN
bptjm-30	427	29	forces	force	VERB
bptjm-30	427	30	veterans	veteran	NOUN
bptjm-30	427	31	.	.	PUNCT
bptjm-30	428	1	chronic	chronic	ADJ
bptjm-30	428	2	stress	stress	NOUN
bptjm-30	428	3	.	.	PUNCT
bptjm-30	429	1	2020;4:247054702093956	2020;4:247054702093956	NUM
bptjm-30	429	2	.	.	PUNCT
bptjm-30	430	1	doi:10.1177/2470547020939564	doi:10.1177/2470547020939564	ADP
bptjm-30	430	2	40	40	NUM
bptjm-30	430	3	.	.	PUNCT
bptjm-30	431	1	loizaga	loizaga	NOUN
bptjm-30	431	2	-	-	PUNCT
bptjm-30	431	3	velder	velder	NOUN
bptjm-30	431	4	a	a	PRON
bptjm-30	431	5	,	,	PUNCT
bptjm-30	431	6	verres	verres	PROPN
bptjm-30	431	7	r.	r.	PROPN
bptjm-30	431	8	therapeutic	therapeutic	ADJ
bptjm-30	431	9	effects	effect	NOUN
bptjm-30	431	10	of	of	ADP
bptjm-30	431	11	ritual	ritual	ADJ
bptjm-30	431	12	ayahuasca	ayahuasca	PROPN
bptjm-30	431	13	use	use	NOUN
bptjm-30	431	14	in	in	ADP
bptjm-30	431	15	the	the	DET
bptjm-30	431	16	treatment	treatment	NOUN
bptjm-30	431	17	of	of	ADP
bptjm-30	431	18	substance	substance	NOUN
bptjm-30	431	19	dependence	dependence	NOUN
bptjm-30	431	20	—	—	PUNCT
bptjm-30	431	21	qualitative	qualitative	ADJ
bptjm-30	431	22	results	result	NOUN
bptjm-30	431	23	.	.	PUNCT
bptjm-30	432	1	journal	journal	NOUN
bptjm-30	432	2	of	of	ADP
bptjm-30	432	3	psychoactive	psychoactive	ADJ
bptjm-30	432	4	drugs	drug	NOUN
bptjm-30	432	5	.	.	PUNCT
bptjm-30	433	1	2014;46(1):63	2014;46(1):63	NUM
bptjm-30	433	2	-	-	SYM
bptjm-30	433	3	72	72	NUM
bptjm-30	433	4	.	.	PUNCT
bptjm-30	434	1	doi:10.1080/02791072.2013.873157	doi:10.1080/02791072.2013.873157	PROPN
bptjm-30	434	2	41	41	NUM
bptjm-30	434	3	.	.	PUNCT
bptjm-30	435	1	ly	ly	ADP
bptjm-30	436	1	c	c	X
bptjm-30	436	2	,	,	PUNCT
bptjm-30	436	3	greb	greb	PROPN
bptjm-30	436	4	ac	ac	PROPN
bptjm-30	436	5	,	,	PUNCT
bptjm-30	436	6	cameron	cameron	PROPN
bptjm-30	436	7	lp	lp	PROPN
bptjm-30	436	8	,	,	PUNCT
bptjm-30	436	9	et	et	PROPN
bptjm-30	436	10	al	al	PROPN
bptjm-30	436	11	.	.	PROPN
bptjm-30	437	1	berkeley	berkeley	PROPN
bptjm-30	437	2	pharma	pharma	PROPN
bptjm-30	437	3	tech	tech	PROPN
bptjm-30	437	4	journal	journal	NOUN
bptjm-30	437	5	of	of	ADP
bptjm-30	437	6	medicine	medicine	NOUN
bptjm-30	437	7	|	|	ADV
bptjm-30	437	8	46	46	NUM
bptjm-30	437	9	psychedelics	psychedelic	NOUN
bptjm-30	437	10	promote	promote	VERB
bptjm-30	437	11	structural	structural	ADJ
bptjm-30	437	12	and	and	CCONJ
bptjm-30	437	13	functional	functional	ADJ
bptjm-30	437	14	neural	neural	ADJ
bptjm-30	437	15	plasticity	plasticity	NOUN
bptjm-30	437	16	.	.	PUNCT
bptjm-30	438	1	cell	cell	NOUN
bptjm-30	438	2	reports	report	NOUN
bptjm-30	438	3	.	.	PUNCT
bptjm-30	439	1	2018;23(11):31703182	2018;23(11):31703182	X
bptjm-30	439	2	.	.	PUNCT
bptjm-30	439	3	doi:10.1016	doi:10.1016	PROPN
bptjm-30	439	4	/	/	SYM
bptjm-30	439	5	j.celrep.2018.05.022	j.celrep.2018.05.022	PROPN
bptjm-30	439	6	42	42	NUM
bptjm-30	439	7	.	.	PUNCT
bptjm-30	440	1	fuentes	fuentes	PROPN
bptjm-30	440	2	jj	jj	PROPN
bptjm-30	440	3	,	,	PUNCT
bptjm-30	440	4	fonseca	fonseca	PROPN
bptjm-30	440	5	f	f	PROPN
bptjm-30	440	6	,	,	PUNCT
bptjm-30	440	7	elices	elice	VERB
bptjm-30	440	8	m	m	PROPN
bptjm-30	440	9	,	,	PUNCT
bptjm-30	440	10	farré	farré	NOUN
bptjm-30	440	11	m	m	NOUN
bptjm-30	440	12	,	,	PUNCT
bptjm-30	440	13	torrens	torrens	PROPN
bptjm-30	440	14	m.	m.	NOUN
bptjm-30	440	15	therapeutic	therapeutic	ADJ
bptjm-30	440	16	use	use	NOUN
bptjm-30	440	17	of	of	ADP
bptjm-30	440	18	lsd	lsd	NOUN
bptjm-30	440	19	in	in	ADP
bptjm-30	440	20	psychiatry	psychiatry	NOUN
bptjm-30	440	21	:	:	PUNCT
bptjm-30	440	22	a	a	DET
bptjm-30	440	23	systematic	systematic	ADJ
bptjm-30	440	24	review	review	NOUN
bptjm-30	440	25	of	of	ADP
bptjm-30	440	26	randomizedcontrolled	randomizedcontrolle	VERB
bptjm-30	440	27	clinical	clinical	ADJ
bptjm-30	440	28	trials	trial	NOUN
bptjm-30	440	29	.	.	PUNCT
bptjm-30	441	1	frontiers	frontier	NOUN
bptjm-30	441	2	in	in	ADP
bptjm-30	441	3	psychiatry	psychiatry	NOUN
bptjm-30	441	4	.	.	PUNCT
bptjm-30	442	1	2020;10	2020;10	NUM
bptjm-30	442	2	.	.	PUNCT
bptjm-30	443	1	doi:10.3389	doi:10.3389	PROPN
bptjm-30	443	2	/	/	SYM
bptjm-30	443	3	fpsyt.2019.00943	fpsyt.2019.00943	PROPN
bptjm-30	443	4	43	43	NUM
bptjm-30	443	5	.	.	PUNCT
bptjm-30	444	1	mueller	mueller	PROPN
bptjm-30	444	2	f	f	PROPN
bptjm-30	444	3	,	,	PUNCT
bptjm-30	444	4	lenz	lenz	PROPN
bptjm-30	444	5	c	c	PROPN
bptjm-30	444	6	,	,	PUNCT
bptjm-30	444	7	dolder	dolder	NOUN
bptjm-30	444	8	pc	pc	NOUN
bptjm-30	444	9	,	,	PUNCT
bptjm-30	444	10	et	et	PROPN
bptjm-30	444	11	al	al	PROPN
bptjm-30	444	12	.	.	PUNCT
bptjm-30	444	13	acute	acute	PROPN
bptjm-30	444	14	effects	effect	NOUN
bptjm-30	444	15	of	of	ADP
bptjm-30	444	16	lsd	lsd	NOUN
bptjm-30	444	17	on	on	ADP
bptjm-30	444	18	amygdala	amygdala	NOUN
bptjm-30	444	19	activity	activity	NOUN
bptjm-30	444	20	during	during	ADP
bptjm-30	444	21	processing	processing	NOUN
bptjm-30	444	22	of	of	ADP
bptjm-30	444	23	fearful	fearful	ADJ
bptjm-30	444	24	stimuli	stimulus	NOUN
bptjm-30	444	25	in	in	ADP
bptjm-30	444	26	healthy	healthy	ADJ
bptjm-30	444	27	subjects	subject	NOUN
bptjm-30	444	28	.	.	PUNCT
bptjm-30	445	1	translational	translational	ADJ
bptjm-30	445	2	psychiatry	psychiatry	NOUN
bptjm-30	445	3	.	.	PUNCT
bptjm-30	446	1	2017;7(4):e1084	2017;7(4):e1084	NOUN
bptjm-30	446	2	-	-	PUNCT
bptjm-30	446	3	e1084	e1084	NOUN
bptjm-30	446	4	.	.	PUNCT
bptjm-30	446	5	doi:10.1038	doi:10.1038	PROPN
bptjm-30	446	6	/	/	SYM
bptjm-30	446	7	tp.2017.54	tp.2017.54	PROPN
bptjm-30	446	8	44	44	NUM
bptjm-30	446	9	.	.	PUNCT
bptjm-30	447	1	hendricks	hendricks	PROPN
bptjm-30	447	2	ps	ps	PROPN
bptjm-30	447	3	,	,	PUNCT
bptjm-30	447	4	thorne	thorne	PROPN
bptjm-30	447	5	cb	cb	PROPN
bptjm-30	447	6	,	,	PUNCT
bptjm-30	447	7	clark	clark	PROPN
bptjm-30	447	8	cb	cb	PROPN
bptjm-30	447	9	,	,	PUNCT
bptjm-30	447	10	coombs	coombs	PROPN
bptjm-30	447	11	dw	dw	PROPN
bptjm-30	447	12	,	,	PUNCT
bptjm-30	447	13	johnson	johnson	PROPN
bptjm-30	447	14	mw	mw	PROPN
bptjm-30	447	15	.	.	PROPN
bptjm-30	447	16	classic	classic	ADJ
bptjm-30	447	17	psychedelic	psychedelic	ADJ
bptjm-30	447	18	use	use	NOUN
bptjm-30	447	19	is	be	AUX
bptjm-30	447	20	associated	associate	VERB
bptjm-30	447	21	with	with	ADP
bptjm-30	447	22	reduced	reduced	ADJ
bptjm-30	447	23	psychological	psychological	ADJ
bptjm-30	447	24	distress	distress	NOUN
bptjm-30	447	25	and	and	CCONJ
bptjm-30	447	26	suicidality	suicidality	NOUN
bptjm-30	447	27	in	in	ADP
bptjm-30	447	28	the	the	DET
bptjm-30	447	29	united	united	PROPN
bptjm-30	447	30	states	states	PROPN
bptjm-30	447	31	adult	adult	PROPN
bptjm-30	447	32	population	population	NOUN
bptjm-30	447	33	.	.	PUNCT
bptjm-30	448	1	journal	journal	PROPN
bptjm-30	448	2	of	of	ADP
bptjm-30	448	3	psychopharmacology	psychopharmacology	NOUN
bptjm-30	448	4	.	.	PUNCT
bptjm-30	449	1	2015;29(3):280	2015;29(3):280	NUM
bptjm-30	449	2	-	-	SYM
bptjm-30	449	3	288	288	NUM
bptjm-30	449	4	.	.	PUNCT
bptjm-30	450	1	doi:10.1177/0269881114565653	doi:10.1177/0269881114565653	ADJ
bptjm-30	450	2	45	45	NUM
bptjm-30	450	3	.	.	PUNCT
bptjm-30	450	4	gregorio	gregorio	PROPN
bptjm-30	450	5	dd	dd	PROPN
bptjm-30	450	6	,	,	PUNCT
bptjm-30	450	7	popic	popic	PROPN
bptjm-30	450	8	j	j	PROPN
bptjm-30	450	9	,	,	PUNCT
bptjm-30	450	10	enns	enns	PROPN
bptjm-30	450	11	jp	jp	PROPN
bptjm-30	450	12	,	,	PUNCT
bptjm-30	450	13	et	et	PROPN
bptjm-30	450	14	al	al	PROPN
bptjm-30	450	15	.	.	PROPN
bptjm-30	450	16	lysergic	lysergic	PROPN
bptjm-30	450	17	acid	acid	PROPN
bptjm-30	450	18	diethylamide	diethylamide	NOUN
bptjm-30	450	19	(	(	PUNCT
bptjm-30	450	20	lsd	lsd	NOUN
bptjm-30	450	21	)	)	PUNCT
bptjm-30	450	22	promotes	promote	VERB
bptjm-30	450	23	social	social	ADJ
bptjm-30	450	24	behavior	behavior	NOUN
bptjm-30	450	25	through	through	ADP
bptjm-30	450	26	mtorc1	mtorc1	NOUN
bptjm-30	450	27	in	in	ADP
bptjm-30	450	28	the	the	DET
bptjm-30	450	29	excitatory	excitatory	ADJ
bptjm-30	450	30	neurotransmission	neurotransmission	NOUN
bptjm-30	450	31	.	.	PUNCT
bptjm-30	451	1	proceedings	proceeding	NOUN
bptjm-30	451	2	of	of	ADP
bptjm-30	451	3	the	the	DET
bptjm-30	451	4	national	national	PROPN
bptjm-30	451	5	academy	academy	PROPN
bptjm-30	451	6	of	of	ADP
bptjm-30	451	7	sciences	sciences	PROPN
bptjm-30	451	8	.	.	PUNCT
bptjm-30	452	1	2021;118(5	2021;118(5	NUM
bptjm-30	452	2	)	)	PUNCT
bptjm-30	452	3	.	.	PUNCT
bptjm-30	453	1	doi:10.1073	doi:10.1073	NOUN
bptjm-30	453	2	/	/	SYM
bptjm-30	453	3	pnas.2020705118	pnas.2020705118	PROPN
bptjm-30	453	4	46	46	NUM
bptjm-30	453	5	.	.	PUNCT
bptjm-30	454	1	carhart	carhart	NOUN
bptjm-30	454	2	-	-	PUNCT
bptjm-30	454	3	harris	harris	PROPN
bptjm-30	454	4	rl	rl	PROPN
bptjm-30	454	5	,	,	PUNCT
bptjm-30	454	6	kaelen	kaelen	PROPN
bptjm-30	454	7	m	m	PROPN
bptjm-30	454	8	,	,	PUNCT
bptjm-30	454	9	bolstridge	bolstridge	PROPN
bptjm-30	454	10	m	m	PROPN
bptjm-30	454	11	,	,	PUNCT
bptjm-30	454	12	et	et	PROPN
bptjm-30	454	13	al	al	PROPN
bptjm-30	454	14	.	.	PUNCT
bptjm-30	455	1	the	the	DET
bptjm-30	455	2	paradoxical	paradoxical	ADJ
bptjm-30	455	3	psychological	psychological	ADJ
bptjm-30	455	4	effects	effect	NOUN
bptjm-30	455	5	of	of	ADP
bptjm-30	455	6	lysergic	lysergic	NOUN
bptjm-30	455	7	acid	acid	NOUN
bptjm-30	455	8	diethylamide	diethylamide	NOUN
bptjm-30	455	9	(	(	PUNCT
bptjm-30	455	10	lsd	lsd	NOUN
bptjm-30	455	11	)	)	PUNCT
bptjm-30	455	12	.	.	PUNCT
bptjm-30	456	1	psychological	psychological	ADJ
bptjm-30	456	2	medicine	medicine	NOUN
bptjm-30	456	3	.	.	PUNCT
bptjm-30	457	1	2016;46(7):1379	2016;46(7):1379	NUM
bptjm-30	457	2	-	-	SYM
bptjm-30	457	3	1390	1390	NUM
bptjm-30	457	4	.	.	PUNCT
bptjm-30	458	1	doi:10.1017	doi:10.1017	NOUN
bptjm-30	458	2	/	/	SYM
bptjm-30	458	3	s0033291715002901	s0033291715002901	PROPN
bptjm-30	458	4	47	47	NUM
bptjm-30	458	5	.	.	PUNCT
bptjm-30	459	1	liechti	liechti	VERB
bptjm-30	459	2	me	i	PRON
bptjm-30	459	3	.	.	PUNCT
bptjm-30	460	1	modern	modern	ADJ
bptjm-30	460	2	clinical	clinical	ADJ
bptjm-30	460	3	research	research	NOUN
bptjm-30	460	4	on	on	ADP
bptjm-30	460	5	lsd	lsd	NOUN
bptjm-30	460	6	.	.	PUNCT
bptjm-30	461	1	neuropsychopharmacology	neuropsychopharmacology	PROPN
bptjm-30	461	2	.	.	PUNCT
bptjm-30	462	1	2017;42(11):2114	2017;42(11):2114	NUM
bptjm-30	462	2	-	-	SYM
bptjm-30	462	3	2127	2127	NUM
bptjm-30	462	4	.	.	PUNCT
bptjm-30	463	1	doi:10.1038	doi:10.1038	NOUN
bptjm-30	463	2	/	/	SYM
bptjm-30	463	3	npp.2017.86	npp.2017.86	NUM
bptjm-30	463	4	48	48	NUM
bptjm-30	463	5	.	.	PUNCT
bptjm-30	464	1	dai	dai	PROPN
bptjm-30	464	2	w	w	PROPN
bptjm-30	464	3	,	,	PUNCT
bptjm-30	464	4	feng	feng	PROPN
bptjm-30	464	5	k	k	PROPN
bptjm-30	464	6	,	,	PUNCT
bptjm-30	464	7	sun	sun	PROPN
bptjm-30	464	8	x	x	AUX
bptjm-30	464	9	,	,	PUNCT
bptjm-30	464	10	et	et	PROPN
bptjm-30	464	11	al	al	PROPN
bptjm-30	464	12	.	.	PROPN
bptjm-30	464	13	natural	natural	ADJ
bptjm-30	464	14	products	product	NOUN
bptjm-30	464	15	for	for	ADP
bptjm-30	464	16	the	the	DET
bptjm-30	464	17	treatment	treatment	NOUN
bptjm-30	464	18	of	of	ADP
bptjm-30	464	19	stress	stress	NOUN
bptjm-30	464	20	-	-	PUNCT
bptjm-30	464	21	induced	induce	VERB
bptjm-30	464	22	depression	depression	NOUN
bptjm-30	464	23	:	:	PUNCT
bptjm-30	464	24	pharmacology	pharmacology	NOUN
bptjm-30	464	25	,	,	PUNCT
bptjm-30	464	26	mechanism	mechanism	NOUN
bptjm-30	464	27	and	and	CCONJ
bptjm-30	464	28	traditional	traditional	ADJ
bptjm-30	464	29	use	use	NOUN
bptjm-30	464	30	.	.	PUNCT
bptjm-30	465	1	journal	journal	NOUN
bptjm-30	465	2	of	of	ADP
bptjm-30	465	3	ethnopharmacology	ethnopharmacology	NOUN
bptjm-30	465	4	.	.	PUNCT
bptjm-30	466	1	2022;285:114692	2022;285:114692	X
bptjm-30	466	2	.	.	PUNCT
bptjm-30	466	3	doi:10.1016	doi:10.1016	PROPN
bptjm-30	466	4	/	/	SYM
bptjm-30	466	5	j.jep.2021.114692	j.jep.2021.114692	PROPN
bptjm-30	466	6	49	49	NUM
bptjm-30	466	7	.	.	PUNCT
bptjm-30	467	1	noori	noori	PROPN
bptjm-30	467	2	t	t	PROPN
bptjm-30	467	3	,	,	PUNCT
bptjm-30	467	4	sureda	sureda	VERB
bptjm-30	467	5	a	a	DET
bptjm-30	467	6	,	,	PUNCT
bptjm-30	467	7	sobarzo	sobarzo	PROPN
bptjm-30	467	8	-	-	PUNCT
bptjm-30	467	9	sánchez	sánchez	NOUN
bptjm-30	467	10	e	e	NOUN
bptjm-30	467	11	,	,	PUNCT
bptjm-30	467	12	shirooie	shirooie	PROPN
bptjm-30	467	13	s.	s.	PROPN
bptjm-30	468	1	the	the	DET
bptjm-30	468	2	role	role	NOUN
bptjm-30	468	3	of	of	ADP
bptjm-30	468	4	natural	natural	ADJ
bptjm-30	468	5	products	product	NOUN
bptjm-30	468	6	in	in	ADP
bptjm-30	468	7	treatment	treatment	NOUN
bptjm-30	468	8	of	of	ADP
bptjm-30	468	9	depressive	depressive	ADJ
bptjm-30	468	10	disorder	disorder	NOUN
bptjm-30	468	11	.	.	PUNCT
bptjm-30	469	1	curr	curr	PROPN
bptjm-30	469	2	neuropharmacol	neuropharmacol	PROPN
bptjm-30	469	3	.	.	PUNCT
bptjm-30	470	1	2022;20(5):929	2022;20(5):929	NOUN
bptjm-30	470	2	-	-	SYM
bptjm-30	470	3	949	949	NUM
bptjm-30	470	4	.	.	PUNCT
bptjm-30	471	1	doi:10.2174/1570159x20666220103140834	doi:10.2174/1570159x20666220103140834	NOUN
bptjm-30	471	2	50	50	NUM
bptjm-30	471	3	.	.	PUNCT
bptjm-30	472	1	rajkowska	rajkowska	PROPN
bptjm-30	472	2	g	g	PROPN
bptjm-30	472	3	,	,	PUNCT
bptjm-30	472	4	miguel	miguel	PROPN
bptjm-30	472	5	-	-	PUNCT
bptjm-30	472	6	hidalgo	hidalgo	PROPN
bptjm-30	472	7	j.	j.	PROPN
bptjm-30	472	8	gliogenesis	gliogenesis	PROPN
bptjm-30	472	9	and	and	CCONJ
bptjm-30	472	10	glial	glial	ADJ
bptjm-30	472	11	pathology	pathology	NOUN
bptjm-30	472	12	in	in	ADP
bptjm-30	472	13	depression	depression	NOUN
bptjm-30	472	14	.	.	PUNCT
bptjm-30	473	1	cns	cns	PROPN
bptjm-30	473	2	&	&	CCONJ
bptjm-30	473	3	neurological	neurological	ADJ
bptjm-30	473	4	disorders	disorder	NOUN
bptjm-30	473	5	drug	drug	NOUN
bptjm-30	473	6	targets	target	NOUN
bptjm-30	473	7	.	.	PUNCT
bptjm-30	474	1	2007;6(3):219	2007;6(3):219	NUM
bptjm-30	474	2	-	-	SYM
bptjm-30	474	3	233	233	NUM
bptjm-30	474	4	.	.	PUNCT
bptjm-30	475	1	doi:10.2174/187152707780619326	doi:10.2174/187152707780619326	PROPN
bptjm-30	476	1	51	51	NUM
bptjm-30	476	2	.	.	PUNCT
bptjm-30	477	1	tetragonia	tetragonia	NOUN
bptjm-30	477	2	tetragonioides	tetragonioide	NOUN
bptjm-30	477	3	(	(	PUNCT
bptjm-30	477	4	new	new	PROPN
bptjm-30	477	5	zealand	zealand	PROPN
bptjm-30	477	6	spinach	spinach	NOUN
bptjm-30	477	7	)	)	PUNCT
bptjm-30	477	8	.	.	PUNCT
bptjm-30	478	1	www.cabi.org	www.cabi.org	PROPN
bptjm-30	478	2	.	.	PROPN
bptjm-30	478	3	https://www.cabi.org/isc/datasheet/52942	https://www.cabi.org/isc/datasheet/52942	VERB
bptjm-30	478	4	52	52	NUM
bptjm-30	478	5	.	.	PUNCT
bptjm-30	479	1	ma	ma	PROPN
bptjm-30	479	2	k	k	PROPN
bptjm-30	479	3	,	,	PUNCT
bptjm-30	479	4	baloch	baloch	PROPN
bptjm-30	479	5	z	z	PROPN
bptjm-30	479	6	,	,	PUNCT
bptjm-30	479	7	mao	mao	PROPN
bptjm-30	479	8	f.	f.	PROPN
bptjm-30	479	9	natural	natural	ADJ
bptjm-30	479	10	products	product	NOUN
bptjm-30	479	11	as	as	ADP
bptjm-30	479	12	a	a	DET
bptjm-30	479	13	source	source	NOUN
bptjm-30	479	14	for	for	ADP
bptjm-30	479	15	new	new	ADJ
bptjm-30	479	16	leads	lead	NOUN
bptjm-30	479	17	in	in	ADP
bptjm-30	479	18	depression	depression	NOUN
bptjm-30	479	19	treatment	treatment	NOUN
bptjm-30	479	20	.	.	PUNCT
bptjm-30	480	1	evidence	evidence	NOUN
bptjm-30	480	2	-	-	PUNCT
bptjm-30	480	3	based	base	VERB
bptjm-30	480	4	complementary	complementary	ADJ
bptjm-30	480	5	and	and	CCONJ
bptjm-30	480	6	alternative	alternative	ADJ
bptjm-30	480	7	medicine	medicine	NOUN
bptjm-30	480	8	.	.	PUNCT
bptjm-30	481	1	2022;2022	2022;2022	NUM
bptjm-30	481	2	:	:	PUNCT
bptjm-30	482	1	e9791434	e9791434	VERB
bptjm-30	482	2	.	.	PUNCT
bptjm-30	483	1	doi:10.1155/2022/9791434	doi:10.1155/2022/9791434	PROPN
bptjm-30	483	2	53	53	NUM
bptjm-30	483	3	.	.	PUNCT
bptjm-30	484	1	felger	felger	PROPN
bptjm-30	484	2	jc	jc	PROPN
bptjm-30	484	3	,	,	PUNCT
bptjm-30	484	4	lotrich	lotrich	ADV
bptjm-30	484	5	fe	fe	X
bptjm-30	484	6	.	.	PUNCT
bptjm-30	484	7	inflammatory	inflammatory	ADJ
bptjm-30	484	8	cytokines	cytokine	NOUN
bptjm-30	484	9	in	in	ADP
bptjm-30	484	10	depression	depression	NOUN
bptjm-30	484	11	:	:	PUNCT
bptjm-30	484	12	neurobiological	neurobiological	ADJ
bptjm-30	484	13	mechanisms	mechanism	NOUN
bptjm-30	484	14	and	and	CCONJ
bptjm-30	484	15	therapeutic	therapeutic	ADJ
bptjm-30	484	16	implications	implication	NOUN
bptjm-30	484	17	.	.	PUNCT
bptjm-30	485	1	neuroscience	neuroscience	NOUN
bptjm-30	485	2	.	.	PUNCT
bptjm-30	486	1	2013;246:199	2013;246:199	NUM
bptjm-30	486	2	-	-	SYM
bptjm-30	486	3	229	229	NUM
bptjm-30	486	4	.	.	PUNCT
bptjm-30	487	1	doi:10.1016	doi:10.1016	PROPN
bptjm-30	487	2	/	/	SYM
bptjm-30	487	3	j.neuroscience.2013.04.060	j.neuroscience.2013.04.060	PROPN
bptjm-30	487	4	54	54	NUM
bptjm-30	487	5	.	.	PUNCT
bptjm-30	488	1	cleveland	cleveland	PROPN
bptjm-30	488	2	clinic	clinic	PROPN
bptjm-30	488	3	.	.	PUNCT
bptjm-30	489	1	alternative	alternative	ADJ
bptjm-30	489	2	therapies	therapy	NOUN
bptjm-30	489	3	for	for	ADP
bptjm-30	489	4	depression	depression	NOUN
bptjm-30	489	5	|	|	PROPN
bptjm-30	489	6	cleveland	cleveland	PROPN
bptjm-30	489	7	clinic	clinic	PROPN
bptjm-30	489	8	.	.	PUNCT
bptjm-30	490	1	cleveland	cleveland	PROPN
bptjm-30	490	2	clinic	clinic	PROPN
bptjm-30	490	3	.	.	PUNCT
bptjm-30	491	1	published	publish	VERB
bptjm-30	491	2	2013	2013	NUM
bptjm-30	491	3	.	.	PUNCT
bptjm-30	492	1	https://my.clevelandclinic.org/health/treatments	https://my.clevelandclinic.org/health/treatment	NOUN
bptjm-30	492	2	/9303	/9303	NOUN
bptjm-30	492	3	-	-	PUNCT
bptjm-30	492	4	depression	depression	NOUN
bptjm-30	492	5	-	-	PUNCT
bptjm-30	492	6	alternative	alternative	NOUN
bptjm-30	492	7	-	-	PUNCT
bptjm-30	492	8	therapies	therapy	NOUN
bptjm-30	492	9	http://www.cabi.org/	http://www.cabi.org/	VERB
bptjm-30	492	10	https://www.cabi.org/isc/datasheet/52942	https://www.cabi.org/isc/datasheet/52942	VERB
bptjm-30	492	11	https://my.clevelandclinic.org/health/treatments/9303-depression-alternative-therapies	https://my.clevelandclinic.org/health/treatments/9303-depression-alternative-therapie	NOUN
bptjm-30	492	12	https://my.clevelandclinic.org/health/treatments/9303-depression-alternative-therapies	https://my.clevelandclinic.org/health/treatments/9303-depression-alternative-therapie	NOUN
bptjm-30	492	13	https://my.clevelandclinic.org/health/treatments/9303-depression-alternative-therapies	https://my.clevelandclinic.org/health/treatments/9303-depression-alternative-therapie	NOUN
bptjm-30	492	14	berkeley	berkeley	PROPN
bptjm-30	492	15	pharma	pharma	PROPN
bptjm-30	492	16	tech	tech	NOUN
bptjm-30	492	17	journal	journal	NOUN
bptjm-30	492	18	of	of	ADP
bptjm-30	492	19	medicine	medicine	NOUN
bptjm-30	492	20	|	|	ADV
bptjm-30	492	21	47	47	NUM
bptjm-30	492	22	55	55	NUM
bptjm-30	492	23	.	.	PUNCT
bptjm-30	493	1	hara	hara	PROPN
bptjm-30	493	2	j	j	PROPN
bptjm-30	493	3	,	,	PUNCT
bptjm-30	493	4	gerashchenko	gerashchenko	PROPN
bptjm-30	493	5	d	d	PROPN
bptjm-30	493	6	,	,	PUNCT
bptjm-30	493	7	wisor	wisor	NOUN
bptjm-30	493	8	jp	jp	PROPN
bptjm-30	493	9	,	,	PUNCT
bptjm-30	493	10	sakurai	sakurai	PROPN
bptjm-30	493	11	t	t	PROPN
bptjm-30	493	12	,	,	PUNCT
bptjm-30	493	13	xie	xie	PROPN
bptjm-30	493	14	x	x	PROPN
bptjm-30	493	15	,	,	PUNCT
bptjm-30	493	16	kilduff	kilduff	PROPN
bptjm-30	493	17	ts	ts	PROPN
bptjm-30	493	18	.	.	PUNCT
bptjm-30	494	1	thyrotropin	thyrotropin	NOUN
bptjm-30	494	2	-	-	PUNCT
bptjm-30	494	3	releasing	release	VERB
bptjm-30	494	4	hormone	hormone	NOUN
bptjm-30	494	5	increases	increase	VERB
bptjm-30	494	6	behavioral	behavioral	ADJ
bptjm-30	494	7	arousal	arousal	NOUN
bptjm-30	494	8	through	through	ADP
bptjm-30	494	9	modulation	modulation	NOUN
bptjm-30	494	10	of	of	ADP
bptjm-30	494	11	hypocretin	hypocretin	NOUN
bptjm-30	494	12	/	/	SYM
bptjm-30	494	13	orexin	orexin	NOUN
bptjm-30	494	14	neurons	neuron	NOUN
bptjm-30	494	15	.	.	PUNCT
bptjm-30	495	1	journal	journal	NOUN
bptjm-30	495	2	of	of	ADP
bptjm-30	495	3	neuroscience	neuroscience	NOUN
bptjm-30	495	4	.	.	PUNCT
bptjm-30	496	1	2009;29(12):3705	2009;29(12):3705	NUM
bptjm-30	496	2	-	-	SYM
bptjm-30	496	3	3714	3714	NUM
bptjm-30	496	4	.	.	PUNCT
bptjm-30	497	1	doi:10.1523	doi:10.1523	NOUN
bptjm-30	497	2	/	/	SYM
bptjm-30	498	1	jneurosci.0431	jneurosci.0431	PROPN
bptjm-30	498	2	-	-	PUNCT
bptjm-30	498	3	09.2009	09.2009	NUM
bptjm-30	498	4	56	56	NUM
bptjm-30	498	5	.	.	PUNCT
bptjm-30	499	1	shahid	shahid	PROPN
bptjm-30	499	2	ma	ma	PROPN
bptjm-30	499	3	,	,	PUNCT
bptjm-30	499	4	sandeep	sandeep	PROPN
bptjm-30	499	5	sharma	sharma	PROPN
bptjm-30	499	6	.	.	PUNCT
bptjm-30	500	1	physiology	physiology	NOUN
bptjm-30	500	2	,	,	PUNCT
bptjm-30	500	3	thyroid	thyroid	NOUN
bptjm-30	500	4	hormone	hormone	NOUN
bptjm-30	500	5	.	.	PUNCT
bptjm-30	501	1	nih.gov	nih.gov	NOUN
bptjm-30	501	2	.	.	PUNCT
bptjm-30	502	1	published	publish	VERB
bptjm-30	502	2	march	march	PROPN
bptjm-30	502	3	23	23	NUM
bptjm-30	502	4	,	,	PUNCT
bptjm-30	502	5	2019	2019	NUM
bptjm-30	502	6	.	.	PUNCT
bptjm-30	503	1	https://www.ncbi.nlm.nih.gov/books/nbk500	https://www.ncbi.nlm.nih.gov/books/nbk500	NOUN
bptjm-30	503	2	006/	006/	NOUN
bptjm-30	503	3	57	57	NUM
bptjm-30	503	4	.	.	PUNCT
bptjm-30	504	1	mcewen	mcewen	PROPN
bptjm-30	504	2	bs	bs	PROPN
bptjm-30	504	3	,	,	PUNCT
bptjm-30	504	4	akama	akama	PROPN
bptjm-30	504	5	kt	kt	PROPN
bptjm-30	504	6	,	,	PUNCT
bptjm-30	504	7	spencer	spencer	PROPN
bptjm-30	504	8	-	-	PUNCT
bptjm-30	504	9	segal	segal	PROPN
bptjm-30	504	10	jl	jl	PROPN
bptjm-30	504	11	,	,	PUNCT
bptjm-30	504	12	milner	milner	PROPN
bptjm-30	504	13	ta	ta	PROPN
bptjm-30	504	14	,	,	PUNCT
bptjm-30	504	15	waters	water	VERB
bptjm-30	504	16	em	em	PRON
bptjm-30	504	17	.	.	PUNCT
bptjm-30	505	1	estrogen	estrogen	NOUN
bptjm-30	505	2	effects	effect	NOUN
bptjm-30	505	3	on	on	ADP
bptjm-30	505	4	the	the	DET
bptjm-30	505	5	brain	brain	NOUN
bptjm-30	505	6	:	:	PUNCT
bptjm-30	505	7	actions	action	NOUN
bptjm-30	505	8	beyond	beyond	ADP
bptjm-30	505	9	the	the	DET
bptjm-30	505	10	hypothalamus	hypothalamus	NOUN
bptjm-30	505	11	via	via	ADP
bptjm-30	505	12	novel	novel	ADJ
bptjm-30	505	13	mechanisms	mechanism	NOUN
bptjm-30	505	14	.	.	PUNCT
bptjm-30	506	1	behavioral	behavioral	ADJ
bptjm-30	506	2	neuroscience	neuroscience	NOUN
bptjm-30	506	3	.	.	PUNCT
bptjm-30	507	1	2012;126(1):4	2012;126(1):4	NUM
bptjm-30	507	2	-	-	SYM
bptjm-30	507	3	16	16	NUM
bptjm-30	507	4	.	.	PUNCT
bptjm-30	508	1	doi:10.1037	doi:10.1037	NOUN
bptjm-30	508	2	/	/	SYM
bptjm-30	508	3	a0026708	a0026708	PROPN
bptjm-30	508	4	58	58	PROPN
bptjm-30	508	5	.	.	PUNCT
bptjm-30	509	1	tonon	tonon	PROPN
bptjm-30	509	2	ac	ac	PROPN
bptjm-30	509	3	,	,	PUNCT
bptjm-30	509	4	pilz	pilz	PROPN
bptjm-30	509	5	lk	lk	PROPN
bptjm-30	509	6	,	,	PUNCT
bptjm-30	509	7	markus	markus	NOUN
bptjm-30	509	8	rp	rp	NOUN
bptjm-30	509	9	,	,	PUNCT
bptjm-30	509	10	hidalgo	hidalgo	PROPN
bptjm-30	509	11	mp	mp	PROPN
bptjm-30	509	12	,	,	PUNCT
bptjm-30	509	13	elisabetsky	elisabetsky	PROPN
bptjm-30	509	14	e.	e.	PROPN
bptjm-30	509	15	melatonin	melatonin	PROPN
bptjm-30	509	16	and	and	CCONJ
bptjm-30	509	17	depression	depression	NOUN
bptjm-30	509	18	:	:	PUNCT
bptjm-30	509	19	a	a	DET
bptjm-30	509	20	translational	translational	ADJ
bptjm-30	509	21	perspective	perspective	NOUN
bptjm-30	509	22	from	from	ADP
bptjm-30	509	23	animal	animal	NOUN
bptjm-30	509	24	models	model	NOUN
bptjm-30	509	25	to	to	ADP
bptjm-30	509	26	clinical	clinical	ADJ
bptjm-30	509	27	studies	study	NOUN
bptjm-30	509	28	.	.	PUNCT
bptjm-30	510	1	frontiers	frontier	NOUN
bptjm-30	510	2	in	in	ADP
bptjm-30	510	3	psychiatry	psychiatry	NOUN
bptjm-30	510	4	.	.	PUNCT
bptjm-30	511	1	2021;12	2021;12	X
bptjm-30	511	2	.	.	PUNCT
bptjm-30	511	3	doi:10.3389	doi:10.3389	PROPN
bptjm-30	511	4	/	/	SYM
bptjm-30	511	5	fpsyt.2021.638981	fpsyt.2021.638981	PROPN
bptjm-30	511	6	29	29	NUM
bptjm-30	511	7	.	.	PUNCT
bptjm-30	511	8	doi:10.1177/1179573520907397	doi:10.1177/1179573520907397	NOUN
bptjm-30	512	1	https://www.ncbi.nlm.nih.gov/books/nbk500006/	https://www.ncbi.nlm.nih.gov/books/nbk500006/	PROPN
bptjm-30	512	2	https://www.ncbi.nlm.nih.gov/books/nbk500006/	https://www.ncbi.nlm.nih.gov/books/nbk500006/	PROPN
bptjm-30	512	3	https://www.ncbi.nlm.nih.gov/books/nbk500006/	https://www.ncbi.nlm.nih.gov/books/nbk500006/	ADJ
bptjm-30	512	4	front	front	ADJ
bptjm-30	512	5	page	page	NOUN
bptjm-30	512	6	sharma	sharma	PROPN
bptjm-30	512	7	et	et	PROPN
bptjm-30	512	8	al	al	PROPN
bptjm-30	512	9	.	.	PROPN
bptjm-30	512	10	body	body	PROPN
bptjm-30	512	11	template_sharma	template_sharma	PROPN
bptjm-30	512	12	et	et	NOUN
bptjm-30	512	13	al	al	PROPN
bptjm-30	512	14	.	.	PROPN
bptjm-30	513	1	2	2	NUM
bptjm-30	513	2	.	.	X
bptjm-30	513	3	pathophysiology	pathophysiology	NOUN
bptjm-30	513	4	of	of	ADP
bptjm-30	513	5	depression	depression	NOUN
bptjm-30	513	6	4	4	NUM
bptjm-30	513	7	.	.	PUNCT
bptjm-30	513	8	molecular	molecular	ADJ
bptjm-30	513	9	mechanisms	mechanism	NOUN
bptjm-30	513	10	of	of	ADP
bptjm-30	513	11	antidepressants	antidepressant	NOUN
bptjm-30	513	12	5.1	5.1	NUM
bptjm-30	513	13	.	.	PUNCT
bptjm-30	514	1	ketamine	ketamine	PROPN
bptjm-30	514	2	as	as	ADP
bptjm-30	514	3	a	a	DET
bptjm-30	514	4	short	short	ADJ
bptjm-30	514	5	-	-	PUNCT
bptjm-30	514	6	term	term	NOUN
bptjm-30	514	7	therapeutic	therapeutic	ADJ
bptjm-30	514	8	option	option	NOUN
bptjm-30	514	9	5.2	5.2	NUM
bptjm-30	514	10	.	.	PUNCT
bptjm-30	515	1	psilocybin	psilocybin	NOUN
bptjm-30	515	2	as	as	ADP
bptjm-30	515	3	a	a	DET
bptjm-30	515	4	long	long	ADJ
bptjm-30	515	5	-	-	PUNCT
bptjm-30	515	6	term	term	NOUN
bptjm-30	515	7	treatment	treatment	NOUN
bptjm-30	515	8	option	option	NOUN
bptjm-30	515	9	5.3	5.3	NUM
bptjm-30	515	10	.	.	PUNCT
bptjm-30	516	1	psychedelic	psychedelic	ADJ
bptjm-30	516	2	-	-	PUNCT
bptjm-30	516	3	related	relate	VERB
bptjm-30	516	4	drugs	drug	NOUN
bptjm-30	516	5	we	we	PRON
bptjm-30	516	6	have	have	AUX
bptjm-30	516	7	already	already	ADV
bptjm-30	516	8	seen	see	VERB
bptjm-30	516	9	an	an	DET
bptjm-30	516	10	example	example	NOUN
bptjm-30	516	11	of	of	ADP
bptjm-30	516	12	a	a	DET
bptjm-30	516	13	popular	popular	ADJ
bptjm-30	516	14	,	,	PUNCT
bptjm-30	516	15	effective	effective	ADJ
bptjm-30	516	16	psychedelic	psychedelic	ADJ
bptjm-30	516	17	-	-	PUNCT
bptjm-30	516	18	related	relate	VERB
bptjm-30	516	19	drug	drug	NOUN
bptjm-30	516	20	–	–	PUNCT
bptjm-30	516	21	psilocybin	psilocybin	NOUN
bptjm-30	516	22	.	.	PUNCT
bptjm-30	517	1	other	other	ADJ
bptjm-30	517	2	drugs	drug	NOUN
bptjm-30	517	3	of	of	ADP
bptjm-30	517	4	similar	similar	ADJ
bptjm-30	517	5	properties	property	NOUN
bptjm-30	517	6	will	will	AUX
bptjm-30	517	7	be	be	AUX
bptjm-30	517	8	discussed	discuss	VERB
bptjm-30	517	9	in	in	ADP
bptjm-30	517	10	this	this	DET
bptjm-30	517	11	section	section	NOUN
bptjm-30	517	12	.	.	PUNCT
bptjm-30	518	1	ayahuasca	ayahuasca	PROPN
bptjm-30	518	2	is	be	AUX
bptjm-30	518	3	a	a	DET
bptjm-30	518	4	psychoactive	psychoactive	ADJ
bptjm-30	518	5	drink	drink	NOUN
bptjm-30	518	6	shown	show	VERB
bptjm-30	518	7	to	to	PART
bptjm-30	518	8	have	have	VERB
bptjm-30	518	9	medicinal	medicinal	ADJ
bptjm-30	518	10	potential	potential	NOUN
bptjm-30	518	11	in	in	ADP
bptjm-30	518	12	treating	treat	VERB
bptjm-30	518	13	psycholo	psycholo	NOUN
bptjm-30	518	14	...	...	PUNCT
bptjm-30	518	15	5.5	5.5	NUM
bptjm-30	518	16	.	.	PUNCT
bptjm-30	519	1	hormonal	hormonal	ADJ
bptjm-30	519	2	treatment	treatment	NOUN
bptjm-30	519	3	6	6	NUM
bptjm-30	519	4	.	.	PUNCT
bptjm-30	519	5	practical	practical	ADJ
bptjm-30	519	6	considerations	consideration	NOUN
bptjm-30	519	7	7	7	NUM
bptjm-30	519	8	.	.	PUNCT
bptjm-30	519	9	future	future	ADJ
bptjm-30	519	10	directions	direction	NOUN
bptjm-30	519	11	8	8	NUM
bptjm-30	519	12	.	.	PUNCT
bptjm-30	519	13	conclusion	conclusion	NOUN
bptjm-30	519	14	references_sharma	references_sharma	PROPN
bptjm-30	519	15	et	et	X
bptjm-30	519	16	.	.	PUNCT
bptjm-30	520	1	al	al	PROPN
bptjm-30	520	2	.	.	PUNCT